
<html lang="en"     class="pb-page"  data-request-id="4365a421-b26a-4045-94c7-58db2012c659"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2020.63.issue-14;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.9b01733;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Dihydropyrrolo[1,2-a]pyrazin-3(4H)-one-Based Second-Generation GluN2C- and GluN2D-Selective Positive Allosteric Modulators (PAMs) of the N-Methyl-d-Aspartate (NMDA) Receptor" /></meta><meta name="dc.Creator" content="Matthew P.  Epplin" /></meta><meta name="dc.Creator" content="Ayush  Mohan" /></meta><meta name="dc.Creator" content="Lynnea D.  Harris" /></meta><meta name="dc.Creator" content="Zongjian  Zhu" /></meta><meta name="dc.Creator" content="Katie L.  Strong" /></meta><meta name="dc.Creator" content="John  Bacsa" /></meta><meta name="dc.Creator" content="Phuong  Le" /></meta><meta name="dc.Creator" content="David S.  Menaldino" /></meta><meta name="dc.Creator" content="Stephen F.  Traynelis" /></meta><meta name="dc.Creator" content="Dennis C.  Liotta" /></meta><meta name="dc.Description" content="The N-methyl-d-aspartate receptor (NMDAR) is an ion channel that mediates the slow, Ca2+-permeable component of glutamatergic synaptic transmission in the central nervous system (CNS). NMDARs are k..." /></meta><meta name="Description" content="The N-methyl-d-aspartate receptor (NMDAR) is an ion channel that mediates the slow, Ca2+-permeable component of glutamatergic synaptic transmission in the central nervous system (CNS). NMDARs are k..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 15, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01733" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01733" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01733" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01733" /></link>
        
    
    

<title>Discovery of Dihydropyrrolo[1,2-a]pyrazin-3(4H)-one-Based Second-Generation GluN2C- and GluN2D-Selective Positive Allosteric Modulators (PAMs) of the N-Methyl-d-Aspartate (NMDA) Receptor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01733" /></meta><meta property="og:title" content="Discovery of Dihydropyrrolo[1,2-a]pyrazin-3(4H)-one-Based Second-Generation GluN2C- and GluN2D-Selective Positive Allosteric Modulators (PAMs) of the N-Methyl-d-Aspartate (NMDA) Receptor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0020.jpeg" /></meta><meta property="og:description" content="The N-methyl-d-aspartate receptor (NMDAR) is an ion channel that mediates the slow, Ca2+-permeable component of glutamatergic synaptic transmission in the central nervous system (CNS). NMDARs are known to play a significant role in basic neurological functions, and their dysfunction has been implicated in several CNS disorders. Herein, we report the discovery of second-generation GluN2C/D-selective NMDAR-positive allosteric modulators (PAMs) with a dihydropyrrolo[1,2-a]pyrazin-3(4H)-one core. The prototype, R-(+)-EU-1180-453, exhibits log unit improvements in the concentration needed to double receptor response, lipophilic efficiency, and aqueous solubility, and lowers cLogP by one log unit compared to the first-generation prototype CIQ. Additionally, R-(+)-EU-1180-453 was found to increase glutamate potency 2-fold, increase the response to maximally effective concentration of agonist 4-fold, and the racemate is brain-penetrant. These compounds are useful second-generation in vitro tools and a promising step toward in vivo tools for the study of positive modulation of GluN2C- and GluN2D-containing NMDA receptors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01733"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01733">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01733&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01733&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01733&amp;href=/doi/10.1021/acs.jmedchem.9b01733" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 7569-7600</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00403" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00418" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Dihydropyrrolo[1,2-<i>a</i>]pyrazin-3(4<i>H</i>)-one-Based Second-Generation GluN2C- and GluN2D-Selective Positive Allosteric Modulators (PAMs) of the <i>N</i>-Methyl-<span class="smallcaps smallerCapital">d</span>-Aspartate (NMDA) Receptor</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Matthew P. Epplin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthew P. Epplin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+P.++Epplin">Matthew P. Epplin</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1121-3701" title="Orcid link">http://orcid.org/0000-0002-1121-3701</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Ayush Mohan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ayush Mohan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ayush++Mohan">Ayush Mohan</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Lynnea D. Harris</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lynnea D. Harris</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lynnea+D.++Harris">Lynnea D. Harris</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Zongjian Zhu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zongjian Zhu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Chemical Biology, Emory University, 1510 Clifton Road, Atlanta, Georgia 30322, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zongjian++Zhu">Zongjian Zhu</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Katie L. Strong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Katie L. Strong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Katie+L.++Strong">Katie L. Strong</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">John Bacsa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John Bacsa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John++Bacsa">John Bacsa</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5681-4458" title="Orcid link">http://orcid.org/0000-0001-5681-4458</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Phuong Le</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Phuong Le</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Chemical Biology, Emory University, 1510 Clifton Road, Atlanta, Georgia 30322, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Phuong++Le">Phuong Le</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">David S. Menaldino</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David S. Menaldino</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+S.++Menaldino">David S. Menaldino</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Stephen F. Traynelis</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephen F. Traynelis</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Chemical Biology, Emory University, 1510 Clifton Road, Atlanta, Georgia 30322, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#85f6f1f7e4fcebe0c5e0e8eaf7fcabe0e1f0"><span class="__cf_email__" data-cfemail="c5b6b1b7a4bcaba085a0a8aab7bceba0a1b0">[emailÂ protected]</span></a>. Tel.: 404-727-0357.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+F.++Traynelis">Stephen F. Traynelis</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3750-9615" title="Orcid link">http://orcid.org/0000-0002-3750-9615</a></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Dennis C. Liotta</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dennis C. Liotta</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#fe9a9297918a8a9fbe9b93918c87d09b9a8b"><span class="__cf_email__" data-cfemail="7e1a1217110a0a1f3e1b13110c07501b1a0b">[emailÂ protected]</span></a>. Tel.: 404-727-6602.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dennis+C.++Liotta">Dennis C. Liotta</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7736-7113" title="Orcid link">http://orcid.org/0000-0002-7736-7113</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01733&amp;href=/doi/10.1021%2Facs.jmedchem.9b01733" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 7569â7600</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 15, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 March 2020</li><li><span class="item_label"><b>Published</b> online</span>15 June 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 July 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01733" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01733</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7569%26pageCount%3D32%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMatthew%2BP.%2BEpplin%252C%2BAyush%2BMohan%252C%2BLynnea%2BD.%2BHarris%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D14%26contentID%3Dacs.jmedchem.9b01733%26title%3DDiscovery%2Bof%2BDihydropyrrolo%255B1%252C2-a%255Dpyrazin-3%25284H%2529-one-Based%2BSecond-Generation%2BGluN2C-%2Band%2BGluN2D-Selective%2BPositive%2BAllosteric%2BModulators%2B%2528PAMs%2529%2Bof%2Bthe%2BN-Methyl-d-Aspartate%2B%2528NMDA%2529%2BReceptor%26numPages%3D32%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7600%26publicationDate%3DJuly%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01733"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1253</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">1</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01733" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Dihydropyrrolo[1,2-a]pyrazin-3(4H)-one-Based Second-Generation GluN2C- and GluN2D-Selective Positive Allosteric Modulators (PAMs) of the N-Methyl-d-Aspartate (NMDA) Receptor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;P. Epplin&quot;},{&quot;first_name&quot;:&quot;Ayush&quot;,&quot;last_name&quot;:&quot;Mohan&quot;},{&quot;first_name&quot;:&quot;Lynnea&quot;,&quot;last_name&quot;:&quot;D. Harris&quot;},{&quot;first_name&quot;:&quot;Zongjian&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Katie&quot;,&quot;last_name&quot;:&quot;L. Strong&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Bacsa&quot;},{&quot;first_name&quot;:&quot;Phuong&quot;,&quot;last_name&quot;:&quot;Le&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;S. Menaldino&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;F. Traynelis&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;C. Liotta&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;7569-7600&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01733&quot;},&quot;abstract&quot;:&quot;The N-methyl-d-aspartate receptor (NMDAR) is an ion channel that mediates the slow, Ca2+-permeable component of glutamatergic synaptic transmission in the central nervous system (CNS). NMDARs are known to play a significant role in basic neurological functions, and their dysfunction has been implicated in several CNS disorders. Herein, we report the discovery of second-generation GluN2C/D-selective NMDAR-positive allosteric modulators (PAMs) with a dihydropyrrolo[1,2-a]pyrazin-3(4H)-one core. The prototype, R-(+)-EU-1180-453, exhibits log unit improvements in the concentration needed to double receptor response, lipophilic efficiency, and aqueous solubility, and lowers cLogP by one log unit compared to the first-generation prototype CIQ. Additionally, R-(+)-EU-1180-453 was found to increase glutamate potency 2-fold, increase the response to maximally effective concentration of agonist 4-fold, and the racemate is brain-penetrant. These compounds are useful second-generation in vitro tools and a promising step &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01733&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01733" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01733&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01733" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01733&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01733" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01733&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01733&amp;href=/doi/10.1021/acs.jmedchem.9b01733" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01733" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01733" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01733%26sid%3Dliteratum%253Aachs%26pmid%3D32538088%26genre%3Darticle%26aulast%3DEpplin%26date%3D2020%26atitle%3DDiscovery%2Bof%2BDihydropyrrolo%255B1%252C2-a%255Dpyrazin-3%25284H%2529-one-Based%2BSecond-Generation%2BGluN2C-%2Band%2BGluN2D-Selective%2BPositive%2BAllosteric%2BModulators%2B%2528PAMs%2529%2Bof%2Bthe%2BN-Methyl-d-Aspartate%2B%2528NMDA%2529%2BReceptor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D14%26spage%3D7569%26epage%3D7600%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=290888" title="Liquid liquid equilibrium">Liquid liquid equilibrium</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/jmcmar.2020.63.issue-14/20200723/jmcmar.2020.63.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01733&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor (NMDAR) is an ion channel that mediates the slow, Ca<sup>2+</sup>-permeable component of glutamatergic synaptic transmission in the central nervous system (CNS). NMDARs are known to play a significant role in basic neurological functions, and their dysfunction has been implicated in several CNS disorders. Herein, we report the discovery of second-generation GluN2C/D-selective NMDAR-positive allosteric modulators (PAMs) with a dihydropyrrolo[1,2-<i>a</i>]pyrazin-3(4<i>H</i>)-one core. The prototype, <i><b>R</b></i><b>-(+)-EU-1180-453</b>, exhibits log unit improvements in the concentration needed to double receptor response, lipophilic efficiency, and aqueous solubility, and lowers cLogP by one log unit compared to the first-generation prototype <b>CIQ</b>. Additionally, <i><b>R</b></i><b>-(+)-EU-1180-453</b> was found to increase glutamate potency 2-fold, increase the response to maximally effective concentration of agonist 4-fold, and the racemate is brain-penetrant. These compounds are useful second-generation <i>in vitro</i> tools and a promising step toward <i>in vivo</i> tools for the study of positive modulation of GluN2C- and GluN2D-containing NMDA receptors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52648" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52648" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor (NMDAR) belongs to the family of mammalian ligand-gated excitatory ionotropic glutamate receptors (iGluRs) that includes 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl)propanoic acid receptors (AMPARs) and (2<i>S</i>,3<i>S</i>,4<i>S</i>)-3-(carboxymethyl)-4-prop-1-en-2-ylpyrrolidine-2-carboxylic acid (kainate) receptors.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> NMDARs are known to play a role in learning,<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> memory,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> brain development,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and synaptic plasticity<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> and have been implicated in numerous neurological conditions including schizophrenia,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> Alzheimerâs disease,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Parkinsonâs disease,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Huntingtonâs chorea,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> epilepsy,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> neuropathic pain,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> ischemic brain injury,<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15â17)</a> and depression.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> This has driven interest in the development of both positive and negative modulators of the NMDAR for potential therapeutic gain.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a></div><div class="NLM_p">Structurally, NMDARs are heterotetrameric assemblies of two GluN1 and two GluN2 protein subunits, which bind co-agonists glycine and glutamate, respectively. Each subunit contains four semiautonomous domains: an amino terminal domain (ATD), an agonist-binding domain (ABD), a transmembrane domain (TMD), and a carboxyl terminal domain (CTD).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Upon co-agonist binding at the ABD, membrane depolarization occurs, which removes Mg<sup>2+</sup> block<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> from the pore. This allows Ca<sup>2+</sup> and Na<sup>+</sup> ions to flow into the cell, which contribute to postsynaptic signal transmission.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The four isoforms of the GluN2 subunit (GluN2A-D) are expressed with different spatiotemporal patterns in the brain<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25â27)</a> and endow the receptor with unique pharmacological properties including open probability,<a onclick="showRef(event, 'ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30 ref31">(28â31)</a> agonist potency,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and deactivation time.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> For example, GluN2C- and GluN2D-containing NMDA receptors are expressed more prominently in the cerebellum, basal ganglia, thalamus, and cortical and hippocampal interneurons,<a onclick="showRef(event, 'ref25 ref26 ref34'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref34">(25,26,34)</a> compared to GluN2A- and GluN2B-containing receptors. Functionally, GluN2C/GluN2D-containing NMDA receptors show increased glutamate and glycine sensitivity<a onclick="showRef(event, 'ref32 ref35'); return false;" href="javascript:void(0);" class="ref ref32 ref35">(32,35)</a> and reduced open probability,<a onclick="showRef(event, 'ref29 ref30 ref36'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref36">(29,30,36)</a> Mg<sup>2+</sup> sensitivity,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Ca<sup>2+</sup> permeability, and single-channel conductance compared to GluN2A/GluN2B-containing receptors.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p">Because these subunit-specific expression patterns and GluN2-specific functional properties allow NMDARs to serve unique roles at different synapses, subunit-selective modulators provide an opportunity to target the aforementioned diseases through selective modification of specific circuits.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> However, FDA-approved drugs that target NMDARs nonselectively block the highly conserved NMDAR pore, irrespective of subunit composition. This results in the inhibition of all NMDAR subtypes, potentially leading to the neurological side effects that include altered cardiovascular activity, hallucinations, delusions, and impaired motor function.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p">Subunit-selective NMDAR modulators have therefore become a focus of the research community, given their potential to reduce side effects by targeting one subunit in specific areas of the brain for therapeutic gain. Specifically, NMDAR-positive allosteric modulators (PAMs) could be useful in conditions associated with reduced NMDAR activity such as schizophrenia,<a onclick="showRef(event, 'ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42">(40â42)</a> autism spectrum disorders,<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43,44)</a> anti-NMDAR encephalitis,<a onclick="showRef(event, 'ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47">(45â47)</a> and age-related memory loss.<a onclick="showRef(event, 'ref2 ref38 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref2 ref38 ref48 ref49">(2,38,48,49)</a> Further, there is evidence suggesting that positive therapeutic outcomes could be achieved with the development of GluN2C- and/or GluN2D-subtype-selective PAMs. One hypothesis is that the hypofunction of GluN2C-containing receptors plays a role in schizophrenic symptoms<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> and, thus, GluN2C-selective PAMs could have therapeutically relevant actions. Additionally, postmortem examinations of schizophrenic patients with a specific <i>NRG1</i> gene polymorphism revealed reduced GluN2C expression in the right cerebellum.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> GluN2D-containing receptors may also play a role in schizophrenia.<a onclick="showRef(event, 'ref51 ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53 ref54">(51â54)</a> For example, there is evidence to suggest that decreased inhibitory drive can lead to hyperactivity of principal cells and enhanced dopamine release.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Expression of GluN2D in interneurons<a onclick="showRef(event, 'ref25 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref25 ref56 ref57">(25,56,57)</a> suggests that selective enhancement of GluN2D-containing receptor function could potentially rectify this hypothesized circuit imbalance. Finally, (3-chlorophenyl)(6,7-dimethoxy-1-((4-methoxyphenoxy)methyl)-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)methanone (<b>CIQ</b>, <b>1</b>), a GluN2C/D-selective PAM previously developed in our lab (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>),<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58,59)</a> has shown promising results in behavioral mouse models. This includes the ability to recover striatal synaptic plasticity deficit in a Parkinsonâs model,<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> facilitate the retention of fear and extinction learning,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> and prevent MK-801 (a noncompetitive antagonist of NMDARs)-induced prepulse inhibition deficit,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> suggesting the clinical potential of potent positive modulators of these subtypes.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. PAMs of the NMDAR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01733&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">There have been numerous other nonselective and subunit-selective NMDAR PAMs identified in addition to <b>CIQ</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). For example, we have previously identified a GluN2B-preferring class of isopropoxy-substituted tetrahydroisoquinolines (TIQs) based on <b>CIQ</b> (prototype compound <b>2</b>).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Wang et al. published GNE-9278 (<b>3</b>), a nonselective benzenesulfonamide-based PAM that acts on each of the GluN1/GluN2 subtypes in the low micromolar (3â16 Î¼M) range.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Structural determinants suggest a possible binding site near the GluN1 pre-M1 helix, and it was shown to potentiate the receptor by increasing co-agonist affinity, increasing receptor response at saturating co-agonist concentrations, and slowing deactivation after glutamate removal. Other nonselective PAMs include the neurosteroid pregnenolone sulfate (PS, <b>4</b>)<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> and 24(<i>S</i>)-hydroxycholesterol (<b>5</b>).<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Genentech also published a GluN2A-selective series of thiazole derivatives that bind in a similar pocket to the <i>N</i>-(4-(2-benzoylhydrazine-1-carbonyl)benzyl)-3-chloro-4-fluorobenzenesulfonamide (TCN) class of negative allosteric modulators (NAMs). These compounds potentiate via stabilization of the agonist-bound state.<a onclick="showRef(event, 'ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref67 ref68">(67,68)</a> Significant optimization resulted in GNE-5729 (<b>6</b>), a PAM of GluN2A-containing receptors (EC<sub>50</sub> = 37 nM) showing improved AMPAR selectivity and unbound clearance and an excellent secondary pharmacology profile.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> The only known series of compounds able to distinguish between GluN2C- and GluN2D-containing receptors are the pyrrolidinone-based (prototype PYD-106 (<b>7</b>)) GluN2C-selective PAMs.<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70,71)</a> These compounds appear to increase mean open time and open probability via actions on the ATD and S1 domains.</div><div class="NLM_p">Although <b>CIQ</b> has made a significant impact as a first-in-class tool compound, it exhibits several liabilities limiting its use both <i>in vitro</i> and <i>in vivo</i>. These include modest potency, modest potentiation, low aqueous solubility, and high lipophilicity.<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58,59)</a> Herein, we report the discovery of second-generation dihydropyrrolo[1,2-<i>a</i>]pyrazin-3(4<i>H</i>)-one-based GluN2C/D-selective PAMs that are the result of successive core changes from <b>CIQ</b>. First, we modified the TIQ scaffold to a 1,4-dihydroisoquinolin-3(2<i>H</i>)-one core (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, left), which resulted in improved concentrations needed to double receptor response (doubling concentration, 0.5 log unit improvement on average) and lipophilic ligand efficiency (LLE, defined here as LLE = âlog<sub>10</sub>(doubling conc.) â cLogP, 0.4 log unit improvement on average). We have chosen to report the doubling concentration alongside the EC<sub>50</sub> throughout this manuscript as it captures both the potency and potentiation contributions of a PAMâs biological activity in one directly comparable number. Since it considers both contributions, we believe it to be more useful than EC<sub>50</sub> in describing the biological activity of these PAMs, as the EC<sub>50</sub> describes only the potency without information on maximal achievable response. We have also chosen to define LLE using the doubling concentration (compared to the standard definition using EC<sub>50</sub>) due to its increased relevance. Finally, we have chosen 2-fold as the cutoff for several reasons: (1) it is currently unknown what percent potentiation of GluN2C/D-containing receptors will lead to pharmacologically relevant actions, (2) this percent potentiation was achieved by most compounds studied, (3) it is a convenient and memorable cutoff, and (4) to be consistent with previous reports.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Building on this core modification resulted in a dihydropyrrolo[1,2-<i>a</i>]pyrazin-3(4<i>H</i>)-one series (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, right), with derivatives showing roughly log unit improvements in doubling concentration, aqueous solubility, and LLE, and a log unit decrease in cLogP compared to <b>CIQ</b>. The selectivity for GluN2C and GluN2D is maintained at subsaturating concentrations of co-agonists for both new cores. The enantiomers of promising derivatives were separated via chiral high-performance liquid chromatography (HPLC) and show stereo-dependent activity, with one enantiomer inactive against all examined NMDAR subtypes. The active enantiomers exhibit improved potency over the racemic mixture in each case. Finally, a crystal structure was solved for prototypical compound <i><b>R</b></i><b>-(+)-EU-1180-453</b> that allowed for assignment of the absolute configuration of the active enantiomers. Therefore, the improvements in activity and physicochemical properties observed in these two new structural modifications compared to the parent <b>CIQ</b> have created improved <i>in vitro</i> tool compounds for GluN2C- and GluN2D-containing NMDA receptors.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Labeled 1,4-dihydroisoquinolin-3(2<i>H</i>)-one (left) and dihydropyrrolo[1,2-<i>a</i>]pyrazin-3(4<i>H</i>)-one (right) to distinguish between the A-, B-, and C-rings.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01733&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15574" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15574" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Two-Electrode Voltage Clamp (TEVC) Recordings</h3><div class="NLM_p">All compounds synthesized were evaluated via TEVC recordings of <i>Xenopus laevis</i> oocytes expressing four recombinant NMDAR subtypes: GluN1/GluN2A, GluN1/GluN2B, GluN1/GluN2C, and GluN1/GluN2D. Each compound was co-applied at 30 Î¼M with saturating concentrations of glutamate (100 Î¼M) and glycine (30 Î¼M). When the mean potentiated response exceeded 130% of control, concentrationâeffect curves were generated by co-applying increasing concentrations of compound with saturating co-agonists. We determined the pEC<sub>50</sub> value and maximal degree of potentiation by fitting the concentrationâeffect curves with <a class="ref internalNav" href="#eq1" aria-label="eqs 1">eqs 1</a> and <a class="ref internalNav" href="#eq2" aria-label="2">2</a> (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Procedures">Experimental Procedures</a>). Each concentrationâeffect curve was generated with data from 6â19 oocytes from 2â3 frogs; all inactive compounds were tested in 4â10 oocytes from 1 to 2 frogs. <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>â<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> summarize the mean pEC<sub>50</sub> value with 95% confidence interval and average maximum potentiation (max) for each active compound at GluN1/GluN2C and GluN1/GluN2D receptors. The negative log of the doubling concentration (<a class="ref internalNav" href="#eq3" aria-label="eqs 3">eqs 3</a> and <a class="ref internalNav" href="#eq4" aria-label="4">4</a>; see <a class="ref internalNav" href="#sec4" aria-label="Experimental Procedures">Experimental Procedures</a>), aqueous solubility (see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_001.pdf" class="ext-link">Supporting Information</a> for Methods), and LLE (<a class="ref internalNav" href="#eq5" aria-label="eq 5">eq 5</a>; see <a class="ref internalNav" href="#sec4" aria-label="Experimental Procedures">Experimental Procedures</a>) are also reported when appropriate. <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> compares the doubling concentration of select compounds reported here to previously reported compounds. For compounds in which a pEC<sub>50</sub> value was not determined (ND), the maximum potentiation is reported as the average potentiation at 30 Î¼M drug as a percent of control. The average percent potentiation is defined as the mean ratio of current upon application of drug at the stated concentration to the current response in its absence. The doubling concentration is defined as the concentration of test compound at which the response to maximally effective concentration of co-applied glutamate and glycine is increased 2-fold over the response to glutamate and glycine alone. All compounds were also tested at GluN1/GluN2A and GluN1/GluN2B receptors at 10 or 30 Î¼M and were typically found to have no effect (4â17 oocytes from 1 to 3 frogs). Only two compounds (<b>12c</b>â<b>d</b>) exhibited potentiation above 130% at GluN2A- or GluN2B-containing receptors and neither exceeded 2-fold potentiation (Supporting Information <a href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_001.pdf" class="ext-link">Table S1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. 1,4-Dihydroisoquinolin-3(2<i>H</i>)-one Compounds and TIQ Counterparts</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0008.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0009.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Fitted pEC<sub>50</sub> values are shown to two significant figures when potentiation at 30 Î¼M exceeded 130% of control; values in brackets are the 95% confidence interval for the corresponding fitted pEC<sub>50</sub> mean value; and values in parentheses are the fitted maximum response as a percentage of the initial glutamate (100 Î¼M) and glycine (30 Î¼M) current. Data are between 8 and 19 oocytes from 2 to 3 frogs for each compound and receptor.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last"><i>p</i>(doubling conc.) is the negative log of the doubling concentration.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Previously published<a onclick="showRef(event, 'ref59 ref63'); return false;" href="javascript:void(0);" class="ref ref59 ref63">(59,63)</a> data for compounds <b>CIQ</b>, <b>117</b>, <b>2*</b>, <b>88</b>, <b>127</b>, and <b>114</b> were included for comparison. The numbering corresponds to the compoundâs numbering in its respective publication.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Compound <b>2*</b> is compound <b>2</b> from Santangelo et al.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></p></div></div><div></div></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Design of NMDAR Potentiators</h3><div class="NLM_p">Previous computational studies on a <b>CIQ</b> analogue suggested that potency could be improved if the A-ring could be directed to adopt an s<i>-trans</i> conformation within the binding site, with s-<i>cis</i>/s-<i>trans</i> defined by the orientation of the amide carbonyl with respect to the stereocenter.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> To investigate this hypothesis, a novel 1,4-dihydroisoquinolin-3(2<i>H</i>)-one scaffold was designed and synthesized (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<named-content content-type="anchor" rid="fig3" type="simple"></named-content> We predicted that translocation of the amide carbonyl of <b>CIQ</b> into the TIQ ring would provide enough steric influence to favor the s-<i>trans</i> conformation and therefore increase the fraction of drug in the predicted more active pose (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). This phenomenon can be visualized via a crystal structure of prototype <i><b>R</b></i><b>-(+)-EU-1180-453</b>. The crystallographic data and methods can be viewed in <a href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_001.pdf" class="ext-link">Table S2</a> and the Crystal Structure Methods portion of the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_001.pdf" class="ext-link">Supporting Information</a>, respectively.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Model of the steric encumbrance upon translocation of the carbonyl in the 1,4-dihydroisoquinolin-3(2<i>H</i>)-one series. The s-cis conformation was hypothesized to create steric clash between the carbonyl and A-ring, creating preference for the more active s-trans conformation (left). This is visualized on this scaffold through a crystal structure of <b><i>R</i>-(+)-EU-1180-453</b> (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01733&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Dihydroisoquinolinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01733&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) chloroacetyl chloride, SnCl<sub>4</sub>, 1,2-dichloroethane (DCE), reflux, 90 min; (b) 4-methoxyphenol, KI, K<sub>2</sub>CO<sub>3</sub>, reflux, 4 h; (c) substituted primary amines, Ti(O<i>i</i>Pr)<sub>4</sub>, NaBH(OAc)<sub>3</sub>, DCE, 120 Â°C, mw, 20 min; (d) (i) PtO<sub>2</sub>, H<sub>2</sub> (balloon), EtOH, rt, 10 h, (ii) Pd/C, H<sub>2</sub> (50 psi), EtOH, rt, 24 h; (e) NaN<sub>3</sub>, CH<sub>2</sub>O (37% in H<sub>2</sub>O), AcOH, cat. sodium ascorbate, cat. CuSO<sub>4</sub>, tetrahydrofuran (THF), rt, 24 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Chemistry</h3><div class="NLM_p">The synthesis of 1,4-dihydroisoquinolin-3(2<i>H</i>)-one analogues is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Methyl esters <b>8a</b> and <b>8b</b> were prepared according to modified literature procedures,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> while all other similar intermediates were commercially available. Î±-Chloro ketones <b>9aâd</b> were prepared via FriedelâCrafts acylation of the appropriate methyl esters with chloroacetyl chloride and tin(IV) chloride. The resulting Î±-chloroamide was then reacted with 4-methoxyphenol and potassium iodide to give ketones <b>10aâd</b>, which were then cyclized in a microwave reactor using the appropriate amine, titanium(IV) isopropoxide, and sodium triacetoxyborohydride to afford the penultimate eneamide intermediates <b>11aân</b> as inconsequential mixtures of their <i>E</i> and <i>Z</i> isomers. Each eneamide could then either be reduced via hydrogenation at 50 psi using palladium on carbon or in cases with aryl chlorides, hydrogenated with platinum oxide at 1 atm to give the final 1,4-dihydroisoquinolin-3(2<i>H</i>)-one compounds (<b>12aâm</b>).</div><div class="NLM_p">The procedure for the synthesis of B-ring derivatives is outlined in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. The synthesis began with commercially available 3,4-dimethoxyphenethylamine (<b>13</b>), which was acylated with chloroacetyl chloride to give Î±-chloroamide <b>14</b>. This was then reacted with sodium hydride and 4-methoxyphenol to give Î±-hydroxy amides <b>15aâd</b>. Intermediates <b>15a</b> and <b>15d</b> were then cyclized to their respective imine intermediate using modified BischlerâNapieralski conditions and subsequently reduced via sodium borohydride or hydrogenation to yield their respective TIQ amines (<b>16a</b> in the case of <b>15a</b>). These TIQ amines were then acylated using the appropriate benzoyl chloride, deprotected to their respective primary alcohols <b>17aâb</b>, and further functionalized using coupling or S<sub>N</sub>Ar conditions to produce the final compounds (<b>18aâc</b>). Alternatively, in the case where the final B-ring substitution was installed in step (b), such as with <b>15bâc</b>, the respective secondary amine (<b>16bâc</b>) obtained via the BischlerâNapieralski cyclization was directly acylated with 3-(trifluoromethyl)benzoyl chloride to give the final compounds (<b>18dâe</b>).</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of B-Ring Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01733&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) chloroacetyl chloride, Et<sub>3</sub>N, dichloromethane (DCM), 0 Â°C, 30 min; (b) R<sub>1</sub>OH, NaH or Cs<sub>2</sub>CO<sub>3</sub>; (c) POCl<sub>3</sub>, ACN, reflux then NaBH<sub>4</sub>, MeOH, 0 Â°C, 10 min; (d) substituted benzoyl chloride, Et<sub>3</sub>N, DCM, rt, 1 h; (e) Pd/C, H<sub>2</sub> (50 psi), MeOH, o/n; (f) methane sulfonic acid, DCM, rt, 6 h; (g) heteroaryl fluoride, NaH, THF, reflux, o/n, (ii) heteroaryl iodide, 1,10-Phen, CuI, Cs<sub>2</sub>CO<sub>3</sub>, PhMe, 80 Â°C, o/n.</p></p></figure><div class="NLM_p">Heterocyclic derivatives of the C-ring were synthesized utilizing a modified synthesis of <b>CIQ</b><a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> described in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Ethylamine starting materials <b>21aâe</b> were synthesized from the corresponding aldehyde via a Henry-type nitroalkenylation and subsequent reduction via <i>in situ</i> generated alane (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, step a and step b). 2-Methoxy-5-formylthiophene was synthesized according to the literature.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> The remaining synthesis proceeded as described with only slight modifications.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Heterocyclic C-Rings<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01733&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) cat. butylamine, cat. AcOH, 4 Ã MS, MeNO<sub>2</sub>, reflux, 30 min; (b) LiAlH<sub>4</sub>/H<sub>2</sub>SO<sub>4</sub>, THF, 0 Â°C to reflux, 5 min; (c) chloroacetyl chloride, Et<sub>3</sub>N, DCM, 0 Â°C, 30 min; (d) 4-methoxyphenol, Cs<sub>2</sub>CO<sub>3</sub>, o/n, 79â93%; (e) POCl<sub>3</sub>, ACN, reflux, o/n then NaBH<sub>4</sub>, MeOH, 0 Â°C, 10 min; (f) (i) acid chloride, Et<sub>3</sub>N, DCM, rt, 1 h, (ii) carboxylic acid, EDCI, 4-dimethylaminopyridine (DMAP), rt, o/n; (g) Lawessonâs reagent, PhMe, 150 Â°C, mw, 2 h.</p></p></figure><div class="NLM_p">Finally, pyrrolopyrazinone derivatives were synthesized as described in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. This synthesis is a modified version of the synthesis described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, where the pyrrole starting material was made through the ClausonâKaas reaction starting with glycine methyl ester hydrochloride.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Pyrrolopyrazinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01733&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2,5-dimethoxytetrahydrofuran, NaOAc, 2:1 v/v AcOH:water, reflux, 4 h; (b) chloroacetyl chloride, DBN, PhMe, 115 Â°C, 4 h; (c) 4-methoxyphenol, KI, K<sub>2</sub>CO<sub>3</sub>, acetone, rt, o/n; (d) substituted primary amines, Ti(O<i>i</i>Pr)<sub>4</sub>, sodium triacetoxyborohydride (STAB), DCE, 120 Â°C, mw, 2 h; (e) Pd/C, H<sub>2</sub> (1 atm), EtOAc, rt, o/n; (f) Lawessonâs reagent, PhMe, 150 Â°C, mw, 2 h.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> 1,4-Dihydroisoquinolin-3(2<i>H</i>)-one Compounds Show Improved Doubling Concentrations Over TIQ Counterparts</h3><div class="NLM_p">As predicted, compound <b>12m</b> showed improved potentiation (270â340%) of GluN2C/D-containing NMDAR responses to saturating co-agonists compared to <b>CIQ</b> (220â230%) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Compound <b>12m</b> also exhibited similar potency (pEC<sub>50</sub> = 5.0â5.3 at GluN2C/D) and subunit selectivity (no activity at GluN2A/B) to <b>CIQ</b>, resulting in improved doubling concentrations (<i>p</i>(doubling conc.) = 5.1). Selectivity for GluN2C and GluN2D was also maintained upon application of <b>12m</b> and subsaturating levels of co-agonists glutamate and glycine (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_001.pdf" class="ext-link">Table S3</a>). Based on this promising result, we designed and synthesized a targeted library of dihydroisoquinolinones to demonstrate that this trend is maintained irrespective of substitution.</div><div class="NLM_p">We calculated the doubling concentration using <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a> for all synthesized 1,4-dihydroisoquinolin-3(2<i>H</i>)-ones with corresponding TIQs<a onclick="showRef(event, 'ref59 ref63'); return false;" href="javascript:void(0);" class="ref ref59 ref63">(59,63)</a> to demonstrate the trend of improved activity for 1,4-dihydroisoquinolin-3(2<i>H</i>)-one analogues (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The doubling concentration at GluN2C or GluN2D was improved in the 1,4-dihydroisoquinolin-3(2<i>H</i>)-one scaffold in 92% (11/12) of cases. The only case in which it decreased (compare <b>12d</b> and <b>88</b> at GluN2C) resulted in only a 0.2 log unit drop. The average doubling concentration improvement was 0.5 log units, which led to a 0.4 log unit improvement in LLE due to the similar cLogP values of the isomeric scaffolds. These data demonstrate the ability of the 1,4-dihydroisoquinolin-3(2<i>H</i>)-one core to improve activity over the TIQ core.</div><div class="NLM_p last">The modification to a dihydroisoquinolinone core improved doubling concentrations substantially over the previous TIQ series; however, there were still opportunities to improve the physicochemical properties of the series (e.g., its high lipophilicity). Prototypical compounds (e.g., <b>CIQ</b>, <b>12m</b>, etc.) exhibited cLogP values near 6 (and >8 for the most potent analogues) and aqueous solubilities in the single-digit micromolar range (<10 Î¼M for <b>CIQ</b>). The highly lipophilic nature of <b>CIQ</b> is also likely the cause of its low free fraction that limits its concentration and receptor occupancy <i>in vivo</i>,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> making optimization of this property vital in medicinal chemistry efforts. Highly lipophilic compounds also typically exhibit liabilities including high clearance,<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73,74)</a> low membrane permeability,<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> and low oral bioavailability.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> There have been scattered previous attempts at decreasing the lipophilicity of the series,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> but in nearly each case, this led to a substantial or complete loss in potency. With this goal in mind, we developed a series of hydrophilic-focused changes to the three phenyl rings of <b>CIQ</b>, which resulted in the discovery of a brain-penetrant pyrrolopyrazinone-based scaffold with dramatically improved lipophilic efficiency for GluN2C- and GluN2D-containing NMDARs. Prototypical compounds also display an approximate order of magnitude improvement in aqueous solubility, a relatively clean off-target profile, and improved ease of analysis due to elimination of rotamers observed with <b>CIQ</b>. From this point forward, we assume that the structureâactivity relationship (SAR) from the TIQ series is transferrable to the dihydroisoquinolinone series. A subset of analogues is provided to demonstrate the ability to extrapolate between scaffolds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_001.pdf" class="ext-link">Table S4</a>).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Evaluation of A-Ring Replacements</h3><div class="NLM_p">First, we explored replacements of the A-ring on the dihydroisoquinolinone scaffold aimed at lowering cLogP using the synthesis described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Of the alternative substituents examined, only alkyl trifluoromethyl derivative <b>12f</b> (<i>p</i>(doubling conc.) = 5.0â5.1) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) was tolerated. Despite lowering cLogP values by nearly two log units, <b>12f</b> still displayed doubling concentrations in the single-digit micromolar range. Although this result is below desired potency ranges, this substitution may prove to be useful for future promising analogues to fine-tune absorption, distribution, metabolism, and excretion (ADME) properties due to the relatively favorable change in LLE (LLE = 0.9â1.0). Other A-ring substitutions such as aliphatic chains (<b>12g</b>, pEC<sub>50</sub> < 4.5 or <b>12h</b>, max = 94â97%), heterocycles (<b>12l</b>, max = 98â110% or <b>12i</b>, max = 85%), and heterolinear derivatives (<b>12j</b>, max = 98â100% or <b>12k</b>, max = 96â110%) were not tolerated. These results provide evidence that hydrophobic effects dominate receptorâligand interactions in this portion of the molecule. Therefore, based on previous optimization,<a onclick="showRef(event, 'ref59 ref63'); return false;" href="javascript:void(0);" class="ref ref59 ref63">(59,63)</a><i>meta</i>-Cl- or <i>meta</i>-CF<sub>3</sub>-substituted benzyl derivatives were synthesized from this point forward almost exclusively since they provided the most promising combination of activity and lipophilic efficiency.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Hydrophilic A-Ring Substitutions<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0010.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0011.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Fitted pEC<sub>50</sub> values are shown to have two significant figures when potentiation at 30 Î¼M exceeded 130% of control; values in brackets are the 95% confidence interval for the corresponding fitted pEC<sub>50</sub> mean value; and values in parentheses are the fitted maximum response as a percentage of the initial glutamate (100 Î¼M) and glycine (30 Î¼M) current. For compounds in which a pEC<sub>50</sub> value was not determined, maximum potentiation is reported as percent potentiation as a percent of control at 30 Î¼M drug. Data are between 6 and 11 oocytes from 2 frogs for each compound and receptor.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last"><i>p</i>(doubling conc.) is the negative log of the doubling concentration.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Previously published data for <b>CIQ</b> and <b>117</b> were included for comparison. Single methoxy substitution on the C-ring maintains similar or better activity to dimethoxy substitution.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">ND = not determined.</p></div></div><div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Evaluation of Hydrophilic B-Ring Replacements</h3><div class="NLM_p">Next, we examined hydrophilic replacements of the B-ring via the divergent synthesis described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Upon TEVC evaluation, none of the derivatives synthesized were tolerated at any GluN2 subtype. Nitrogen heterocycles such as the 2-pyridinyl (<b>18b</b>), 3-pyridinyl (<b>18e</b>), and 2-pyrimidinyl (<b>18c</b>) derivatives all showed responses when co-applied with agonist that were 88â97% of control for GluN2C- and GluN2D-containing receptors. Incorporation of saturation (<b>18d</b>), bioisosteric replacement with thiophene (<b>18a</b>), and removal of the B-ring completely (<b>17b</b>) were also not tolerated. Para-methoxyphenyl substitution was therefore maintained for subsequent analogues based on previous optimization (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).<a onclick="showRef(event, 'ref59 ref63'); return false;" href="javascript:void(0);" class="ref ref59 ref63">(59,63)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Hydrophilic B-Ring Substitutions<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0012.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0013.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Fitted pEC<sub>50</sub> values are shown to have two significant figures when potentiation at 30 Î¼M exceeded 130% of control; values in parentheses are the fitted maximum response as a percentage of the initial glutamate (100 Î¼M) and glycine (30 Î¼M) current. For compounds in which a pEC<sub>50</sub> value was not determined, maximum potentiation is reported as percent potentiation as a percent of control at 30 Î¼M drug. Data are from 4 oocytes from 1 frog.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Previously published data for compound <b>198</b> were included for comparison.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></p></div></div><div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Effect of Bioisosteric Replacement of the C-Ring</h3><div class="NLM_p">Although derivatization of the three rings of <b>CIQ</b> has led to useful tool compounds,<a onclick="showRef(event, 'ref59 ref63'); return false;" href="javascript:void(0);" class="ref ref59 ref63">(59,63)</a> major changes to the C-ring and TIQ core itself have not been thoroughly explored. We viewed this as an underdeveloped area of the SAR in which opportunities for decreasing lipophilicity and improving affinity for the target protein could emerge, assuming appropriate choice of a hydrophilic core.</div><div class="NLM_p">Due to thiopheneâs known use as a classical phenyl isostere, tetrahydrothienopyridine <b>25a</b> was synthesized (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) and its activity against each of the GluN2 subunits (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) was examined. Compound <b>25a</b> showed improved maximum potentiation (280â350%) while maintaining similar potency (pEC<sub>50</sub> = 5.4) and selectivity (no activity at GluN2A/B) to <b>CIQ</b>. Due to the improved potentiation, <b>25a</b> showed improved doubling concentrations and LLE (<i>p</i>(doubling conc.) = 5.3â5.6 and LLE = â0.3 to 0.0) in comparison to <b>CIQ</b> (<i>p</i>(doubling conc.) = 4.5â4.9 and LLE = â0.7 to â1.1). A regioisomer of <b>25a</b>, compound <b>25h</b>, also showed improved LLE over <b>CIQ</b> (ÎLLE = 0.6â0.9) due to improved potentiation (max = 330â340%). Using these results as a starting point, several tetrahydrothienopyridine-based derivatives were subsequently explored (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> and <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). First, bioisosteric 2-chlorothiophene replacement of the A-ring provided compound <b>25b</b>, which was similarly tolerated (LLE = â0.1 to 0.2) to <b>25a</b> (LLE = â0.3 to 0.0). The trifluorocrotonic acid derivative <b>25c</b> suffered a loss in potency (pEC<sub>50</sub> = 4.8â4.9) compared to <b>CIQ</b>, but resulted in a large improvement in LLE (LLE = 1.2â1.3) due to its notable decrease in cLogP (cLogP = 3.6). Similar to <b>12f</b>, this may be an attractive substitution for fine-tuning the ADME properties of more potent future derivatives but rendered this compound outside the range of useful potency. Finally, methoxy substitution on the thiophene (<b>25d</b>) was examined due to previous promising SAR trends,<a onclick="showRef(event, 'ref59 ref63'); return false;" href="javascript:void(0);" class="ref ref59 ref63">(59,63)</a> but this compound showed no advantages in terms of LLE over <b>CIQ</b>. However, each of these derivatives exemplified that changes to the TIQ core were tolerated, and we hypothesized that other more hydrophilic substitution may follow a similar trend.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Optimization of A- and C-Ring Functionality for Thiophene Core<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0014.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0015.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Fitted pEC<sub>50</sub> values are shown to have two significant figures when potentiation at 30 Î¼M exceeded 130% of control; values in brackets are the 95% confidence interval for the corresponding log-fitted pEC<sub>50</sub> value; and values in parentheses are the fitted maximum response as a percentage of the initial glutamate (100 Î¼M) and glycine (30 Î¼M) current. Data are between 10 and 12 oocytes from 2 frogs for each compound and receptor.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last"><i>p</i>(doubling conc.) is the negative log of the doubling concentration.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Previously published data for <b>CIQ</b> were included for comparison.</p></div></div><div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> SAR of Additional TIQ Core Changes</h3><div class="NLM_p">Several hydrophilic heterocycles were designed and synthesized to test this hypothesis (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a> and <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The furan derivative, <b>25f</b>, was the first compound in the series to show a simultaneous improvement in doubling concentration (<i>p</i>(doubling conc.) = 5.4â5.5) and decrease in cLogP (cLogP = 5.1) compared to CIQ. This led to a dramatic improvement in LLE (LLE = 0.3â0.4). Even more impressive was pyrrolopyrazine <b>25i</b>, which exhibited excellent doubling concentrations (<i>p</i>(doubling conc.) = 5.8â5.9) while also lowering cLogP by 0.7 (cLogP = 4.9) compared to CIQ. This resulted in an approximate two log unit improvement in LLE (LLE = 1.0â1.1). It also maintained the aqueous solubility gains observed with <b>25a</b>, displaying a 4.5-fold improvement over CIQ at 36 Î¼M. However, other more hydrophilic derivatives such as 2-methylthiazole <b>25e</b> (max = 100%) and <i>N</i>-methylpyrazole <b>25g</b> (pEC<sub>50</sub> < 4.5) were both not tolerated. Unsubstituted phenyl derivative <b>36</b> (see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_001.pdf" class="ext-link">Supporting Information</a> for synthesis) was also only weakly active (<i>p</i>(doubling conc.) = 5.0, LLE = â1.0). Replacement of the A-ring amide linker with a thioamide linker has previously been shown to improve potency > 10-fold in certain cases.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> However, this modification was not tolerated in analogue <b>26</b> (max = 94â97%), which contains the tetrahydrothienopyridine scaffold. Nonetheless, compound <b>25i</b> was an exciting discovery in identifying compounds with improved lipophilic efficiencies and other derivatives with this same pyrrolopyrazine core were subsequently developed.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Optimization of Heterocyclic C-Ring Derivatives<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0016.gif" alt="" id="fx9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0017.gif" alt="" id="fx10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Fitted pEC<sub>50</sub> values are shown to have two significant figures when potentiation at 30 Î¼M exceeded 130% of control; values in brackets are the 95% confidence interval for the corresponding log-fitted pEC<sub>50</sub> value; and values in parentheses are the fitted maximum response as a percentage of the initial glutamate (100 Î¼M) and glycine (30 Î¼M) current. For compounds in which a pEC<sub>50</sub> value was not determined, maximum potentiation is reported as percent potentiation at 30 Î¼M drug. Data are between 7 and 15 oocytes from 2 frogs for each compound and receptor for which an EC<sub>50</sub> value was determined and between 4 and 9 oocytes from 1 to 2 frogs for all other analogues.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last"><i>p</i>(doubling conc.) is the negative log of the doubling concentration.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Previously published data for CIQ were included for comparison.</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">ND = not determined.</p></div></div><div></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Pyrrolopyrazine- and Pyrrolopyrazinone-Based Analogues</h3><div class="NLM_p">Based on previously established SAR within the series, a targeted sample of derivatives was designed and synthesized, keeping the pyrrole core consistent throughout (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). First, based on previously described SAR,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> the chlorine of compound <b>25i</b> was substituted for a trifluoromethyl substituent to give compound <b>25j</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). This compound improved the doubling concentrations (<i>p</i>(doubling conc.) = 5.6â6.1) into the nanomolar range while also displaying the highest aqueous solubility (58 Î¼M) of any derivative in the series tested thus far. To examine whether the LLE boosts seen individually with the pyrrolopyrazine core and dihydroisoquinolinone core would synergize, a hybridized pyrrolopyrazinone core was designed and synthesized as described in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. The resulting pyrrolopyrazinone (<b>31a</b>) displayed similar doubling concentrations (<i>p</i>(doubling conc.) = 5.9â6.1) and aqueous solubility (57 Î¼M) to <b>25j</b>. Fluorine was also well tolerated (<b>EU-1180-453</b>) in place of the trifluoromethyl group. Although a slight potency drop was observed (pEC<sub>50</sub> = 5.5), it maintained the improvements in LLE (LLE = 1.2) and doubling concentrations (<i>p</i>(doubling conc.) = 5.7) seen with <b>25i</b>, while improving aqueous solubility nearly an order of magnitude (74 Î¼M) compared to <b>CIQ</b>. <b>EU-1180-453</b> is a free-flowing, white solid that is stable as a powder or a dimethyl sulfoxide (DMSO) stock for at least 30 days (longest time tested) at room temperature under regular atmosphere. Finally, the amide of <b>31a</b> was converted to the thioamide to give <b>32</b>, but this modification resulted in a complete loss of activity on the pyrrolopyrazinone core, similar to that observed for the tetrahydrothienopyridine core above.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Optimization of Potency and Aqueous Solubility for Pyrrolopyrazine- and Pyrrolopyrazinone-Based Derivatives<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0018.gif" alt="" id="fx11" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="2" align="center">pEC<sub>50</sub> [95% CI] (max) (%)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center">Â </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">#</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">GluN2C</th><th class="colsep0 rowsep0" align="center">GluN2D</th><th class="colsep0 rowsep0" align="center" char="."><i>p</i>(doubling conc.) (GluN2C/2D)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">sol. (Î¼M)</th><th class="colsep0 rowsep0" align="center" char=".">cLogP</th><th class="colsep0 rowsep0" align="center">LLE (GluN2C/2D)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left"><b>CIQ</b><a class="ref internalNav" href="#t6fn3" aria-label="c">c</a><b>(TIQ core)</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="center">5.3 (230)</td><td class="colsep0 rowsep0" align="center">5.3 (220)</td><td class="colsep0 rowsep0" align="char" char=".">4.9/4.5</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="left">â0.7/â1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25j</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">5.8 [5.7â5.9] (380)</td><td class="colsep0 rowsep0" align="center">5.7 [5.5â5.9] (290)</td><td class="colsep0 rowsep0" align="char" char=".">6.1/5.6</td><td class="colsep0 rowsep0" align="char" char=".">58</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="left">1.0/0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31a</b></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">5.9 [5.7â6.0] (300)</td><td class="colsep0 rowsep0" align="center">5.8 [5.6â6.0] (400)</td><td class="colsep0 rowsep0" align="char" char=".">5.9/6.1</td><td class="colsep0 rowsep0" align="char" char=".">57</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="left">0.7/0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>EU-1180-453</b></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="center">5.5 [5.4â5.6] (350)</td><td class="colsep0 rowsep0" align="center">5.5 [5.4â5.6] (350)</td><td class="colsep0 rowsep0" align="char" char=".">5.7/5.7</td><td class="colsep0 rowsep0" align="char" char=".">74</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="left">1.2/1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">ND (120)</td><td class="colsep0 rowsep0" align="center">ND (110)</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="left">Â </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Fitted pEC<sub>50</sub> values are shown to have two significant figures when potentiation at 30 Î¼M exceeded 130% of control; values in brackets are the 95% confidence interval for the corresponding log-fitted pEC<sub>50</sub> value; and values in parentheses are the fitted maximum response as a percentage of the initial glutamate (100 Î¼M) and glycine (30 Î¼M) current. For compounds in which a pEC<sub>50</sub> value was not determined, maximum potentiation is reported as percent potentiation at 30 Î¼M drug. Data are from between 7 and 15 oocytes from 2 frogs for each compound and receptor.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last"><i>p</i>(doubling conc.) is the negative log of the doubling concentration.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">Previously published data for <b>CIQ</b> were included for comparison.</p></div><div class="footnote" id="t6fn4"><sup><sup>d</sup></sup><p class="last">ND = not determined.</p></div></div></div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Enantiomers</h3><div class="NLM_p">Four compounds with promising profiles (<b>25i</b>, <b>25j</b>, <b>31a</b>, and <b>EU-1180-453</b>) were selected for separation via chiral HPLC to examine the behavior of the individual enantiomers. Upon separation and isolation, X-ray crystallography studies on <b>(+)-EU-1180-453</b> determined its absolute configuration to be the <i>R</i>-(+)-enantiomer and allowed for absolute stereochemical assignment of the enantiomers.</div><div class="NLM_p">Consistent with <b>CIQ</b> and its derivatives, the <i>R</i>-(+)-enantiomers were active, while the <i>S</i>-(â)-enantiomers were not. We selected compound <i><b>R</b></i><b>-(+)-EU-1180-453</b> for further study because of its attractive doubling concentrations (<i>p</i>(doubling conc.) = 5.8â5.9) and improved aqueous solubility (74 Î¼M), exhibiting a >50:1 aqueous solubility to doubling concentration ratio compared to <1:1 for <b>CIQ</b>. In addition, <i><b>R</b></i><b>-(+)-EU-1180-453</b> had virtually no effect on GluN1/GluN2A and GluN1/GluN2B, or a variety of other receptors (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_001.pdf" class="ext-link">Tables S5 and S6</a>). Together, these properties make this a more attractive and useful compound than <b>CIQ</b> (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Stereodependence of Select Pyrrolopyrazine Cores<a class="ref internalNav" href="#t7fn5" aria-label="e">e</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0019.gif" alt="" id="fx12" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="2" align="center">pEC<sub>50</sub> [95% CI] (max) (%)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center">Â </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">#</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">GluN2C</th><th class="colsep0 rowsep0" align="center">GluN2D</th><th class="colsep0 rowsep0" align="center"><i>p</i>(doubling conc.) (GluN2C/2D)<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">sol. (Î¼M)<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">cLogP</th><th class="colsep0 rowsep0" align="center">LLE (GluN2C/2D)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left"><b>CIQ</b><a class="ref internalNav" href="#t7fn4" aria-label="d">d</a><b>(TIQ core)</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="center">5.3 (230)</td><td class="colsep0 rowsep0" align="center">5.3 (220)</td><td class="colsep0 rowsep0" align="left">4.9/4.5</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="left">â0.7/â1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>S</b></i><b>-(â)-31a</b></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">ND (84)</td><td class="colsep0 rowsep0" align="center">ND (88)</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char=".">57</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>R-</b></i><b>(+)-31a</b></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">6.1 [6.0â6.3] (280)</td><td class="colsep0 rowsep0" align="center">6.1 [6.0â6.2] (330)</td><td class="colsep0 rowsep0" align="left">6.0/6.2</td><td class="colsep0 rowsep0" align="char" char=".">57</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="left">0.8/1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>S</b></i><b>-(â)-25i</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="center">ND (98)</td><td class="colsep0 rowsep0" align="center">ND (99)</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>R</b></i><b>-(+)-25i</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="center">5.7 [5.7â5.8] (410)</td><td class="colsep0 rowsep0" align="center">5.7 [5.7â5.8] (450)</td><td class="colsep0 rowsep0" align="left">6.1/6.2</td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="left">1.2/1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>S</b></i><b>-(â)-25j</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">ND (99)</td><td class="colsep0 rowsep0" align="center">ND (98)</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char=".">58</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>R</b></i><b>-(+)-25j</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">5.9 [5.8â6.0] (460)</td><td class="colsep0 rowsep0" align="center">5.9 [5.8â5.9] (540)</td><td class="colsep0 rowsep0" align="left">6.3/6.4</td><td class="colsep0 rowsep0" align="char" char=".">58</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="left">1.2/1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>S</b></i><b>-(â)-EU-1180-453</b></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="center">ND (100)</td><td class="colsep0 rowsep0" align="center">ND (88)</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="char" char=".">74</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>R</b></i><b>-(+)-EU-1180-453</b></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="center">5.5 [5.4â5.6] (410)</td><td class="colsep0 rowsep0" align="center">5.5 [5.4â5.6] (390)</td><td class="colsep0 rowsep0" align="left">5.9/5.8</td><td class="colsep0 rowsep0" align="char" char=".">74</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="left">1.4/1.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">Fitted pEC<sub>50</sub> values are shown to have two significant figures when potentiation at 30 Î¼M exceeded 130% of control; values in brackets are the 95% confidence interval for the corresponding log-fitted pEC<sub>50</sub> value; and values in parentheses are the fitted maximum response as a percentage of the initial glutamate (100 Î¼M) and glycine (30 Î¼M) current. For compounds in which a pEC<sub>50</sub> value was not determined, maximum potentiation is reported as percent potentiation at 30 Î¼M drug. Data are between 6 and 13 oocytes from 2 frogs for each compound and receptor.</p></div><div class="footnote" id="t7fn2"><sup><sup>b</sup></sup><p class="last"><i>p</i>(doubling conc.) is the negative log of the doubling concentration.</p></div><div class="footnote" id="t7fn3"><sup><sup>c</sup></sup><p class="last">Aqueous solubilities reported from racemic mixtures.</p></div><div class="footnote" id="t7fn4"><sup><sup>d</sup></sup><p class="last">Previously published data for <b>CIQ</b> were included for comparison.</p></div><div class="footnote" id="t7fn5"><sup><sup>e</sup></sup><p class="last">ND = not determined.</p></div></div></div><div class="NLM_p">To better understand the scope of actions for <b>EU-1180-453</b>, we evaluated whether either enantiomer could alter glutamate potency, in addition to their potentiation of the response to maximally effective concentrations of glutamate plus glycine. We measured the ratio of a response to a subsaturating concentration of glutamate in vehicle or <b>EU-1180-453</b> enantiomer to that of a maximally effective concentration of glutamate at GluN1/GluN2D receptors. We did not detect any meaningful effect of <i><b>S</b></i><b>-(â)-EU-1180-453</b> on the ratio of the current response at any receptor combination, suggesting that this stereoisomer has no effect on glutamate potency. This is consistent with the lack of a detectable effect on the maximal response to co-agonists (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>). A similar result was found for 30 Î¼M <i><b>R</b></i><b>-(+)-EU-1180-453</b> for GluN2A and GluN2B, which had no effect on the ratio of submaximal to maximal response (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>) or response to maximally effective agonist for GluN1/GluN2A (108 Â± 2% of control, <i>n</i> = 6) and GluN1/GluN2B (109 Â± 2% of control, <i>n</i> = 7). By contrast, <i><b>R</b></i><b>-(+)-EU-1180-453</b> had strong effects on the ratio of response of submaximal to maximal concentrations of glutamate for GluN1/GluN2C and GluN1/GluN2D (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>), suggesting that this enantiomer may shift the glutamate potency in addition to its ability to potentiate the response to maximally effective concentrations of agonist. We subsequently recorded full concentrationâeffect curves for glutamate activation (in saturating 30 Î¼M glycine) at both GluN1/GluN2C and GluN1/GluN2D in the absence and presence of <i><b>R</b></i><b>-(+)-EU-1180-453</b>. We obtained fitted pEC<sub>50</sub> values (with nonoverlapping 95% confidence intervals) of 6.1 [6.0â6.2] and 6.5 [6.4â6.6] for GluN1/GluN2C (Hill slopes 1.2â1.4, <i>n</i> = 15, 13), and 6.3 [6.2â6.3] and 6.6 [6.5â6.7] for GluN1/GluN2D (Hill slopes 1.1â1.5, <i>n</i> = 16â22) in the absence and presence of <i><b>R</b></i><b>-(+)-EU-1180-453</b>, respectively. These data suggest that even larger potentiation will be observed for subsaturating concentrations of glutamate at GluN2C and GluN2D, as will occur at extrasynaptic receptors.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Single Glutamate Concentration Screen for Changes in Glutamate Potency <b><i>R</i>-(+)-EU-1180-453</b><a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="4" align="center"><i>I</i><sub>30Â Î¼M</sub>/<i>I</i><sub>control</sub> (mean Â± SEM, %) [low glutamate concentration/low glycine concentration, Î¼M]</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">#</th><th class="colsep0 rowsep0" align="center">GluN2A</th><th class="colsep0 rowsep0" align="center">GluN2B</th><th class="colsep0 rowsep0" align="center">GluN2C <i>N</i> = 13</th><th class="colsep0 rowsep0" align="center">GluN2D <i>N</i> = 22</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>vehicle</b></td><td class="colsep0 rowsep0" align="left">40 Â± 4 [3, 30]</td><td class="colsep0 rowsep0" align="left">84 Â± 1 [3, 30]</td><td class="colsep0 rowsep0" align="left">54 Â± 1 [0.5, 30]</td><td class="colsep0 rowsep0" align="left">66 Â± 2 [0.5, 30]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30 Î¼M</b><i><b>S</b></i><b>-(â)-EU-1180-453</b></td><td class="colsep0 rowsep0" align="left">45 Â± 4 [3, 30] <b><i>n</i> = 11</b></td><td class="colsep0 rowsep0" align="left">85 Â± 9 [3, 30] <b><i>n</i> = 6</b></td><td class="colsep0 rowsep0" align="left">57 Â± 2 [0.5, 30] <b><i>n</i> = 13</b></td><td class="colsep0 rowsep0" align="left">72 Â± 2* [0.5, 30] <b><i>n</i> = 7</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>vehicle</b></td><td class="colsep0 rowsep0" align="left">46 Â± 5 [3, 30â100]</td><td class="colsep0 rowsep0" align="left">79 Â± 1 [3, 30â100]</td><td class="colsep0 rowsep0" align="left">19 Â± 3 [0.3, 10]</td><td class="colsep0 rowsep0" align="left">29 Â± 2 [0.3, 10]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30 Î¼M</b><i><b>R</b></i><b>-(+)-EU-1180-453</b></td><td class="colsep0 rowsep0" align="left">53 Â± 2 [3, 30â100] <b><i>n</i> = 28</b></td><td class="colsep0 rowsep0" align="left">77 Â± 1 [3, 30â100] <b><i>n</i> = 22</b></td><td class="colsep0 rowsep0" align="left">48 Â± 4* [0.3, 10] <b><i>n</i> = 13</b></td><td class="colsep0 rowsep0" align="left">55 Â± 6* [0.3, 10] <b><i>n</i> = 16</b></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">Data mean Â± standard error for the relative current response at 0.5â3 Î¼M glutamate compared to maximally active (30â100 Î¼M) glutamate. 30 Î¼M glycine was present in all solutions. *<i>p</i> < 0.05, paired <i>t</i>-test between drug and vehicle.</p></div></div></div><div class="NLM_p last">We also found that <i><b>R</b></i><b>-(+)-EU-1180-453</b> only potentiates activated NMDARs that have bound both co-agonists and does not remove the requirement of either co-agonist. We observed that 30 Î¼M <i><b>R</b></i><b>-(+)-EU-1180-453</b> had virtually no effect on GluN1/GluN2D receptors in 10 Î¼M glycine plus 50 Î¼M racemic 2-amino-5-phosphonopentanoic acid (DL-APV), a selective competitive antagonist of the NMDAR glutamate binding site. This produced 2.5% of the response to a maximally effective concentration of glutamate plus glycine (<i>n</i> = 8 oocytes), which we interpret to reflect an enhanced glutamate potency that increases the small response to contaminant glutamate. Similarly, 30 Î¼M <i><b>R</b></i><b>-(+)-EU-1180-453</b> in 10 Î¼M glutamate plus 10 Î¼M 7-chlorokynurenic acid (7-CKA), a selective competitive antagonist of the NMDAR glycine binding site, produced 0.4% of the response to maximally effective concentration of glutamate and glycine (<i>n</i> = 8 oocytes).</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Off-Target and Pharmacokinetic Profile</h3><div class="NLM_p">Racemic compounds <b>25i</b>, <b>31a</b>, and <b>EU-1180-453</b> were further examined for their behavior against common off-target receptors. First, their specificity against other ion channels in the brain were examined via two-electrode voltage clamp recordings of <i>Xenopus</i> oocytes expressing AMPA, kainate, nicotinic acetylcholine, serotonin, GABA, glycine, and ATP receptors.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Current responses were tested with saturating concentrations of agonist in both the absence of drug and presence of 10 Î¼M <b>25i</b>, <b>31a</b>, or <b>EU-1180-453</b> (ca. 5â10 times the EC<sub>50</sub>). Only one receptorâligand combination (Î±4Î²2-nACh/<b>31a</b>) exhibited >50% inhibition, and none exhibited >75% inhibition (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_001.pdf" class="ext-link">Table S5</a>).</div><div class="NLM_p">Racemic compounds <b>25i</b>, <b>31a</b>, and <b>EU-1180-453</b> were also submitted to the National Institute of Mental Health Psychoactive Drug Screening Program (PDSP, <a href="https://pdsp.unc.edu/ims/investigator/web/" class="extLink">https://pdsp.unc.edu/ims/investigator/web/</a>) to examine the activity of both the pyrrolopyrazine and pyrrolopyrazinone cores at additional off-target receptors (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_001.pdf" class="ext-link">Table S6</a>). The primary binding screen examined inhibition of ligand binding at 10 Î¼M test compound, and if the drug exhibited >50% inhibition, a secondary binding screen was run to determine <i>K</i><sub>i</sub>. Compounds <b>25i</b>, <b>31a</b>, and <b>EU-1180-453</b> showed >50% inhibition at an average of only 3 of the 45 off-target receptors examined, and all <i>K</i><sub>i</sub> values were in the micromolar range, suggesting reasonable selectivity for the GluN2C- and GluN2D-containing NMDA receptors.</div><div class="NLM_p">Racemic<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a><b>EU-1180-453</b> was also dosed in mice to determine its pharmacokinetic behavior. <b>EU-1180-453</b> was dosed i.p. in C57Bl/6 mice (<i>n</i> = 15, 3 per time point) at 10 mg/kg in vehicle consisting of 50% PEG400 in water, and samples were evaluated via LC/MS-MS at 0.25, 0.5, 1, 2, and 4 h (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Procedures">Experimental Procedures</a>). Concentrations in brain (962 Â± 210 ng/mL, 2.5 Â± 0.4 Î¼M) and plasma (695 Â± 111 ng/mL, 1.83 Â± 0.29 Î¼M) peaked at 0.25 h and steadily declined, resulting in excellent brain exposure (brain:plasma_AUC<sub>LAST</sub> = 1.4 Â± 0.5) and an acceptable plasma half-life (<i>t</i><sub>1/2</sub> = 1.07 Â± 0.04 h). <b>CIQ</b> has previously been reported as brain-penetrant but suffers from high plasma protein binding leading to low free fraction.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> We therefore evaluated the plasma protein binding (PPB) of <b>EU-1180-453</b> using equilibrium dialysis and found it to be 98.7% bound to rat plasma protein at 1 Î¼M of drug. This is a greater than 10-fold decrease compared to <b>CIQ</b>, for which we observed >99.9% bound. A comparison of pharmacokinetic data between <b>EU-1180-453</b> and <b>CIQ</b> can be seen in <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Plasma Pharmacokinetics Comparison Between <b>EU-1180-453</b> and <b>CIQ</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="." /></col><col align="char" char="Â±" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">#</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="Â±"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="Â±"><i>C</i><sub>max</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char="Â±"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">PPB, <i>f</i><sub>ub</sub><a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="Â±">[brain]: [plasma]<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">cLogP</th><th class="colsep0 rowsep0" align="center">LLE (GluN2C/2D)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>CIQ</b></td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char="Â±">2090Â Â±Â 20</td><td class="colsep0 rowsep0" align="char" char="Â±">2.16Â Â±Â 0.03</td><td class="colsep0 rowsep0" align="char" char="Â±">1.35Â Â±Â 0.12</td><td class="colsep0 rowsep0" align="char" char="."><0.1</td><td class="colsep0 rowsep0" align="char" char="Â±">6.7Â Â±Â 2.2</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="left">â0.7/â1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>EU-1180-453</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char="Â±">695Â Â±Â 111</td><td class="colsep0 rowsep0" align="char" char="Â±">1.83Â Â±Â 0.29</td><td class="colsep0 rowsep0" align="char" char="Â±">1.07Â Â±Â 0.04</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char="Â±">1.4Â Â±Â 0.5</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="left">1.2/1.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup><sup>a</sup></sup><p class="last">Compounds were dosed i.p. in either 1:4:5 dimethylacetamide:PEG400:(5% dextrose in water) (<b>CIQ</b>, <i>n</i> = 3/group) or 1:1 PEG400:water (<b>EU-1180-453</b>, <i>n</i> = 3/group).</p></div><div class="footnote" id="t9fn2"><sup><sup>b</sup></sup><p class="last">Rat plasma protein binding reported as percent unbound (<i>f</i><sub>ub</sub>) at 1 Î¼M.</p></div><div class="footnote" id="t9fn3"><sup><sup>c</sup></sup><p class="last">Brain and plasma concentrations in ng/g and ng/mL, respectively, at <i>C</i><sub>max</sub>.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85467" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85467" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Although <b>CIQ</b> is a useful <i>in vitro</i> tool compound for the study of GluN2C- and GluN2D-containing receptors, its <i>in vivo</i> and <i>in vitro</i> use is limited due to modest potency and potentiation, low aqueous solubility, and high lipophilicity. We have developed second-generation GluN2C- and GluN2D-selective PAMs that address each of these concerns. For example, racemic <b>EU-1180-453</b> is a more potent potentiator (EC<sub>50</sub> â¼3 Î¼M) that shows log unit improvements in lipophilic efficiency (ÎLLE = 1.9â2.3), doubling concentration (Î<i>p</i>(doubling conc.) = 0.8â1.2), aqueous solubility (8â74 Î¼M), and a log unit decrease in cLogP (ÎcLogP = 1.1) compared to <b>CIQ</b>. It is brain-penetrant, exhibits a reasonable half-life, and shows minimal off-target activity. The active enantiomer, <i><b>R</b></i><b>-(+)-EU-1180-453</b>, exhibits ca. 1â2 Î¼M doubling concentrations due to 4-fold potentiation and results in a doubling concentration to aqueous solubility ratio of >50:1. Limitations at this time center around potency, as there is a question of whether the given combination of <i>in vitro</i> potency, free fraction, and <i>C</i><sub>max,brain</sub> can drive measurable pharmacological activity <i>in vivo</i>. These <i>in vivo</i> experiments are currently ongoing in our lab, and the results will be reported in future publications. Overall, this work has resulted in second-generation <i>in vitro</i> tools to study positive modulation of GluN2C- and GluN2D-containing NMDARs and is an important step toward future <i>in vivo</i> work.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87146" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87146" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Biology</h3><div class="NLM_p">Unfertilized <i>Xenopus laevis</i> oocytes were purchased from Ecocyte (Austin, TX). The oocytes were injected with mRNA to express recombinant rat GluN1/GluN2A, GluN1/GluN2B, GluN1/GluN2C, and GluN1/GluN2D, and two-electrode voltage clamp recordings were performed. Drs. S. Heinemann (Salk Institute), S. Nakanishi (Kyoto University), and P. Seeburg (University of Heidelberg) provided the cDNAs for rat GluN1-1a (GenBank accession numbers U11418 and U08261, referred to as GluN1 henceforth), GluN2A (D13211), GluN2B (U11419), GluN2C (M91563), and GluN2D (D13213). GluN2C and GluN2D were altered according to the literature.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Isolation of oocytes, synthesis of cRNA, and injections of cRNA were each done according to the literature.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Oocytes were placed in a perfusion chamber and continuously washed during TEVC recordings with a solution consisting of the following (in mM): 90 NaCl, 0.5 BaCl, 0.005 ethylenediaminetetraacetic acid (EDTA), 1.0 KCl, and 10 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) at pH 7.4 and 23 Â°C. Glass electrodes were pulled from thin-walled glass capillaries (tip resistance, 0.5â2.5 MÎ©) and filled with 0.3â3.0 M KCl, while the oocyte membrane potential was held constant at â40 mV via an OC-725C amplifier (Warner Instruments Co.). Each compound was brought up in 20 mM DMSO and diluted with recording solution containing 30 Î¼M glycine and 100 Î¼M glutamate to the target concentration. To prevent the current increase typically seen during experiments with oocytes expressing GluN1/GluN2A receptors, some oocytes were either injected with 20 nL of 100 mM K-BAPTA (potassium 1,2-bis(<i>o</i>-aminophenoxy)ethane-<i>N</i>,<i>N</i>,<i>N</i>â²,<i>N</i>â²-tetraacetic acid) or pretreated with 50 Î¼M BAPTA-AM (1,2-bis(<i>o</i>-aminophenoxy)ethane-<i>N</i>,<i>N</i>,<i>N</i>â²,<i>N</i>â²-tetraacetic acid tetraacetoxymethyl ester) for 10 min. Compounds that potentiated GluN2A- and GluN2B-containing receptors were not studied further.</div><div class="NLM_p">Every test compound was recorded at 5â7 concentrations in 4â19 oocytes from 1 to 3 different frogs at GluN2C- and GluN2D-containing NMDA receptors and in 4 to 17 oocytes from 1 to 4 frogs at GluN2A- and GluN2B-containing receptors. The potentiation of certain test compounds at a concentration of 10 Î¼M was averaged and reported as <i>I</i><sub>10Î¼M</sub>/<i>I</i><sub>control</sub> (mean Â± SEM, %), where <i>I</i> is the current. For test compounds with potentiation that exceeded 125% at 30 Î¼M, an average EC<sub>50</sub> value (the half-maximal effective concentration of potentiator) was determined by fitting the following equation<span class="NLM_disp-formula" id="eq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_m001.gif" alt="" id="_i31" /></img><span class="labelSpan">(1)</span></span>to individual concentrationâresponse curves normalized to the current in the absence of the potentiator (100%), where <i>N</i> is the Hill slope and max is the maximal response predicted for saturating concentration of potentiator. This is converted to the negative log of the value through the following<span class="NLM_disp-formula" id="eq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_m002.gif" alt="" id="_i32" /></img><span class="labelSpan">(2)</span></span>The concentration that gave a 2-fold increase in the current response was determined by rearranging <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a> to yield<span class="NLM_disp-formula" id="eq3"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_m003.gif" alt="" id="_i33" /></img><span class="labelSpan">(3)</span></span>where <i>N</i> is the Hill slope. This is also converted to the negative log of the value through the following<span class="NLM_disp-formula" id="eq4"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_m004.gif" alt="" id="_i34" /></img><span class="labelSpan">(4)</span></span>The lipophilic ligand efficiency (LLE) equation used in this paper is a modified version of the metric that was recently reviewed.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> The negative log of the potency (pEC<sub>50</sub>) is replaced by the negative log of the doubling concentration to normalize for positive modulation, while Logâ¯<i>D</i> is replaced by cLogP to give<span class="NLM_disp-formula" id="eq5"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_m005.gif" alt="" id="_i35" /></img><span class="labelSpan">(5)</span></span>IACUC-approved protocols and animal welfare regulations outlined in the âGuide for the Care and Use of Laboratory Animalsâ were both followed during pharmacokinetic evaluation of compound <b>EU-1180-453</b>. <i>In vivo</i> analysis was performed by Pharmaron (Irvine, CA). Briefly, a group (<i>n</i> = 15) of fed, male C57BL/6 mice approximately 6â8 weeks of age were injected IP with 10 mg/kg (10 mL/kg, 1 mg/mL) of drug using 50% PEG400 in water as a vehicle. Samples were collected from the blood and brain at 0.25, 0.5, 1, 2, and 4 h after administration (3 mice per time point) following CO<sub>2</sub> anesthesia. Collection from the brain was performed as follows: the mouse is terminally anesthetized via increasing concentration of CO<sub>2</sub> and as much blood is removed as possible via cardiac puncture. The cardiac puncture is done by opening the chest cavity to expose the heart, cutting an incision in the right auricle using surgical scissors and finally injecting a saline solution (â¼10 mL) slowly into the left ventricle via syringe. The mouse is placed head down at a 45Â° angle to facilitate blood removal. After perfusion, the skull is opened and the brain is removed. The brain is washed with saline, dried with surgical gauze, placed in tared tubes, and stored at â75 Â°C before analysis. For plasma sample preparation at 0.25â2 h time points, 15 Î¼L of blank solution, 30 Î¼L of plasma sample, and 150 Î¼L of acetonitrile were added sequentially for protein precipitation. After centrifugation, 20 Î¼L of the supernatant and 80 Î¼L of CB were combined, and thus the final compound concentration in plasma (ng/mL) was corrected by multiplying by 5. For plasma sample preparation at the 4 h time point, 15 Î¼L of blank solution, 30 Î¼L of plasma sample, and 150 Î¼L of acetonitrile were added sequentially for protein precipitation. For all brain sample preparation, 15 Î¼L of blank solution, 30 Î¼L of brain samples, and 150 Î¼L of acetonitrile were added sequentially for protein precipitation. Brain samples were prepared by adding brain (g) to deionized water (mL) in a 1:4 ratio for homogenization. The mixtures were then vortexed for 30 s and subsequently centrifuged (â¼4000 rpm) for 15 min. The supernatant was diluted 3-fold with water, and a 2 Î¼L aliquot of the diluted supernatant was injected into a Shimadzu LC-30A LC-MS/MS system with Phenomenex 2.6 Î¼ PFP 100A column (30 mm Ã 2.1 mm) using verapamil as an internal standard. A gradient from 95% water (0.1% formic acid) to 95% ACN (0.1% formic acid) was run over 2 min at a flow rate of 0.6 mL/min. Brain and blood samples were collected at 15, 30, 60, 120, and 240 min from three C57Bl/6 mice at each time point.</div><div class="NLM_p">The maximum aqueous solubility for compounds <b>CIQ</b>, <b>25a, 25i, 25j, 31a</b>, and <b>EU-1180-453</b> was determined using a BMG Labtech Nephelostar nephelometer (Offenburg, Germany) according to manufacturerâs instructions. Compound powder (1â3 mg) was taken up in DMSO (Sigma-Aldrich) to a 20 mM stock solution and serially diluted (â¼10 Î¼L) to 15.0, 10.0, 5.00, 2.50, 1.25, and 0.625 Î¼M stock solutions. These, along with a DMSO blank, were distributed in triplicate to black, clear-bottom 96-well plates in 3 Î¼L increments and subsequently diluted 100-fold using the aqueous oocyte recording solution (pH 7.4) described above. DMSO content was â¤1.0% (v/v). Each solution was shaken gently for 30 min before submission to the nephelometer.</div><div class="NLM_p">Receptor binding profiles, <i>K</i><sub>i</sub> determinations, and hERG activity of compounds <b>25i</b>, <b>31a</b>, and <b>EU-1180-453</b> were generously provided by the National Institute of Mental Healthâs Psychoactive Drug Screening Program, Contract #HHSN-271-2013-00017-C (NIMH PDSP). The NIMH PDSP is Directed by Bryan L. Roth at the University of North Carolina at Chapel Hill and Project Officer Jamie Driscoll at NIMH, Bethesda, MD. Radioligand binding was measured in the presence of 10 Î¼M test compound. A <i>K</i><sub>i</sub> value was determined for each receptor at which test compound showed >50% inhibition. For experimental details, refer to the PDSP website <a href="https://pdsp.unc.edu/ims/investigator/web/" class="extLink">https://pdsp.unc.edu/ims/investigator/web/</a>.</div><div class="NLM_p">Compounds <b>25i</b>, <b>31a</b>, and <b>EU-1180-453</b> were also tested at 10 Î¼M for actions at AMPA (GluA1-4), kainate (GluK2), GluN3 (GluN3A-B), nicotinic acetylcholine (Î±1Î²2Î³Î´, Î±4Î²2, Î±7), serotonin (5-HT<sub>3A</sub>), GABA<sub>A</sub> (Î±<sub>1</sub>Î²<sub>2</sub>Î³<sub>2S</sub>), GABA<sub>C</sub> (Ï1), glycine (Î±1), and purinergic (P<sub>2X</sub> human) receptors expressed in <i>Xenopus</i> oocytes. cRNA encoding the receptor subunits was synthesized from linear template cDNA using the mMessage mMachine kit (Ambion). Oocytes were injected with 1â5 ng cRNA in a 50 nL volume and incubated in Barthâs solution at 15 Â°C for 2â5 days prior to recording. Î±1Î²2Î³Î´ nAChR subunits were injected at a 1:1:1:1 ratio, while Î±4Î²2 and Î±7 nAChR subunits were injected at a 1:1 ratio. The cDNAs encoding GABA<sub>C</sub>, glycine, and serotonin subunits were provided by Dr. D. Weiss (University of Texas Health Science Center at San Antonio). cDNAs encoding nicotinic acetylcholine receptor subunits were provided by Drs. R. Papke (University of Florida) and S. Heinemann (Salk Institute). cDNAs encoding the purinergic receptors were provided by Dr. R. Hume (University of Michigan). GABA<sub>A</sub> receptors were activated by 100 Î¼M GABA, and GABA<sub>C</sub> receptors were activated by 100 Î¼M GABA. Acetylcholine was used at the indicated concentrations (in Î¼M) to activate the nicotinic acetylcholine receptors: Î±1Î²2Î³Î´ (1), Î±4Î²2 (10), Î±7(300). 100 Î¼M glycine was used to activate the glycine receptor, 100 Î¼M serotonin was used to activate 5-HT<sub>3A</sub> receptor, and 9 Î¼M ATP was used to activate the purinergic receptors. Responses in the presence of test compound were expressed as a percent of control.</div><div class="NLM_p last">Plasma protein binding was determined by equilibrium dialysis using the Rapid Equilibrium Dialysis RED device (Pierce, Catalog #89810), according to manufacturerâs protocol. Compounds were prepared as 100 Î¼M DMSO stocks and spiked into 1 mL of rat plasma (Bioreclamations) to make a final concentration of 1 Î¼M. Plasma (300 Î¼L) was dispensed into wells separated by an 8 KDa permeable cellulose membrane from wells containing 100 mM potassium phosphate, pH 7.4 (500 Î¼L). The compound was tested in triplicate. The RED device was sealed, and the system was allowed to reach equilibrium for 6 h in a 37 Â°C incubator with gentle agitation at 100 rpm. After incubation, plasma samples were prepared by transferring 10 Î¼L from plasma wells to 90 Î¼L of fresh 100 mM potassium phosphate, pH 7.4, and buffer samples were prepared by transferring 90 Î¼L from buffer wells to 10 Î¼L of naÃ¯ve plasma. In addition, a reference sample without equilibration was prepared in triplicate by mixing 10 Î¼L of plasma containing 1 Î¼M compound with 90 Î¼L of buffer to determine compound recovery from the assay. Two volumes of 1:1 acetonitrile:methanol spiked with the internal standard phenytoin (0.2 Î¼g/mL) were added to reference and samples. Precipitation of plasma protein binding was allowed for 15 min before the reference and samples were centrifuge clarified. Supernatant (10 Î¼L) was used for LC/MS/MS analyses. Compounds were quantified on an API4000 MS/MS System (Applied Biosystems, Concord, Ontario, Canada) interfaced with an Agilent 1100 Series HPLC as previously described.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Chemistry</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> General Experimental</h4><div class="NLM_p">All starting materials were purchased from commercial sources and used directly without further purification. Purification by flash column chromatography was done using a Teledyne ISCO Combiflash Companion instrument using Teledyne Redisep normal phase columns. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Mercury-300, VNMR-400, INOVA-400, INOVA-500, or INOVA-600 NMR spectrometer. Chemical shifts were reported in ppm and referenced to the residual deuterated solvent. Reactions were monitored by thin-layer chromatography on precoated aluminum plates (silica gel 60 F254, 0.25 mm) or liquid chromatographyâmass spectrometry (LCMS) on an Agilent Technologies 1200 series instrument. High-resolution mass spectra were recorded on a VG 70-S Nier Johnson or JEOL instrument by the Emory University Mass Spectroscopy Center. Purity was established via LCMS (Varian) in at least two solvent systems (MeOH:water/ACN:water or MeOH:water/MeOH:water) unless otherwise noted. All compounds described were >95% pure by LCMS besides one compound (<b>12k</b>) that was >85% pure. Optical rotations were established using a PerkinElmer 314 instrument.</div><div id="sec4_2_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> General Procedure for Î±-Chloro Ketones (Procedure I)</h5><div class="NLM_p last">Methyl ester (1 equiv) was dissolved in DCE (1.0 M), and 1 M tin(IV) chloride in DCM (5 equiv) was added dropwise for 10 min at room temperature. 2-Chloroacetyl chloride (4 equiv) was then added at room temperature, and the resulting mixture was heated to reflux for 90 min. Upon completion, the reaction was cooled to room temperature and quenched carefully with 1 M HCl. The aqueous layer was extracted with DCM, washed with saturated NaHCO<sub>3</sub> (2Ã) and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography to afford the title compound.</div></div><div id="sec4_2_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> General Procedure for Biaryl Ketones (Procedure II)</h5><div class="NLM_p last">To a suspension of potassium iodide (1.2 equiv) and potassium carbonate (2 equiv) in acetone (0.17 M) were added Î±-chloro ketone (1 equiv) and phenol (1.2 equiv). The resulting mixture was then heated open to atmosphere at reflux for 4 h. Upon completion, the reaction was cooled to room temperature and solvent was removed <i>in vacuo</i>. The resulting residue was then dissolved in EtOAc and washed with water. The organic layer was then extracted with EtOAc, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography to afford the title compound.</div></div><div id="sec4_2_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> General Procedure for Eneamides (Procedure III)</h5><div class="NLM_p last">An appropriate microwave vial was charged with ketone (1 equiv), primary amine (1.2 equiv), tetraisopropoxytitanium (3 equiv), and DCE (0.2 M). The solution was stirred for 10 min before sodium triacetoxyborohydride (3 equiv) was added, and the mixture was irradiated at 120 Â°C for 30 min. Upon completion, the reaction was cooled to room temperature, diluted with DCM, and washed with 1 M HCl. The organic layer was extracted with DCM, washed with NaHCO<sub>3</sub>, washed with brine (3Ã), dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography to afford the title compound as a mixture of <i>E</i>/<i>Z</i> isomers, the mass was confirmed via LCMS, and carried forward without further characterization.</div></div><div id="sec4_2_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> General Procedure for Final 1,4-Dihydroisoquinolin-3(2<i>H</i>)-one Compounds (Procedure IV-A)</h5><div class="NLM_p last">A 10 mL microwave vial was charged with eneamide (1 equiv), platinum(IV) oxide (10 mol %), and ethanol. The vial was then purged with hydrogen, evacuated (3Ã) and reacted at room temperature under hydrogen for 6â24 h, and monitored via LCMS to ensure no dehalogenation occurred. Upon first sight of dehalogenation via LCMS, the reaction was diluted with MeOH, filtered through a plug of celite washing with MeOH, and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography to afford the title compound.</div></div><div id="sec4_2_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> General Procedure for Final 1,4-Dihydroisoquinolin-3(2<i>H</i>)-one Compounds (Procedure IV-B)</h5><div class="NLM_p last">Eneamide (1 equiv) was dissolved in ethanol, 10% Pd/C (0.15 equiv) was added, and the mixture was hydrogenated at 50 psi overnight. The reaction mixture was filtered through a pad of celite, washed with methanol, and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography to afford the title compound.</div></div><div id="sec4_2_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> General Procedure for Î±-Chloro Amides (Procedure <b>V</b>)</h5><div class="NLM_p last">Primary amine (1 equiv) was dissolved in dry DCM, and triethylamine (2 equiv) was added. The solution was brought to 0 Â°C, 2-chloroacetyl chloride (1.2 equiv) was added, and the mixture was reacted at room temperature for 1 h, when deemed complete by LCMS. The reaction was then quenched with 1 M HCl, extracted into DCM, washed with brine (3Ã), dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography to afford the title compound.</div></div><div id="sec4_2_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> General Procedure for Alkylation of Alkyl Halides Using Cesium Carbonate (Procedure <b>VI</b>)</h5><div class="NLM_p last">Phenol (1.2 equiv) was dissolved in acetonitrile and cesium carbonate (4 equiv) was added. This mixture was stirred at room temperature for 2 h before Î±-chloroamide (1 equiv) in acetonitrile was added and allowed to react at room temperature overnight. The reaction was then quenched with saturated ammonium chloride, and the product extracted into EtOAc, washed with brine (3Ã), dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography to afford the title compound.</div></div><div id="sec4_2_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> General Procedure for Alkylation of Alkyl Halide Using Sodium Hydride (Procedure <b>VII</b>)</h5><div class="NLM_p last">60% Sodium hydride dispersion in mineral oil (1.4â3 equiv) was added to a solution of alcohol (1.2 equiv) in dry THF or DMF (ca. 0.4â0.8 M) at 0 Â°C under argon. After 30 min, alkyl halide in dry THF (â¼0.4â0.8 M) was added dropwise, and the mixture was stirred at room temperature overnight. Upon reaction completion, excess sodium hydride was quenched with water, poured over ice, and 1 M HCl was added. The organic layer was extracted with ethyl acetate (3Ã), and the organic layers were combined, washed with brine (1Ã), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography to afford the title compound.</div></div><div id="sec4_2_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> General Procedure for BischlerâNapieralski Cyclization (Procedure <b>VIII</b>)</h5><div class="NLM_p last">Acetamide (1 equiv) was dissolved in dry acetonitrile (â¼0.05 M), and POCl<sub>3</sub> (3 equiv) was added. This was reacted at reflux overnight when the reaction was deemed complete via thin-layer chromatography (TLC). The reaction was cooled to room temperature and concentrated <i>in vacuo</i> to afford the crude compound. The crude imine was dissolved in dry MeOH and cooled to 0 Â°C before sodium borohydride (3 equiv) was added in â¼100 mg portions. The mixture was stirred at room temperature for 10 min. The reaction was then concentrated and subsequently partitioned between EtOAc and H<sub>2</sub>O. The product was then extracted into EtOAc, washed with brine (3Ã), dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography to afford the title compound.</div></div><div id="sec4_2_1_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> General Procedure for Tetrahydroisoquinolines (Procedure <b>IX</b>)</h5><div class="NLM_p last">Secondary amine (1 equiv) was dissolved in dry DCM, triethylamine (2 equiv) was added, and the solution was brought to 0 Â°C before acid chloride (1.2 equiv) was added dropwise. The mixture was stirred at room temperature for 1 h. The reaction was then quenched with 1 M HCl, and the organic layer was extracted into DCM, washed with brine (3Ã), dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography to afford the title compound.</div></div><div id="sec4_2_1_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> General Procedure for S<sub>N</sub>Ar Reactions (Procedure <b>X</b>)</h5><div class="NLM_p last">Primary alcohol (1 equiv) was dissolved in dry THF or DMF (â¼0.2 M), and 60% sodium hydride dispersion in mineral oil (2â3 equiv) was added. This mixture was stirred for 30 min at room temperature before heteroaryl halide (1.5 equiv) was added. The reaction was stirred at 70 Â°C overnight and then cooled to room temperature, quenched carefully with water, and diluted with both EtOAc and water. The aqueous layer was extracted with EtOAc, the organic layers were combined, washed with brine (3Ã), dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography to afford the title compound.</div></div><div id="sec4_2_1_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> General Procedure for Nitro Alkenes (Procedure <b>XI</b>)</h5><div class="NLM_p last">Aldehyde (1 equiv) was dissolved in dry nitromethane (â¼1 M), and to this solution butylamine (0.12 equiv), acetic acid (0.2 equiv), and 4 Ã molecular sieves (â¼10 wt %) were added. The solution was brought to reflux for 30 min before the mixture was concentrated <i>in vacuo</i>, and the crude material was purified via flash column chromatography to afford the title compound.</div></div><div id="sec4_2_1_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> General Procedure for Ethylamines (Procedure <b>XII</b>)</h5><div class="NLM_p last">Sulfuric acid (2.23 equiv) was added dropwise to a solution of lithium aluminum hydride (4.46 equiv) in THF (â¼0.15 M) at 0 Â°C and stirred for 20 min. Nitroalkene (1 equiv) dissolved in dry THF (â¼1.5 M) was then added dropwise at 0 Â°C and stirred for 10 min. The mixture was then heated to reflux for 5 min, cooled to 0 Â°C, and quenched carefully with <i>i</i>PrOH (6 equiv) and NaOH (9 equiv). The resulting suspension was then filtered and concentrated <i>in vacuo</i> to afford the crude title compound that was carried forward without further purification.</div></div><div id="sec4_2_1_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> General Procedure for Carboxylic Acid Coupling to Final Compounds (Procedure <b>XIII</b>)</h5><div class="NLM_p last">Carboxylic acid (1.1 equiv) was dissolved in dry DCM and cooled to 0 Â°C. EDCI (1.2 equiv) and DMAP (1.2 equiv) were then added and stirred for 2 h before the free amine (1 equiv) was added, and the mixture was stirred at room temperature overnight. The reaction was then quenched with deionized water, and the organic layer was extracted into DCM, washed with brine (3Ã), dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography to afford the title compound.</div></div><div id="sec4_2_1_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> General Procedure for Thioamides (Procedure <b>XIV</b>)</h5><div class="NLM_p last">Amide (1 equiv) in a microwave vial was dissolved in toluene and Lawessonâs reagent (1.5 equiv) was added. This mixture was allowed to react in microwave at 150 Â°C for 20 min. The reaction was then diluted with DCM; washed with saturated NaHCO<sub>3</sub>, water, and brine; dried over MgSO<sub>4</sub>; and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography to afford the title compound.</div></div><div id="sec4_2_1_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> General Procedure for Î±-Chloro Ketones Using DBN (Procedure <b>XV</b>)</h5><div class="NLM_p last">Methyl ester (1 equiv) was dissolved in PhMe (0.5 M) and DBN (0.15 equiv) was added followed by chloroacetyl chloride (1.2 equiv). The mixture was heated to 115 Â°C and reacted for 4 h. The reaction was then diluted with DCM, and the organic layer was washed with 1 M HCL followed by 1 M NaOH. The organic layer was then dried over MgSO<sub>4</sub> and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography to afford the title compound.</div></div><div id="sec4_2_1_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> General Procedure for Biaryl Ketones (Procedure <b>XVI</b>)</h5><div class="NLM_p last">To a suspension of potassium iodide (1.2 equiv) and potassium carbonate (2 equiv) in acetone (0.3 M) were added Î±-chloro ketone (1 equiv) and phenol (1.2 equiv). The resulting mixture was then stirred open to atmosphere at room temperature overnight. Upon completion, the solvent was removed <i>in vacuo</i> and the resulting residue was dissolved in EtOAc and washed with water. The aqueous layer was then extracted with EtOAc, and all organic layers were combined, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography to afford the title compound.</div></div><div id="sec4_2_1_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> General Procedure for Tertiary Eneamides (Procedure <b>XVII</b>)</h5><div class="NLM_p last">An appropriate microwave vial was charged with ketone (1 equiv), primary amine (1.2 equiv), tetraisopropoxytitanium (3 equiv), and DCE (0.2 M), and the solution was stirred for 10 min before sodium triacetoxyborohydride (3 equiv) was added. The mixture was irradiated at 120 Â°C for 2 h. Upon completion, the reaction was cooled to room temperature, diluted with DCM, and washed with 1 M HCl. The organic layer was extracted with DCM, washed with NaHCO<sub>3</sub>, washed with brine (3Ã), dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography to afford the title compound as a mixture of <i>E</i>/<i>Z</i> isomers, mass was confirmed via LCMS, and it was carried forward without further characterization.</div></div><div id="sec4_2_1_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> General Procedure for Final Pyrrolopyrazinone Compounds (Procedure <b>XVIII</b>)</h5><div class="NLM_p last">Eneamide (1 equiv) was dissolved in EtOAc, and 10% Pd/C (0.15 equiv) was added. The flask was purged with hydrogen from a balloon (3Ã), and the mixture was hydrogenated (1 atm) overnight. The reaction mixture was filtered through a pad of celite, washed with methanol, and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography to afford the title compound.</div></div><div id="sec4_2_1_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> Methyl 2-(3-Isopropoxyphenyl)acetate (<b>8a</b>)</h5><div class="NLM_p last">Methyl 2-(3-hydroxyphenyl)acetate (7.83 g, 47.1 mmol) was dissolved in THF (196 mL), and isopropanol (5.40 mL, 70.7 mmol), triphenylphosphine (18.5 g, 70.7 mmol), and 40% diethyl azodicarboxylate in toluene (32.2 mL, 70.7 mmol) were added and allowed to react overnight at room temperature. The crude product was purified via flash column chromatography (ISCO, Redisep 120 g column, 0â60% EtOAc/hexanes gradient) to afford the title compound as a clear oil (8.19 g, 83%). <i>R<sub>f</sub></i> (1:1 EtOAC/Hex): 0.88; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.22 (t, <i>J</i> = 8.1 Hz, 1H), 6.88â6.76 (m, 3H), 4.55 (hept, <i>J</i> = 6.1 Hz, 1H), 3.69 (s, 3H), 3.59 (s, 2H), 1.34 (d, <i>J</i> = 6.1 Hz, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 171.9, 158.0, 135.3, 129.5, 121.3, 116.8, 114.3, 69.7, 52.0, 41.2, 22.0. HRMS calcd for C<sub>12</sub>H<sub>17</sub>O<sub>3</sub>, 209.11722 [M + H]<sup>+</sup>; found 209.11720 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> Methyl 2-(3-Isobutoxyphenyl)acetate (<b>8b</b>)</h5><div class="NLM_p last">Methyl 2-(3-hydroxyphenyl)acetate (2.50 g, 15.0 mmol) was dissolved in dry DMF (46 mL) and potassium carbonate (8.32 g, 60.2 mmol) was added. This mixture was stirred at room temperature for 2 h before 1-iodo-2-methylpropane (3.70 mL, 30.1 mmol) was added. The resulting mixture was allowed to react at 60 Â°C overnight, after which the reaction was deemed complete via TLC. The product was then extracted into EtOAc, washed with brine (3Ã), dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography (ISCO, Redisep 40 g column, 0â20% EtOAc/hexanes gradient) to afford the title compound as a clear oil (1.64 g, 49%). <i>R<sub>f</sub></i> (1:1 EtOAC/Hex): 0.91; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.25â7.20 (m, 1H), 6.88â6.77 (m, 3H), 3.72 (d, <i>J</i> = 6.5 Hz, 2H), 3.70 (s, 3H), 3.60 (s, 2H), 2.16â2.01 (m, 1H), 1.03 (d, <i>J</i> = 6.7 Hz, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 172.0, 159.4, 135.3, 129.5, 121.3, 115.5, 113.2, 74.3, 52.1, 41.2, 28.3, 19.3. HRMS calcd for C<sub>13</sub>H<sub>19</sub>O<sub>3</sub>, 223.13287 [M + H]<sup>+</sup>; found 223.13264 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> Methyl 2-(2-(2-Chloroacetyl)-5-isopropoxyphenyl)acetate (<b>9a</b>)</h5><div class="NLM_p last">General procedure I was followed using <b>8a</b> (8.10 g, 38.9 mmol), 1 M tin(IV) chloride in DCM (194 mL, 194 mmol), and 2-chloroacetyl chloride (12.5 mL, 156 mmol) in DCE (39 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 80 g column, 0â30% EtOAc/hexanes gradient) to afford the title compound as a white solid (5.20 g, 47%). <i>R<sub>f</sub></i> (1:1 EtOAC/Hex): 0.81; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.74 (d, <i>J</i> = 8.7 Hz, 1H), 6.82 (dd, <i>J</i> = 8.7, 2.6 Hz, 1H), 6.75 (d, <i>J</i> = 2.6 Hz, 1H), 4.63 (hept, <i>J</i> = 5.8 Hz, 3H), 4.63 (s, 2H), 3.91 (s, 2H), 3.68 (s, 3H), 1.35 (d, <i>J</i> = 6.1 Hz, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 191.6, 171.6, 161.4, 138.6, 132.3, 125.9, 120.5, 113.1, 70.2, 51.95, 47.2, 40.7, 21.9. HRMS calcd for C<sub>14</sub>H<sub>18</sub>O<sub>4</sub>Cl, 285.08881 [M + H]<sup>+</sup>; found 285.08867 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> Methyl 2-(2-(2-Chloroacetyl)-5-isobutoxyphenyl)acetate (<b>9b</b>)</h5><div class="NLM_p last">General procedure I was followed using <b>8b</b> (1.08 g, 4.86 mmol), 1 M tin(IV) chloride in DCM (24.3 mL, 24.3 mmol), and 2-chloroacetyl chloride (1.56 mL, 19.4 mmol) in DCE (4.9 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 80 g column, 0â30% EtOAc/hexanes gradient) to afford the title compound as a white solid (0.70 g, 48%). <i>R<sub>f</sub></i> (1:1 EtOAC/Hex): 0.88; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.74 (d, <i>J</i> = 8.7 Hz, 1H), 6.85 (dd, <i>J</i> = 8.7, 2.6 Hz, 1H), 6.79 (d, <i>J</i> = 2.6 Hz, 1H), 4.63 (s, 2H), 3.92 (s, 2H), 3.77 (d, <i>J</i> = 6.5 Hz, 2H), 3.69 (s, 3H), 2.08 (hept, <i>J</i> = 6.7 Hz, 1H), 1.01 (d, <i>J</i> = 6.7 Hz, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 191.7, 171.6, 162.6, 138.5, 132.2, 126.1, 119.6, 112.4, 74.5, 52.0, 47.2, 40.7, 28.1, 19.1. HRMS calcd for C<sub>15</sub>H<sub>20</sub>O<sub>4</sub>Cl, 299.10446 [M + H]<sup>+</sup>; found 299.10431 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> Methyl 2-(2-(2-Chloroacetyl)-5-methoxyphenyl)acetate (<b>9c</b>)</h5><div class="NLM_p last">General procedure I was followed using methyl 2-(3-methoxyphenyl)acetate (<b>8c</b>) (2.23 mL, 13.9 mmol), 1 M tin(IV) chloride in DCM (69.4 mL, 69.4 mmol), and 2-chloroacetyl chloride (4.45 mL, 55.5 mmol) in DCE (14 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 40 g column, 0â50% EtOAc/hexanes gradient) to afford the title compound as a white solid (1.65 g, 46%). <i>R<sub>f</sub></i> (1:1 EtOAC/Hex): 0.66; <sup>1</sup>H NMR (399 MHz, CDCl<sub>3</sub>) Î´ 7.75 (d, <i>J</i> = 8.7 Hz, 1H), 6.86 (dd, <i>J</i> = 8.7, 2.6 Hz, 1H), 6.78 (d, <i>J</i> = 2.6 Hz, 1H), 4.63 (s, 2H), 3.92 (s, 2H), 3.85 (s, 3H), 3.69 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 191.8, 171.5, 162.8, 138.6, 132.1, 126.6, 119.1, 112.0, 55.5, 51.9, 47.1, 40.6. HRMS calcd for C<sub>12</sub>H<sub>14</sub>O<sub>4</sub>Cl, 257.05751 [M + H]<sup>+</sup>; found 257.05751 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> Methyl 2-(2-(2-Chloroacetyl)-4,5-dimethoxyphenyl)acetate (<b>9d</b>)</h5><div class="NLM_p last">General procedure I was followed using methyl 2-(3,4-dimethoxyphenyl)acetate (<b>8d</b>) (2.50 g, 11.9 mmol), 1 M tin(IV) chloride in DCM (59.5 mL, 59.5 mmol), and 2-chloroacetyl chloride (3.81 mL, 47.6 mmol) in DCE (12 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 40 g column, 0â55% EtOAc/hexanes gradient) to afford the title compound as a white solid (1.13 g, 33%). <i>R<sub>f</sub></i> (1:1 EtOAC/Hex): 0.45; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.23 (s, 1H), 6.74 (s, 1H), 4.63 (s, 2H), 3.92 (s, 3H), 3.91 (s, 3H), 3.88 (s, 2H), 3.68 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 191.9, 171.8, 152.4, 147.4, 130.5, 126.0, 115.6, 112.7, 56.2, 56.0, 52.0, 47.2, 40.0. HRMS calcd for C<sub>13</sub>H<sub>16</sub>O<sub>5</sub>Cl, 287.06808 [M + H]<sup>+</sup>; found 287.06795 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> Methyl 2-(5-Isopropoxy-2-(2-(4-methoxyphenoxy)acetyl)phenyl)acetate (<b>10a</b>)</h5><div class="NLM_p last">General procedure II was followed using <b>9a</b> (332 mg, 1.17 mmol), potassium iodide (232 mg, 1.40 mmol), 4-methoxyphenol (174 mg, 1.40 mmol), and potassium carbonate (322 mg, 2.33 mmol) in acetone (7 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 0â50% EtOAc/hexanes gradient) to afford the title compound as a white solid (289 mg, 67%). <i>R<sub>f</sub></i> (1:1 EtOAC/Hex): 0.73; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.83 (d, <i>J</i> = 8.7 Hz, 1H), 6.92â6.74 (m, 6H), 5.11 (s, 2H), 4.65 (hept, <i>J</i> = 6.0 Hz, 1H), 3.94 (s, 2H), 3.75 (s, 3H), 3.67 (s, 3H), 1.36 (d, <i>J</i> = 6.1 Hz, 6H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 195.5, 171.8, 161.3, 154.3, 152.3, 138.32, 131.8, 126.3, 120.4, 115.9, 114.6, 113.1, 76.8, 72.1, 70.2, 55.7, 52.0, 40.5, 21.9. HRMS calcd for C<sub>21</sub>H<sub>25</sub>O<sub>6</sub>, 373.17043 [M + H]<sup>+</sup>; found 373.17143 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> Methyl 2-(5-Isobutoxy-2-(2-(4-methoxyphenoxy)acetyl)phenyl)acetate (<b>10b</b>)</h5><div class="NLM_p last">General procedure II was followed using <b>9b</b> (700 mg, 2.34 mmol), potassium iodide (467 mg, 2.81 mmol), 4-methoxyphenol (349 mg, 2.81 mmol), and potassium carbonate (648 mg, 4.69 mmol) in acetone (14 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 0â30% EtOAc/hexanes gradient) to afford the title compound as a white solid (469 mg, 52%). <i>R<sub>f</sub></i> (1:1 EtOAC/Hex): 0.90; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.83 (d, <i>J</i> = 8.7 Hz, 1H), 6.90â6.73 (m, 6H), 5.11 (s, 2H), 3.94 (s, 2H), 3.78 (d, <i>J</i> = 6.6 Hz, 2H), 3.75 (s, 3H), 3.67 (s, 3H), 2.10 (hept, <i>J</i> = 6.5 Hz, 1H), 1.03 (d, <i>J</i> = 6.7 Hz, 6H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 195.6, 171.8, 162.5, 154.3, 152.3, 138.3, 131.8, 126.5, 119.5, 114.6, 112.4, 74.6, 72.1, 55.7, 52.0, 40.5, 28.2, 19.2. HRMS calcd for C<sub>22</sub>H<sub>27</sub>O<sub>6</sub>, 387.18022 [M + H]<sup>+</sup>; found 387.18013 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> Methyl 2-(5-Methoxy-2-(2-(4-methoxyphenoxy)acetyl)phenyl)acetate (<b>10c</b>)</h5><div class="NLM_p last">General procedure II was followed using <b>9c</b> (10.2 g, 39.7 mmol), potassium iodide (7.92 g, 47.7 mmol), 4-methoxyphenol (5.92 g, 47.7 mmol), and potassium carbonate (11.0 g, 79.0 mmol) in acetone (238 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 120 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as a white solid (7.23 g, 53%). <i>R<sub>f</sub></i> (1:1 EtOAC/Hex): 0.59; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.83 (d, <i>J</i> = 8.7 Hz, 1H), 6.88â6.77 (m, 6H), 5.10 (s, 2H), 3.94 (s, 2H), 3.85 (s, 3H), 3.74 (s, 3H), 3.66 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 195.6, 171.7, 162.7, 154.3, 152.2, 138.2, 131.7, 126.8, 119.0, 115.8, 114.6, 112.0, 72.0, 55.6, 55.5, 51.9, 40.5. HRMS calcd for C<sub>19</sub>H<sub>21</sub>O<sub>6</sub>, 345.13326 [M + H]<sup>+</sup>; found 345.13321 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> Methyl 2-(4,5-Dimethoxy-2-(2-(4-methoxyphenoxy)acetyl)phenyl)acetate (<b>10d</b>)</h5><div class="NLM_p last">General procedure II was followed using <b>9d</b> (1.08 g, 3.77 mmol), potassium iodide (750 mg, 4.52 mmol), 4-methoxyphenol (561 mg, 4.52 mmol), and potassium carbonate (1.04 g, 7.53 mmol) in acetone (23 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 24 g column, 20â90% EtOAc/hexanes gradient) to afford the title compound as a white solid (503 mg, 36%). <i>R<sub>f</sub></i> (1:1 EtOAC/Hex): 0.45; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.36 (s, 1H), 6.89â6.78 (m, 4H), 6.75 (s, 1H), 5.08 (s, 2H), 3.93 (s, 3H), 3.91 (s, 3H), 3.90 (s, 2H), 3.75 (s, 3H), 3.67 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 196.1, 172.0, 154.4, 152.3, 152.2, 147.4, 130.2, 126.4, 115.9, 115.5, 114.7, 112.6, 72.6, 56.3, 56.1, 55.7, 52.0, 39.9. HRMS calcd for C<sub>20</sub>H<sub>23</sub>O<sub>7</sub>, 375.14383 [M + H]<sup>+</sup>; found 375.14387 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> (<i>E</i>/<i>Z</i>)-2-(3-Chlorobenzyl)-6-isopropoxy-1-((4-methoxyphenoxy)methylene)-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (<b>11a</b>)</h5><div class="NLM_p last">General procedure III was followed using compound <b>10a</b> (148 mg, 0.397 mmol), 3-chlorobenzylamine (58 Î¼L, 0.48 mmol), tetraisopropoxytitanium (362 Î¼L, 1.19 mmol), and sodium triacetoxyborohydride (253 mg, 1.19 mmol) in DCE (2.0 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 0â35% EtOAc/hexanes gradient) to afford the title compound as a mixture of <i>E</i>/<i>Z</i> isomers and an orange oil (130 mg, 71%). HRMS calcd for C<sub>27</sub>H<sub>27</sub>O<sub>4</sub>NCl, 464.16231 [M + H]<sup>+</sup>; found 464.16224 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> (<i>E</i>/<i>Z</i>)-6-Isopropoxy-1-((4-methoxyphenoxy)methylene)-2-(3-(trifluoromethyl)benzyl)-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (<b>11b</b>)</h5><div class="NLM_p last">General procedure III was followed using compound <b>10a</b> (75 mg, 0.22 mmol), 3-(trifluoromethyl)benzylamine (37 Î¼L, 0.26 mmol), tetraisopropoxytitanium (198 Î¼L, 0.653 mmol), and sodium triacetoxyborohydride (138 mg, 0.653 mmol) in DCE (1.1 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 0â35% EtOAc/hexanes gradient) to afford the title compound as a mixture of <i>E</i>/<i>Z</i> isomers and a yellow oil (45 mg, 45%). HRMS calcd for C<sub>28</sub>H<sub>29</sub>O<sub>4</sub>NF<sub>3</sub>, 500.20432 [M + H]<sup>+</sup>; found 500.20464 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> (<i>E</i>/<i>Z</i>)-2-(3-Fluorobenzyl)-6-isopropoxy-1-((4-methoxyphenoxy)methylene)-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (<b>11c</b>)</h5><div class="NLM_p last">General procedure III was followed using compound <b>10a</b> (50 mg, 0.13 mmol), 3-fluorobenzylamine (18 Î¼L, 0.16 mmol), tetraisopropoxytitanium (122 Î¼L, 0.403 mmol), and sodium triacetoxyborohydride (85 mg, 0.40 mmol) in DCE (0.7 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â35% EtOAc/hexanes gradient) to afford the title compound as a mixture of <i>E</i>/<i>Z</i> isomers and an orange oil (35 mg, 58%). HRMS calcd for C<sub>27</sub>H<sub>27</sub>O<sub>4</sub>NF, 448.19186 [M + H]<sup>+</sup>; found 448.19096 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> (<i>E</i>/<i>Z</i>)-2-(3-Chlorobenzyl)-6-isobutoxy-1-((4-methoxyphenoxy)methylene)-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (<b>11d</b>)</h5><div class="NLM_p last">General procedure III was followed using compound <b>10b</b> (500 mg, 1.29 mmol), 3-chlorobenzylamine (190 Î¼L, 1.55 mmol), tetraisopropoxytitanium (1.18 mL, 3.88 mmol), and sodium triacetoxyborohydride (823 mg, 3.88 mmol) in DCE (6.5 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 0â25% EtOAc/hexanes gradient) to afford the title compound as a mixture of <i>E</i>/<i>Z</i> isomers and an orange oil (450 mg, 73%). HRMS calcd for C<sub>28</sub>H<sub>29</sub>O<sub>4</sub>NCl, 478.17796 [M + H]<sup>+</sup>; found 478.17837 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> (<i>E</i>/<i>Z</i>)-2-(3-Chlorobenzyl)-6-methoxy-1-((4-methoxyphenoxy)methylene)-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (<b>11e</b>)</h5><div class="NLM_p last">General procedure III was followed using compound <b>10c</b> (100 mg, 0.290 mmol), 3-chlorobenzylamine (43 Î¼L, 0.35 mmol), tetraisopropoxytitanium (260 Î¼L, 0.87 mmol), and sodium triacetoxyborohydride (185 mg, 0.871 mmol) in DCE (1.5 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 0â30% EtOAc/hexanes gradient) to afford the title compound as an â¼1:2 mixture of <i>E</i>/<i>Z</i> isomers and an orange oil (74 mg, 59%). HRMS calcd for C<sub>25</sub>H<sub>23</sub>O<sub>4</sub>NCl, 436.13101 [M + H]<sup>+</sup>; found 436.13017 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 85â95% MeOH in water over 5 min at 1 mL/min (retention time = 2.68 min). Method 2: 85â95% ACN in water over 6 min at 1 mL/min (retention time = 2.32 min).</div></div><div id="sec4_2_1_35" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> (<i>E</i>/<i>Z</i>)-6-Methoxy-1-((4-methoxyphenoxy)methylene)-2-(4,4,4-trifluorobutyl)-1,2-dihydroisoquinolin-3(4<i>H</i>)-one (<b>11f</b>)</h5><div class="NLM_p last">General procedure III was followed using compound <b>10c</b> (100 mg, 0.290 mmol), 4,4,4-trifluorobutan-1-amine (44 mg, 0.35 mmol), tetraisopropoxytitanium (260 Î¼L, 0.87 mmol), and sodium triacetoxyborohydride (185 mg, 0.871 mmol) in DCE (1.5 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 0â30% EtOAc/hexanes gradient) to afford the title compound as a mixture of <i>E</i>/<i>Z</i> isomers and an orange oil (42 mg, 34%). HRMS calcd for C<sub>22</sub>H<sub>23</sub>O<sub>4</sub>NF<sub>3</sub>, 422.15737 [M + H]<sup>+</sup>; found 422.15750 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_36" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> (<i>E</i>/<i>Z</i>)-6-Methoxy-1-((4-methoxyphenoxy)methylene)-2-(2,2,2-trifluoroethyl)-1,2-dihydroisoquinolin-3(4<i>H</i>)-one (<b>11g</b>)</h5><div class="NLM_p last">General procedure III was followed using compound <b>10c</b> (150 mg, 0.436 mmol), 2,2,2-trifluoroethanamine (69 Î¼L, 0.87 mmol, 2 equiv), tetraisopropoxytitanium (400 Î¼L, 1.3 mmol), and sodium triacetoxyborohydride (277 mg, 1.31 mmol) in DCE (2 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 0â30% EtOAc/hexanes gradient) to afford the title compound as a mixture of <i>E</i>/<i>Z</i> isomers and a yellow oil (33 mg, 19%). HRMS calcd for C<sub>20</sub>H<sub>19</sub>O<sub>4</sub>NF<sub>3</sub>, 394.12607 [M + H]<sup>+</sup>; found 394.12617 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_37" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> (<i>E</i>/<i>Z</i>)-6-Methoxy-1-((4-methoxyphenoxy)methylene)-2-propyl-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (<b>11h</b>)</h5><div class="NLM_p last">General procedure III was followed using compound <b>10c</b> (75 mg, 0.22 mmol), propylamine (21 Î¼L, 0.26 mmol), tetraisopropoxytitanium (198 Î¼L, 0.653 mmol), and sodium triacetoxyborohydride (138 mg, 0.653 mmol) in DCE (1.1 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 0â40% EtOAc/hexanes gradient) to afford the title compound as a mixture of <i>E</i>/<i>Z</i> isomers and a brown oil (31 mg, 40%). HRMS calcd for C<sub>21</sub>H<sub>28</sub>O<sub>4</sub>N, 358.20128 [M + H]<sup>+</sup>; found 358.20118 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_38" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> (<i>E</i>/<i>Z</i>)-2-(2-(1<i>H</i>-Indol-3-yl)ethyl)-6-methoxy-1-((4-methoxyphenoxy)methylene)-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (<b>11i</b>)</h5><div class="NLM_p last">General procedure III was followed using compound <b>10c</b> (75 mg, 0.22 mmol), tryptamine (42 mg, 0.26 mmol), tetraisopropoxytitanium (198 Î¼L, 0.653 mmol), and sodium triacetoxyborohydride (138 mg, 0.653 mmol) in DCE (1.1 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 0â35% EtOAc/hexanes gradient) to afford the title compound as a mixture of <i>E</i>/<i>Z</i> isomers and a red oil (20 mg, 40%). HRMS calcd for C<sub>28</sub>H<sub>27</sub>O<sub>4</sub>N<sub>2</sub>, 455.19653 [M + H]<sup>+</sup>; found 455.19586 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_39" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76"> (<i>E</i>/<i>Z</i>)-6-Methoxy-2-(2-(2-methoxyethoxy)ethyl)-1-((4-methoxyphenoxy)methylene)-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (<b>11j</b>)</h5><div class="NLM_p last">General procedure III was followed using compound <b>10c</b> (60 mg, 0.18 mmol), 2-(2-methoxyethoxy)ethanamine (25 mg, 0.21 mmol), tetraisopropoxytitanium (159 Î¼L, 0.524 mmol), and sodium triacetoxyborohydride (111 mg, 0.524 mmol) in DCE (0.9 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as a mixture of <i>E</i>/<i>Z</i> isomers and a red oil (14 mg, 19%). HRMS calcd for C<sub>23</sub>H<sub>28</sub>O<sub>6</sub>N, 414.19111 [M + H]<sup>+</sup>; found 414.19038 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_40" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> (<i>E</i>/<i>Z</i>)-2-(3-(Dimethylamino)propyl)-6-methoxy-1-((4-methoxyphenoxy)methylene)-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (<b>11k</b>)</h5><div class="NLM_p last">General procedure III was followed using compound <b>10c</b> (50 mg, 0.15 mmol), 3-(dimethylamino)-1-propylamine (37 Î¼L, 0.29 mmol, 2 equiv), tetraisopropoxytitanium (132 Î¼L, 0.436 mmol), and sodium triacetoxyborohydride (92 mg, 0.44 mmol) in DCE (0.7 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 0â10% DCM/(1% NH<sub>4</sub>OH in MeOH) gradient) to afford the title compound as a mixture of <i>E</i>/<i>Z</i> isomers and a red oil (13 mg, 23%). HRMS calcd for C<sub>23</sub>H<sub>29</sub>O<sub>4</sub>N<sub>2</sub>, 397.21218 [M + H]<sup>+</sup>; found 397.21243 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_41" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78"> (<i>E</i>/<i>Z</i>)-6-Methoxy-1-((4-methoxyphenoxy)methylene)-2-(prop-2-yn-1-yl)-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (<b>11l</b>)</h5><div class="NLM_p last">General procedure III was followed using compound <b>10c</b> (200 mg, 0.581 mmol), propargylamine (112 Î¼L, 1.74 mmol), tetraisopropoxytitanium (495 Î¼L, 1.74 mmol), and sodium triacetoxyborohydride (369 mg, 1.74 mmol) in DCE (3 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 0â30% EtOAc/hexanes gradient) to afford the title compound as a single <i>E</i>/<i>Z</i> isomer and a white solid (160 mg, 80%). HRMS calcd for C<sub>21</sub>H<sub>20</sub>O<sub>4</sub>N, 350.13868 [M + H]<sup>+</sup>; found 350.13837 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_42" class="NLM_sec NLM_sec_level_4"><div id="ac_i79" class="anchor-spacer"></div><h5 class="article-section__title" id="_i79"> 2-((1<i>H</i>-1,2,3-Triazol-4-yl)methyl)-6-methoxy-1-((4-methoxyphenoxy)methylene)-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (<b>11m</b>)</h5><div class="NLM_p last">37% Formaldehyde in H<sub>2</sub>O (0.17 mL, 2.2 mmol, 10 equiv) and acetic acid (0.018 mL, 0.32 mmol, 1.5 equiv) were dissolved in THF (0.2 mL) and stirred for 15 min. Sodium azide (21 mg, 0.32 mmol, 1.5 equiv) and <b>11l</b> (75 mg, 0.22 mmol, 1 equiv) dissolved in THF (0.2 mL) were then added in succession and stirred for 10 min. Then, sodium ascorbate (9.0 mg, 0.045 mmol, 0.2 equiv) was added, followed by an aqueous CuSO<sub>4</sub> solution (200 mg/mL, 0.05 equiv), and the reaction was stirred at room temperature for 24 h. The reaction was then concentrated before being dissolved in EtOAc and washed with 1 M NaOH. The organic layer was extracted with EtOAc, washed with brine (3Ã), dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 0â10% DCM/(1% NH<sub>4</sub>OH in MeOH) gradient) to afford the title compound as a single <i>E</i>/<i>Z</i> isomer and a yellow oil (24 mg, 29%). <i>R<sub>f</sub></i> (90:10:0.1 DCM/MeOH/NH<sub>4</sub>OH): 0.46; <sup>1</sup>H NMR (399 MHz, CDCl<sub>3</sub>) Î´ 7.51 (s, 1H), 7.20 (d, <i>J</i> = 8.5 Hz, 1H), 6.99â6.95 (m, 2H), 6.88â6.83 (m, 3H), 6.75 (dd, <i>J</i> = 8.5, 2.6 Hz, 1H), 6.70 (d, <i>J</i> = 2.4 Hz, 1H), 6.53 (s, 1H), 5.23 (s, 2H), 3.79 (s, 3H), 3.78 (s, 3H), 3.68 (s, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 169.5, 159.5, 156.0, 150.7, 132.1, 130.8, 130.8, 123.8, 123.7, 121.9, 117.8, 114.9, 114.8, 113.2, 112.1, 55.7, 55.4, 40.0, 39.0. HRMS calcd for C<sub>21</sub>H<sub>21</sub>O<sub>4</sub>N<sub>4</sub>, 393.15573 [M + H]<sup>+</sup>; found 393.15487 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_43" class="NLM_sec NLM_sec_level_4"><div id="ac_i80" class="anchor-spacer"></div><h5 class="article-section__title" id="_i80"> (<i>E</i>/<i>Z</i>)-2-(3-Chlorobenzyl)-6,7-dimethoxy-1-((4-methoxyphenoxy)methylene)-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (<b>11n</b>)</h5><div class="NLM_p last">General procedure III was followed using compound <b>10d</b> (200 mg, 0.534 mmol), 3-chlorobenzylamine (78 Î¼L, 0.64 mmol), tetraisopropoxytitanium (486 Î¼L, 1.60 mmol), and sodium triacetoxyborohydride (340 mg, 1.60 mmol) in DCE (2.7 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 0â35% EtOAc/hexanes gradient) to afford the title compound as a mixture of <i>E</i>/<i>Z</i> isomers and a white solid (150 mg, 59%). HRMS calcd for C<sub>26</sub>H<sub>25</sub>O<sub>5</sub>NCl, 466.14158 [M + H]<sup>+</sup>; found 466.14082 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_44" class="NLM_sec NLM_sec_level_4"><div id="ac_i81" class="anchor-spacer"></div><h5 class="article-section__title" id="_i81"> 2-(3-Chlorobenzyl)-6-isopropoxy-1-((4-methoxyphenoxy)methyl)-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (<b>12a</b>)</h5><div class="NLM_p last">General procedure IV-A was followed using compound <b>11a</b> (150 mg, 0.323 mmol) and PtO<sub>2</sub> (19 mg, 0.046 mmol) in ethanol (2.6 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â50% EtOAc/hexanes gradient) to afford the title compound as an orange oil (15 mg, 10%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.59; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.22â7.15 (m, 3H), 7.09â7.05 (m, 1H), 7.04 (d, <i>J</i> = 8.4 Hz, 1H), 6.81â6.69 (m, 6H), 5.46 (d, <i>J</i> = 15.4 Hz, 1H), 4.63â4.59 (m, 1H), 4.54 (hept, <i>J</i> = 6.1 Hz, 1H), 4.37 (d, <i>J</i> = 15.4 Hz, 1H), 4.08â3.99 (m, 2H), 3.91 (d, <i>J</i> = 19.3 Hz, 1H), 3.75 (s, 3H), 3.64 (d, <i>J</i> = 19.3 Hz, 1H), 1.33 (d, <i>J</i> = 6.1 Hz, 6H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 169.7, 157.8, 154.3, 152.2, 139.2, 134.5, 134.1, 130.0, 128.0, 127.6, 127.1, 125.8, 124.3, 115.4, 114.7, 114.4, 114.3, 71.7, 70.0, 59.9, 55.7, 48.6, 37.7, 22.1. HRMS calcd for C<sub>27</sub>H<sub>29</sub>O<sub>4</sub>NCl, 466.17796 [M + H]<sup>+</sup>; found 466.17791 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 90â95% MeOH in water over 5 min at 1 mL/min (retention time = 2.56 min). Method 2: 85â95% ACN in water over 6 min at 1 mL/min (retention time = 3.00 min).</div></div><div id="sec4_2_1_45" class="NLM_sec NLM_sec_level_4"><div id="ac_i82" class="anchor-spacer"></div><h5 class="article-section__title" id="_i82"> 6-Isopropoxy-1-((4-methoxyphenoxy)methyl)-2-(3-(trifluoromethyl)benzyl)-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (<b>12b</b>)</h5><div class="NLM_p last">General procedure IV-B was followed using compound <b>11b</b> (45 mg, 0.090 mmol) and 10% Pd/C (14 mg, 0.014 mmol) in ethanol (5 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â50% EtOAc/hexanes gradient) to afford the title compound as a clear oil (32 mg, 71%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.65; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.51â7.44 (m, 2H), 7.39â7.34 (m, 2H), 7.04 (d, <i>J</i> = 8.4 Hz, 1H), 6.82â6.77 (m, 2H), 6.76â6.73 (m, 1H), 6.73â6.66 (m, 3H), 5.52 (d, <i>J</i> = 15.6 Hz, 1H), 4.65â4.59 (m, 1H), 4.58â4.51 (m, 1H), 4.48 (d, <i>J</i> = 15.5 Hz, 1H), 4.10â4.00 (m, 2H), 3.93 (d, <i>J</i> = 19.2 Hz, 1H), 3.75 (s, 3H), 3.66 (d, <i>J</i> = 19.3 Hz, 1H), 1.33 (d, <i>J</i> = 6.1 Hz, 6H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 169.8, 157.9, 154.3, 152.1, 138.2, 134.0, 130.9, 130.9 (q, <i>J</i> = 32.0 Hz, <sup>2</sup><i>J</i>), 129.2, 127.1, 124.5 (q, <i>J</i> = 3.8 Hz, <sup>3</sup><i>J</i>), 124.3 (q, <i>J</i> = 3.9 Hz, <sup>3</sup><i>J</i>), 124.2, 124.0 (q, <i>J</i> = 272.5 Hz, <sup>1</sup><i>J</i>), 115.4, 114.7, 114.5, 114.3, 71.7, 70.0, 60.1, 55.7, 48.9, 37.7, 22.0. HRMS calcd for C<sub>28</sub>H<sub>29</sub>O<sub>4</sub>NF<sub>3</sub>, 500.20432 [M + H]<sup>+</sup>; found 500.20333 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 85â95% MeOH in water over 5 min at 1 mL/min (retention time = 3.54 min). Method 2: 95% MeOH in water over 3 min at 1 mL/min (retention time = 1.05 min).</div></div><div id="sec4_2_1_46" class="NLM_sec NLM_sec_level_4"><div id="ac_i83" class="anchor-spacer"></div><h5 class="article-section__title" id="_i83"> 2-(3-Fluorobenzyl)-6-isopropoxy-1-((4-methoxyphenoxy)methyl)-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (<b>12c</b>)</h5><div class="NLM_p last">General procedure IV-B was followed using compound <b>11c</b> (104 mg, 0.232 mmol) and 10% Pd/C (37 mg, 0.035 mmol) in ethanol (5 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â50% EtOAc/hexanes gradient) to afford the title compound as a yellow oil (67 mg, 64%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.57; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.25â7.19 (m, 1H), 7.04 (d, <i>J</i> = 8.4 Hz, 1H), 6.98 (d, <i>J</i> = 7.7 Hz, 1H), 6.94â6.88 (m, 2H), 6.81â6.69 (m, 6H), 5.49 (d, <i>J</i> = 15.5 Hz, 1H), 4.65â4.60 (m, 1H), 4.54 (hept, <i>J</i> = 6.0 Hz, 1H), 4.39 (d, <i>J</i> = 15.5 Hz, 1H), 4.10â3.99 (m, 2H), 3.92 (d, <i>J</i> = 19.2 Hz, 1H), 3.75 (s, 3H), 3.65 (d, <i>J</i> = 19.3 Hz, 1H), 1.34 (d, <i>J</i> = 6.1 Hz, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 169.7, 163.0 (d, <i>J</i> = 246.5 Hz, <sup>1</sup><i>J</i>), 157.8, 154.2, 152.2, 139.7 (d, <i>J</i> = 7.0 Hz, <sup>3</sup><i>J</i>), 134.1, 130.1 (d, <i>J</i> = 8.2 Hz, <sup>3</sup><i>J</i>), 127.1, 124.3, 123.2 (d, <i>J</i> = 2.8 Hz, <sup>4</sup><i>J</i>), 115.4, 114.6, 114.6 (d, <i>J</i> = 21.6 Hz, <sup>2</sup><i>J</i>), 114.4, 114.3 (d, <i>J</i> = 21.3 Hz, <sup>2</sup><i>J</i>), 114.2, 71.6, 69.9, 59.9, 55.7, 48.6, 37.6, 22.0. HRMS calcd for C<sub>27</sub>H<sub>29</sub>O<sub>4</sub>NF, 450.20751 [M + H]<sup>+</sup>; found 450.20731 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 90â95% MeOH in water over 5 min at 1 mL/min (retention time = 1.54 min). Method 2: 95% MeOH in water over 3 min at 1 mL/min (retention time = 1.01 min).</div></div><div id="sec4_2_1_47" class="NLM_sec NLM_sec_level_4"><div id="ac_i84" class="anchor-spacer"></div><h5 class="article-section__title" id="_i84"> 2-(3-Chlorobenzyl)-6-isobutoxy-1-((4-methoxyphenoxy)methyl)-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (12d)</h5><div class="NLM_p last">General procedure IV-A was followed using compound <b>11d</b> (200 mg, 0.418 mmol) and PtO<sub>2</sub> (24 mg, 0.059 mmol) in ethanol (3.3 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â50% EtOAc/hexanes gradient) to afford the title compound as a red foam (82 mg, 54%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.76; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.22â7.14 (m, 3H), 7.09â7.03 (m, 2H), 6.81â6.69 (m, 6H), 5.46 (d, <i>J</i> = 15.5 Hz, 1H), 4.62 (t, <i>J</i> = 5.0 Hz, 1H), 4.37 (d, <i>J</i> = 15.5 Hz, 1H), 4.09â3.99 (m, 2H), 3.94 (d, <i>J</i> = 19.3 Hz, 1H), 3.75 (s, 3H), 3.71 (d, <i>J</i> = 6.5 Hz, 2H), 3.66 (d, <i>J</i> = 19.3 Hz, 1H), 2.08 (hept, <i>J</i> = 6.9 Hz, 1H), 1.02 (d, <i>J</i> = 6.7 Hz, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 169.7, 159.1, 154.2, 152.2, 139.2, 134.5, 134.0, 129.9, 127.9, 127.6, 127.0, 125.7, 124.3, 115.4, 114.7, 113.3, 113.0, 74.5, 71.6, 59.9, 55.7, 48.6, 37.6, 28.2, 19.2. HRMS calcd for C<sub>28</sub>H<sub>31</sub>O<sub>4</sub>NCl, 480.19361 [M + H]<sup>+</sup>; found 480.19404 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 85â95% MeOH in water over 5 min at 1 mL/min (retention time = 2.05 min). Method 2: 95% MeOH in water over 3 min at 1 mL/min (retention time = 0.86 min).</div></div><div id="sec4_2_1_48" class="NLM_sec NLM_sec_level_4"><div id="ac_i85" class="anchor-spacer"></div><h5 class="article-section__title" id="_i85"> 2-(3-Chlorobenzyl)-6-methoxy-1-((4-methoxyphenoxy)methyl)-1,2-dihydroisoquinolin-3(4<i>H</i>)-one (<b>12e</b>)</h5><div class="NLM_p last">General procedure IV-A was followed using compound <b>11e</b> (113 mg, 0.259 mmol) and PtO<sub>2</sub> (8.4 mg, 0.037 mmol) in ethanol (2 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â30% EtOAc/hexanes gradient) to afford the title compound as a clear oil (63 mg, 56%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.59; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.22â7.11 (m, 3H), 7.09â7.02 (m, 2H), 6.82â6.67 (m, 6H), 5.44 (d, <i>J</i> = 15.5 Hz, 1H), 4.62 (t, <i>J</i> = 5.0 Hz, 1H), 4.37 (d, <i>J</i> = 15.5 Hz, 1H), 4.08â3.99 (m, 2H), 3.94 (d, <i>J</i> = 19.1 Hz, 1H), 3.78 (s, 3H), 3.73 (s, 3H), 3.66 (d, <i>J</i> = 19.2 Hz, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 169.6, 159.4, 154.2, 152.1, 139.2, 134.4, 134.1, 129.9, 127.8, 127.6, 127.1, 125.7, 124.6, 115.4, 114.6, 112.8, 112.3, 71.5, 59.9, 55.7, 55.3, 48.6, 37.6. HRMS calcd for C<sub>25</sub>H<sub>25</sub>O<sub>4</sub>NCl, 438.14666 [M + H]<sup>+</sup>; found 438.14644 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 85â95% MeOH in water over 5 min at 1 mL/min (retention time = 1.83 min).</div></div><div id="sec4_2_1_49" class="NLM_sec NLM_sec_level_4"><div id="ac_i86" class="anchor-spacer"></div><h5 class="article-section__title" id="_i86"> 6-Methoxy-1-((4-methoxyphenoxy)methyl)-2-(4,4,4-trifluorobutyl)-1,2-dihydroisoquinolin-3(4<i>H</i>)-one (12f)</h5><div class="NLM_p last">General procedure IV-B was followed using compound <b>11f</b> (79 mg, 0.19 mmol) and 10% Pd/C (30 mg, 0.028 mmol) in ethanol (5 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â30% EtOAc/hexanes gradient) to afford the title compound as a clear oil (18 mg, 23%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.47; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.19 (d, <i>J</i> = 8.4 Hz, 1H), 6.83 (d, <i>J</i> = 2.6 Hz, 1H), 6.82â6.69 (m, 5H), 4.68 (t, <i>J</i> = 5.4 Hz, 1H), 4.09â3.98 (m, 2H), 3.81 (d, <i>J</i> = 19.3 Hz, 1H), 3.81 (s, 3H), 3.74 (s, 3H), 3.56 (d, <i>J</i> = 19.3 Hz, 1H), 3.37â3.26 (m, 2H), 2.18â2.05 (m, 2H), 1.94â1.83 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 169.5, 159.6, 154.3, 152.2, 134.2, 127.1, 127.0 (q, <i>J</i> = 276.2 Hz, <sup>1</sup><i>J</i>), 124.6, 115.4, 114.7, 112.9, 112.4, 71.7, 61.2, 55.7, 55.4, 45.7, 37.7, 31.3 (q, <i>J</i> = 29.1 Hz, <sup>2</sup><i>J</i>), 20.5 (q, <i>J</i> = 2.6 Hz, <sup>3</sup><i>J</i>). HRMS calcd for C<sub>22</sub>H<sub>25</sub>O<sub>4</sub>NF<sub>3</sub>, 424.17302 [M + H]<sup>+</sup>; found 424.17256 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 75â95% MeOH in water over 6 min at 1 mL/min (retention time = 4.69 min). Method 2: 85â95% ACN in water over 6 min at 1 mL/min (retention time = 1.48 min).</div></div><div id="sec4_2_1_50" class="NLM_sec NLM_sec_level_4"><div id="ac_i87" class="anchor-spacer"></div><h5 class="article-section__title" id="_i87"> 6-Methoxy-1-((4-methoxyphenoxy)methyl)-2-(2,2,2-trifluoroethyl)-1,2-dihydroisoquinolin-3(4<i>H</i>)-one (12g)</h5><div class="NLM_p last">General procedure IV-B was followed using compound <b>11g</b> (33 mg, 0.084 mmol) and 10% Pd/C (13 mg, 0.013 mmol) in ethanol (5 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â30% EtOAc/hexanes gradient) to afford the title compound as a clear oil (8.8 mg, 27%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.60; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.19 (d, <i>J</i> = 8.4 Hz, 1H), 6.84 (dd, <i>J</i> = 8.6, 2.8 Hz, 1H), 6.81â6.72 (m, 4H), 6.72 (d, <i>J</i> = 2.3 Hz, 1H), 5.07â4.96 (m, 1H), 4.94 (dd, <i>J</i> = 7.6, 4.0 Hz, 1H), 4.09 (dd, <i>J</i> = 9.7, 3.8 Hz, 1H), 3.99 (dd, <i>J</i> = 9.7, 7.8 Hz, 1H), 3.96â3.82 (m, 2H), 3.81 (s, 3H), 3.75 (s, 3H), 3.68 (d, <i>J</i> = 19.6 Hz, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 169.9, 159.7, 154.4, 151.9, 133.6, 127.3, 126.7 (q, <i>J</i> = 273.5 Hz, <sup>1</sup><i>J</i>), 123.6, 115.3, 114.7, 113.1, 112.6, 72.1, 61.3, 55.7, 55.4, 46.3 (q, <i>J</i> = 33.6 Hz, <sup>2</sup><i>J</i>), 37.4. HRMS calcd for C<sub>20</sub>H<sub>21</sub>O<sub>4</sub>NF<sub>3</sub>, 396.14172 [M + H]<sup>+</sup>; found 396.14143 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 85â95% MeOH in water over 10 min at 1 mL/min (retention time = 1.21 min). Method 2: 75â95% MeOH in water over 6 min at 1 mL/min (retention time = 3.78 min).</div></div><div id="sec4_2_1_51" class="NLM_sec NLM_sec_level_4"><div id="ac_i88" class="anchor-spacer"></div><h5 class="article-section__title" id="_i88"> 6-Methoxy-1-((4-methoxyphenoxy)methyl)-2-propyl-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (<b>12h</b>)</h5><div class="NLM_p last">General procedure IV-B was followed using compound <b>11h</b> (31 mg, 0.088 mmol) and 10% Pd/C (14 mg, 0.013 mmol) in ethanol (5 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â50% EtOAc/hexanes gradient) to afford the title compound as a clear oil (15 mg, 48%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.28; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.19 (d, <i>J</i> = 8.4 Hz, 1H), 6.83â6.68 (m, 6H), 4.68 (t, <i>J</i> = 5.3 Hz, 1H), 4.16â4.00 (m, 3H), 3.84 (d, <i>J</i> = 19.2 Hz, 1H), 3.80 (s, 3H), 3.74 (s, 3H), 3.56 (d, <i>J</i> = 19.2 Hz, 1H), 3.14â3.06 (m, 1H), 1.70â1.55 (m, 2H), 0.89 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 169.2, 159.4, 154.2, 152.4, 134.5, 127.4, 125.1, 115.5, 114.7, 112.7, 112.3, 71.4, 60.9, 55.7, 55.4, 48.3, 37.8, 21.0, 11.4.NMR (126 MHz, CDCl<sub>3</sub>) Î´ 169.3, 159.4, 154.2, 152.3, 134.3, 127.1, 124.6, 115.4, 114.7, 112.8, 112.2, 71.5, 63.1, 55.7, 55.4, 37.3, 34.7. HRMS calcd for C<sub>21</sub>H<sub>26</sub>O<sub>4</sub>N, 356.18563 [M + H]<sup>+</sup>; found 356.18553 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 75â95% MeOH in water over 3 min at 1 mL/min (retention time = 1.35 min). Method 2: 85â95% MeOH in water over 5 min at 1 mL/min (retention time = 0.81 min).</div></div><div id="sec4_2_1_52" class="NLM_sec NLM_sec_level_4"><div id="ac_i89" class="anchor-spacer"></div><h5 class="article-section__title" id="_i89"> 2-(2-(1<i>H</i>-Indol-3-yl)ethyl)-6-methoxy-1-((4-methoxyphenoxy)methyl)-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (<b>12i</b>)</h5><div class="NLM_p last">A modified version of general procedure IV-B was followed using compound <b>11i</b> (21 mg, 0.046 mmol), 10% Pd/C (7.3 mg, 0.0069 mmol), and AcOH (catalytic) in ethanol (5 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â70% EtOAc/hexanes gradient) to afford the title compound as a clear oil (10 mg, 45%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.17; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.88 (s, 1H), 7.65 (d, <i>J</i> = 7.9 Hz, 1H), 7.34 (d, <i>J</i> = 7.3 Hz, 1H), 7.19 (t, <i>J</i> = 7.6 Hz, 1H), 7.10 (t, <i>J</i> = 7.5 Hz, 1H), 6.89â6.83 (m, 2H), 6.78â6.62 (m, 6H), 4.42â4.33 (m, 2H), 3.94â3.89 (m, 2H), 3.84 (d, <i>J</i> = 19.2 Hz, 1H), 3.81 (s, 3H), 3.73 (s, 3H), 3.58 (d, <i>J</i> = 19.0 Hz, 1H), 3.53â3.43 (m, 1H), 3.08 (t, <i>J</i> = 7.2 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 169.3, 159.3, 154.1, 152.3, 136.2, 134.4, 127.3, 127.0, 125.2, 122.2, 122.0, 119.4, 118.8, 115.4, 114.6, 113.1, 112.6, 112.1, 111.1, 71.4, 61.9, 55.7, 55.4, 48.0, 37.9, 23.7. HRMS calcd for C<sub>28</sub>H<sub>29</sub>O<sub>4</sub>N<sub>2</sub>, 457.21218 [M + H]<sup>+</sup>; found 457.21230 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 85â95% MeOH in water over 5 min at 1 mL/min (retention time = 2.29 min). Method 2: 95% MeOH in water over 3 min at 1 mL/min (retention time = 0.94 min).</div></div><div id="sec4_2_1_53" class="NLM_sec NLM_sec_level_4"><div id="ac_i90" class="anchor-spacer"></div><h5 class="article-section__title" id="_i90"> 6-Methoxy-2-(2-(2-methoxyethoxy)ethyl)-1-((4-methoxyphenoxy)methyl)-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (<b>12j</b>)</h5><div class="NLM_p last">General procedure IV-B was followed using compound <b>11j</b> (16 mg, 0.039 mmol) and 10% Pd/C (6.2 mg, 0.0059 mmol) in ethanol (5 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as a red oil (10 mg, 83%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.44; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.16 (d, <i>J</i> = 8.4 Hz, 1H), 6.83â6.66 (m, 6H), 4.93 (t, <i>J</i> = 5.0 Hz, 1H), 4.18â4.01 (m, 3H), 3.84 (d, <i>J</i> = 18.2 Hz, 1H), 3.80 (s, 3H), 3.74 (s, 3H), 3.73â3.68 (m, 1H), 3.65â3.59 (m, 1H), 3.59â3.51 (m, 3H), 3.51â3.45 (m, 1H), 3.44â3.40 (m, 2H), 3.31 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 169.6, 159.3, 154.1, 152.5, 134.4, 127.2, 125.4, 115.4, 114.6, 112.6, 112.2, 71.8, 71.4, 70.4, 70.0, 62.3, 59.0, 55.7, 55.4, 46.9, 37.8. HRMS calcd for C<sub>23</sub>H<sub>30</sub>O<sub>6</sub>N, 416.20676 [M + H]<sup>+</sup>; found 416.20700 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 75â95% MeOH in water over 6 min at 1 mL/min (retention time = 3.58 min). Method 2: 95% MeOH in water over 3 min at 1 mL/min (retention time = 0.86 min).</div></div><div id="sec4_2_1_54" class="NLM_sec NLM_sec_level_4"><div id="ac_i91" class="anchor-spacer"></div><h5 class="article-section__title" id="_i91"> 2-(3-(Dimethylamino)propyl)-6-methoxy-1-((4-methoxyphenoxy)methyl)-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (<b>12k</b>)</h5><div class="NLM_p last">A modified version of general procedure IV-B was followed using compound <b>11k</b> (16 mg, 0.039 mmol), 10% Pd/C (6.2 mg, 0.0059 mmol), and AcOH (catalytic) in ethanol (5 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as a red oil (10 mg, 83%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.40; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.16 (d, <i>J</i> = 8.4 Hz, 1H), 6.83â6.66 (m, 6H), 4.93 (t, <i>J</i> = 5.0 Hz, 1H), 4.18â4.01 (m, 3H), 3.84 (d, <i>J</i> = 18.2 Hz, 1H), 3.80 (s, 3H), 3.74 (s, 3H), 3.73â3.68 (m, 1H), 3.65â3.59 (m, 1H), 3.59â3.51 (m, 3H), 3.51â3.45 (m, 1H), 3.44â3.40 (m, 2H), 3.31 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 169.6, 159.3, 154.1, 152.5, 134.4, 127.2, 125.4, 115.4, 114.6, 112.6, 112.2, 71.8, 71.4, 70.4, 70.0, 62.3, 59.0, 55.7, 55.4, 46.9, 37.8. HRMS calcd for C<sub>23</sub>H<sub>31</sub>O<sub>4</sub>N<sub>2</sub>, 399.22783 [M + H]<sup>+</sup>; found 399.22743 [M + H]<sup>+</sup>. Purity was established to be 85% pure using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 50â95% MeOH in water over 6 min at 1 mL/min (retention time = 5.56 min). Method 2: 75â95% MeOH in water over 6 min at 1 mL/min (retention time = 1.18 min).</div></div><div id="sec4_2_1_55" class="NLM_sec NLM_sec_level_4"><div id="ac_i92" class="anchor-spacer"></div><h5 class="article-section__title" id="_i92"> 2-((1<i>H</i>-1,2,3-Triazol-4-yl)methyl)-6-methoxy-1-((4-methoxyphenoxy)methyl)-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (<b>12l</b>)</h5><div class="NLM_p last">A modified version of general procedure IV-B was followed using compound <b>11m</b> (22 mg, 0.056 mmol), 10% Pd/C (8.9 mg, 0.0083 mmol), and AcOH (catalytic) in ethanol (5 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â50% EtOAc/hexanes gradient) to afford the title compound as a yellow oil (15 mg, 68%). <i>R<sub>f</sub></i> (9:1 DCM/MeOH): 0.43; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.66 (s, 1H), 7.10 (d, <i>J</i> = 8.5 Hz, 1H), 6.80â6.65 (m, 6H), 5.27 (d, <i>J</i> = 15.3 Hz, 1H), 4.87 (t, <i>J</i> = 4.8 Hz, 1H), 4.68 (d, <i>J</i> = 15.2 Hz, 1H), 4.16â4.00 (m, 2H), 3.91 (d, <i>J</i> = 19.3 Hz, 1H), 3.77 (s, 3H), 3.73 (s, 3H), 3.60 (d, <i>J</i> = 19.4 Hz, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 170.1, 159.4, 154.2, 152.2, 133.7, 127.1, 124.3, 115.4, 114.6, 112.9, 112.2, 71.6, 61.1, 55.7, 55.4, 41.1, 37.5. HRMS calcd for C<sub>21</sub>H<sub>23</sub>O<sub>4</sub>N<sub>4</sub>, 395.17138 [M + H]<sup>+</sup>; found 395.17077 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 75â95% MeOH in water over 6 min at 1 mL/min (retention time = 1.78 min). Method 2: 75â95% MeOH in water over 3 min at 1 mL/min (retention time = 1.53 min).</div></div><div id="sec4_2_1_56" class="NLM_sec NLM_sec_level_4"><div id="ac_i93" class="anchor-spacer"></div><h5 class="article-section__title" id="_i93"> 2-(3-Chlorobenzyl)-6,7-dimethoxy-1-((4-methoxyphenoxy)methyl)-1,4-dihydroisoquinolin-3(2<i>H</i>)-one (<b>12m</b>)</h5><div class="NLM_p last">General procedure IV-A was followed using compound <b>11n</b> (136 mg, 0.292 mmol) and PtO<sub>2</sub> (17 mg, 0.041 mmol) in ethanol (2.3 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â50% EtOAc/hexanes gradient) to afford the title compound as a clear oil (30 mg, 22%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.28; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 7.24â7.16 (m, 3H), 7.12â7.06 (m, 1H), 6.82â6.63 (m, 6H), 5.49 (d, <i>J</i> = 15.5 Hz, 1H), 4.59 (t, <i>J</i> = 5.1 Hz, 1H), 4.37 (d, <i>J</i> = 15.5 Hz, 1H), 4.08â4.03 (m, 2H), 3.97â3.92 (m, 1H), 3.90 (s, 1H), 3.89 (s, 3H), 3.84 (s, 3H), 3.75 (s, 3H), 3.73â3.59 (m, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) Î´ 169.8, 154.3, 152.2, 149.0, 147.8, 139.2, 134.5, 130.0, 127.9, 127.6, 125.8, 124.7, 124.2, 115.4, 114.7, 110.2, 109.0, 71.5, 60.1, 56.1, 56.0, 55.7, 48.5, 36.9. HRMS calcd for C<sub>26</sub>H<sub>27</sub>O<sub>5</sub>NCl, 468.15723 [M + H]<sup>+</sup>; found 468.15734 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 85â95% MeOH in water over 5 min at 1 mL/min (retention time = 1.45 min). Method 2: 85â95% ACN in water over 6 min at 1 mL/min (retention time = 1.34 min).</div></div><div id="sec4_2_1_57" class="NLM_sec NLM_sec_level_4"><div id="ac_i94" class="anchor-spacer"></div><h5 class="article-section__title" id="_i94"> 2-(3,4-Dimethoxyphenyl)ethanamine (<b>14</b>)</h5><div class="NLM_p last">General procedure V was followed using compound 3,4-dimethoxyphenethylamine (<b>13</b>) (5.59 mL, 33.1 mmol), triethylamine (9.23 mL, 66.2 mmol), and 2-chloroacetyl chloride (3.16 mL, 39.7 mmol) in dry DCM (120 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 40 g column, 10â80% EtOAc/hexanes gradient) to afford the title compound as a white solid (6.32 g, 74%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.56; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 6.82 (d, <i>J</i> = 8.0 Hz, 1H), 6.77â6.69 (m, 2H), 6.64 (s, 0H), 4.02 (s, 2H), 3.87 (s, 3H), 3.86 (s, 3H), 3.53 (q, <i>J</i> = 6.9 Hz, 2H), 2.78 (t, <i>J</i> = 7.0 Hz, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) Î´ 165.7, 149.0, 147.8, 130.8, 120.6, 111.8, 111.3, 55.9, 42.7, 41.1, 35.1. HRMS calcd for C<sub>12</sub>H<sub>17</sub>O<sub>3</sub>NCl, 258.08915 [M + H]<sup>+</sup>; found 258.08876 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_58" class="NLM_sec NLM_sec_level_4"><div id="ac_i95" class="anchor-spacer"></div><h5 class="article-section__title" id="_i95"> 2-(Benzyloxy)-<i>N</i>-(3,4-dimethoxyphenethyl)acetamide (<b>15a</b>)</h5><div class="NLM_p last">General procedure VII was followed using compound <b>14</b> (2.97 g, 11.5 mmol), benzyl alcohol (1.41 g, 13.0 mmol), and 60% sodium hydride dispersion in mineral oil (0.61 g, 15 mmol) in THF (28 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 40 g column, 30â100% EtOAc/hexanes gradient) to afford the title compound as a yellow oil (2.7 g, 70%). <i>R<sub>f</sub></i> (1:1 EtOAC/Hex): 0.19; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.40â7.20 (m, 4H), 6.85â6.65 (m, 4H), 4.49 (s, 2H), 3.97 (s, 2H), 3.84 (s, 3H), 3.83 (s, 3H), 3.54 (q, <i>J</i> = 6.8 Hz, 2H), 2.78 (t, <i>J</i> = 7.0 Hz, 2H).<sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 171.1, 169.4, 149.0, 147.6, 136.8, 131.1, 128.5, 128.1, 127.8, 120.6, 111.7, 111.2, 73.4, 69.5, 55.8, 40.0, 35.2. HRMS calcd for C<sub>19</sub>H<sub>24</sub>O<sub>4</sub>N, 330.16998 [M + H]<sup>+</sup>; found 330.16945 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_59" class="NLM_sec NLM_sec_level_4"><div id="ac_i96" class="anchor-spacer"></div><h5 class="article-section__title" id="_i96"> <i>N</i>-(3,4-Dimethoxyphenethyl)-2-((tetrahydro-2<i>H</i>-pyran-4-yl)oxy)acetamide (<b>15b</b>)</h5><div class="NLM_p last">General procedure VII was followed using compound <b>14</b> (0.20 g, 0.78 mmol), 4-hydroxytetrahydropyran (95 mg, 0.93 mmol), and 60% sodium hydride dispersion in mineral oil (43 mg, 1.1 mmol) in THF (3.9 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 0â10% MeOH/DCM gradient) to afford the title compound as a white solid (0.19 g, 75%). <i>R<sub>f</sub></i> (9:1 DCM/MeOH): 0.62; <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) Î´ 6.79 (d, <i>J</i> = 7.9 Hz, 1H), 6.75â6.70 (m, 2H), 6.62 (s, 1H), 3.93 (s, 2H), 3.90â3.83 (m, 8H), 3.53 (q, <i>J</i> = 6.9 Hz, 2H), 3.47 (tt, <i>J</i> = 8.7, 4.0 Hz, 1H), 3.39 (ddd, <i>J</i> = 12.0, 9.7, 2.7 Hz, 2H), 2.78 (t, <i>J</i> = 7.1 Hz, 2H), 1.85â1.78 (m, 2H), 1.56â1.45 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 169.7, 149.1, 147.8, 131.1, 120.6, 111.8, 111.3, 75.0, 67.3, 65.3, 55.9, 55.9, 39.9, 35.2, 32.1. HRMS calcd for C<sub>17</sub>H<sub>26</sub>O<sub>5</sub>N, 324.18055 [M + H]<sup>+</sup>; found 324.18056 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_60" class="NLM_sec NLM_sec_level_4"><div id="ac_i97" class="anchor-spacer"></div><h5 class="article-section__title" id="_i97"> <i>N</i>-(3,4-Dimethoxyphenethyl)-2-(pyridine-3-yloxy)acetamide (<b>15c</b>)</h5><div class="NLM_p last">General procedure VI was followed using compound <b>14</b> (0.20 g, 0.78 mmol), 3-hydroxypyridine (89 mg, 0.93 mmol), and cesium carbonate (1.0 g, 3.1 mmol) in acetonitrile (4.6 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 0â10% MeOH/DCM gradient) to afford the title compound as a white solid (0.15 g, 60%). <i>R<sub>f</sub></i> (9:1 DCM/MeOH): 0.49; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 8.28â8.23 (m, 2H), 7.24â7.18 (m, 1H), 7.14â7.08 (m, 1H), 6.75 (d, <i>J</i> = 8.1 Hz, 1H), 6.70â6.63 (m, 3H), 4.47 (s, 2H), 3.83 (s, 3H), 3.81 (s, 3H), 3.57 (q, <i>J</i> = 6.9 Hz, 2H), 2.78 (t, <i>J</i> = 7.0 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 167.2, 153.4, 149.1, 147.8, 143.4, 138.3, 130.9, 124.0, 120.9, 120.7, 111.8, 111.4, 67.5, 55.9, 55.8, 40.2, 35.2. HRMS calcd for C<sub>17</sub>H<sub>21</sub>O<sub>4</sub>N<sub>2</sub>, 317.14958 [M + H]<sup>+</sup>; found 317.14920 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_61" class="NLM_sec NLM_sec_level_4"><div id="ac_i98" class="anchor-spacer"></div><h5 class="article-section__title" id="_i98"> <i>N</i>-(3,4-Dimethoxyphenethyl)-2-((4-methoxybenzyl)oxy)acetamide (<b>15d</b>)</h5><div class="NLM_p last">General procedure VII was followed using compound <b>14</b> (18.8 g, 73.0 mmol), 4-methoxybenzyl alcohol (12.1 g, 87.5 mmol), and 60% sodium hydride dispersion in mineral oil (4.38 g, 110. Mmol) in THF (196 mL). The crude material was purified via flash column chromatography (ISCO, Redisep 320 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as an orange solid (20.1 g, 74%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.67; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.22 (t, <i>J</i> = 7.8 Hz, 1H), 7.19â7.13 (m, 2H), 6.91â6.84 (m, 2H), 6.81â6.73 (m, 3H), 6.65 (s, 1H), 4.43 (s, 2H), 3.94 (s, 2H), 3.81 (s, 3H), 3.78 (s, 3H), 3.54 (q, <i>J</i> = 7.0 Hz, 2H), 2.80 (t, <i>J</i> = 7.1 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 169.6, 159.9, 159.6, 140.3, 129.6, 129.5, 128.9, 121.1, 114.4, 114.0, 112.0, 73.2, 69.3, 55.3, 55.2, 39.8, 35.7. HRMS calcd for C<sub>20</sub>H<sub>26</sub>O<sub>5</sub>N, 360.18055 [M + H]<sup>+</sup>; found 360.18023 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_62" class="NLM_sec NLM_sec_level_4"><div id="ac_i99" class="anchor-spacer"></div><h5 class="article-section__title" id="_i99"> 1-((Benzyloxy)methyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline (<b>16a</b>)</h5><div class="NLM_p last">General procedure VIII was followed using compound <b>15a</b> (2.67 g, 8.11 mmol), phosphorous oxychloride (2.27 mL, 24.3 mmol), and sodium borohydride (0.64 g, 24 mmol) in acetonitrile (â¼40 mL) and MeOH (â¼10 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 40 g column, 10â90% EtOAc/hexanes gradient) to afford the title compound as a white foam (1.6 g, 62% over two steps). <i>R<sub>f</sub></i> (1:1 EtOAC/Hex): 0.29; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 7.38â7.26 (m, 5H), 6.58 (s, 2H), 4.68â4.50 (m, 2H), 4.17 (dd, <i>J</i> = 8.2, 3.9 Hz, 1H), 3.83 (s, 3H), 3.79 (s, 3H), 3.75â3.62 (m, 2H), 3.25â3.10 (m, 1H), 3.04â2.90 (m, 1H), 2.74 (t, <i>J</i> = 5.8 Hz, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 147.6, 147.1, 138.0, 128.4, 127.8, 127.7, 127.7, 126.6, 111.8, 109.2, 73.3, 72.9, 55.9, 55.8, 55.0, 40.0, 29.0. HRMS calcd for C<sub>19</sub>H<sub>24</sub>O<sub>3</sub>N, 314.17507 [M + H]<sup>+</sup>; found 314.17453 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_63" class="NLM_sec NLM_sec_level_4"><div id="ac_i100" class="anchor-spacer"></div><h5 class="article-section__title" id="_i100"> 6,7-Dimethoxy-1-(((tetrahydro-2<i>H</i>-pyran-4-yl)oxy)methyl)-1,2,3,4-tetrahydroisoquinoline (<b>16b</b>)</h5><div class="NLM_p last">General procedure VIII was followed using compound <b>15b</b> (187 mg, 0.578 mmol), phosphorous oxychloride (0.27 mL, 2.9 mmol), and sodium borohydride (66 mg, 1.7 mmol) in acetonitrile (9.2 mL) and MeOH (2.4 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 0â10% MeOH/DCM gradient) to afford the title compound as a clear oil (29 mg, 16%). <i>R<sub>f</sub></i> (9:1 DCM/MeOH): 0.44; <sup>1</sup>H NMR (399 MHz, chloroform-<i>d</i>) Î´ 6.62 (s, 1H), 6.58 (s, 1H), 4.08 (dd, <i>J</i> = 8.8, 3.9 Hz, 1H), 3.98â3.87 (m, 2H), 3.83 (s, 3H), 3.82 (s, 3H), 3.72 (dd, <i>J</i> = 9.2, 4.0 Hz, 1H), 3.63â3.49 (m, 2H), 3.48â3.37 (m, 2H), 3.18 (dt, <i>J</i> = 11.7, 5.7 Hz, 1H), 2.96 (dt, <i>J</i> = 11.8, 5.9 Hz, 1H), 2.73 (t, <i>J</i> = 5.8 Hz, 2H), 2.40 (s, 1H), 1.97â1.85 (m, 2H), 1.69â1.52 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 147.6, 147.0, 127.9, 127.2, 111.9, 109.3, 74.4, 70.9, 65.6, 56.0(0), 55.9(9), 55.8, 55.2, 40.2, 32.6, 32.3, 29.3. HRMS calcd for C<sub>17</sub>H<sub>26</sub>O<sub>4</sub>N, 308.18563 [M + H]<sup>+</sup>; found 308.18552 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_64" class="NLM_sec NLM_sec_level_4"><div id="ac_i101" class="anchor-spacer"></div><h5 class="article-section__title" id="_i101"> 6,7-Dimethoxy-1-((pyridin-3-yloxy)methyl)-1,2,3,4-tetrahydroisoquinoline (16c)</h5><div class="NLM_p last">General procedure VIII was followed using compound <b>15c</b> (0.20 g, 0.64 mmol), phosphorous oxychloride (0.30 mL, 3.2 mmol), and sodium borohydride (72 mg, 1.9 mmol) in acetonitrile (7.4 mL) and MeOH (1.9 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 0â20% MeOH/DCM gradient) to afford the title compound as a white solid (0.12 g, 60%). <i>R<sub>f</sub></i> (8:2 DCM/MeOH): 0.66; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 8.34 (dd, <i>J</i> = 2.6, 0.9 Hz, 1H), 8.21 (dd, <i>J</i> = 4.1, 1.9 Hz, 1H), 7.25â7.16 (m, 2H), 6.65 (s, 1H), 6.61 (s, 1H), 4.36 (dd, <i>J</i> = 7.9, 4.6 Hz, 1H), 4.21â4.12 (m, 2H), 3.84 (s, 4H), 3.82 (s, 3H), 3.19 (ddd, <i>J</i> = 12.2, 6.8, 5.4 Hz, 1H), 3.03 (dt, <i>J</i> = 12.1, 5.5 Hz, 1H), 2.75 (q, <i>J</i> = 5.3 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 148.0, 147.3, 142.4, 138.1, 128.3, 126.0, 123.9, 121.2, 112.1, 109.5, 71.2, 56.1, 55.8, 54.6, 39.8, 29.2. HRMS calcd for C<sub>17</sub>H<sub>21</sub>O<sub>3</sub>N<sub>2</sub>, 301.15467 [M + H]<sup>+</sup>; found 301.15442 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_65" class="NLM_sec NLM_sec_level_4"><div id="ac_i102" class="anchor-spacer"></div><h5 class="article-section__title" id="_i102"> (3-Chlorophenyl)(1-(hydroxymethyl)-6,7-dimethoxy-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)methanone (<b>17a</b>)</h5><div class="NLM_p last">General procedure IX was followed using compound <b>16a</b> (1.56 g, 4.98 mmol), triethylamine (1.39 mL, 9.96 mmol), and 3-chlorobenzoyl chloride (0.77 mL, 6.0 mmol) in DCM (80 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 24 g column, 10-90% EtOAc/hexanes gradient) to afford the title compound as a white foam (1.4 g) that was carried forward without further characterization. This material (1.4 g, 3.0 mmol) was dissolved in a 2:3 mixture of chloroform (40 mL) and methane sulfonic acid (60 mL) and allowed to react at room temperature for 6 h. The reaction was then poured over ice, dilute with EtOAc, and quenched with saturated NaHCO<sub>3</sub>. The organic layer was then washed with brine (3Ã), dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 10â90% EtOAc/hexanes gradient) to afford the title compound as a white foam (0.48 g, 44% over two steps). <i>R<sub>f</sub></i> (1:1 EtOAC/Hex): 0.07; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.60â6.97 (m, 4H), 6.78â6.38 (m, 2H), 5.75 (dd, <i>J</i> = 8.6, 3.7 Hz, 0.5H), 4.83â4.74 (m, 0.5H), 4.08 (dd, <i>J</i> = 11.6, 3.9 Hz, 1H), 3.93 (dd, <i>J</i> = 11.5, 8.9 Hz, 1H), 3.89â3.70 (m, 6H), 3.67 (dd, <i>J</i> = 11.8, 4.2 Hz, 0.5H), 3.57 (td, <i>J</i> = 13.5, 12.9, 4.0 Hz, 1H), 3.23 (td, <i>J</i> = 13.0, 4.2 Hz, 0.5H), 3.06 (td, <i>J</i> = 14.1, 12.2, 6.0 Hz, 0.5H), 2.92 (ddd, <i>J</i> = 17.1, 11.9, 5.8 Hz, 1H), 2.69 (t, <i>J</i> = 15.6 Hz, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 171.1, 170.4, 148.3, 148.2, 147.8, 147.4, 138.0, 137.6, 134.6, 134.3, 130.1, 130.0, 129.7, 129.6, 129.6, 128.4, 128.0, 127.8, 127.0, 126.6, 125.7, 125.7, 124.9, 124.4, 124.3, 111.7, 111.3, 110.0, 109.5, 66.5, 65.8, 64.6, 64.6, 59.6, 56.0, 56.0, 55.9, 55.2, 42.1, 35.5, 28.8, 27.6, 15.3. HRMS calcd for C<sub>19</sub>H<sub>21</sub>O<sub>4</sub>NCl, 362.11536 [M + H]<sup>+</sup>; found 362.11479 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_66" class="NLM_sec NLM_sec_level_4"><div id="ac_i103" class="anchor-spacer"></div><h5 class="article-section__title" id="_i103"> (1-(Hydroxymethyl)-6,7-dimethoxy-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)(3-(trifluoromethyl)phenyl)methanone (<b>17b</b>)</h5><div class="NLM_p last">In step 1, a modified version of general procedure VIII was followed, in which the material was refluxed for only 1 h instead of overnight and only one equivalent of POCl<sub>3</sub> was used due to the loss of the PMB-protecting group and conversion to the alkyl chloride upon continued heating. This proceeded using compound <b>15d</b> (11.1 g, 30.8 mmol), phosphorous oxychloride (2.87 mL, 30.8 mmol), and sodium borohydride (3.50 g, 92.5 mmol) in acetonitrile (493 mL) and MeOH (123 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 24 g column, 0â15% MeOH/DCM gradient) to afford crude 6,7-dimethoxy-1-(((4-methoxybenzyl)oxy)methyl)-1,2,3,4-tetrahydroisoquinoline as a clear oil (4.71 g) that was carried forward without further characterization. General procedure IX was followed for step 2 using the above compound (4.71 g, 13.7 mmol), triethylamine (3.82 mL, 27.4 mmol), and 3-(trifluoromethyl)benzoyl chloride (2.48 mL, 16.4 mmol) in DCM (214 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 80 g column, 0â100% EtOAc/hexanes gradient) to afford impure (6,7-dimethoxy-1-(((4-methoxybenzyl)oxy)methyl)-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)(3-(trifluoromethyl)phenyl)methanone as a clear oil (2.77 g) that was carried forward without further characterization. Finally, this compound (2.77 g, 5.37 mmol) was hydrogenated at 50 psi using 10% Pd/C (0.57 g, 0.54 mmol) in MeOH (32 mL) overnight. The reaction mixture was filtered through a pad of celite, washed with methanol, and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography (ISCO, Redisep 40 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as a white foam (1.01 g, 8% over three steps). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.84â7.54 (m, 4H), 6.76â6.37 (m, 2H), 5.77 (dd, <i>J</i> = 8.8, 3.6 Hz, 0.8H), 4.88â4.71 (m, 0.2H), 4.14â4.07 (m, 1H), 4.02â3.93 (m, 1H), 3.88 (s, 2.5H), 3.86 (s, 3.5H), 3.79â3.70 (m, 2H), 3.64â3.55 (m, 0.8H), 3.31â3.21 (m, 0.2H), 3.09 (ddd, <i>J</i> = 17.7, 12.5, 6.5 Hz, 0.2H), 2.94 (ddd, <i>J</i> = 17.0, 11.9, 5.7 Hz, 0.8H), 2.74â2.66 (m, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 171.4, 148.4, 148.1, 136.7, 130.2, 129.3, 126.8, 125.8, 124.3, 123.9, 111.5, 110.1, 66.9, 56.1, 55.9, 55.5, 42.3, 28.7. (Unable to discern between fluorine splitting and minor peaks; only major peaks reported; major CF<sub>3</sub> peak not reported.) HRMS calcd for C<sub>20</sub>H<sub>21</sub>O<sub>4</sub>NF<sub>3</sub>, 396.14172 [M + H]<sup>+</sup>; found 369.14133 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_67" class="NLM_sec NLM_sec_level_4"><div id="ac_i104" class="anchor-spacer"></div><h5 class="article-section__title" id="_i104"> (3-Chlorophenyl)(6,7-dimethoxy-1-(((5-methoxythiophen-2-yl)oxy)methyl)-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)methanone (<b>18a</b>)</h5><div class="NLM_p last">Compound <b>17a</b> (100 mg, 0.276 mmol), 2-iodo-5-methoxythiophene (73 mg, 0.30 mmol), 1,10-phenanthroline (10 mg, 0.055 mmol), copper(I) iodide (11 mg, 0.055 mmol), and cesium carbonate (0.18 g, 0.55 mmol) were charged to a 10 mL microwave vial. The vial was capped, purged with argon, evacuated three times, and toluene (0.5 mL) was added. The vial was heated to 80 Â°C and allowed to react for 24 h. Upon completion, the reaction was cooled to room temperature, filtered through a pad of celite, washed with EtOAc, and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 10â90% EtOAc/hexanes gradient) to afford the title compound as a white foam (28 mg, 21%). <i>R<sub>f</sub></i> (1:1 EtOAC/Hex): 0.47; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.58â7.28 (m, 4H), 6.79â6.41 (m, 2H), 5.92 (dd, <i>J</i> = 13.0, 4.5 Hz, 1H), 5.77 (s, 1H), 5.05 (dd, <i>J</i> = 9.0, 3.2 Hz, 0.5H), 4.88 (dd, <i>J</i> = 13.1, 5.4 Hz, 0.5H), 4.38 (d, <i>J</i> = 5.1 Hz, 1H), 4.18 (t, <i>J</i> = 10.0 Hz, 0.5H) 4.01 (dd, <i>J</i> = 10.5, 4.0 Hz, 0.5H), 3.95â3.72 (m, 9H), 3.62 (td, <i>J</i> = 13.1, 3.6 Hz, 1H), 3.24 (td, <i>J</i> = 12.9, 3.7 Hz, 0.5H), 3.09 (td, <i>J</i> = 16.8, 5.9 Hz, 0.5H), 2.86 (ddd, <i>J</i> = 15.3, 13.1, 5.9 Hz, 0.5H), 2.76 (dd, <i>J</i> = 16.2, 3.0 Hz, 0.5H), 2.68 (d, <i>J</i> = 15.4 Hz, 0.5H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 170.1, 169.4, 168.4, 155.1, 155.0, 152.7, 152.0, 148.7, 148.5, 148.3, 147.9, 147.9, 147.6, 139.9, 137.9, 134.7, 134.6, 134.4, 130.0, 130.0, 129.9, 129.8, 129.8, 129.6, 127.7, 127.1, 126.8, 126.7, 126.1, 125.5, 124.7, 124.6, 124.3, 123.1, 116.4, 111.8, 111.4, 111.3, 109.9, 109.8, 109.5, 103.4, 102.8, 100.7, 77.2, 76.2, 74.8, 68.8, 65.9, 60.5, 60.4, 57.0, 56.0, 55.9, 51.8, 51.5, 51.1, 42.7, 42.2, 35.5, 28.9, 28.8, 27.6, 15.3. HRMS calcd for C<sub>24</sub>H<sub>25</sub>O<sub>5</sub>NClS, 474.11365 [M + H]<sup>+</sup>; found 474.11362 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 85â95% MeOH in water over 5 min at 1 mL/min (retention time = 1.74 min). Method 2: 75â95% ACN in water over 5 min at 1 mL/min (retention time = 3.56 min).</div></div><div id="sec4_2_1_68" class="NLM_sec NLM_sec_level_4"><div id="ac_i105" class="anchor-spacer"></div><h5 class="article-section__title" id="_i105"> (6,7-Dimethoxy-1-((pyridin-2-yloxy)methyl)-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)(3-(trifluoromethyl)phenyl)methanone (<b>18b</b>)</h5><div class="NLM_p last">General procedure X was followed using compound <b>17b</b> (25 mg, 0.063 mmol), 2-fluoropyrimidine (8.2 Î¼L, 0.095 mmol), and 60% sodium hydride dispersion in mineral oil (4.6 mg, 0.19 mmol) in THF (0.3 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as a white foam (8.0 mg, 27%). <i>R<sub>f</sub></i> (1:1 EtOAC/Hex): 0.40; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) Î´ 8.08 (d, <i>J</i> = 3.7 Hz, 0.5H), 7.91 (d, <i>J</i> = 4.1 Hz, 0.5H), 7.67 (s, 0.5H), 7.59 (d, <i>J</i> = 7.6 Hz, 0.5H), 7.52 (t, <i>J</i> = 7.1 Hz, 1.5H), 7.45 (t, <i>J</i> = 8.4 Hz, 1H), 7.40â7.35 (m, 1H), 7.33 (t, <i>J</i> = 7.6 Hz, 0.5H), 6.86â6.76 (m, 1.5H), 6.71 (d, <i>J</i> = 8.3 Hz, 0.5H), 6.66 (d, <i>J</i> = 8.3 Hz, 0.5H), 6.61 (s, 0.5H), 6.54 (s, 1H), 6.06â6.01 (m, 0.5H), 5.14â5.09 (m, 0.5H), 4.89â4.78 (m, 1H), 4.63 (dd, <i>J</i> = 11.2, 4.2 Hz, 0.5H), 4.50 (t, <i>J</i> = 10.8 Hz, 0.5H), 4.39 (dd, <i>J</i> = 11.8, 3.4 Hz, 0.5H), 3.83 (s, 1.5H), 3.81 (s, 1.5H), 3.79 (s, 1.5H), 3.75 (s, 1.5H), 3.71â3.63 (m, 0.5H), 3.63â3.57 (m, 0.5H), 3.29 (td, <i>J</i> = 12.9, 4.2 Hz, 0.5H), 3.06 (ddd, <i>J</i> = 17.7, 12.6, 6.2 Hz, 0.5H), 2.83â2.70 (m, 1H), 2.60 (d, <i>J</i> = 15.2 Hz, 0.5H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) Î´ 170.0, 169.3, 163.4, 162.9, 148.7, 148.3, 147.9, 147.6, 146.6, 146.5, 139.0, 137.3, 137.0, 131.2, 130.9, 130.9, 130.6, 130.5, 129.8, 129.2, 128.7, 127.0, 126.2, 126.1, 126.0, 125.8, 124.7, 124.7, 123.9, 123.5, 117.3, 117.2, 111.8, 111.4, 111.4, 111.1, 110.4, 109.8, 66.8, 66.6, 57.0, 56.1, 55.9, 51.7, 42.0, 35.5, 28.9, 27.7. (Unable to discern between fluorine splitting and minor peaks, all peaks reported as seen.) HRMS calcd for C<sub>25</sub>H<sub>24</sub>O<sub>4</sub>N<sub>2</sub>F<sub>3</sub>, 473.16827 [M + H]<sup>+</sup>; found 473.16871 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 50â95% MeOH in water over 6 min at 1 mL/min (retention time = 4.27 min). Method 2: 75â95% MeOH in water over 3 min at 1 mL/min (retention time = 1.10 min).</div></div><div id="sec4_2_1_69" class="NLM_sec NLM_sec_level_4"><div id="ac_i106" class="anchor-spacer"></div><h5 class="article-section__title" id="_i106"> (6,7-Dimethoxy-1-((pyrimidin-2-yloxy)methyl)-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)(3-(trifluoromethyl)phenyl)methanone (<b>18c</b>)</h5><div class="NLM_p last">General procedure X was followed using compound <b>17b</b> (25 mg, 0.063 mmol), 2-chloropyrimidine (11 mg, 0.095 mmol), and 60% sodium hydride dispersion in mineral oil (3.1 mg, 0.13 mmol) in DMF (0.3 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as a clear oil (14 mg, 47%). <i>R<sub>f</sub></i> (9:1 DCM/MeOH): 0.67; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) Î´ 8.45 (d, <i>J</i> = 4.5 Hz, 1H), 8.37 (d, <i>J</i> = 4.6 Hz, 1H), 7.66â7.29 (m, 4H), 6.90â6.82 (m, 1.5H), 6.62 (s, 0.5H), 6.54 (d, <i>J</i> = 7.0 Hz, 1H), 6.07â6.02 (m, 0.5H), 5.11 (dd, <i>J</i> = 9.2, 3.3 Hz, 0.5H), 4.87 (dd, <i>J</i> = 11.4, 4.2 Hz, 0.5H), 4.81 (dd, <i>J</i> = 13.1, 6.0 Hz, 0.5H), 4.71 (dd, <i>J</i> = 11.3, 6.8 Hz, 0.5H), 4.61â4.54 (m, 0.5H), 4.45 (dd, <i>J</i> = 11.8, 3.8 Hz, 0.5H), 3.84 (s, 1.5H), 3.82 (s, 1.5H), 3.79 (s, 1.5H), 3.76 (s, 1.5H), 3.72â3.67 (m, 1H), 3.34â3.27 (m, 0.5H), 3.06 (ddd, <i>J</i> = 17.5, 12.5, 6.3 Hz, 0.5H), 2.81 (ddd, <i>J</i> = 17.4, 10.8, 6.9 Hz, 0.5H), 2.77â2.71 (m, 0.5H), 2.65 (d, <i>J</i> = 16.1 Hz, 0.5H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) Î´ 170.0, 169.4, 165.0, 164.6, 159.3, 148.8, 148.3, 147.9, 147.7, 137.2, 136.9, 131.2, 131.0, 130.9, 130.8, 130.7, 123.0, 129.2, 128.8, 127.2, 126.4, 126.3, 126.0, 125.9, 124.6, 124.5, 123.7, 123.5, 122.8, 121.0, 115.5, 115.3, 111.8, 111.4, 110.2, 109.8, 68.7, 67.9, 56.6, 56.1, 55.9, 51.2, 42.5, 35.6, 28.9, 27.7 (Unable to discern between fluorine splitting and minor peaks, all peaks reported as seen.) HRMS calcd for C<sub>24</sub>H<sub>23</sub>O<sub>4</sub>N<sub>3</sub>F<sub>3</sub>, 474.16325 [M + H]<sup>+</sup>; found 474.16477 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 50â95% MeOH in water over 3 min at 1 mL/min (retention time = 2.84 min). Method 2: 75â95% MeOH in water over 3 min at 1 mL/min (retention time = 0.82 min).</div></div><div id="sec4_2_1_70" class="NLM_sec NLM_sec_level_4"><div id="ac_i107" class="anchor-spacer"></div><h5 class="article-section__title" id="_i107"> (6,7-Dimethoxy-1-(((tetrahydro-2<i>H</i>-pyran-4-yl)oxy)methyl)-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)(3-(trifluoromethyl)phenyl)methanone (<b>18d</b>)</h5><div class="NLM_p last">General procedure IX was followed using compound <b>16b</b> (29 mg, 0.094 mmol), triethylamine (26 Î¼L, 0.19 mmol), and 3-(trifluoromethyl)benzoyl chloride (17 Î¼L, 0.11 mmol) in DCM (1.5 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as a white foam (45 mg, quant.). <i>R<sub>f</sub></i> (1:1 EtOAC/Hex): 0.62; <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) Î´ 7.85 (s, 0.5H), 7.71â7.45 (m, 3.5H), 6.79 (s, 0.5H), 6.64 (s, 0.5H), 6.60 (s, 0.5H), 6.41 (s, 0.5H), 5.77 (t, <i>J</i> = 5.5 Hz, 0.5H), 4.83 (ddd, <i>J</i> = 13.8, 11.3, 5.1 Hz, 1H), 3.95â3.83 (m, 7.5H), 3.77 (s, 1.5H), 3.74â3.53 (m, 2.5H), 3.51â3.36 (m, 2.5H), 3.22 (td, <i>J</i> = 12.7, 4.2 Hz, 0.5H), 3.09 (td, <i>J</i> = 14.4, 12.3, 6.2 Hz, 0.5H), 2.85 (ddd, <i>J</i> = 17.0, 11.7, 6.0 Hz, 0.5H), 2.75 (dd, <i>J</i> = 16.2, 3.4 Hz, 0.5H), 2.65 (d, <i>J</i> = 15.7 Hz, 0.5H), 1.93â1.82 (m, 2H), 1.65â1.49 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 170.2, 169.1, 148.6, 148.2, 147.8, 147.5, 137.4, 137.3, 131.3, 131.0, 130.8, 130.5, 129.9, 129.3, 129.0, 128.8, 126.8, 126.3, 126.2, 126.1, 125.8, 125.7, 125.0(8), 125.0(6), 124.4, 123.6, 111.8, 111.4, 110.3, 109.8, 75.0, 74.0, 70.0, 69.6, 65.5, 65.4, 65.3, 57.9, 56.0, 55.9, 52.0, 42.6, 35.4, 32.4, 32.3, 32.1, 32.0, 29.0, 27.6. (Unable to discern between fluorine splitting and minor peaks, all peaks reported as seen.) HRMS calcd for C<sub>25</sub>H<sub>29</sub>O<sub>5</sub>NF<sub>3</sub>, 480.19923 [M + H]<sup>+</sup>; found 480.19912 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 50â95% MeOH in water over 6 min at 1 mL/min (retention time = 3.62 min). Method 2: 75â95% MeOH in water over 3 min at 1 mL/min (retention time = 0.88 min).</div></div><div id="sec4_2_1_71" class="NLM_sec NLM_sec_level_4"><div id="ac_i108" class="anchor-spacer"></div><h5 class="article-section__title" id="_i108"> (6,7-Dimethoxy-1-((pyridin-3-yloxy)methyl)-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)(3-(trifluoromethyl)phenyl)methanone (<b>18e</b>)</h5><div class="NLM_p last">General procedure IX was followed using compound <b>16c</b> (25 mg, 0.082 mmol), triethylamine (23 Î¼L, 0.16 mmol), and 3-(trifluoromethyl)benzoyl chloride (15 Î¼L, 0.10 mmol) in DCM (1.3 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as a white foam (17 mg, 44%). <i>R<sub>f</sub></i> (9:1 DCM/MeOH): 0.64; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) Î´ 8.08 (d, <i>J</i> = 3.7 Hz, 0.5H), 7.91 (d, <i>J</i> = 4.1 Hz, 0.5H), 7.67 (s, 0.5H), 7.59 (d, <i>J</i> = 7.6 Hz, 0.5H), 7.52 (t, <i>J</i> = 7.1 Hz, 1.5H), 7.45 (t, <i>J</i> = 8.4 Hz, 1H), 7.40â7.35 (m, 1H), 7.33 (t, <i>J</i> = 7.6 Hz, 0.5H), 6.86â6.76 (m, 1.5H), 6.71 (d, <i>J</i> = 8.3 Hz, 0.5H), 6.66 (d, <i>J</i> = 8.3 Hz, 0.5H), 6.61 (s, 0.5H), 6.54 (s, 1H), 6.06â6.01 (m, 0.5H), 5.14â5.09 (m, 0.5H), 4.89â4.78 (m, 1H), 4.63 (dd, <i>J</i> = 11.2, 4.2 Hz, 0.5H), 4.50 (t, <i>J</i> = 10.8 Hz, 0.5H), 4.39 (dd, <i>J</i> = 11.8, 3.4 Hz, 0.5H), 3.83 (s, 1.5H), 3.81 (s, 1.5H), 3.79 (s, 1.5H), 3.75 (s, 1.5H), 3.71â3.63 (m, 0.5H), 3.63â3.57 (m, 0.5H), 3.29 (td, <i>J</i> = 12.9, 4.2 Hz, 0.5H), 3.06 (ddd, <i>J</i> = 17.7, 12.6, 6.2 Hz, 0.5H), 2.83â2.70 (m, 1H), 2.60 (d, <i>J</i> = 15.2 Hz, 0.5H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) Î´ 170.0, 169.3, 163.4, 162.9, 148.7, 148.3, 147.9, 147.6, 146.6, 146.5, 139.0, 137.3, 137.0, 131.2, 130.9, 130.9, 130.6, 130.5, 129.8, 129.2, 128.7, 127.0, 126.2, 126.1, 126.0, 125.8, 124.7, 124.7, 123.9, 123.5, 117.3, 117.2, 111.8, 111.4, 111.4, 111.1, 110.4, 109.8, 66.8, 66.6, 57.0, 56.7, 55.9, 51.7, 42.0, 35.5, 28.9, 27.7. (Unable to discern between fluorine splitting and minor peaks, all peaks reported as seen.) HRMS calcd for C<sub>26</sub>H<sub>20</sub>O<sub>4</sub>N<sub>2</sub>F<sub>3</sub>, 473.16827 [M + H]<sup>+</sup>; found 473.16919 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 50â95% MeOH in water over 3 min at 1 mL/min (retention time = 2.59 min). Method 2: 75â95% MeOH in water over 3 min at 1 mL/min (retention time = 0.77 min).</div></div><div id="sec4_2_1_72" class="NLM_sec NLM_sec_level_4"><div id="ac_i109" class="anchor-spacer"></div><h5 class="article-section__title" id="_i109"> 3-(2-Nitrovinyl)thiophene (<b>20a</b>)</h5><div class="NLM_p last">General procedure XI was followed using thiophene-3-carbaldehyde (<b>19a</b>) (3.00 g, 26.7 mmol), butylamine (0.32 mL, 3.2 mmol), acetic acid (0.31 mL, 5.4 mmol), and 4 Ã molecular sieves (300 mg) in nitromethane (27 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 40 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as a yellow solid (3.3 g, 79%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.58; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 8.01 (dd, <i>J</i> = 13.5, 0.5 Hz, 1H), 7.73 (ddd, <i>J</i> = 2.5, 1.3, 0.6 Hz, 1H), 7.49 (d, <i>J</i> = 13.5 Hz, 1H), 7.44 (ddd, <i>J</i> = 5.1, 2.9, 0.7 Hz, 1H), 7.28 (ddd, <i>J</i> = 5.1, 1.3, 0.5 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 136.7, 132.6, 132.5, 132.2, 128.2, 125.1. HRMS calcd for C<sub>6</sub>H<sub>6</sub>O<sub>2</sub>NS, 156.01138 [M + H]<sup>+</sup>; found 156.01151 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_73" class="NLM_sec NLM_sec_level_4"><div id="ac_i110" class="anchor-spacer"></div><h5 class="article-section__title" id="_i110"> 2-Methoxy-5-(2-nitrovinyl)thiophene (<b>20b</b>)</h5><div class="NLM_p last">2-Methoxythiophene (1.06 g, 9.28 mmol) was dissolved in Et<sub>2</sub>O (19 mL, 0.5 M), and <i>n</i>-butyllithium (5.57 mL, 13.9 mmol, 2.5 M in hexanes) was added dropwise under nitrogen at 0 Â°C. The mixture was then heated to reflux and allowed to react for 1 h. The reaction was then cooled to 0 Â°C and quenched carefully via dropwise addition of water before the organic layer was extracted with Et<sub>2</sub>O, washed with brine (3Ã), dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i> to give the crude 5-methoxythiophene-2-carbaldehyde (<b>19b</b>) as a yellow oil (1.32 g, 100%) that was carried forward without further purification. General procedure XI was then followed using the crude material (1.32 g, 9.28 mmol), butylamine (0.110 mL, 1.11 mmol), acetic acid (0.106 mL, 1.86 mmol), and 4 Ã molecular sieves (132 mg) in nitromethane (19 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 40 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as a red solid (1.25 g over two steps, 73%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.66; <sup>1</sup>H NMR (399 MHz, CDCl<sub>3</sub>) Î´ 8.02 (d, <i>J</i> = 13.1 Hz, 1H), 7.24 (d, <i>J</i> = 13.1 Hz, 2H), 7.18 (d, <i>J</i> = 4.2 Hz, 1H), 6.25 (d, <i>J</i> = 4.2 Hz, 1H), 3.97 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 172.2, 136.2, 133.7, 131.9, 120.4, 106.4, 60.6. HRMS calcd for C<sub>7</sub>H<sub>8</sub>O<sub>3</sub>NS, 186.02194 [M + H]<sup>+</sup>; found 186.02186 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_74" class="NLM_sec NLM_sec_level_4"><div id="ac_i111" class="anchor-spacer"></div><h5 class="article-section__title" id="_i111"> 2-Methyl-4-(2-nitrovinyl)thiazole (<b>20c</b>)</h5><div class="NLM_p last">General procedure XI was followed using 2-methylthiazole-4-carbaldehyde (<b>19c</b>) (1.00 g, 7.86 mmol), butylamine (93 Î¼L, 0.94 mmol), acetic acid (90 Î¼L, 1.6 mmol), and 4 Ã molecular sieves (100 mg) in nitromethane (8 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 24 g column, 0â80% EtOAc/hexanes gradient) to afford the title compound as a yellow solid (0.41 g, 31%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.70; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.85 (s, 1H), 7.85 (s, 1H), 7.54 (s, 1H), 2.75 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 167.9, 146.9, 139.1, 130.5, 126.2, 19.4. HRMS calcd for C<sub>6</sub>H<sub>7</sub>O<sub>2</sub>N<sub>2</sub>S, 171.02227 [M + H]<sup>+</sup>; found 171.02191 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_75" class="NLM_sec NLM_sec_level_4"><div id="ac_i112" class="anchor-spacer"></div><h5 class="article-section__title" id="_i112"> 3-(2-Nitrovinyl)furan (<b>20d</b>)</h5><div class="NLM_p last">General procedure XI was followed using furan-3-carbaldehyde (<b>19d</b>) (1.80 mL, 20.8 mmol), butylamine (0.25 mL, 2.5 mmol), acetic acid (0.24 mL, 4.2 mmol), and 4 Ã molecular sieves (200 mg) in nitromethane (21 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 40 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as a yellow solid (2.9 g, quant.). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.83; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.93 (d, <i>J</i> = 13.5 Hz, 1H), 7.86â7.81 (m, 1H), 7.56â7.48 (m, 1H), 7.39 (d, <i>J</i> = 13.5 Hz, 1H), 6.59â6.55 (m, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 147.3, 145.3, 136.7, 129.6, 118.2, 107.2. No ionization observed by HRMS.</div></div><div id="sec4_2_1_76" class="NLM_sec NLM_sec_level_4"><div id="ac_i113" class="anchor-spacer"></div><h5 class="article-section__title" id="_i113"> 1-Methyl-5-(2-nitrovinyl)-1<i>H</i>-pyrazole (<b>20e</b>)</h5><div class="NLM_p last">General procedure XI was followed using 1-methyl-1H-pyrazole-5-carbaldehyde (<b>19e</b>) (2.00 g, 18.2 mmol), butylamine (0.22 mL, 2.2 mmol), acetic acid (0.21 mL, 3.6 mmol), and 4 Ã molecular sieves (200 mg) in nitromethane (18 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 40 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as a yellow solid (1.7 g, 62%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.65; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.94 (d, <i>J</i> = 13.4 Hz, 1H), 7.54 (d, <i>J</i> = 2.2 Hz, 1H), 7.51 (d, <i>J</i> = 13.4 Hz, 1H), 6.66 (d, <i>J</i> = 2.2 Hz, 1H), 4.02 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 139.4, 137.6, 133.2, 124.4, 107.5, 37.3. HRMS calcd for C<sub>6</sub>H<sub>8</sub>O<sub>2</sub>N<sub>3</sub>, 154.06110 [M + H]<sup>+</sup>; found 154.06109 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_77" class="NLM_sec NLM_sec_level_4"><div id="ac_i114" class="anchor-spacer"></div><h5 class="article-section__title" id="_i114"> 2-(Thiophen-3-yl)ethan-1-amine (<b>21a</b>)</h5><div class="NLM_p last">General procedure XII was followed using compound <b>20a</b> (3.27 g, 21.1 mmol), sulfuric acid (2.51 mL, 47.0 mmol), and 2 M lithium aluminum hydride in THF (47.0 mL, 94.0 mmol) in THF (144 mL) to afford the title compound as a red oil (2.10 g). The crude material was confirmed via LCMS and carried forward without further purification.</div></div><div id="sec4_2_1_78" class="NLM_sec NLM_sec_level_4"><div id="ac_i115" class="anchor-spacer"></div><h5 class="article-section__title" id="_i115"> 2-(5-Methoxythiophen-2-yl)ethan-1-amine (<b>21b</b>)</h5><div class="NLM_p last">General procedure XII was followed using compound <b>20b</b> (1.19 g, 6.43 mmol), sulfuric acid (0.76 mL, 14 mmol), and 2 M lithium aluminum hydride in THF (14.3 mL, 28.7 mmol) in THF (39 mL) to afford the crude title compound as a pale yellow oil (1.01 g). The crude material was confirmed via LCMS and carried forward without further purification.</div></div><div id="sec4_2_1_79" class="NLM_sec NLM_sec_level_4"><div id="ac_i116" class="anchor-spacer"></div><h5 class="article-section__title" id="_i116"> 2-(2-Methylthiazol-4-yl)ethan-1-amine (<b>21c</b>)</h5><div class="NLM_p last">General procedure XII was followed using compound <b>20c</b> (411 mg, 2.42 mmol), sulfuric acid (0.29 mL, 5.4 mmol), and 1 M lithium aluminum hydride in THF (10.8 mL, 10.8 mmol) in THF (17 mL) to afford the title compound as a red oil (60 mg). The crude material was confirmed via LCMS and carried forward without further purification.</div></div><div id="sec4_2_1_80" class="NLM_sec NLM_sec_level_4"><div id="ac_i117" class="anchor-spacer"></div><h5 class="article-section__title" id="_i117"> 2-(Furan-3-yl)ethan-1-amine (<b>21d</b>)</h5><div class="NLM_p last">General procedure XII was followed using compound <b>20d</b> (1.45 g, 10.4 mmol), sulfuric acid (1.24 mL, 23.2 mmol), and 2 M lithium aluminum hydride in THF (23.2 mL, 46.5 mmol) in THF (71 mL) to afford the title compound as a yellow oil (0.89 g). The crude material was confirmed via LCMS and carried forward without further purification.</div></div><div id="sec4_2_1_81" class="NLM_sec NLM_sec_level_4"><div id="ac_i118" class="anchor-spacer"></div><h5 class="article-section__title" id="_i118"> 2-(1-Methyl-1<i>H</i>-pyrazol-5-yl)ethan-1-amine (<b>21e</b>)</h5><div class="NLM_p last">General procedure XII was followed using compound <b>20e</b> (1.60 g, 10.5 mmol), sulfuric acid (1.24 mL, 23.3 mmol), and 2 M lithium aluminum hydride in THF (23.3 mL, 46.6 mmol) in THF (71 mL) to afford the title compound as a pale yellow oil (0.80 g). The crude material was confirmed via LCMS and carried forward without further purification.</div></div><div id="sec4_2_1_82" class="NLM_sec NLM_sec_level_4"><div id="ac_i119" class="anchor-spacer"></div><h5 class="article-section__title" id="_i119"> 2-Chloro-<i>N</i>-(2-(thiophen-3-yl)ethyl)acetamide (<b>22a</b>)</h5><div class="NLM_p last">General procedure V was followed using crude compound <b>21a</b> (2.10 g, 16.5 mmol), triethylamine (3.34 mL, 33.0 mmol), and 2-chloroacetyl chloride (1.59 mL, 19.8 mmol) in DCM (60 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 40 g column, 0-100% EtOAc/hexanes gradient) to afford the title compound as a white solid (2.20 g, 51% over two steps). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.47; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.30 (dd, <i>J</i> = 4.9, 2.9 Hz, 1H), 7.05â7.01 (m, 1H), 6.96 (dd, <i>J</i> = 4.9, 1.3 Hz, 1H), 6.65 (s, 1H), 4.02 (s, 2H), 3.56 (d, <i>J</i> = 6.1 Hz, 2H), 2.89 (t, <i>J</i> = 6.9 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 165.8, 138.6, 127.9, 126.2, 121.6, 42.7, 40.2, 23.0. HRMS calcd for C<sub>8</sub>H<sub>11</sub>ONClS, 204.02444 [M + H]<sup>+</sup>; found 204.02490 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_83" class="NLM_sec NLM_sec_level_4"><div id="ac_i120" class="anchor-spacer"></div><h5 class="article-section__title" id="_i120"> 2-Chloro-<i>N</i>-(2-(5-methoxythiophen-2-yl)ethyl)acetamide (<b>22b</b>)</h5><div class="NLM_p last">General procedure V was followed using crude compound <b>21b</b> (1.01 g, 6.43 mmol), triethylamine (1.79 mL, 12.9 mmol), and 2-chloroacetyl chloride (0.62 mL, 7.7 mmol) in DCM (23 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 24 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as an orange solid (0.92 g, 61% over two steps). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.43; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.75 (s, 1H), 6.47â6.41 (m, 1H), 6.01 (d, <i>J</i> = 3.7 Hz, 1H), 4.04 (s, 2H), 3.85 (s, 3H), 3.51 (q, <i>J</i> = 6.5 Hz, 2H), 2.89 (t, <i>J</i> = 7.0 Hz, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 166.0, 165.0, 126.6, 122.8, 103.2, 60.2, 42.6, 40.9, 30.1. HRMS calcd for C<sub>9</sub>H<sub>13</sub>O<sub>2</sub>NClS, 234.03500 [M + H]<sup>+</sup>; found 234.03492 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_84" class="NLM_sec NLM_sec_level_4"><div id="ac_i121" class="anchor-spacer"></div><h5 class="article-section__title" id="_i121"> 2-Chloro<i>-N</i>-(2-(2-methylthiazol-4-yl)ethyl)acetamide (<b>22c</b>)</h5><div class="NLM_p last">General procedure V was followed using crude compound <b>21c</b> (60 mg, 0.42 mmol), triethylamine (0.12 mL, 0.84 mmol), and 2-chloroacetyl chloride (34 Î¼L, 0.42 mmol) in DCM (1.5 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as a yellow oil (27 mg, 5% over two steps). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.39; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.59 (s, 0H), 6.81 (s, 1H), 4.03 (s, 2H), 3.62 (q, <i>J</i> = 6.5 Hz, 2H), 2.93 (t, <i>J</i> = 6.3 Hz, 2H), 2.68 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 166.3, 165.9, 153.5, 114.0, 42.8, 39.3, 30.4. HRMS calcd for C<sub>8</sub>H<sub>11</sub>ON<sub>2</sub>ClS, 219.03534 [M + H]<sup>+</sup>; found 219.03522 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_85" class="NLM_sec NLM_sec_level_4"><div id="ac_i122" class="anchor-spacer"></div><h5 class="article-section__title" id="_i122"> 2-Chloro-<i>N</i>-(2-(furan-3-yl)ethyl)acetamide (<b>22d</b>)</h5><div class="NLM_p last">General procedure V was followed using crude compound <b>21d</b> (0.860 g, 7.74 mmol), triethylamine (2.16 mL, 15.5 mmol), and 2-chloroacetyl chloride (0.74 mL, 9.3 mmol) in DCM (28 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 40 g column, 0â70% EtOAc/hexanes gradient) to afford the title compound as a red oil (0.84 g, 43% over two steps). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.61; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.39 (t, <i>J</i> = 1.7 Hz, 1H), 7.31â7.26 (m, 1H), 6.66 (s, 1H), 6.30 (dd, <i>J</i> = 1.8, 0.9 Hz, 1H), 4.03 (s, 2H), 3.50 (q, <i>J</i> = 6.2 Hz, 2H), 2.68 (t, <i>J</i> = 6.9 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 165.8, 143.4, 139.7, 121.3, 110.7, 42.7, 39.8, 24.8. HRMS calcd for C<sub>8</sub>H<sub>10</sub>O<sub>2</sub>NClNa, 210.02923 [M + H]<sup>+</sup>; found 210.02875 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_86" class="NLM_sec NLM_sec_level_4"><div id="ac_i123" class="anchor-spacer"></div><h5 class="article-section__title" id="_i123"> 2-Chloro-<i>N</i>-(2-(1-methyl-1<i>H</i>-pyrazol-5-yl)ethyl)acetamide (<b>22e</b>)</h5><div class="NLM_p last">General procedure V was followed using crude compound <b>21e</b> (0.78 g, 6.2 mmol), triethylamine (1.74 mL, 12.5 mmol), and 2-chloroacetyl chloride (0.60 mL, 7.5 mmol) in DCM (23 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 24 g column, 0â10% (1% NH<sub>4</sub>OH in MeOH)/DCM gradient) to afford the title compound as a yellow oil (0.86 g, 41% over two steps). <i>R<sub>f</sub></i> (90:10:0.1 DCM/MeOH/NH<sub>4</sub>OH): 0.43; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.40 (d, <i>J</i> = 1.9 Hz, 1H), 6.79 (bs, 1H), 6.07 (dt, <i>J</i> = 1.9, 0.6 Hz, 1H), 4.03 (s, 2H), 3.81 (s, 3H), 3.57 (dt, <i>J</i> = 7.1, 6.0 Hz, 3H), 2.88 (t, <i>J</i> = 7.1 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 166.1, 139.0, 138.5, 104.8, 42.6, 38.5, 36.2, 25.5. HRMS calcd for C<sub>8</sub>H<sub>13</sub>ON<sub>3</sub>Cl, 202.07417 [M + H]<sup>+</sup>; found 202.07392 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_87" class="NLM_sec NLM_sec_level_4"><div id="ac_i124" class="anchor-spacer"></div><h5 class="article-section__title" id="_i124"> 2-Chloro-<i>N</i>-(2-(thiophen-2-yl)ethyl)acetamide (<b>22f</b>)</h5><div class="NLM_p last">General procedure V was followed using 2-(thiophen-2-yl)ethan-1-amine (<b>21f</b>) (2.00 g, 15.7 mmol), triethylamine (3.18 mL, 31.4 mmol), and 2-chloroacetyl chloride (1.51 mL, 18.9 mmol) in DCM (57 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 40 g column, 0â60% EtOAc/hexanes gradient) to afford the title compound as a red oil (2.64 g, 82%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.51; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.18 (dd, <i>J</i> = 5.2, 1.2 Hz, 1H), 6.95 (dd, <i>J</i> = 5.1, 3.4 Hz, 1H), 6.88â6.83 (m, 1H), 6.75 (s, 1H), 4.03 (s, 2H), 3.58 (q, <i>J</i> = 6.7 Hz, 2H), 3.07 (t, <i>J</i> = 6.7 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 165.9, 140.6, 127.2, 125.6, 124.2, 42.7, 41.1, 29.7. HRMS calcd for C<sub>8</sub>H<sub>10</sub>ONClNaS, 226.00638 [M + Na]<sup>+</sup>; found 226.00658 [M + Na]<sup>+</sup>.</div></div><div id="sec4_2_1_88" class="NLM_sec NLM_sec_level_4"><div id="ac_i125" class="anchor-spacer"></div><h5 class="article-section__title" id="_i125"> <i>N</i>-(2-(1<i>H</i>-Pyrrol-1-yl)ethyl)-2-chloroacetamide (<b>22g</b>)</h5><div class="NLM_p last">General procedure V was followed using 2-(1H-pyrrol-1-yl)ethanamine (<b>21g</b>) (1.00 g, 9.08 mmol), triethylamine (2.53 mL, 18.2 mmol), and 2-chloroacetyl chloride (0.87 mL, 11 mmol) in DCM (33 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 24 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as an orange solid (1.7 g, quant.). <i>R<sub>f</sub></i> (90:10:0.1 DCM/MeOH/NH<sub>4</sub>OH): 0.69; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 6.66 (t, <i>J</i> = 2.0 Hz, 2H), 6.19 (t, <i>J</i> = 2.0 Hz, 2H), 4.05 (t, <i>J</i> = 5.9 Hz, 2H), 4.03 (s, 2H), 3.62 (q, <i>J</i> = 5.9 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 166.3, 120.6, 109.0, 48.6, 42.5, 41.3. HRMS calcd for C<sub>8</sub>H<sub>12</sub>ON<sub>2</sub>Cl, 187.06327 [M + H]<sup>+</sup>; found 187.06360 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_89" class="NLM_sec NLM_sec_level_4"><div id="ac_i126" class="anchor-spacer"></div><h5 class="article-section__title" id="_i126"> 2-(4-Methoxyphenoxy)-<i>N</i>-(2-(thiophen-3-yl)ethyl)acetamide (<b>23a</b>)</h5><div class="NLM_p last">General procedure VI was followed using compound <b>22a</b> (1.00 g, 4.91 mmol), 4-methoxyphenol (0.731 g, 5.89 mmol), and cesium carbonate (6.40 g, 19.6 mmol) in acetonitrile (15 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 24 g column, 0â70% EtOAc/hexanes gradient) to afford the title compound as a white solid (1.20 g, 84%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.40; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.28 (dd, <i>J</i> = 4.9, 3.0 Hz, 1H), 6.97â6.94 (m, 1H), 6.93 (dd, <i>J</i> = 4.9, 1.3 Hz, 1H), 6.87â6.77 (m, 4H), 6.66 (s, 1H), 4.42 (s, 2H), 3.77 (s, 3H), 3.60 (d, <i>J</i> = 6.1 Hz, 2H), 2.87 (t, <i>J</i> = 6.9 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 168.4, 154.7, 151.3, 138.8, 128.0, 126.1, 121.6, 115.6, 114.9, 68.1, 55.7, 39.3, 30.2. HRMS calcd for C<sub>15</sub>H<sub>18</sub>O<sub>3</sub>NS, 292.10019 [M + H]<sup>+</sup>; found 292.10028 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_90" class="NLM_sec NLM_sec_level_4"><div id="ac_i127" class="anchor-spacer"></div><h5 class="article-section__title" id="_i127"> 2-(4-Methoxyphenoxy)-<i>N</i>-(2-(5-methoxythiophen-2-yl)ethyl)acetamide (<b>23b</b>)</h5><div class="NLM_p last">General procedure VI was followed using compound <b>22b</b> (0.89 g, 3.8 mmol), 4-methoxyphenol (0.57 g, 4.6 mmol) and cesium carbonate (4.96 g, 15.2 mmol) in acetonitrile (38 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 24 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as a white solid (0.97 g, 79%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.41; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.88â6.79 (m, 4H), 6.75 (bs, 1H), 6.37 (dt, <i>J</i> = 3.7, 0.8 Hz, 1H), 5.98 (d, <i>J</i> = 3.7 Hz, 1H), 4.43 (s, 2H), 3.84 (s, 3H), 3.77 (s, 3H), 3.55 (q, <i>J</i> = 6.6 Hz, 2H), 2.88 (t, <i>J</i> = 7.0 Hz, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 168.4, 164.9, 154.7, 151.3, 126.9, 122.7, 115.6, 114.8, 103.2, 68.1, 60.2, 55.7, 40.1, 30.3. HRMS calcd for C<sub>16</sub>H<sub>20</sub>O<sub>4</sub>NS, 322.11076 [M + H]<sup>+</sup>; found 322.11032 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_91" class="NLM_sec NLM_sec_level_4"><div id="ac_i128" class="anchor-spacer"></div><h5 class="article-section__title" id="_i128"> 2-(4-Methoxyphenoxy)-<i>N</i>-(2-(2-methylthiazol-4-yl)ethyl)acetamide (<b>23c</b>)</h5><div class="NLM_p last">General procedure VI was followed using compound <b>22c</b> (27 mg, 0.12 mmol), 4-methoxyphenol (18 mg, 0.15 mmol), and cesium carbonate (161 mg, 0.494 mmol) in acetonitrile (0.4 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as a clear oil (35 mg, 93%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.08; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.31 (s, 1H), 6.82 (s, 4H), 6.74 (s, 1H), 4.43 (s, 2H), 3.76 (s, 3H), 3.67 (q, <i>J</i> = 6.1 Hz, 2H), 2.93 (t, <i>J</i> = 6.8 Hz, 2H), 2.65 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 168.5, 166.1, 154.6, 153.6, 151.5, 115.6, 114.8, 113.9, 68.2, 55.7, 38.3, 30.9, 19.2. HRMS calcd for C<sub>15</sub>H<sub>19</sub>O<sub>3</sub>N<sub>2</sub>S, 307.11109 [M + H]<sup>+</sup>; found 307.11127 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_92" class="NLM_sec NLM_sec_level_4"><div id="ac_i129" class="anchor-spacer"></div><h5 class="article-section__title" id="_i129"> <i>N</i>-(2-(Furan-3-yl)ethyl)-2-(4-methoxyphenoxy)acetamide (<b>23d</b>)</h5><div class="NLM_p last">General procedure VI was followed using compound <b>22d</b> (0.837 g, 4.46 mmol), 4-methoxyphenol (0.665 g, 5.35 mmol), and cesium carbonate (5.81 g, 17.8 mmol) in acetonitrile (13 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 24 g column, 0â70% EtOAc/hexanes gradient) to afford the title compound as a clear oil (1.07 g, 87%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.18; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.37 (t, <i>J</i> = 1.7 Hz, 1H), 7.23â7.18 (m, 1H), 6.87â6.76 (m, 4H), 6.67 (bs, 0H), 6.27 (dd, <i>J</i> = 1.8, 0.9 Hz, 1H), 4.42 (s, 2H), 3.77 (s, 3H), 3.54 (q, <i>J</i> = 6.9 Hz, 2H), 2.66 (t, <i>J</i> = 6.9 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 168.4, 154.7, 151.3, 143.3, 139.6, 121.5, 115.6, 114.8, 110.7, 68.1, 55.7, 38.9, 25.0. HRMS calcd for C<sub>15</sub>H<sub>18</sub>O<sub>4</sub>N, 276.12303 [M + H]<sup>+</sup>; found 276.12303 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_93" class="NLM_sec NLM_sec_level_4"><div id="ac_i130" class="anchor-spacer"></div><h5 class="article-section__title" id="_i130"> 2-(4-Methoxyphenoxy)-<i>N</i>-(2-(1-methyl-1<i>H</i>-pyrazol-5-yl)ethyl)acetamide (<b>23e</b>)</h5><div class="NLM_p last">General procedure VI was followed using compound <b>22e</b> (0.83 g, 4.1 mmol), 4-methoxyphenol (0.613 g, 4.94 mmol), and cesium carbonate (5.36 g, 16.5 mmol) in acetonitrile (24 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 24 g column, 0â10% EtOAc/hexanes gradient) to afford the title compound as a white solid (1.0 g, 84%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.76; <sup>1</sup>H NMR (399 MHz, CDCl<sub>3</sub>) Î´ 7.39 (d, <i>J</i> = 1.8 Hz, 1H), 6.87â6.76 (m, 5H), 6.03 (d, <i>J</i> = 1.9 Hz, 1H), 4.43 (s, 2H), 3.81 (s, 3H), 3.77 (s, 3H), 3.61 (q, <i>J</i> = 6.9 Hz, 2H), 2.88 (t, <i>J</i> = 7.1 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 168.7, 154.8, 151.2, 139.1, 138.3, 115.6, 114.8, 104.7, 68.0, 55.7, 37.7, 36.2, 25.8. HRMS calcd for C<sub>15</sub>H<sub>20</sub>O<sub>3</sub>N<sub>3</sub>, 290.14992 [M + H]<sup>+</sup>; found 290.14994 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_94" class="NLM_sec NLM_sec_level_4"><div id="ac_i131" class="anchor-spacer"></div><h5 class="article-section__title" id="_i131"> 2-(4-Methoxyphenoxy)-<i>N</i>-(2-(thiophen-2-yl)ethyl)acetamide (<b>23f</b>)</h5><div class="NLM_p last">General procedure VI was followed using compound <b>22f</b> (2.64 g, 13.0 mmol), 4-methoxyphenol (1.93 g, 15.6 mmol), and cesium carbonate (16.9 g, 51.8 mmol) in acetonitrile (39 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 24 g column, 0â70% EtOAc/hexanes gradient) to afford the title compound as an orange solid (3.26 g, 86%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.40; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.16 (dd, <i>J</i> = 5.1, 1.2 Hz, 1H), 6.93 (dd, <i>J</i> = 5.1, 3.4 Hz, 1H), 6.87â6.77 (m, 6H), 4.43 (s, 2H), 3.77 (s, 3H), 3.61 (q, <i>J</i> = 6.7 Hz, 2H), 3.07 (t, <i>J</i> = 6.8 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 168.5, 154.7, 151.3, 140.9, 127.1, 125.5, 124.1, 115.7, 114.8, 68.1, 55.7, 40.3, 29.9. HRMS calcd for C<sub>30</sub>H<sub>35</sub>O<sub>6</sub>N<sub>2</sub>S<sub>2</sub>, 583.19361 [2M + H]<sup>+</sup>; found 583.19343 [2M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_95" class="NLM_sec NLM_sec_level_4"><div id="ac_i132" class="anchor-spacer"></div><h5 class="article-section__title" id="_i132"> <i>N</i>-(2-(1<i>H</i>-Pyrrol-1-yl)ethyl)-2-(4-methoxyphenoxy)acetamide (<b>23g</b>)</h5><div class="NLM_p last">General procedure VI was followed using compound <b>22g</b> (0.87 g, 4.7 mmol), 4-methoxyphenol (0.694 g, 5.59 mmol), and cesium carbonate (6.08 g, 18.7 mmol) in acetonitrile (28 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 24 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as a yellow oil (1.1 g, 89%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.30; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 6.88â6.76 (m, 4H), 6.69 (s, 1H), 6.61 (t, <i>J</i> = 2.1 Hz, 2H), 6.17 (t, <i>J</i> = 2.1 Hz, 2H), 4.43 (s, 2H), 4.08â4.01 (m, 2H), 3.78 (s, 3H), 3.65 (q, <i>J</i> = 6.1 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 168.8, 154.8, 151.2, 120.6, 115.6, 114.8, 108.9, 68.0, 55.7, 48.9, 40.4. HRMS calcd for C<sub>15</sub>H<sub>19</sub>O<sub>3</sub>N<sub>2</sub>, 275.13902 [M + H]<sup>+</sup>; found 275.13913 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_96" class="NLM_sec NLM_sec_level_4"><div id="ac_i133" class="anchor-spacer"></div><h5 class="article-section__title" id="_i133"> 7-((4-Methoxyphenoxy)methyl)-4,5,6,7-tetrahydrothieno[2,3-<i>c</i>]pyridine (<b>24a</b>)</h5><div class="NLM_p last">General procedure VIII was followed using compound <b>23a</b> (1.17 g, 4.02 mmol), POCl<sub>3</sub> (1.87 mL, 20.1 mmol), and sodium borohydride (0.456 g, 12.1 mmol) in acetonitrile (60 mL) and then methanol (17 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 24 g column, 0â10% (1% NH<sub>4</sub>OH in MeOH)/DCM gradient) to afford the title compound as an orange oil (0.120 g, 11%). <i>R<sub>f</sub></i> (90:10:0.1 DCM/MeOH/NH<sub>4</sub>OH): 0.63; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.16 (d, <i>J</i> = 5.1 Hz, 1H), 6.91â6.88 (m, 2H), 6.85â6.82 (m, 3H), 4.49â4.43 (m, 1H), 4.17â4.06 (m, 2H), 3.77 (s, 3H), 3.70 (dd, <i>J</i> = 20.3, 11.2 Hz, 1H), 3.31 (dt, <i>J</i> = 12.5, 4.8 Hz, 1H), 3.06 (ddd, <i>J</i> = 13.0, 8.4, 4.9 Hz, 1H), 2.80â2.63 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 154.1, 152.7, 135.5, 133.9, 127.5, 123.0, 115.7, 114.6, 72.2, 55.7, 54.3, 41.7, 26.7. HRMS calcd for C<sub>15</sub>H<sub>18</sub>O<sub>2</sub>NS, 276.10528 [M + H]<sup>+</sup>; found 276.10526 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_97" class="NLM_sec NLM_sec_level_4"><div id="ac_i134" class="anchor-spacer"></div><h5 class="article-section__title" id="_i134"> 2-Methoxy-4-((4-methoxyphenoxy)methyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine (<b>24b</b>)</h5><div class="NLM_p last">General procedure VII was followed using compound <b>23b</b> (0.94 g, 2.9 mmol), POCl<sub>3</sub> (1.36 mL, 14.6 mmol), and sodium borohydride (0.33 g, 8.8 mmol) in acetonitrile (58 mL) and then methanol (15 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 24 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as a red oil (0.17 g, 19%). <i>R<sub>f</sub></i> (EtOAc): 0.17; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 6.88â6.82 (m, 4H), 5.95 (s, 1H), 4.22â4.16 (m, 1H), 4.10 (dd, <i>J</i> = 9.2, 3.7 Hz, 1H), 4.02â3.94 (m, 1H), 3.83 (s, 3H), 3.76 (s, 3H), 3.28 (dt, <i>J</i> = 12.1, 5.2 Hz, 1H), 3.07 (ddd, <i>J</i> = 12.2, 7.4, 4.9 Hz, 1H), 2.76â2.59 (m, 2H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) Î´ 163.9, 154.0, 152.9, 130.7, 122.2, 115.6, 114.7, 101.3, 71.2, 60.3, 55.7, 54.1, 41.4, 25.4. HRMS calcd for C<sub>16</sub>H<sub>20</sub>O<sub>3</sub>NS, 306.11584 [M + H]<sup>+</sup>; found 306.11537 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_98" class="NLM_sec NLM_sec_level_4"><div id="ac_i135" class="anchor-spacer"></div><h5 class="article-section__title" id="_i135"> 4-((4-Methoxyphenoxy)methyl)-2-methyl-4,5,6,7-tetrahydrothiazolo[5,4-<i>c</i>]pyridine (<b>24c</b>)</h5><div class="NLM_p last">General procedure VIII was followed using compound <b>23c</b> (35 mg, 0.11 mmol), POCl<sub>3</sub> (53 Î¼L, 0.57 mmol), and sodium borohydride (13 mg, 0.34 mmol) in acetonitrile (1.8 mL) and then methanol (0.5 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â10% (1% NH<sub>4</sub>OH in MeOH)/DCM gradient) to afford the title compound as a clear oil (3.6 mg, 9%). <i>R<sub>f</sub></i> (90:10:0.1 DCM/MeOH/NH<sub>4</sub>OH): 0.40; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 6.79 (s, 4H), 4.03 (t, <i>J</i> = 5.2 Hz, 2H), 3.73 (s, 3H), 3.12â2.92 (m, 6H), 2.65 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 165.8, 154.3, 153.9, 152.8, 115.5, 114.6, 113.4, 67.5, 55.7, 48.7, 48.5, 31.4, 19.1. HRMS calcd for C<sub>15</sub>H<sub>19</sub>O<sub>2</sub>N<sub>2</sub>S, 291.11618 [M + H]<sup>+</sup>; found 291.11615 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_99" class="NLM_sec NLM_sec_level_4"><div id="ac_i136" class="anchor-spacer"></div><h5 class="article-section__title" id="_i136"> 7-((4-Methoxyphenoxy)methyl)-4,5,6,7-tetrahydrofuro[2,3-<i>c</i>]pyridine (<b>24d</b>)</h5><div class="NLM_p last">General procedure VIII was followed using compound <b>23d</b> (1.02 g, 3.71 mmol), POCl<sub>3</sub> (1.73 mL, 18.5 mmol), and sodium borohydride (0.421 g, 11.1 mmol) in acetonitrile (59 mL) and then methanol (15 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 24 g column, 0â20% (1% NH<sub>4</sub>OH in MeOH)/DCM gradient) to afford the title compound as an orange oil (0.570 g, 59%). <i>R<sub>f</sub></i> (90:10:0.1 DCM/MeOH/NH<sub>4</sub>OH): 0.59; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.31â7.26 (m, 1H), 6.91â6.79 (m, 4H), 6.26 (d, <i>J</i> = 1.9 Hz, 1H), 4.33â4.25 (m, 2H), 4.11â4.03 (m, 1H), 3.76 (s, 3H), 3.21 (dt, <i>J</i> = 12.7, 5.0 Hz, 1H), 2.98 (ddd, <i>J</i> = 12.6, 7.7, 4.9 Hz, 1H), 2.62â2.44 (m, 2H), 2.21 (bs, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 154.0, 152.9, 148.3, 141.1, 117.4, 115.7, 114.6, 110.4, 69.5, 55.7, 52.8, 41.6, 23.9. HRMS calcd for C<sub>15</sub>H<sub>18</sub>O<sub>3</sub>N, 260.12812 [M + H]<sup>+</sup>; found 260.12799 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_100" class="NLM_sec NLM_sec_level_4"><div id="ac_i137" class="anchor-spacer"></div><h5 class="article-section__title" id="_i137"> 4-((4-Methoxyphenoxy)methyl)-1-methyl-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine (<b>24e</b>)</h5><div class="NLM_p last">General procedure VIII was followed using compound <b>23e</b> (0.70 g, 2.4 mmol), POCl<sub>3</sub> (1.13 mL, 12.1 mmol), and sodium borohydride (0.275 g, 7.26 mmol) in acetonitrile (39 mL) and then methanol (10 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 24 g column, 0â10% (1% NH<sub>4</sub>OH in MeOH)/DCM gradient) to afford the title compound as a clear oil (0.25 g, 38%). <i>R<sub>f</sub></i> (90:10:0.1 DCM/MeOH/NH<sub>4</sub>OH): 0.47; <sup>1</sup>H NMR (399 MHz, CDCl<sub>3</sub>) Î´ 7.33 (s, 1H), 6.92â6.78 (m, 4H), 4.28 (dd, <i>J</i> = 8.5, 4.0 Hz, 1H), 4.11 (dd, <i>J</i> = 9.1, 4.0 Hz, 1H), 3.92 (t, <i>J</i> = 8.8 Hz, 1H), 3.76 (s, 3H), 3.76 (s, 3H), 3.32 (dt, <i>J</i> = 12.3, 5.0 Hz, 1H), 3.07â2.98 (m, 1H), 2.74â2.55 (m, 2H), 2.16 (bs, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 154.0, 152.9, 137.5, 134.3, 115.6, 115.2, 114.6, 71.6, 55.7, 51.2, 40.9, 35.6, 22.7. HRMS calcd. HRMS calcd for C<sub>15</sub>H<sub>20</sub>O<sub>2</sub>N<sub>3</sub>, 274.15500 [M + H]<sup>+</sup>; found 274.15504 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_101" class="NLM_sec NLM_sec_level_4"><div id="ac_i138" class="anchor-spacer"></div><h5 class="article-section__title" id="_i138"> 4-((4-Methoxyphenoxy)methyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine (<b>24f</b>)</h5><div class="NLM_p last">General procedure VIII was followed using compound <b>23f</b> (1.00 g, 3.43 mmol), POCl<sub>3</sub> (1.60 mL, 17.2 mmol), and sodium borohydride (0.390 g, 10.3 mmol) in acetonitrile (60 mL) and then methanol (17 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 24 g column, 0â10% (1% NH<sub>4</sub>OH in MeOH)/DCM gradient) to afford the title compound as an orange oil (371 mg, 39%). <i>R<sub>f</sub></i> (90:10:0.1 DCM/MeOH/NH<sub>4</sub>OH): 0.86; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.11 (d, <i>J</i> = 5.2 Hz, 1H), 6.91â6.80 (m, 5H), 4.39â4.33 (m, 1H), 4.19 (dd, <i>J</i> = 9.2, 3.8 Hz, 1H), 4.06â3.99 (m, 1H), 3.77 (s, 3H), 3.70 (dd, <i>J</i> = 21.8, 11.2 Hz, 1H), 3.37â3.28 (m, 1H), 3.14â3.05 (m, 1H), 2.97â2.80 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 154.0, 152.9, 135.9, 133.7, 124.6, 122.4, 115.6, 114.7, 71.2, 55.7, 54.2, 41.3, 25.9. HRMS calcd for C<sub>15</sub>H<sub>18</sub>O<sub>2</sub>NS, 276.10528 [M + H]<sup>+</sup>; found 276.10513 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_102" class="NLM_sec NLM_sec_level_4"><div id="ac_i139" class="anchor-spacer"></div><h5 class="article-section__title" id="_i139"> 1-((4-Methoxyphenoxy)methyl)-1,2,3,4-tetrahydropyrrolo[1,2-<i>a</i>]pyrazine (<b>24g</b>)</h5><div class="NLM_p last">General procedure VIII was followed using compound <b>23g</b> (1.12 g, 4.08 mmol), POCl<sub>3</sub> (1.90 mL, 20.4 mmol), and sodium borohydride (0.463 g, 12.3 mmol) in acetonitrile (65 mL) and then methanol (16 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 24 g column, 0-10% (1% NH<sub>4</sub>OH in MeOH)/DCM gradient) to afford the title compound as a white solid (0.777 g, 74%). <i>R<sub>f</sub></i> (90:10:0.1 DCM/MeOH/NH<sub>4</sub>OH): 0.58; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 6.93â6.81 (m, 4H), 6.61 (t, <i>J</i> = 2.0 Hz, 1H), 6.18 (t, <i>J</i> = 3.0 Hz, 1H), 5.96 (dt, <i>J</i> = 3.3, 1.3 Hz, 1H), 4.46 (dd, <i>J</i> = 8.9, 3.3 Hz, 1H), 4.25 (dd, <i>J</i> = 9.2, 3.4 Hz, 1H), 4.06â3.93 (m, 3H), 3.78 (s, 3H), 3.37 (dt, <i>J</i> = 12.4, 4.0 Hz, 1H), 3.24â3.15 (m, 1H), 2.28 (s, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 154.0, 152.8, 126.8, 119.5, 115.5, 114.7, 107.8, 102.8, 71.3, 55.7, 53.0, 45.6, 42.0. HRMS calcd for C<sub>15</sub>H<sub>19</sub>O<sub>2</sub>N<sub>2</sub>, 259.14410 [M + H]<sup>+</sup>; found 259.14418 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_103" class="NLM_sec NLM_sec_level_4"><div id="ac_i140" class="anchor-spacer"></div><h5 class="article-section__title" id="_i140"> (3-Chlorophenyl)(7-((4-methoxyphenoxy)methyl)-4,7-dihydrothieno[2,3-<i>c</i>]pyridin-6(5<i>H</i>)-yl)methanone (<b>25a</b>)</h5><div class="NLM_p last">General procedure IX was followed using compound <b>24a</b> (100 mg, 0.363 mmol), triethylamine (101 Î¼L, 0.726 mmol), and 3-chlorobenzoyl chloride (56 Î¼L, 0.44 mmol) in DCM (5.7 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â50% EtOAc/hexanes gradient) to afford the title compound as rotamers in solution and a white foam (50 mg, 33%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.69; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>, probe temp: â25 Â°C) Î´ 8.05â8.01 (m, 0.05H), 7.96â7.92 (m, 0.05H), 7.63 (bs, 0.3H), 7.57â7.52 (m, 0.5H), 7.45â7.32 (m, 3.3H), 7.32â7.23 (m, 2H), 6.95â6.78 (m, 5.2H), 6.09 (t, <i>J</i> = 5.4 Hz, 0.6H), 5.31 (dd, <i>J</i> = 9.1, 4.3 Hz, 0.4H), 4.92 (dd, <i>J</i> = 13.3, 5.6 Hz, 0.4H), 4.36 (dd, <i>J</i> = 9.3, 5.2 Hz, 0.6H), 4.28 (dd, <i>J</i> = 9.3, 6.1 Hz, 0.6H), 4.19 (t, <i>J</i> = 9.6 Hz, 0.4H), 3.98 (dd, <i>J</i> = 9.9, 4.4 Hz, 0.4H), 3.89 (dd, <i>J</i> = 13.7, 4.8 Hz, 0.6H), 3.77 (s, 3H), 3.63â3.54 (m, 0.6H), 3.26â3.15 (m, 0.4H), 2.99 (ddd, <i>J</i> = 17.1, 12.4, 5.7 Hz, 0.4H), 2.83â2.74 (m, 1H), 2.71 (dd, <i>J</i> = 15.9, 3.1 Hz, 0.6H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>, probe temp: â25 Â°C) Î´ 170.5, 169.6, 153.9, 153.8, 152.3, 151.8, 137.6, 137.4, 136.0, 134.7, 134.4, 134.1, 132.1, 130.3, 130.1, 130.0, 130.0, 128.2, 127.8, 127.3, 126.8, 126.7, 125.5, 124.8, 124.7, 124.6, 124.3, 69.9, 69.6, 55.7, 55.6, 50.7, 43.2, 35.9, 26.5, 25.4. HRMS calcd for C<sub>22</sub>H<sub>21</sub>O<sub>3</sub>NClS, 414.09252 [M + H]<sup>+</sup>; found 414.09298 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 75â95% MeOH in water over 3 min at 1 mL/min (retention time = 2.42 min). Method 2: 95% MeOH in water over 3 min at 1 mL/min (retention time = 0.702 min).</div></div><div id="sec4_2_1_104" class="NLM_sec NLM_sec_level_4"><div id="ac_i141" class="anchor-spacer"></div><h5 class="article-section__title" id="_i141"> (5-Chlorothiophen-2-yl)(7-((4-methoxyphenoxy)methyl)-4,7-dihydrothieno[2,3-<i>c</i>]pyridin-6(5<i>H</i>)-yl)methanone (<b>25b</b>)</h5><div class="NLM_p last">General procedure XIII was followed using compound <b>24a</b> (25 mg, 0.091 mmol), EDCI (17 mg, 0.11 mmol), DMAP (13 mg, 0.11 mmol), and 5-chlorothiophene-2-carboxylic acid (16 mg, 0.10 mmol) in DCM (0.4 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â70% EtOAc/hexanes gradient) to afford the title compound as rotamers in solution and a clear oil (10 mg, 26%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.90; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>, probe temp: â25 Â°C) Î´ 7.41 (dd, <i>J</i> = 15.3, 1.8 Hz, 0.7H), 7.30 (d, <i>J</i> = 5.1 Hz, 0.7H), 7.24 (d, <i>J</i> = 5.1 Hz, 0.3H), 7.08 (dd, <i>J</i> = 15.3, 1.9 Hz, 0.3H), 6.89â6.73 (m, 6H), 6.02 (t, <i>J</i> = 5.2 Hz, 0.3H), 5.47 (dd, <i>J</i> = 8.9, 4.2 Hz, 0.7H), 4.91 (dd, <i>J</i> = 13.3, 4.7 Hz, 0.7H), 4.27 (dd, <i>J</i> = 9.4, 4.9 Hz, 0.3H), 4.22â4.15 (m, 2H), 4.12 (dd, <i>J</i> = 13.6, 4.3 Hz, 0.3H), 3.77 (s, 2H), 3.76 (s, 1H), 3.05 (td, <i>J</i> = 13.1, 4.3 Hz, 0.7H), 2.89â2.73 (m, 2H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>, probe temp: â25 Â°C) Î´ 163.8, 162.9, 154.0, 153.8, 152.1, 151.6, 136.6, 134.1, 132.0, 130.0, 129.8, 129.7, 129.4, 129.4, 129.3, 129.3, 129.3, 129.2, 129.2, 129.0, 128.0, 127.3, 126.7, 125.0, 124.7, 123.5, 121.8, 115.4, 114.8, 114.6, 114.4, 69.9, 55.7, 55.7, 54.6, 51.0, 42.1, 36.1, 26.6, 25.4. HRMS calcd for C<sub>20</sub>H<sub>19</sub>O<sub>3</sub>NClS<sub>2</sub>, 420.04894 [M + H]<sup>+</sup>; found 420.04910 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 75â95% MeOH in water over 3 min at 1 mL/min (retention time = 2.68 min). Method 2: 95% MeOH in water over 3 min at 1 mL/min (retention time = 0.76 min).</div></div><div id="sec4_2_1_105" class="NLM_sec NLM_sec_level_4"><div id="ac_i142" class="anchor-spacer"></div><h5 class="article-section__title" id="_i142"> (<i>E</i>)-4,4,4-Trifluoro-1-(7-((4-methoxyphenoxy)methyl)-4,7-dihydrothieno[2,3-<i>c</i>]pyridin-6(5<i>H</i>)-yl)but-2-en-1-one (<b>25c</b>)</h5><div class="NLM_p last">General procedure XIII was followed using compound <b>24a</b> (25 mg, 0.091 mmol), EDCI (17 mg, 0.11 mmol), DMAP (13 mg, 0.11 mmol), and (<i>E</i>)-4,4,4-trifluorobut-2-enoic acid (14 mg, 0.10 mmol) in DCM (0.4 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â70% EtOAc/hexanes gradient) to afford the title compound as rotamers in solution and a yellow oil (12 mg, 33%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.71; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>, probe temp: â25 Â°C) Î´ 7.62 (d, <i>J</i> = 3.9 Hz, 0.5H), 7.28â7.24 (m, 1H), 7.15 (d, <i>J</i> = 3.8 Hz, 0.5H), 6.95â6.77 (m, 6H), 5.91 (t, <i>J</i> = 5.0 Hz, 0.5H), 5.81 (dd, <i>J</i> = 8.5, 5.0 Hz, 0.5H), 4.74 (dd, <i>J</i> = 13.4, 5.1 Hz, 0.5H), 4.47 (dd, <i>J</i> = 14.0, 4.8 Hz, 0.5H), 4.39â4.34 (m, 0.5H), 4.31â4.17 (m, 1.5H), 3.78 (s, 1.5H), 3.76 (s, 1.5H), 3.74â3.67 (m, 0.5H), 3.19 (td, <i>J</i> = 12.9, 3.5 Hz, 0.5H), 3.02â2.87 (m, 1H), 2.86â2.79 (m, 0.5H), 2.73 (dd, <i>J</i> = 16.4, 3.0 Hz, 0.5H). HRMS calcd for C<sub>19</sub>H<sub>19</sub>O<sub>3</sub>NF<sub>3</sub>S, 398.10323 [M + H]<sup>+</sup>; found 398.10325 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 75â95% MeOH in water over 3 min at 1 mL/min (retention time = 2.00 min). Method 2: 95% MeOH in water over 3 min at 1 mL/min (retention time = 0.64 min).</div></div><div id="sec4_2_1_106" class="NLM_sec NLM_sec_level_4"><div id="ac_i143" class="anchor-spacer"></div><h5 class="article-section__title" id="_i143"> (3-Chlorophenyl)(2-methoxy-4-((4-methoxyphenoxy)methyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridin-5(4<i>H</i>)-yl)methanone (<b>25d</b>)</h5><div class="NLM_p last">General procedure IX was followed using compound <b>24b</b> (25 mg, 0.082 mmol), triethylamine (23 Î¼L, 0.16 mmol), and 3-chlorobenzoyl chloride (13 Î¼L, 0.10 mmol) in DCM (1.3 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as a mixture of rotamers in solution and a yellow oil (13 mg, 36%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.63; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>, probe temp: â25 Â°C) Î´ 7.65 (bs, 0.5H), 7.44â7.32 (m, 3.5H), 7.29â7.24 (m, 0.5H), 6.90â6.76 (m, 4.5H), 6.01 (s, 0.5H), 5.79 (t, <i>J</i> = 4.6 Hz, 0.5H), 5.79 (s, 0.5H), 5.03 (dd, <i>J</i> = 9.5, 3.0 Hz, 0.5H), 4.94 (dd, <i>J</i> = 13.2, 5.6 Hz, 0.5H), 4.37â4.26 (m, 1H), 4.10 (t, <i>J</i> = 9.8 Hz, 0.5H), 3.94â3.86 (m, 1H), 3.86 (s, 1.5H), 3.81 (s, 1.5H), 3.77 (s, 3H), 3.73â3.67 (m, 0.5H), 3.24 (td, <i>J</i> = 12.8, 4.2 Hz, 0.5H), 3.06â2.97 (m, 0.5H), 2.85â2.76 (m, 0.5H), 2.68 (dd, <i>J</i> = 16.2, 3.6 Hz, 0.5H), 2.63â2.57 (m, 0.5H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>, probe temp: â25 Â°C) Î´ 172.5, 170.6, 169.7, 164.5, 164.5, 153.8, 153.7, 152.5, 152.0, 137.7, 137.6, 134.7, 134.2, 130.3, 130.0, 129.9, 129.8, 129.1, 127.9, 127.7, 126.8, 125.7, 124.7, 121.9, 119.7, 115.3, 114.8, 114.5, 114.4, 101.0, 100.8, 69.4, 68.2, 60.1, 60.1, 56.1, 55.7, 55.7, 51.0, 43.5, 36.1, 25.2, 24.1. HRMS calcd for C<sub>23</sub>H<sub>23</sub>O<sub>4</sub>NClS, 444.10308 [M + H]<sup>+</sup>; found 444.10290 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 75â95% MeOH in water over 3 min at 1 mL/min (retention time = 2.33 min). Method 2: 95% MeOH in water over 3 min at 1 mL/min (retention time = 0.69 min).</div></div><div id="sec4_2_1_107" class="NLM_sec NLM_sec_level_4"><div id="ac_i144" class="anchor-spacer"></div><h5 class="article-section__title" id="_i144"> (3-Chlorophenyl)(4-((4-methoxyphenoxy)methyl)-2-methyl-6,7-dihydrothiazolo[5,4-<i>c</i>]pyridin-5(4<i>H</i>)-yl)methanone (<b>25e</b>)</h5><div class="NLM_p last">General procedure IX was followed using compound <b>24c</b> (5.0 mg, 0.014 mmol), triethylamine (3.8 Î¼L, 0.028 mmol), and 3-chlorobenzoyl chloride (2.1 Î¼L, 0.017 mmol) in DCM (0.2 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as rotamers in solution and a yellow oil (5.5 mg, 93%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.61; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>, probe temp: â25 Â°C) Î´ 7.58 (s, 0.2H), 7.46â7.34 (m, 3H), 7.32â7.27 (m, 0.8H), 6.92â6.77 (m, 4H), 6.02â5.97 (m, 0.8H), 5.26â5.21 (m, 0.2H), 4.95 (dd, <i>J</i> = 13.3, 5.7 Hz, 0.2H), 4.34 (dd, <i>J</i> = 9.0, 4.6 Hz, 0.8H), 4.19â4.13 (m, 1H), 3.99â3.91 (m, 1H), 3.76 (s, 2H), 3.75 (s, 1H), 3.65â3.56 (m, 0.8H), 3.28â3.19 (m, 0.2H), 3.14â3.04 (m, 0.2H), 2.93â2.81 (m, 1.8H), 2.68 (s, 2H), 2.67 (s, 1H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>, probe temp: â25 Â°C) Î´ 172.5, 170.4, 169.6, 165.8, 154.0, 153.9, 152.0, 151.6, 149.9, 148.0, 137.2, 137.1, 134.8, 134.5, 130.3, 130.3, 130.2, 130.2, 127.6, 127.0, 125.6, 125.2, 124.6, 123.7, 115.3, 114.9, 114.5, 114.5, 69.1, 68.9, 55.7, 54.4, 49.6, 43.4, 36.4, 27.6, 26.7, 19.5, 19.4. HRMS calcd for C<sub>22</sub>H<sub>22</sub>O<sub>3</sub>N<sub>2</sub>ClS, 429.10342 [M + H]<sup>+</sup>; found 429.10342 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 75â95% MeOH in water over 3 min at 1 mL/min (retention time = 1.69 min). Method 2: 95% MeOH in water over 3 min at 1 mL/min (retention time = 0.65 min).</div></div><div id="sec4_2_1_108" class="NLM_sec NLM_sec_level_4"><div id="ac_i145" class="anchor-spacer"></div><h5 class="article-section__title" id="_i145"> (3-Chlorophenyl)(7-((4-methoxyphenoxy)methyl)-4,7-dihydrofuro[2,3-<i>c</i>]pyridin-6(5<i>H</i>)-yl)methanone (<b>25f</b>)</h5><div class="NLM_p last">General procedure IX was followed using compound <b>24d</b> (28 mg, 0.108 mmol), triethylamine (30 Î¼L, 0.21 mmol), and 3-chlorobenzoyl chloride (17 Î¼L, 0.13 mmol) in DCM (1.7 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as rotamers in solution and a clear oil (19 mg, 44%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.44; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>, probe temp: â25 Â°C) Î´ 7.62 (s, 0.3H), 7.44â7.32 (m, 4H), 7.28â7.24 (m, 0.7H), 6.86â6.77 (m, 4H), 6.35â6.30 (m, 1H), 5.86 (t, <i>J</i> = 4.1 Hz, 0.7H), 5.17 (dd, <i>J</i> = 8.8, 2.3 Hz, 0.3H), 4.89 (dd, <i>J</i> = 13.3, 5.3 Hz, 0.3H), 4.49 (dd, <i>J</i> = 10.1, 3.2 Hz, 0.7H), 4.40 (dd, <i>J</i> = 10.1, 4.2 Hz, 0.7H), 4.11 (t, <i>J</i> = 9.7 Hz, 0.3H), 4.05 (dd, <i>J</i> = 10.1, 3.2 Hz, 0.3H), 3.83 (dd, <i>J</i> = 13.7, 4.9 Hz, 0.7H), 3.77 (s, 1H), 3.77 (s, 2H), 3.75â3.68 (m, 0.7H), 3.25â3.13 (m, 0.3H), 2.88â2.78 (m, 0.3H), 2.67â2.58 (m, 0.7H), 2.58â2.45 (m, 1H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>, probe temp: â25 Â°C) Î´ 170.9, 169.9, 153.8, 153.7, 152.5, 151.9, 145.7, 144.8, 142.6, 142.3, 137.7, 137.4, 134.6, 134.3, 130.2, 130.0, 129.9, 129.9, 127.8, 126.8, 125.6, 124.7, 118.5, 116.9, 115.3, 114.8, 114.5, 114.4, 110.5, 110.1, 68.5, 67.4, 55.7, 54.9, 50.1, 44.4, 36.7, 23.2, 22.0. HRMS calcd for C<sub>22</sub>H<sub>21</sub>O<sub>4</sub>NCl, 398.11536 [M + H]<sup>+</sup>; found 398.11536 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 75â95% MeOH in water over 3 min at 1 mL/min (retention time = 2.11 min). Method 2: 95% MeOH in water over 3 min at 1 mL/min (retention time = 0.67 min).</div></div><div id="sec4_2_1_109" class="NLM_sec NLM_sec_level_4"><div id="ac_i146" class="anchor-spacer"></div><h5 class="article-section__title" id="_i146"> (3-Chlorophenyl)(4-((4-methoxyphenoxy)methyl)-1-methyl-1,4,6,7-tetrahydro-5<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridin-5-yl)methanone (<b>25g</b>)</h5><div class="NLM_p last">General procedure IX was followed using compound <b>24e</b> (49 mg, 0.18 mmol), triethylamine (50 Î¼L, 0.36 mmol), and 3-chlorobenzoyl chloride (28 Î¼L, 0.38 mmol) in DCM (2.8 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as rotamers in solution and a white solid (71 mg, 96%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.64; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>, probe temp: â25 Â°C) Î´ 7.62 (s, 0.5H), 7.47 (s, 0.5H), 7.44â7.31 (m, 3H), 7.29â7.23 (m, 0.5H), 7.18 (dd, <i>J</i> = 7.5, 3.9 Hz, 0.5H), 6.89â6.76 (m, 4H), 5.96 (d, <i>J</i> = 5.4 Hz, 0.5H), 5.18 (dd, <i>J</i> = 9.5, 4.0 Hz, 0.5H), 4.98 (dd, <i>J</i> = 13.4, 5.8 Hz, 0.5H), 4.26 (dd, <i>J</i> = 9.4, 5.4 Hz, 0.5H), 4.20 (dd, <i>J</i> = 9.4, 5.7 Hz, 0.5H), 4.04 (t, <i>J</i> = 9.8 Hz, 0.5H), 3.93 (dd, <i>J</i> = 13.9, 5.3 Hz, 0.5H), 3.84 (dd, <i>J</i> = 10.0, 4.1 Hz, 0.5H), 3.79 (s, 1.5H), 3.79 (s, 1.5H), 3.76 (s, 3H), 3.63â3.53 (m, 0.5H), 3.17 (td, <i>J</i> = 13.0, 4.3 Hz, 0.5H), 2.93 (ddd, <i>J</i> = 17.5, 12.0, 5.9 Hz, 0.5H), 2.79â2.68 (m, 1H), 2.65 (dd, <i>J</i> = 15.5, 3.5 Hz, 0.5H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>, probe temp: â25 Â°C) Î´ 171.0, 169.9, 153.8, 153.7, 152.4, 151.9, 137.8, 137.6, 137.5, 135.9, 135.6, 134.9, 134.7, 134.3, 130.3, 130.1, 130.0, 130.0, 129.1, 128.3, 127.8, 126.7, 125.5, 125.4, 124.6, 115.3, 114.8, 114.5, 114.4, 113.8, 112.8, 69.4, 68.7, 55.7, 53.0, 47.8, 42.4, 36.1, 35.1, 22.5, 21.7, 21.4. HRMS calcd for C<sub>22</sub>H<sub>23</sub>O<sub>3</sub>N<sub>3</sub>Cl, 412.14225 [M + H]<sup>+</sup>; found 412.14237 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 75â95% MeOH in water over 3 min at 1 mL/min (retention time = 1.53 min). Method 2: 85â95% MeOH in water over 5 min at 1 mL/min (retention time = 0.82 min).</div></div><div id="sec4_2_1_110" class="NLM_sec NLM_sec_level_4"><div id="ac_i147" class="anchor-spacer"></div><h5 class="article-section__title" id="_i147"> (3-Chlorophenyl)(4-((4-methoxyphenoxy)methyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridin-5(4<i>H</i>)-yl)methanone (<b>25h</b>)</h5><div class="NLM_p last">General procedure IX was followed using compound <b>24f</b> (50 mg, 0.18 mmol), triethylamine (51 Î¼L, 0.36 mmol), and 3-chlorobenzoyl chloride (28 Î¼L, 0.22 mmol) in DCM (2.8 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â70% EtOAc/hexanes gradient) to afford the title compound as rotamers in solution and a white foam (49 mg, 65%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.77; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>, probe temp: â25 Â°C) Î´ 7.67 (bs, 0.5H), 7.45â7.34 (m, 3H), 7.31â7.27 (m, 0.5H), 7.19 (dd, <i>J</i> = 16.2, 5.2 Hz, 1H), 6.99 (d, <i>J</i> = 5.2 Hz, 0.5H), 6.91â6.78 (m, 4H), 6.75 (d, <i>J</i> = 5.2 Hz, 0.5H), 5.99 (t, <i>J</i> = 4.8 Hz, 0.5H), 5.22 (dd, <i>J</i> = 9.6, 3.5 Hz, 0.5H), 4.99 (dd, <i>J</i> = 13.1, 5.4 Hz, 0.5H), 4.35 (qd, <i>J</i> = 9.8, 5.1 Hz, 1H), 4.11 (t, <i>J</i> = 9.8 Hz, 0.5H), 3.97â3.90 (m, 1H), 3.77 (s, 3H), 3.73â3.65 (m, 0.5H), 3.25 (td, <i>J</i> = 12.7, 4.0 Hz, 0.5H), 3.19â3.07 (m, 0.5H), 2.97â2.89 (m, 1H), 2.84 (dd, <i>J</i> = 16.0, 3.1 Hz, 0.5H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>, probe temp: â25 Â°C) Î´ 170.7, 169.8, 153.8, 153.7, 152.5, 152.0, 137.7, 137.6, 136.3, 134.7, 134.3, 133.9, 132.3, 130.9, 130.3, 130.0, 129.9, 129.9, 128.0, 126.8, 125.7, 125.6, 125.0, 124.7, 123.9, 123.8, 69.5, 68.4, 56.2, 55.7, 51.1, 43.3, 36.1, 25.8, 24.8. HRMS calcd for C<sub>44</sub>H<sub>40</sub>O<sub>6</sub>N<sub>2</sub>Cl<sub>2</sub>NaS<sub>2</sub>, 849.15970 [2M + Na]<sup>+</sup>; found 849.16095 [2M + Na]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 75â95% MeOH in water over 3 min at 1 mL/min (retention time = 2.33 min). Method 2: 95% MeOH in water over 3 min at 1 mL/min (retention time = 0.69 min).</div></div><div id="sec4_2_1_111" class="NLM_sec NLM_sec_level_4"><div id="ac_i148" class="anchor-spacer"></div><h5 class="article-section__title" id="_i148"> (3-Chlorophenyl)(1-((4-methoxyphenoxy)methyl)-3,4-dihydropyrrolo[1,2-<i>a</i>]pyrazin-2(1<i>H</i>)-yl)methanone (<b>25i</b>)</h5><div class="NLM_p last">General procedure IX was followed using compound <b>24g</b> (50 mg, 0.19 mmol), triethylamine (54 Î¼L, 0.39 mmol), and 3-chlorobenzoyl chloride (30 Î¼L, 0.23 mmol) in DCM (3.0 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â70% EtOAc/hexanes gradient) to afford the title compound as rotamers in solution and a white foam (67 mg, 87%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.58; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>, probe temp: â25 Â°C) Î´ 7.69 (bs, 0.7H), 7.48â7.31 (m, 3H), 7.26â7.22 (m, 0.3H), 6.88â6.74 (m, 4H), 6.72â6.68 (m, 0.7H), 6.67â6.62 (m, 0.3H), 6.24 (t, <i>J</i> = 3.1 Hz, 0.3H), 6.21 (t, <i>J</i> = 3.1 Hz, 0.7H), 6.17 (t, <i>J</i> = 4.9 Hz, 0.3H), 6.12 (d, <i>J</i> = 3.4 Hz, 0.3H), 5.94 (d, <i>J</i> = 2.4 Hz, 0.7H), 5.44 (dd, <i>J</i> = 10.2, 3.8 Hz, 0.7H), 4.97 (dd, <i>J</i> = 13.7, 3.9 Hz, 0.7H), 4.40 (dd, <i>J</i> = 9.8, 4.2 Hz, 0.3H), 4.28 (dd, <i>J</i> = 9.8, 5.8 Hz, 0.3H), 4.20â4.07 (m, 2H), 4.04â3.84 (m, 2H), 3.77 (s, 3H), 3.51â3.42 (m, 0.7H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>, probe temp: â25 Â°C) Î´ 170.7, 169.5, 153.8, 153.7, 152.5, 151.9, 137.2, 136.8, 134.8, 134.3, 130.4, 130.2, 130.1, 129.9, 128.1, 126.9, 125.9, 124.8, 124.6, 123.2, 120.2, 119.5, 115.4, 114.8, 114.5, 114.4, 108.8, 108.6, 105.0, 104.8, 70.2, 68.7, 55.7, 54.3, 49.4, 45.0, 44.3, 43.5, 35.9. HRMS calcd for C<sub>22</sub>H<sub>22</sub>O<sub>3</sub>N<sub>2</sub>Cl, 397.13135 [M + H]<sup>+</sup>; found 397.13144 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 75â95% MeOH in water over 3 min at 1 mL/min (retention time = 1.87 min). Method 2: 85â95% MeOH in water over 5 min at 1 mL/min (retention time = 0.96 min).</div></div><div id="sec4_2_1_112" class="NLM_sec NLM_sec_level_4"><div id="ac_i149" class="anchor-spacer"></div><h5 class="article-section__title" id="_i149"> (1-((4-Methoxyphenoxy)methyl)-3,4-dihydropyrrolo[1,2-<i>a</i>]pyrazin-2(1<i>H</i>)-yl)(3-(trifluoromethyl)phenyl)methanone (<b>25j</b>)</h5><div class="NLM_p last">General procedure IX was followed using compound <b>24g</b> (100 mg, 0.387 mmol), triethylamine (108 Î¼L, 0.774 mmol), and 3-chlorobenzoyl chloride (70 Î¼L, 0.46 mmol) in DCM (6.5 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â70% EtOAc/hexanes gradient) to afford the title compound as rotamers in solution and a white foam (0.10 g, 62%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.60; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>, probe temp: â25 Â°C) Î´ 8.01 (bs, 0.7H), 7.80 (d, <i>J</i> = 7.2 Hz, 0.7H), 7.72 (d, <i>J</i> = 7.6 Hz, 1H), 7.65 (s, 0.3H), 7.63â7.54 (m, 1.3H), 6.89â6.75 (m, 4H), 6.74â6.70 (m, 0.7H), 6.66 (m, 0.3H), 6.28â6.17 (m, 1H), 6.14 (d, <i>J</i> = 3.3 Hz, 0.3H), 5.95 (d, <i>J</i> = 2.5 Hz, 0.7H), 5.42 (dd, <i>J</i> = 10.4, 3.8 Hz, 0.7H), 5.00 (dd, <i>J</i> = 13.7, 4.0 Hz, 0.7H), 4.43 (dd, <i>J</i> = 9.9, 4.2 Hz, 0.3H), 4.34â4.29 (m, 0.3H), 4.23â4.09 (m, 2H), 4.06â3.95 (m, 1H), 3.89 (dd, <i>J</i> = 10.1, 4.0 Hz, 1H), 3.77 (s, 3H), 3.50 (td, <i>J</i> = 13.5, 4.1 Hz, 1H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) Î´ 170.8, 169.5, 153.9, 153.7, 152.5, 151.8, 136.3, 136.0, 131.2, 130.8, 130.6, 130.0, 129.6, 129.1, 126.9, 125.1, 124.7, 124.6, 123.8, 123.0, 122.9, 120.3, 119.5, 115.4, 114.8, 114.5, 114.4, 108.9, 108.6, 105.1, 104.9, 70.2, 68.6, 55.7, 54.3, 49.5, 44.9, 44.3, 43.5, 35.9. HRMS calcd for C<sub>23</sub>H<sub>22</sub>O<sub>3</sub>N<sub>2</sub>F<sub>3</sub>, 431.15770 [M + H]<sup>+</sup>; found 431.15762 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 75â95% MeOH in water over 3 min at 1 mL/min (retention time = 1.90 min). Method 2: 95% MeOH in water over 3 min at 1 mL/min (retention time = 0.90 min).</div></div><div id="sec4_2_1_113" class="NLM_sec NLM_sec_level_4"><div id="ac_i150" class="anchor-spacer"></div><h5 class="article-section__title" id="_i150"> (3-Chlorophenyl)(4-((4-methoxyphenoxy)methyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridin-5(4<i>H</i>)-yl)methanethione (<b>26</b>)</h5><div class="NLM_p last">General procedure XIV was followed using compound <b>25a</b> (48 mg, 0.12 mmol) and Lawessonâs reagent (80 mg, 0.20 mmol) in toluene (1.5 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â40% EtOAc/hexanes gradient) to afford the title compound as a clear oil (11 mg, 18%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.77; <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) Î´ 7.24â7.15 (m, 3H), 7.06â7.01 (m, 2H), 6.83â6.77 (m, 3H), 6.76â6.71 (m, 3H), 6.49 (d, <i>J</i> = 15.2 Hz, 1H), 4.91 (dd, <i>J</i> = 6.9, 4.7 Hz, 1H), 4.82 (d, <i>J</i> = 15.2 Hz, 1H), 4.53 (d, <i>J</i> = 19.6 Hz, 1H), 4.28 (d, <i>J</i> = 19.6 Hz, 1H), 4.11â4.03 (m, 2H), 3.81 (s, 3H), 3.76 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 199.4, 159.9, 154.4, 151.8, 137.2, 134.6, 133.4, 130.1, 127.9, 127.7, 126.7, 125.5, 123.1, 115.5, 114.7, 113.3, 111.6, 70.6, 62.7, 56.2, 55.7, 55.4, 47.7. HRMS calcd for C<sub>25</sub>H<sub>25</sub>O<sub>3</sub>NClS, 454.12382 [M + H]<sup>+</sup>; found 454.12380 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 75â95% MeOH in water over 3 min at 1 mL/min (retention time = 2.84 min). Method 2: 85â95% MeOH in water over 5 min at 1 mL/min (retention time = 1.41 min).</div></div><div id="sec4_2_1_114" class="NLM_sec NLM_sec_level_4"><div id="ac_i151" class="anchor-spacer"></div><h5 class="article-section__title" id="_i151"> Methyl 2-(1<i>H</i>-Pyrrol-1-yl)acetate (<b>27</b>)</h5><div class="NLM_p last">Glycine methyl ester hydrochloride (<b>26</b>) (5.00 g, 39.8 mmol, 1 equiv) and sodium acetate (4.90 g, 59.7 mmol, 1.5 equiv) were dissolved in a 2:1 (v/v) mixture of acetic acid (50 mL) and water (25 mL). 2,5-Dimethoxytetrahydrofuran (5.66 mL, 43.8 mmol, 1.1 equiv) was then added, and the resulting mixture was heated to 100 Â°C for 4 h before cooling to room temperature. The crude mixture was poured into water, washed with EtOAc, and the aqueous phase was neutralized with solid Na<sub>2</sub>CO<sub>3</sub>. This was then extracted with EtOAc, washed with brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The crude product was purified via flash column chromatography (ISCO, Redisep 40 g column, 0â50% EtOAc/hexanes gradient) to afford the title compound as a clear oil (3.76 g, 68%). <i>R<sub>f</sub></i> (1:1 EtOAC/Hex): 0.68; <sup>1</sup>H NMR (399 MHz, CDCl<sub>3</sub>) Î´ 6.70 (t, <i>J</i> = 2.1 Hz, 2H), 6.24 (t, <i>J</i> = 2.1 Hz, 2H), 4.67 (s, 2H), 3.79 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 169.3, 121.8, 109.1, 52.5, 50.7. HRMS calcd for C<sub>7</sub>H<sub>10</sub>O<sub>2</sub>N, 140.07061 [M + H]<sup>+</sup>; found 140.07063 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_115" class="NLM_sec NLM_sec_level_4"><div id="ac_i152" class="anchor-spacer"></div><h5 class="article-section__title" id="_i152"> Methyl 2-(2-(2-Chloroacetyl)-1<i>H</i>-pyrrol-1-yl)acetate (<b>28</b>)</h5><div class="NLM_p last">General procedure XV was followed using <b>27</b> (6.80 g, 48.9 mmol), DBN (0.91 g, 7.3 mmol), and 2-chloroacetyl chloride (4.70 mL, 58.6 mmol) in PhMe (82 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 40 g column, 0â100% EtOAc/hexanes gradient) to afford the title compound as a white solid (8.8 g, 83%). <i>R<sub>f</sub></i> (1:1 EtOAC/Hex): 0.60; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.06 (dd, <i>J</i> = 4.2, 1.6 Hz, 1H), 6.92 (dd, <i>J</i> = 2.4, 1.7 Hz, 1H), 6.26 (dd, <i>J</i> = 4.2, 2.6 Hz, 1H), 5.03 (s, 2H), 4.51 (s, 2H), 3.76 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 181.6, 168.8, 132.3, 127.7, 120.4, 109.5, 51.0, 45.5. HRMS calcd for C<sub>9</sub>H<sub>13</sub>O<sub>3</sub>NCl, 216.04220 [M + H]<sup>+</sup>; found 216.04225 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_116" class="NLM_sec NLM_sec_level_4"><div id="ac_i153" class="anchor-spacer"></div><h5 class="article-section__title" id="_i153"> Methyl 2-(2-(2-(4-Methoxyphenoxy)acetyl)-1<i>H</i>-pyrrol-1-yl)acetate (<b>29</b>)</h5><div class="NLM_p last">General procedure XVI was followed using <b>28</b> (0.84 g, 3.9 mmol), potassium iodide (0.77 g, 4.6 mmol), 4-methoxyphenol (0.94 g, 4.6 mmol), and potassium carbonate (2.14 g, 15.5 mmol) in acetone (19 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 24 g column, 0â70% EtOAc/hexanes gradient) to afford the title compound as a white solid (1.6 g, quant.). <i>R<sub>f</sub></i> (1:1 EtOAC/Hex): 0.76; <sup>1</sup>H NMR (399 MHz, CDCl<sub>3</sub>) Î´ 7.17 (dd, <i>J</i> = 4.1, 1.6 Hz, 1H), 6.90 (dd, <i>J</i> = 2.5, 1.5 Hz, 1H), 6.89â6.76 (m, 4H), 6.26 (dd, <i>J</i> = 4.2, 2.6 Hz, 1H), 5.05 (s, 2H), 5.00 (s, 2H), 3.75 (s, 3H), 3.74 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 185.5, 168.9, 154.2, 152.3, 131.6, 127.8, 119.6, 115.7, 114.6, 109.4, 70.8, 55.7, 52.4, 51.0. HRMS calcd for C<sub>16</sub>H<sub>18</sub>O<sub>5</sub>N, 304.11795 [M + H]<sup>+</sup>; found 304.11780 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_117" class="NLM_sec NLM_sec_level_4"><div id="ac_i154" class="anchor-spacer"></div><h5 class="article-section__title" id="_i154"> 1-((4-Methoxyphenoxy)methylene)-2-(3-(trifluoromethyl)benzyl)-1,2-dihydropyrrolo[1,2-<i>a</i>]pyrazin-3(4<i>H</i>)-one (<b>30a</b>)</h5><div class="NLM_p last">This procedure was run at a concentration of 1 M due to incomplete conversion of the starting material to product. General procedure XVII was followed using compound <b>29</b> (0.20 g, 0.66 mmol), 3-(trifluoromethyl)benzylamine (113 Î¼L, 0.790 mmol), tetraisopropoxytitanium (0.58 mL, 2.0 mmol), and sodium triacetoxyborohydride (0.42 g, 2.0 mmol) in DCE (0.8 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 12 g column, 0â35% EtOAc/hexanes gradient) to afford the title compound as a mixture of <i>E</i>/<i>Z</i> isomers and a white solid (89 mg, 32%). HRMS calcd for C<sub>23</sub>H<sub>20</sub>O<sub>3</sub>N<sub>2</sub>F<sub>3</sub>, 429.14205 [M + H]<sup>+</sup>; found 429.14178 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_118" class="NLM_sec NLM_sec_level_4"><div id="ac_i155" class="anchor-spacer"></div><h5 class="article-section__title" id="_i155"> 2-(3-Fluorobenzyl)-1-((4-methoxyphenoxy)methylene)-1,2-dihydropyrrolo[1,2-<i>a</i>]pyrazin-3(4<i>H</i>)-one (<b>30b</b>)</h5><div class="NLM_p last">This procedure was run at a concentration of 1 M due to incomplete conversion of the starting material to product. General procedure XVII was followed using compound <b>29</b> (50 mg, 0.16 mmol), 3-fluorobenzylamine (28 Î¼L, 0.20 mmol), tetraisopropoxytitanium (0.15 mL, 0.49 mmol), and sodium triacetoxyborohydride (0.10 g, 0.49 mmol) in DCE (0.16 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â35% EtOAc/hexanes gradient) to afford the title compound as a mixture of <i>E</i>/<i>Z</i> isomers and a white solid (24 mg, 38%). HRMS calcd for C<sub>22</sub>H<sub>20</sub>O<sub>3</sub>N<sub>2</sub>F, 379.14525 [M + H]<sup>+</sup>; found 379.14551 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_1_119" class="NLM_sec NLM_sec_level_4"><div id="ac_i156" class="anchor-spacer"></div><h5 class="article-section__title" id="_i156"> 1-((4-Methoxyphenoxy)methyl)-2-(3-(trifluoromethyl)benzyl)-1,2-dihydropyrrolo[1,2-<i>a</i>]pyrazin-3(4<i>H</i>)-one (<b>31a</b>)</h5><div class="NLM_p last">General procedure XVIII was followed using compound <b>30a</b> (55 mg, 0.13 mmol) and Pd/C (20 mg, 0.019 mmol) in EtOAc (5 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â35% EtOAc/hexanes gradient) to afford the title compound as a white foam (20 mg, 36%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.62; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.54â7.50 (m, 2H), 7.45 (d, <i>J</i> = 7.7 Hz, 1H), 7.42â7.37 (m, 1H), 6.82â6.75 (m, 2H), 6.71â6.66 (m, 2H), 6.65 (dd, <i>J</i> = 2.7, 1.6 Hz, 1H), 6.22 (dd, <i>J</i> = 3.5, 2.8 Hz, 1H), 6.00 (dd, <i>J</i> = 3.5, 1.5 Hz, 1H), 5.44 (d, <i>J</i> = 15.4 Hz, 1H), 4.87 (d, <i>J</i> = 17.0 Hz, 1H), 4.83 (dd, <i>J</i> = 4.5, 3.3 Hz, 1H), 4.77 (d, <i>J</i> = 17.0 Hz, 1H), 4.49 (d, <i>J</i> = 15.4 Hz, 1H), 4.15 (dd, <i>J</i> = 9.7, 3.2 Hz, 1H), 4.04 (dd, <i>J</i> = 9.7, 4.7 Hz, 1H), 3.75 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 166.3, 154.5, 152.0, 137.4, 131.2, 131.1 (q, <i>J</i> = 31.7 Hz, <sup>2</sup><i>J</i>), 129.35, 124.80 (q, <i>J</i> = 3.8 Hz, <sup>3</sup><i>J</i>), 124.6 (q, <i>J</i> = 3.8 Hz, <sup>3</sup><i>J</i>), 124.0, 123.9 (q, <i>J</i> = 272.5 Hz, <sup>1</sup><i>J</i>), 118.9, 115.6, 114.7, 109.6, 103.9, 72.4, 55.7, 55.0, 49.0, 48.6. HRMS calcd for C<sub>23</sub>H<sub>22</sub>O<sub>3</sub>N<sub>2</sub>F<sub>3</sub>, 431.15770 [M + H]<sup>+</sup>; found 431.15735 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 75â95% MeOH in water over 3 min at 1 mL/min (retention time = 1.82 min). Method 2: 85â95% MeOH in water over 5 min at 1 mL/min (retention time = 0.87 min).</div></div><div id="sec4_2_1_120" class="NLM_sec NLM_sec_level_4"><div id="ac_i157" class="anchor-spacer"></div><h5 class="article-section__title" id="_i157"> 2-(3-Fluorobenzyl)-1-((4-methoxyphenoxy)methyl)-1,2-dihydropyrrolo[1,2-<i>a</i>]pyrazin-3(4<i>H</i>)-one (EU-1180-453)</h5><div class="NLM_p last">General procedure XVIII was followed using compound <b>30b</b> (24 mg, 0.063 mmol) and Pd/C (10 mg, 0.010 mmol) in EtOAc (5 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â35% EtOAc/hexanes gradient) to afford the title compound as a white solid (14 mg, 58%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.68; mp 87â88 Â°C, <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.30â7.20 (m, 1H), 7.03 (d, <i>J</i> = 7.9 Hz, 1H), 7.00â6.90 (m, 2H), 6.83â6.74 (m, 2H), 6.73â6.65 (m, 2H), 6.64 (dd, <i>J</i> = 2.7, 1.6 Hz, 1H), 6.22 (dd, <i>J</i> = 3.3, 2.8 Hz, 1H), 5.99 (dd, <i>J</i> = 3.5, 1.5 Hz, 1H), 5.43 (d, <i>J</i> = 15.4 Hz, 1H), 4.86 (d, <i>J</i> = 17.0 Hz, 1H), 4.82 (d, <i>J</i> = 3.7 Hz, 2H), 4.75 (d, <i>J</i> = 17.0 Hz, 1H), 4.37 (d, <i>J</i> = 15.4 Hz, 1H), 4.15 (dd, <i>J</i> = 9.7, 3.2 Hz, 1H), 4.02 (dd, <i>J</i> = 9.7, 4.5 Hz, 1H), 3.75 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 166.2, 163.0(d, <i>J</i> = 246.9 Hz, <sup>1</sup><i>J</i>), 154.3, 152.0, 138.7 (d, <i>J</i> = 7.1 Hz, <sup>3</sup><i>J</i>), 130.33 (d, <i>J</i> = 8.2 Hz, <sup>3</sup><i>J</i>), 124.1, 123.5 (d, <i>J</i> = 2.9 Hz, <sup>4</sup><i>J</i>), 118.8, 115.6, 114.9 (d, <i>J</i> = 21.9 Hz, <sup>2</sup><i>J</i>), 114.7 (d, <i>J</i> = 21.2 Hz, <sup>2</sup><i>J</i>), 114.6, 109.5, 103.8, 72.2, 55.7, 54.6, 49.0, 48.2. HRMS calcd for C<sub>22</sub>H<sub>22</sub>O<sub>3</sub>N<sub>2</sub>F, 381.16090 [M + H]<sup>+</sup>; found 381.16132 [M + H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 75â95% MeOH in water over 3 min at 1 mL/min (retention time = 1.41 min). Method 2: 85â95% MeOH in water over 5 min at 1 mL/min (retention time = 0.80 min).</div></div><div id="sec4_2_1_121" class="NLM_sec NLM_sec_level_4"><div id="ac_i158" class="anchor-spacer"></div><h5 class="article-section__title" id="_i158"> 1-((4-Ethoxyphenoxy)methyl)-2-(3-(trifluoromethyl)benzyl)-1,2-dihydropyrrolo[1,2-<i>a</i>]pyrazine-3(4<i>H</i>)-thione (<b>32</b>)</h5><div class="NLM_p last">General procedure XIV was followed using compound <b>31a</b> (13 mg, 0.030 mmol) and Lawessonâs reagent (18 mg, 0.045 mmol) in toluene (0.5 mL). The crude product was purified via flash column chromatography (ISCO, Redisep 4 g column, 0â20% EtOAc/hexanes gradient) to afford the title compound as a yellow oil (4.3 mg, 32%). <i>R<sub>f</sub></i> (1:1 EtOAc/Hex): 0.83; <sup>1</sup>H NMR (399 MHz, CDCl<sub>3</sub>) Î´ 7.57â7.48 (m, 2H), 7.43â7.37 (m, 2H), 6.84â6.69 (m, 4H), 6.67 (dd, <i>J</i> = 2.7, 1.6 Hz, 1H), 6.40 (d, <i>J</i> = 15.3 Hz, 1H), 6.22 (dd, <i>J</i> = 3.5, 2.8 Hz, 1H), 6.00 (dd, <i>J</i> = 3.5, 1.4 Hz, 1H), 5.44 (d, <i>J</i> = 18.0 Hz, 1H), 5.15 (d, <i>J</i> = 18.0 Hz, 1H), 5.07 (dd, <i>J</i> = 6.0, 3.4 Hz, 1H), 4.93 (d, <i>J</i> = 15.3 Hz, 1H), 4.17 (dd, <i>J</i> = 10.0, 3.4 Hz, 1H), 4.10 (dd, <i>J</i> = 10.0, 6.1 Hz, 1H), 3.76 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 195.2, 154.6, 151.7, 135.7, 131.2 (q, <i>J</i> = 32.5 Hz, <sup>2</sup><i>J</i>), 130.8, 124.9 (q, <i>J</i> = 3.7 Hz, <sup>3</sup><i>J</i>), 124.7 (q, <i>J</i> = 3.7 Hz, <sup>3</sup><i>J</i>), 124.4 (q, <i>J</i> = 271.8 Hz, <sup>1</sup><i>J</i>), 122.8, 118.7, 115.6, 114.7, 109.4, 104.1, 77.2, 72.0, 58.2, 56.6, 55.7. HRMS calcd for C<sub>23</sub>H<sub>21</sub>O<sub>2</sub>N<sub>2</sub>F<sub>3</sub>S, 445.12031 [M â H]<sup>+</sup>; found 445.12034 [M â H]<sup>+</sup>. Purity was established using an Agilent pump on a Zorbax XBD-C18 column (4.6 mm Ã 50 mm, 3.5 Î¼m). Method 1: 75â95% MeOH in water over 3 min at 1 mL/min (retention time = 2.59 min). Method 2: 85â95% MeOH in water over 5 min at 1 mL/min (retention time = 1.17 min).</div></div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i159" class="anchor-spacer"></div><h4 class="article-section__title" id="_i159"> Separation of <b>25i</b> Enantiomers</h4><div class="NLM_p last">Semipreparative separation of enantiomers from racemic <b>25i</b> (0.020 g) was done using a ChiralPak AD-H (30 mm Ã 250 mm) with the following conditions: 20 mL/min flow rate, 10 mL injection volume (2 mg/1 mL), 90% hexanes/10% IPA over 90 min to afford <i><b>R</b></i><b>-(+)-25i</b>, <i>t</i><sub>R</sub> 59.2 min; <i><b>S</b></i><b>-(â)-25i</b>, <i>t</i><sub>R</sub> 70.7 min. The enantiomeric excess (ee) was determined using an Agilent pump on a ChiralPak OD-H column (4.6 mm Ã 150 mm, 5 Î¼m) with the following conditions: 1 mL/min flow rate, 10 Î¼L injection volume, 90% hexanes/10% IPA. <i><b>R</b></i><b>-(+)-25i</b>: <i>t</i><sub>R</sub> 31.5 min; >99% ee; [Î±]<sub class="stack">D</sub><sup class="stack">20</sup> = +172 (c 0.10, dry CHCl<sub>3</sub>). <i><b>S</b></i><b>-(â)-25i</b>: <i>t</i><sub>R</sub> 41.4 min, >99% ee; [Î±]<sub class="stack">D</sub><sup class="stack">20</sup> = â173 (c 0.10, dry CHCl<sub>3</sub>).</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i160" class="anchor-spacer"></div><h4 class="article-section__title" id="_i160"> Separation of <b>25j</b> Enantiomers</h4><div class="NLM_p last">Semipreparative separation of <b>25j</b> enantiomers from racemic <b>25j</b> (0.020 g) was done using a ChiralPak AD-H (30 mm Ã 250 mm) with the following conditions: 20 mL/min flow rate, 10 mL injection volume (2 mg/1 mL), 90% hexanes/10% IPA over 60 min to afford <i><b>R</b></i><b>-(+)-25j</b>, <i>t</i><sub>R</sub> 41.4 min; <i><b>S</b></i><b>-(â)-25j</b>, <i>t</i><sub>R</sub> 50.5 min. The enantiomeric excess (ee) was determined using an Agilent pump on a ChiralPak OD-H column (4.6 mm Ã 150 mm, 5 Î¼m) with the following conditions: 1 mL/min flow rate, 10 Î¼L injection volume, 90% hexanes/10% IPA. <i><b>R</b></i><b>-(+)-25j</b>: <i>t</i><sub>R</sub> 27.1 min; >99% ee; [Î±]<sub class="stack">D</sub><sup class="stack">20</sup> = +148 (c 0.10, dry CHCl<sub>3</sub>). <i><b>S</b></i><b>-(â)-25j</b>: <i>t</i><sub>R</sub> 32.4 min, >99% ee; [Î±]<sub class="stack">D</sub><sup class="stack">20</sup> = â149 (c 0.10, dry CHCl<sub>3</sub>).</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i161" class="anchor-spacer"></div><h4 class="article-section__title" id="_i161"> Separation of <b>31a</b> Enantiomers</h4><div class="NLM_p last">Semipreparative separation of <b>31a</b> enantiomers from racemic <b>31a</b> (0.020 g) was done using a ChiralPak AD-H (30 mm Ã 250 mm) with the following conditions: 20 mL/min flow rate, 10 mL injection volume (2 mg/1 mL), 90% hexanes/10% IPA over 60 min to afford <i><b>S</b></i><b>-(â)-31a</b>, <i>t</i><sub>R</sub> 33.8 min; <i><b>R</b></i><b>-(+)-31a</b>, <i>t</i><sub>R</sub> 47.2 min. The enantiomeric excess (ee) was determined using an Agilent pump on a ChiralPak OD-H column (4.6 mm Ã 150 mm, 5 Î¼m) with the following conditions: 1 mL/min flow rate, 10 Î¼L injection volume, 90% hexanes/10% IPA. <i><b>S</b></i><b>-(â)-31a</b>: <i>t</i><sub>R</sub> 21.4 min;>99% ee; [Î±]<sub class="stack">D</sub><sup class="stack">20</sup> = â45 (c 0.10, dry CHCl<sub>3</sub>). <i><b>R</b></i><b>-(+)-31a</b>: <i>t</i><sub>R</sub> 30.1 min, >99% ee; [Î±]<sub class="stack">D</sub><sup class="stack">20</sup> = +45 (c 0.10, dry CHCl<sub>3</sub>).</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i162" class="anchor-spacer"></div><h4 class="article-section__title" id="_i162"> Separation of <b>EU-1180-453</b> Enantiomers</h4><div class="NLM_p last">Semipreparative separation of <b>EU-1180-453</b> enantiomers from racemic <b>EU-1180-453</b> (0.020 g) was done using a ChiralPak AD-H (30 mm Ã 250 mm) with the following conditions: 20 mL/min flow rate, 10 mL injection volume (2 mg/1 mL), 75% hexanes/25% IPA over 60 min to afford <i><b>S</b></i><b>-(â)-EU-1180-453</b>, <i>t</i><sub>R</sub> 24.3 min; <i><b>R</b></i><b>-(+)-EU-1180-453</b>, <i>t</i><sub>R</sub> 37.5 min. The enantiomeric excess (ee) was determined using an Agilent pump on a ChiralPak AD-H column (4.6 mm Ã 150 mm, 5 Î¼m) with the following conditions: 1 mL/min flow rate, 10 Î¼L injection volume, 80% hexanes/20% IPA. <i><b>S</b></i><b>-(â)-EU-1180-453</b>: <i>t</i><sub>R</sub> 14.5 min; >99% ee; [Î±]<sub class="stack">D</sub><sup class="stack">20</sup> = â43 (c 0.10, dry CHCl<sub>3</sub>). <i><b>R</b></i><b>-(+)-EU-1180-453</b>: <i>t</i><sub>R</sub> 22.1 min, >99% ee; [Î±]<sub class="stack">D</sub><sup class="stack">20</sup> = +44 (c 0.10, dry CHCl<sub>3</sub>).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i163"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01733" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10281" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10281" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01733?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01733</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Chemistry experimental procedures along with crystal structure information (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">LCMS and HPLC traces for key compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_003.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_001.pdf">jm9b01733_si_001.pdf (257.98 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_002.csv">jm9b01733_si_002.csv (4.86 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_003.pdf">jm9b01733_si_003.pdf (199.77 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01733" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88432" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88432" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen F. Traynelis</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Chemical Biology, Emory
University, 1510 Clifton Road, Atlanta, Georgia 30322, United
States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3750-9615" title="Orcid link">http://orcid.org/0000-0002-3750-9615</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5c2f282e3d2532391c3931332e2572393829"><span class="__cf_email__" data-cfemail="e4979096859d8a81a481898b969dca818091">[emailÂ protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis C. Liotta</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7736-7113" title="Orcid link">http://orcid.org/0000-0002-7736-7113</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5d3931343229293c1d3830322f2473383928"><span class="__cf_email__" data-cfemail="3a5e5653554e4e5b7a5f57554843145f5e4f">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew P. Epplin</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1121-3701" title="Orcid link">http://orcid.org/0000-0002-1121-3701</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ayush Mohan</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lynnea D. Harris</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zongjian Zhu</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Chemical Biology, Emory
University, 1510 Clifton Road, Atlanta, Georgia 30322, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katie L. Strong</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Bacsa</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5681-4458" title="Orcid link">http://orcid.org/0000-0001-5681-4458</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Phuong Le</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Chemical Biology, Emory
University, 1510 Clifton Road, Atlanta, Georgia 30322, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David S. Menaldino</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): SFT is a PI on research grants from Allergan, Biogen, and Janssen to Emory, is a member of the SAB for Sage Therapeutics, the GRIN2B Foundation, CureGRIN Foundation, is a co-founder of NeurOp Inc and AgriThera, and receives licensing fees and royalties for software. DCL is a member of the Board of Directors for NeurOp Inc and co-founder of AgriThera. DCL, DSM, KLS, MPE, SFT are co-inventors on Emory-owned Intellectual Property that includes positive allosteric modulators of NMDA receptor function.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e10663-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i164">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66243" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66243" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the NIH-NINDS (NS065371, NS111619 SFT). The authors thank Janssen Research & Development, LLC, Bartosz Balana, Robert Neff, and Tim Lovenberg for their support and help with pharmacokinetic analysis. They also thank Jing Zhang for excellent technical assistance. The opinions expressed in this publication are those of the author(s) and do not necessarily reflect the views of the NIH.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">AMPA</td><td class="NLM_def"><p class="first last">Î±-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid</p></td></tr><tr><td class="NLM_term">ACN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">AMPAR</td><td class="NLM_def"><p class="first last">AMPA receptor</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">ABD</td><td class="NLM_def"><p class="first last">agonist binding domain</p></td></tr><tr><td class="NLM_term">ATD</td><td class="NLM_def"><p class="first last">amino terminal domain</p></td></tr><tr><td class="NLM_term">BAPTA-AM</td><td class="NLM_def"><p class="first last">1,2-bis(<i>o</i>-aminophenoxy)ethane-<i>N</i>,<i>N</i>,<i>N</i>â²,<i>N</i>â²-tetraacetic acid tetraacetoxymethyl ester</p></td></tr><tr><td class="NLM_term">CTD</td><td class="NLM_def"><p class="first last">carboxy terminal domain</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CIQ</td><td class="NLM_def"><p class="first last">(3-chlorophenyl)(6,7-dimethoxy-1-((4-methoxyphenoxy)methyl)-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)methanone</p></td></tr><tr><td class="NLM_term">DNA</td><td class="NLM_def"><p class="first last">deoxyribonucleic acid</p></td></tr><tr><td class="NLM_term">DBN</td><td class="NLM_def"><p class="first last">1,5-diazabicyclo[4.3.0]non-5-ene</p></td></tr><tr><td class="NLM_term">DCE</td><td class="NLM_def"><p class="first last">dichloroethylene</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-(3-dimethylaminopropyl)-carbonyldiimide hydrochloride</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">Ethylenediaminetetraacetic acid</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr><tr><td class="NLM_term">GABA</td><td class="NLM_def"><p class="first last">Î³-aminobutyric acid</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">IACUC</td><td class="NLM_def"><p class="first last">Institutional Animal Care and Use Committee</p></td></tr><tr><td class="NLM_term">IP</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">iGluR</td><td class="NLM_def"><p class="first last">ionotropic glutamate receptor</p></td></tr><tr><td class="NLM_term">LCMS</td><td class="NLM_def"><p class="first last">liquid chromatographyâmass spectrometry</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency</p></td></tr><tr><td class="NLM_term">NAM</td><td class="NLM_def"><p class="first last">negative allosteric modulator</p></td></tr><tr><td class="NLM_term">TCN</td><td class="NLM_def"><p class="first last"><i>N</i>-(4-(2-benzoylhydrazine-1-carbonyl)benzyl)-3-chloro-4-fluorobenzenesulfonamide</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartic acid</p></td></tr><tr><td class="NLM_term">NMDAR</td><td class="NLM_def"><p class="first last">NMDA receptor</p></td></tr><tr><td class="NLM_term">NIMH</td><td class="NLM_def"><p class="first last">National Institute for Mental Health</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">PFP</td><td class="NLM_def"><p class="first last">pentafluorophenyl</p></td></tr><tr><td class="NLM_term">PAM</td><td class="NLM_def"><p class="first last">positive allosteric modulator</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">poly(ethylene glycol)</p></td></tr><tr><td class="NLM_term">K-BAPTA</td><td class="NLM_def"><p class="first last">potassium 1,2-bis(<i>o</i>-aminophenoxy)ethane-<i>N</i>,<i>N</i>,<i>N</i>â²,<i>N</i>â²-tetraacetic acid</p></td></tr><tr><td class="NLM_term">PS</td><td class="NLM_def"><p class="first last">pregnenolone sulfate</p></td></tr><tr><td class="NLM_term">PDSP</td><td class="NLM_def"><p class="first last">Psychoactive Drug Screening Program</p></td></tr><tr><td class="NLM_term">RNA</td><td class="NLM_def"><p class="first last">ribonucleic acid</p></td></tr><tr><td class="NLM_term">RPM</td><td class="NLM_def"><p class="first last">rotations per minute</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structureâactivity relationship</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TEVC</td><td class="NLM_def"><p class="first last">two-electrode voltage clamp</p></td></tr><tr><td class="NLM_term">TIQ</td><td class="NLM_def"><p class="first last">tetrahydroisoquinoline</p></td></tr><tr><td class="NLM_term">TMD</td><td class="NLM_def"><p class="first last">transmembrane domain</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i166">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44414" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44414" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 81 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wollmuth, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBain, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menniti, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingledine, R.</span></span> <span> </span><span class="NLM_article-title">Glutamate receptor ion channels: structure, regulation, and function</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">405</span>â <span class="NLM_lpage">496</span>, <span class="refDoi">Â DOI: 10.1124/pr.109.002451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1124%2Fpr.109.002451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=20716669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=405-496&author=S.+F.+Traynelisauthor=L.+P.+Wollmuthauthor=C.+J.+McBainauthor=F.+S.+Mennitiauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=K.+B.+Hansenauthor=H.+Yuanauthor=S.+J.+Myersauthor=R.+Dingledine&title=Glutamate+receptor+ion+channels%3A+structure%2C+regulation%2C+and+function&doi=10.1124%2Fpr.109.002451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate receptor ion channels: structure, regulation, and function</span></div><div class="casAuthors">Traynelis, Stephen F.; Wollmuth, Lonnie P.; McBain, Chris J.; Menniti, Frank S.; Vance, Katie M.; Ogden, Kevin K.; Hansen, Kasper B.; Yuan, Hongjie; Myers, Scott J.; Dingledine, Ray</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">405-496</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The mammalian ionotropic glutamate receptor family encodes 18 gene products that coassemble to form ligand-gated ion channels contg. an agonist recognition site, a transmembrane ion permeation pathway, and gating elements that couple agonist-induced conformational changes to the opening or closing of the permeation pore.  Glutamate receptors mediate fast excitatory synaptic transmission in the central nervous system and are localized on neuronal and non-neuronal cells.  These receptors regulate a broad spectrum of processes in the brain, spinal cord, retina, and peripheral nervous system.  Glutamate receptors are postulated to play important roles in numerous neurol. diseases and have attracted intense scrutiny.  The description of glutamate receptor structure, including its transmembrane elements, reveals a complex assembly of multiple semiautonomous extracellular domains linked to a pore-forming element with striking resemblance to an inverted potassium channel.  In this review we discuss International Union of Basic and Clin. Pharmacol. glutamate receptor nomenclature, structure, assembly, accessory subunits, interacting proteins, gene expression and translation, post-translational modifications, agonist and antagonist pharmacol., allosteric modulation, mechanisms of gating and permeation, roles in normal physiol. function, as well as the potential therapeutic use of pharmacol. agents acting at glutamate receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov0rj4nMr5ObVg90H21EOLACvtfcHk0ljZ49gSfFA96g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ&md5=5d0a7945b5ad99113adf9f6312bafe13</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.109.002451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.109.002451%26sid%3Dliteratum%253Aachs%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DWollmuth%26aufirst%3DL.%2BP.%26aulast%3DMcBain%26aufirst%3DC.%2BJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DMyers%26aufirst%3DS.%2BJ.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DGlutamate%2520receptor%2520ion%2520channels%253A%2520structure%252C%2520regulation%252C%2520and%2520function%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D405%26epage%3D496%26doi%3D10.1124%2Fpr.109.002451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dube, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerchner, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsien, J. Z.</span></span> <span> </span><span class="NLM_article-title">Genetic enhancement of learning and memory in mice</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>401</i></span>,  <span class="NLM_fpage">63</span>â <span class="NLM_lpage">69</span>, <span class="refDoi">Â DOI: 10.1038/43432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2F43432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10485705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaK1MXlvVGms70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=1999&pages=63-69&author=Y.-P.+Tangauthor=E.+Shimizuauthor=G.+R.+Dubeauthor=C.+Ramponauthor=G.+A.+Kerchnerauthor=M.+Zhuoauthor=G.+Liuauthor=J.+Z.+Tsien&title=Genetic+enhancement+of+learning+and+memory+in+mice&doi=10.1038%2F43432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic enhancement of learning and memory in mice</span></div><div class="casAuthors">Tang, Ya-Ping; Shimizu, Eiji; Dube, Gilles, R.; Rampon, Claire; Kerchner, Geoffrey; Zhuo, Min; Liu, Guosong; Tsien, Joe Z.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">6748</span>),
    <span class="NLM_cas:pages">63-69</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Hebb's rule (1949) states that learning and memory are based on modifications of synaptic strength among neurons that are simultaneously active.  This implies that enhanced synaptic coincidence detection would lead to better learning and memory.  If the NMDA (N-methyl-D-aspartate) receptor, a synaptic coincidence detection would lead to better learning and memory.  If the NMDA (N-methyl-D-aspartate) receptor, a synaptic coincidence detector, acts as a graded switch for memory formation, enhanced signal detection by NMDA receptors should enhance learning and memory.  Here we show that overexpression of NMDA receptor 2B (NR2B) in the forebrains of transgenic mice leads to enhanced activation of NMDA receptors, facilitating synaptic potentiation in response to stimulation at 10-100 Hz.  These mice exhibit superior ability in learning and memory in various behavioral tasks, showing that NR2B is crit. in gating the age-dependent threshold for plasticity and memory formation.  NMDA-receptor-dependent modifications of synaptic efficacy, therefore, represent a unifying mechanism for associative learning and memory.  Our results suggest that genetic enhancement of mental and cognitive attributes such as intelligence and memory in mammals is feasible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpztBLI9qsOIbVg90H21EOLACvtfcHk0ljLyQHP0j6hdA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvVGms70%253D&md5=b2ef8b0610c3c070063f869f82a838e6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F43432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F43432%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DY.-P.%26aulast%3DShimizu%26aufirst%3DE.%26aulast%3DDube%26aufirst%3DG.%2BR.%26aulast%3DRampon%26aufirst%3DC.%26aulast%3DKerchner%26aufirst%3DG.%2BA.%26aulast%3DZhuo%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DTsien%26aufirst%3DJ.%2BZ.%26atitle%3DGenetic%2520enhancement%2520of%2520learning%2520and%2520memory%2520in%2520mice%26jtitle%3DNature%26date%3D1999%26volume%3D401%26spage%3D63%26epage%3D69%26doi%3D10.1038%2F43432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collingridge, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volianskis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">France, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidball, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaghan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolotto, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molnar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodge, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jane, D. E.</span></span> <span> </span><span class="NLM_article-title">The NMDA receptor as a target for cognitive enhacement</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">13</span>â <span class="NLM_lpage">26</span>, <span class="refDoi">Â DOI: 10.1016/j.neuropharm.2012.06.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2Fj.neuropharm.2012.06.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=22796429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFahsL3P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=13-26&author=G.+L.+Collingridgeauthor=A.+Volianskisauthor=N.+Bannisterauthor=G.+Franceauthor=L.+Hannaauthor=M.+Mercierauthor=P.+Tidballauthor=G.+Fangauthor=M.+W.+Irvineauthor=B.+M.+Costaauthor=D.+T.+Monaghanauthor=Z.+A.+Bortolottoauthor=E.+Molnarauthor=D.+Lodgeauthor=D.+E.+Jane&title=The+NMDA+receptor+as+a+target+for+cognitive+enhacement&doi=10.1016%2Fj.neuropharm.2012.06.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The NMDA receptor as a target for cognitive enhancement</span></div><div class="casAuthors">Collingridge, Graham L.; Volianskis, Arturas; Bannister, Neil; France, Grace; Hanna, Lydia; Mercier, Marion; Tidball, Patrick; Fang, Guangyu; Irvine, Mark W.; Costa, Blaise M.; Monaghan, Daniel T.; Bortolotto, Zuner A.; Molnar, Elek; Lodge, David; Jane, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-26</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  NMDA receptors (NMDARs) play an important role in neural plasticity including long-term potentiation and long-term depression, which are likely to explain their importance for learning and memory.  Cognitive decline is a major problem facing an aging human population, so much so that its reversal has become an important goal for scientific research and pharmaceutical development.  Enhancement of NMDAR function is a core strategy toward this goal.  In this review we indicate some of the major ways of potentiating NMDAR function by both direct and indirect modulation.  There is good evidence that both pos. and neg. modulation can enhance function suggesting that a subtle approach correcting imbalances in particular clin. situations will be required.  Excessive activation and the resultant deleterious effects will need to be carefully avoided.  Finally we describe some novel pos. allosteric modulators of NMDARs, with some subunit selectivity, and show initial evidence of their ability to affect NMDAR mediated events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwosQmB8cQb7Vg90H21EOLACvtfcHk0ljLyQHP0j6hdA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFahsL3P&md5=4d63552250a5bb940a8d0a7a2d51fd75</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2012.06.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2012.06.051%26sid%3Dliteratum%253Aachs%26aulast%3DCollingridge%26aufirst%3DG.%2BL.%26aulast%3DVolianskis%26aufirst%3DA.%26aulast%3DBannister%26aufirst%3DN.%26aulast%3DFrance%26aufirst%3DG.%26aulast%3DHanna%26aufirst%3DL.%26aulast%3DMercier%26aufirst%3DM.%26aulast%3DTidball%26aufirst%3DP.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DCosta%26aufirst%3DB.%2BM.%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26aulast%3DBortolotto%26aufirst%3DZ.%2BA.%26aulast%3DMolnar%26aufirst%3DE.%26aulast%3DLodge%26aufirst%3DD.%26aulast%3DJane%26aufirst%3DD.%2BE.%26atitle%3DThe%2520NMDA%2520receptor%2520as%2520a%2520target%2520for%2520cognitive%2520enhacement%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D13%26epage%3D26%26doi%3D10.1016%2Fj.neuropharm.2012.06.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rezvani, A. M.</span></span> <span> </span><span class="NLM_article-title">Involvement of the NMDA System in Learning and Memory</span>. In  <i>Animal Models of Cognitive Impairment</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, E. D.</span>; <span class="NLM_string-name">Buccafusco, J. J.</span></span>, Eds.; <span class="NLM_publisher-name">CRC Press/Taylor & Francis</span>: <span class="NLM_publisher-loc">Boca Raton (FL)</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1201%2F9781420004335.ch4" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=A.+M.+Rezvaniauthor=E.+D.+Levin&author=J.+J.+Buccafusco&title=Animal+Models+of+Cognitive+Impairment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1201%2F9781420004335.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1201%252F9781420004335.ch4%26sid%3Dliteratum%253Aachs%26aulast%3DRezvani%26aufirst%3DA.%2BM.%26atitle%3DInvolvement%2520of%2520the%2520NMDA%2520System%2520in%2520Learning%2520and%2520Memory%26btitle%3DAnimal%2520Models%2520of%2520Cognitive%2520Impairment%26aulast%3DLevin%26aufirst%3DE.%2BD.%26pub%3DCRC%2520Press%252FTaylor%2520%2526%2520Francis%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ewald, R. C.</span>; <span class="NLM_string-name">Cline, H. T.</span></span> <span> </span><span class="NLM_article-title">NMDA Receptors and Brain Development</span>. In  <i>Biology of the NMDA Receptor</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Dongen, A. M.</span></span>, Ed.; <span class="NLM_publisher-name">CRC Press/Taylor & Francis</span>: <span class="NLM_publisher-loc">Boca Raton (FL)</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=R.+C.+Ewald&author=H.+T.+Clineauthor=A.+M.+Van+Dongen&title=Biology+of+the+NMDA+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DEwald%26aufirst%3DR.%2BC.%26atitle%3DNMDA%2520Receptors%2520and%2520Brain%2520Development%26btitle%3DBiology%2520of%2520the%2520NMDA%2520Receptor%26aulast%3DVan%2BDongen%26aufirst%3DA.%2BM.%26pub%3DCRC%2520Press%252FTaylor%2520%2526%2520Francis%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auerbach, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meiri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bengzon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, R. D. G.</span></span> <span> </span><span class="NLM_article-title">Hippocampal synaptic Plasticity in mice overexpresssing an embryonic subunit of the NMDA receptor</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">4177</span>â <span class="NLM_lpage">4188</span>, <span class="refDoi">Â DOI: 10.1523/JNEUROSCI.18-11-04177.1998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1523%2FJNEUROSCI.18-11-04177.1998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=9592097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaK1cXjsV2qt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=4177-4188&author=S.+Okabeauthor=C.+Collinauthor=J.+M.+Auerbachauthor=N.+Meiriauthor=J.+Bengzonauthor=M.+B.+Kennedyauthor=M.+Segalauthor=R.+D.+G.+McKay&title=Hippocampal+synaptic+Plasticity+in+mice+overexpresssing+an+embryonic+subunit+of+the+NMDA+receptor&doi=10.1523%2FJNEUROSCI.18-11-04177.1998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Hippocampal synaptic plasticity in mice overexpressing an embryonic subunit of the NMDA receptor</span></div><div class="casAuthors">Okabe, Shigeo; Collin, Carlos; Auerbach, Jonathan M.; Meiri, Noam; Bengzon, Johan; Kennedy, Mary B.; Segal, Menahem; Mckay, Ronald D. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4177-4188</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The effects of changing NMDA receptor subunit compn. on synaptic plasticity in the hippocampus were analyzed by creating transgenic mice overexpressing NR2D, a predominantly embryonic NMDA receptor subunit.  NMDA-evoked currents in the transgenic mice had smaller amplitudes and slower kinetics.  The transgenics also displayed age-dependent deficits in synaptic plasticity in area CA1 of the hippocampus.  Long-term depression was selectively impaired in juvenile mice when NR2D overexpression was moderate.  In mature mice, overexpression of NR2D was assocd. with a redn. of both NR2B and Ca2+-independent activity of Ca2+- and calmodulin-dependent protein kinase II.  These biochem. changes were correlated with a marked impairment of NMDA-dependent long-term potentiation, but spatial behavior was normal in these mice.  These results show that the developmental regulation of NMDA receptor subunit compn. alters the frequency at which modification of synaptic responses occur after afferent stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtTcwOC9Oju7Vg90H21EOLACvtfcHk0liBNqvubmCePw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsV2qt7k%253D&md5=db180bf444a50a64fde6dba0a822c92f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.18-11-04177.1998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.18-11-04177.1998%26sid%3Dliteratum%253Aachs%26aulast%3DOkabe%26aufirst%3DS.%26aulast%3DCollin%26aufirst%3DC.%26aulast%3DAuerbach%26aufirst%3DJ.%2BM.%26aulast%3DMeiri%26aufirst%3DN.%26aulast%3DBengzon%26aufirst%3DJ.%26aulast%3DKennedy%26aufirst%3DM.%2BB.%26aulast%3DSegal%26aufirst%3DM.%26aulast%3DMcKay%26aufirst%3DR.%2BD.%2BG.%26atitle%3DHippocampal%2520synaptic%2520Plasticity%2520in%2520mice%2520overexpresssing%2520an%2520embryonic%2520subunit%2520of%2520the%2520NMDA%2520receptor%26jtitle%3DJ.%2520Neurosci.%26date%3D1998%26volume%3D18%26spage%3D4177%26epage%3D4188%26doi%3D10.1523%2FJNEUROSCI.18-11-04177.1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bliss, T. V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collingridge, G. L.</span></span> <span> </span><span class="NLM_article-title">A synapti model of memory: long-term potentiation in the hippocampus</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">31</span>â <span class="NLM_lpage">39</span>, <span class="refDoi">Â DOI: 10.1038/361031a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2F361031a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=8421494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaK3sXntlOntw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=1993&pages=31-39&author=T.+V.+P.+Blissauthor=G.+L.+Collingridge&title=A+synapti+model+of+memory%3A+long-term+potentiation+in+the+hippocampus&doi=10.1038%2F361031a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A synaptic model of memory:  long-term potentiation in the hippocampus</span></div><div class="casAuthors">Bliss, T. V. P.; Collingridge, G. L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">6407</span>),
    <span class="NLM_cas:pages">31-9</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">A review, with 174 refs., of long-term potentiation (LTP) of synaptic transmission in the hippocampus as the primary exptl. model for investigating the synaptic basis of learning and memory in vertebrates.  Topics discussed were: properties of hippocampal LTP; induction of LTP; and expression of LTP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD1tHZif2aP7Vg90H21EOLACvtfcHk0liBNqvubmCePw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXntlOntw%253D%253D&md5=285f5a175da5a77f4f57a3f5236e3e0a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F361031a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F361031a0%26sid%3Dliteratum%253Aachs%26aulast%3DBliss%26aufirst%3DT.%2BV.%2BP.%26aulast%3DCollingridge%26aufirst%3DG.%2BL.%26atitle%3DA%2520synapti%2520model%2520of%2520memory%253A%2520long-term%2520potentiation%2520in%2520the%2520hippocampus%26jtitle%3DNature%26date%3D1993%26volume%3D361%26spage%3D31%26epage%3D39%26doi%3D10.1038%2F361031a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. T.</span></span> <span> </span><span class="NLM_article-title">NMDA receptor and schizophrenia: a brief history</span>. <i>Schizophr. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">920</span>â <span class="NLM_lpage">926</span>, <span class="refDoi">Â DOI: 10.1093/schbul/sbs076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1093%2Fschbul%2Fsbs076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=22987850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BC38bnvFaltw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2012&pages=920-926&author=J.+T.+Coyle&title=NMDA+receptor+and+schizophrenia%3A+a+brief+history&doi=10.1093%2Fschbul%2Fsbs076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor and schizophrenia: a brief history</span></div><div class="casAuthors">Coyle Joseph T</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia bulletin</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">920-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although glutamate was first hypothesized to be involved in the pathophysiology of schizophrenia in the 1980s, it was the demonstration that N-methyl-D-aspartate (NMDA) receptor antagonists, the dissociative anesthetics, could replicate the full range of psychotic, negative, cognitive, and physiologic features of schizophrenia in normal subjects that placed the "NMDA receptor hypofunction hypothesis" on firm footing.  Additional support came from the demonstration that a variety of agents that enhanced NMDA receptor function at the glycine modulatory site significantly reduced negative symptoms and variably improved cognition in patients with schizophrenia receiving antipsychotic drugs.  Finally, persistent blockade of NMDA receptors recreates in experimental animals the critical pathologic features of schizophrenia including downregulation of  parvalbumin-positive cortical GABAergic neurons,  pyramidal neuron dendritic dysgenesis, and reduced spine density.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR_w6r8iGW247mQt-ICR3qNfW6udTcc2eajWAVM-rpaDbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bnvFaltw%253D%253D&md5=fe18091248ba019a2c9e83b55401a55d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fschbul%2Fsbs076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fschbul%252Fsbs076%26sid%3Dliteratum%253Aachs%26aulast%3DCoyle%26aufirst%3DJ.%2BT.%26atitle%3DNMDA%2520receptor%2520and%2520schizophrenia%253A%2520a%2520brief%2520history%26jtitle%3DSchizophr.%2520Bull.%26date%3D2012%26volume%3D38%26spage%3D920%26epage%3D926%26doi%3D10.1093%2Fschbul%2Fsbs076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olney, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomer, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farber, N. B.</span></span> <span> </span><span class="NLM_article-title">NMDA receptor hypofunction model of schizophrenia</span>. <i>J. Psychiatr. Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">523</span>â <span class="NLM_lpage">533</span>, <span class="refDoi">Â DOI: 10.1016/S0022-3956(99)00029-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2FS0022-3956%2899%2900029-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10628529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BD3c%252Fpt1Wisg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1999&pages=523-533&author=J.+W.+Olneyauthor=J.+W.+Newcomerauthor=N.+B.+Farber&title=NMDA+receptor+hypofunction+model+of+schizophrenia&doi=10.1016%2FS0022-3956%2899%2900029-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor hypofunction model of schizophrenia</span></div><div class="casAuthors">Olney J W; Newcomer J W; Farber N B</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatric research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">523-33</span>
        ISSN:<span class="NLM_cas:issn">0022-3956</span>.
    </div><div class="casAbstract">Several decades of research attempting to explain schizophrenia in terms of the dopamine hyperactivity hypothesis have produced disappointing results.  A new hypothesis focusing on hypofunction of the NMDA glutamate transmitter system is emerging as a potentially more promising concept.  In this article, we present a version of the NMDA receptor hypofunction hypothesis that has evolved from our recent studies pertaining to the neurotoxic and psychotomimetic effects of PCP and related NMDA antagonist drugs.  In this article, we examine this hypothesis in terms of its strengths and weaknesses, its therapeutic implications and ways in which it can be further tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8PJv1HPbUrDEC-75aqa5AfW6udTcc2eajWAVM-rpaDbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c%252Fpt1Wisg%253D%253D&md5=1450b1d092fbd5075e730c8aa68f1153</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0022-3956%2899%2900029-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-3956%252899%252900029-1%26sid%3Dliteratum%253Aachs%26aulast%3DOlney%26aufirst%3DJ.%2BW.%26aulast%3DNewcomer%26aufirst%3DJ.%2BW.%26aulast%3DFarber%26aufirst%3DN.%2BB.%26atitle%3DNMDA%2520receptor%2520hypofunction%2520model%2520of%2520schizophrenia%26jtitle%3DJ.%2520Psychiatr.%2520Res.%26date%3D1999%26volume%3D33%26spage%3D523%26epage%3D533%26doi%3D10.1016%2FS0022-3956%2899%2900029-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reisberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doody, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">StÃ¶ffler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¶bius, H. J.</span></span> <span> </span><span class="NLM_article-title">Memantine in moderate-to-severe Alzheimerâs disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">1333</span>â <span class="NLM_lpage">1341</span>, <span class="refDoi">Â DOI: 10.1056/NEJMoa013128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1056%2FNEJMoa013128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=12672860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1egt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=1333-1341&author=B.+Reisbergauthor=R.+Doodyauthor=A.+St%C3%B6fflerauthor=F.+Schmittauthor=S.+Ferrisauthor=H.+J.+M%C3%B6bius&title=Memantine+in+moderate-to-severe+Alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMoa013128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Memantine in moderate-to-severe Alzheimer's disease</span></div><div class="casAuthors">Reisberg, Barry; Doody, Rachelle; Stoeffler, Albrecht; Schmitt, Frederick; Ferris, Steven; Moebius, Hans Joerg; Apter, J. T.; Baumel, B.; Bernick, C.; Carman, J. S.; Charles, L. P.; Corey-Bloom, J.; DeCarli, C.; Duara, R.; DuBoff, E.; Edwards, N.; Eisner, L.; Farlow, M. R.; Flitman, S.; Hubbard, R. H.; Jacobson, A.; Jurkowski, C. L.; Kiev, A.; Kirby, L. C.; Margolin, D.; Merideth, C.; Mintzer, J. E.; Pfeiffer, E.; Richter, R.; Sadowsky, C. H.; Solomon, P.; Targum, S.; Tilker, H.; Usman, M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1333-1341</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Memantine, an NMDA antagonist, was investigated for the treatment of Alzheimer's disease.  Patients with moderate-to-severe Alzheimer's disease were randomly assigned to receive placebo or 20 mg memantine daily for 28 wk.  Two hundred fifty-two patients (67% women; mean age, 76 yr) from 32 U.S. centers were enrolled.  Of these, 181 (72%) completed the study and were evaluated at week 28.  Seventy-one patients discontinued treatment prematurely (42 taking placebo and 29 taking memantine).  Patients receiving memantine had a better outcome than those receiving placebo, according to the results of several tests.  Memantine treatment was not assocd. with a significant frequency of adverse events.  Thus, antiglutamatergic treatment reduced clin. deterioration in moderate-to-severe Alzheimer's disease, a phase assocd. with distress for patients and burden on caregivers, for which no other treatments are available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouAMuYZycKVrVg90H21EOLACvtfcHk0ljTT_Wcrndteg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1egt7k%253D&md5=f25ba456c00ead51c0a6426ca8701c5b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa013128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa013128%26sid%3Dliteratum%253Aachs%26aulast%3DReisberg%26aufirst%3DB.%26aulast%3DDoody%26aufirst%3DR.%26aulast%3DSt%25C3%25B6ffler%26aufirst%3DA.%26aulast%3DSchmitt%26aufirst%3DF.%26aulast%3DFerris%26aufirst%3DS.%26aulast%3DM%25C3%25B6bius%26aufirst%3DH.%2BJ.%26atitle%3DMemantine%2520in%2520moderate-to-severe%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D348%26spage%3D1333%26epage%3D1341%26doi%3D10.1056%2FNEJMoa013128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hallett, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Standaert, D. G.</span></span> <span> </span><span class="NLM_article-title">Rationale for and use of NMDA receptor antagonists in Parkinonâs disease</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">155</span>â <span class="NLM_lpage">174</span>, <span class="refDoi">Â DOI: 10.1016/j.pharmthera.2004.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2Fj.pharmthera.2004.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=15163596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVCiur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2004&pages=155-174&author=P.+J.+Hallettauthor=D.+G.+Standaert&title=Rationale+for+and+use+of+NMDA+receptor+antagonists+in+Parkinon%E2%80%99s+disease&doi=10.1016%2Fj.pharmthera.2004.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Rationale for and use of NMDA receptor antagonists in Parkinson's disease</span></div><div class="casAuthors">Hallett, Penelope J.; Standaert, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-174</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  N-Methyl-D-aspartate (NMDA) glutamate receptors are a class of excitatory amino acid receptors, which have several important functions in the motor circuits of the basal ganglia, and are viewed as important targets for the development of new drugs to prevent or treat Parkinson's disease (PD).  NMDA receptors are ligand-gated ion channels composed of multiple subunits, each of which has distinct cellular and regional patterns of expression.  They have complex regulatory properties, with both agonist and co-agonist binding sites and regulation by phosphorylation and protein-protein interactions.  They are found in all of the structures of the basal ganglia, although the subunit compn. in the various structures is different.  NMDA receptors present in the striatum are crucial for dopamine-glutamate interactions.  The abundance, structure, and function of striatal receptors are altered by the dopamine depletion and further modified by the pharmacol. treatments used in PD.  In animal models, NMDA receptor antagonists are effective antiparkinsonian agents and can reduce the complications of chronic dopaminergic therapy (wearing off and dyskinesias).  Use of these agents in humans has been limited because of the adverse effects assocd. with nonselective blockade of NMDA receptor function, but the development of more potent and selective pharmaceuticals holds the promise of an important new therapeutic approach for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3ar05ZbM9e7Vg90H21EOLACvtfcHk0ljTT_Wcrndteg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVCiur4%253D&md5=9a8db709281a9e22c8d77438d6862562</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2004.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2004.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DHallett%26aufirst%3DP.%2BJ.%26aulast%3DStandaert%26aufirst%3DD.%2BG.%26atitle%3DRationale%2520for%2520and%2520use%2520of%2520NMDA%2520receptor%2520antagonists%2520in%2520Parkinon%25E2%2580%2599s%2520disease%26jtitle%3DPharmacol.%2520Ther.%26date%3D2004%26volume%3D102%26spage%3D155%26epage%3D174%26doi%3D10.1016%2Fj.pharmthera.2004.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Milnerwood, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raymond, L. A.</span></span> <span> </span><span class="NLM_article-title">Early synaptic pathophysiology in neurodegeneration: insights from Huntingtonâs disease</span>. <i>Trends Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">513</span>â <span class="NLM_lpage">523</span>, <span class="refDoi">Â DOI: 10.1016/j.tins.2010.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2Fj.tins.2010.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=20850189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlensb7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=513-523&author=A.+J.+Milnerwoodauthor=L.+A.+Raymond&title=Early+synaptic+pathophysiology+in+neurodegeneration%3A+insights+from+Huntington%E2%80%99s+disease&doi=10.1016%2Fj.tins.2010.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease</span></div><div class="casAuthors">Milnerwood, Austen J.; Raymond, Lynn A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Neurosciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">513-523</span>CODEN:
                <span class="NLM_cas:coden">TNSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-2236</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Investigations of synaptic transmission and plasticity in mouse models of Huntington's disease (HD) demonstrate neuronal dysfunction long before the onset of classical disease indicators.  Similarly, recent human studies reveal synaptic dysfunction decades before predicted clin. diagnosis in HD gene carriers.  These studies guide premanifest tracking of disease and the development of treatment assessment tools.  New discoveries of mechanisms underlying early neuronal dysfunction, including elevated pathogenic extrasynaptic NMDA receptor signaling, reduced synaptic connectivity and loss of brain-derived neurotrophic factor (BDNF) support have led to pharmacol. interventions that can reverse or delay phenotype onset and disease progression in HD mice.  Further understanding the primary effects of gene mutations assocd. with late-onset neurodegeneration should translate to novel treatments for HD families and guide therapeutic strategies for other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_uV2DR-YcILVg90H21EOLACvtfcHk0ljTT_Wcrndteg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlensb7M&md5=f7ac827cd01948f918d0f19815c49d53</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2010.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2010.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DMilnerwood%26aufirst%3DA.%2BJ.%26aulast%3DRaymond%26aufirst%3DL.%2BA.%26atitle%3DEarly%2520synaptic%2520pathophysiology%2520in%2520neurodegeneration%253A%2520insights%2520from%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Neurosci.%26date%3D2010%26volume%3D33%26spage%3D513%26epage%3D523%26doi%3D10.1016%2Fj.tins.2010.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">XiangWei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span> <span> </span><span class="NLM_article-title">De novo mutations and rare variants occurring in NMDA receptors</span>. <i>Curr. Opin. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">27</span>â <span class="NLM_lpage">35</span>, <span class="refDoi">Â DOI: 10.1016/j.cophys.2017.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2Fj.cophys.2017.12.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=29756080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BC1MfislGnug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2018&pages=27-35&author=W.+XiangWeiauthor=Y.+Jiangauthor=H.+Yuan&title=De+novo+mutations+and+rare+variants+occurring+in+NMDA+receptors&doi=10.1016%2Fj.cophys.2017.12.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">De Novo Mutations and Rare Variants Occurring in NMDA Receptors</span></div><div class="casAuthors">XiangWei Wenshu; Jiang Yuwu; Jiang Yuwu; Yuan Hongjie; Yuan Hongjie</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in physiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A significant number of variants/mutations in the N-methyl-D-aspartate glutamatergic receptor (NMDAR) gene family (GRIN) have been identified along with stunning advances in the technologies of next generation of whole-exome sequencing.  Mutations in human GRIN genes are distributed throughout the entire gene, from amino terminal domain to C-terminal domain, in patients with various neuropsychiatric disorders, including autism spectrum disorders, epilepsy, intellectual disability, attention deficit hyperactivity disorder, and schizophrenia.  Analyzing the currently available human genetic variations illustrates the genetic variation intolerance to missense mutations differs significantly among domains within the GRIN genes.  Functional analyses of these mutations and their pharmacological profiles provide the first opportunity to understand the molecular mechanism and targeted therapeutic strategies for these neurological and psychiatric disorders, as well as unfold novel clues to channel function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQdzJKhR8JOSqqcneEtCi92fW6udTcc2ebgjptGz13ZZbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MfislGnug%253D%253D&md5=80f8773fdfd10eaadeb57d47028e55e3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cophys.2017.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cophys.2017.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DXiangWei%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DH.%26atitle%3DDe%2520novo%2520mutations%2520and%2520rare%2520variants%2520occurring%2520in%2520NMDA%2520receptors%26jtitle%3DCurr.%2520Opin.%2520Physiol.%26date%3D2018%26volume%3D2%26spage%3D27%26epage%3D35%26doi%3D10.1016%2Fj.cophys.2017.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, M.</span></span> <span> </span><span class="NLM_article-title">Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">693</span>â <span class="NLM_lpage">702</span>, <span class="refDoi">Â DOI: 10.1016/j.nurt.2009.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2Fj.nurt.2009.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=19789073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVKqu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=693-702&author=L.+J.+Wuauthor=M.+Zhuo&title=Targeting+the+NMDA+receptor+subunit+NR2B+for+the+treatment+of+neuropathic+pain&doi=10.1016%2Fj.nurt.2009.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain</span></div><div class="casAuthors">Wu, Long-Jun; Zhuo, Min</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">693-702</span>CODEN:
                <span class="NLM_cas:coden">NEURNV</span>;
        ISSN:<span class="NLM_cas:issn">1933-7213</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Neuropathic pain is generally defined as a chronic pain state resulting from peripheral or central nerve injury, or both.  An effective treatment for neuropathic pain is still lacking.  The NMDA receptor, one type of the ionotropic glutamate receptors, is known to be important for triggering long-lasting changes in synapses.  NMDA receptor-dependent synaptic plasticity plays roles not only in physiol. functions such as learning and memory, but also in unwanted pathol. conditions such as chronic pain.  This review addresses recent progress on NMDA receptors in neuropathic pain, with particular emphasis on the NR2B-subunit-contg. receptors.  The expression and function of NMDA receptors in synaptic plasticity in the pain transmission pathway from dorsal root ganglia to the anterior cingulate cortex is reviewed, and preclin. and clin. investigations of selective NMDA receptor in neuropathic pain are discussed.  The NMDA receptors, in particular NR2B-contg. NMDA receptors, serve as promising targets for treatment of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJj_EcDQHnR7Vg90H21EOLACvtfcHk0ljyuvhI57_NgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVKqu7g%253D&md5=b68285897a56e8c4e2b02233cf2c8de7</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.nurt.2009.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nurt.2009.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DL.%2BJ.%26aulast%3DZhuo%26aufirst%3DM.%26atitle%3DTargeting%2520the%2520NMDA%2520receptor%2520subunit%2520NR2B%2520for%2520the%2520treatment%2520of%2520neuropathic%2520pain%26jtitle%3DNeurotherapeutics%26date%3D2009%26volume%3D6%26spage%3D693%26epage%3D702%26doi%3D10.1016%2Fj.nurt.2009.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehls, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teasdale, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCulloch, J.</span></span> <span> </span><span class="NLM_article-title">The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">543</span>â <span class="NLM_lpage">551</span>, <span class="refDoi">Â DOI: 10.1002/ana.410240411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1002%2Fana.410240411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=2853604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaL1cXmt1agtLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1988&pages=543-551&author=C.+K.+Parkauthor=D.+G.+Nehlsauthor=D.+I.+Grahamauthor=G.+M.+Teasdaleauthor=J.+McCulloch&title=The+glutamate+antagonist+MK-801+reduces+focal+ischemic+brain+damage+in+the+rat&doi=10.1002%2Fana.410240411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat</span></div><div class="casAuthors">Park, C. K.; Nehls, D. G.; Graham, D. I.; Teasdale, G. M.; McCulloch, J.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">543-51</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">Focal cerebral ischemia was produced by the permanent occlusion of one middle cerebral artery (MCA), and the animals were killed 3 h after the arterial occlusion.  MK-801 (0.5 mg/kg) was administered i.v. either 30 min prior to MCA occlusion or 30 min after the induction of ischemia.  Pretreatment with MK-801 reduced the vol. of ischemic damage both in the cerebral cortex (by 38% compared with untreated rats with MCA occlusion, and in the caudate nucleus (by 18% compared with controls).  Treatment with MK-801, initiated 30 min after MCA occlusion, reduced the vol. of ischemic damage in the cerebral cortex (by 52% compared with controls).  The vol. of ischemic damage in the caudate nucleus was minimally influenced by MK-801 treatment initiated after MCA occlusion.  The antiischemic effects of MK-801 were readily demonstrable despite the hypotension that MK-801 induced in rats anesthetized with halothane (0.5%), N2O (70%), and O (30%).  The potency of MK-801 in reducing ischemic brain damage, even when administered after the induction of ischemia, highlights the potential use of N-methyl-D-aspartate receptor antagonists for the treatment of focal cerebral ischemia in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg60Bc9vNYHrVg90H21EOLACvtfcHk0ljyuvhI57_NgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXmt1agtLc%253D&md5=113494a1ddee98d9ee935b322c06e7b0</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fana.410240411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410240411%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DC.%2BK.%26aulast%3DNehls%26aufirst%3DD.%2BG.%26aulast%3DGraham%26aufirst%3DD.%2BI.%26aulast%3DTeasdale%26aufirst%3DG.%2BM.%26aulast%3DMcCulloch%26aufirst%3DJ.%26atitle%3DThe%2520glutamate%2520antagonist%2520MK-801%2520reduces%2520focal%2520ischemic%2520brain%2520damage%2520in%2520the%2520rat%26jtitle%3DAnn.%2520Neurol.%26date%3D1988%26volume%3D24%26spage%3D543%26epage%3D551%26doi%3D10.1002%2Fana.410240411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simon, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swan, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meldrum, B. S.</span></span> <span> </span><span class="NLM_article-title">Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>226</i></span>,  <span class="NLM_fpage">850</span>â <span class="NLM_lpage">852</span>, <span class="refDoi">Â DOI: 10.1126/science.6093256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1126%2Fscience.6093256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=6093256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaL2MXjsl0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=1984&pages=850-852&author=R.+P.+Simonauthor=J.+H.+Swanauthor=T.+Griffithsauthor=B.+S.+Meldrum&title=Blockade+of+N-methyl-D-aspartate+receptors+may+protect+against+ischemic+damage+in+the+brain&doi=10.1126%2Fscience.6093256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain</span></div><div class="casAuthors">Simon, R. P.; Swan, J. H.; Griffiths, T.; Meldrum, B. S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">4676</span>),
    <span class="NLM_cas:pages">850-2</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">In rats ischemia of the forebrain induced by a 30-min occlusion of the carotid artery followed by 120 min of arterial reperfusion produced ischemic lesions of selectively vulnerable pyramidal cells in both hippocampi.  Focal microinfusion into the dorsal hippocampus of 2-amino-7-phosphonoheptanoic acid  [85797-13-3], an antagonist of excitation at the N-methyl-D-aspartate-preferring receptor, before ischemia was induced protected against the development of ischemic damage.  Apparently, excitatory neurotransmission plays an important role in selective neuronal loss due to cerebral ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZAGwtHGrEWrVg90H21EOLACvtfcHk0lhotbADvQiKGw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXjsl0%253D&md5=057560bcd8ee07a6a4bc35862e4b4424</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.6093256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.6093256%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DR.%2BP.%26aulast%3DSwan%26aufirst%3DJ.%2BH.%26aulast%3DGriffiths%26aufirst%3DT.%26aulast%3DMeldrum%26aufirst%3DB.%2BS.%26atitle%3DBlockade%2520of%2520N-methyl-D-aspartate%2520receptors%2520may%2520protect%2520against%2520ischemic%2520damage%2520in%2520the%2520brain%26jtitle%3DScience%26date%3D1984%26volume%3D226%26spage%3D850%26epage%3D852%26doi%3D10.1126%2Fscience.6093256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morikawa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirino, T.</span></span> <span> </span><span class="NLM_article-title">Attenuation of focal ischemic brain injury in mice deficient in the epsilon1 (NR2A) subunit of NMDA receptor</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">9727</span>â <span class="NLM_lpage">9732</span>, <span class="refDoi">Â DOI: 10.1523/JNEUROSCI.18-23-09727.1998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1523%2FJNEUROSCI.18-23-09727.1998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=9822733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaK1cXnslyru7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=9727-9732&author=E.+Morikawaauthor=H.+Moriauthor=Y.+Kiyamaauthor=M.+Mishinaauthor=T.+Asanoauthor=T.+Kirino&title=Attenuation+of+focal+ischemic+brain+injury+in+mice+deficient+in+the+epsilon1+%28NR2A%29+subunit+of+NMDA+receptor&doi=10.1523%2FJNEUROSCI.18-23-09727.1998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation of focal ischemic brain injury in mice deficient in the Îµ1 (NR2A) subunit of NMDA receptor</span></div><div class="casAuthors">Morikawa, Eiharu; Mori, Hisashi; Kiyama, Yuji; Mishina, Masayoshi; Asano, Takao; Kirino, Takaaki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9727-9732</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The role of glutamate neurotoxicity in cerebral ischemia has long been advocated but still remains controversial, because various glutamate receptor (GluR) antagonists showed inconsistent protective efficacy in brain ischemia models.  To address this central issue of ischemic brain damage more directly, the authors used mutant mice deficient in the GluRÎµ1 (NR2A) subunit of NMDA receptor with or without addnl. heterozygous mutation in the GluRÎµ2 (NR2B) subunit.  Those mutant mice, as well as their littermates, were subjected to focal cerebral ischemia by introducing a 6-0 nylon suture from left common carotid artery.  Brain injury vols. after 2 h of suture insertion, as evaluated by 2,3,5-triphenyltetrazolium chloride staining at 24 h after ischemia, revealed significantly smaller injury size in GluRÎµ1 subunit knock-out mice compared with their wild-type littermates.  The redn. in injury vol. was not attributable to differences in body temp. or in blood flow during ischemia.  Addnl. heterozygous GluRÎµ2 subunit disruption did not result in further redn. in injury vol.  These data directly demonstrate relevance of NMDA receptor-mediated tissue injury after brain ischemia and provide evidence that GluRÎµ1 subunit is involved in these injurious mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0UGwap3Z-r7Vg90H21EOLACvtfcHk0lhotbADvQiKGw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnslyru7o%253D&md5=8a952c73015b06db44d4a8d53abac22b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.18-23-09727.1998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.18-23-09727.1998%26sid%3Dliteratum%253Aachs%26aulast%3DMorikawa%26aufirst%3DE.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DY.%26aulast%3DMishina%26aufirst%3DM.%26aulast%3DAsano%26aufirst%3DT.%26aulast%3DKirino%26aufirst%3DT.%26atitle%3DAttenuation%2520of%2520focal%2520ischemic%2520brain%2520injury%2520in%2520mice%2520deficient%2520in%2520the%2520epsilon1%2520%2528NR2A%2529%2520subunit%2520of%2520NMDA%2520receptor%26jtitle%3DJ.%2520Neurosci.%26date%3D1998%26volume%3D18%26spage%3D9727%26epage%3D9732%26doi%3D10.1523%2FJNEUROSCI.18-23-09727.1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berman, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappiello, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oren, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heninger, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charney, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krystal, J. H.</span></span> <span> </span><span class="NLM_article-title">Antidepressant effects of ketamine in depressed patients</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">351</span>â <span class="NLM_lpage">354</span>, <span class="refDoi">Â DOI: 10.1016/S0006-3223(99)00230-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2FS0006-3223%2899%2900230-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10686270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD3cXht1KqtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2000&pages=351-354&author=R.+M.+Bermanauthor=A.+Cappielloauthor=A.+Anandauthor=D.+A.+Orenauthor=G.+R.+Heningerauthor=D.+S.+Charneyauthor=J.+H.+Krystal&title=Antidepressant+effects+of+ketamine+in+depressed+patients&doi=10.1016%2FS0006-3223%2899%2900230-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant effects of ketamine in depressed patients</span></div><div class="casAuthors">Berman, R. M.; Cappiello, A.; Anand, A.; Oren, D. A.; Heninger, G. R.; Charney, D. S.; Krystal, J. H.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">351-354</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Subjects with major depression completed 2 test days that involved i.v. treatment with ketamine-HCl [an N-methyl-D-aspartate (NMDA) receptor antagonist] (0.5 mg/kg) or saline solns. under randomized, double-blind conditions. The subjects evidenced significant improvement in depressive symptoms within 72 h after ketamine but not placebo infusion. These results suggest a potential role for NMDA receptor-modulating drugs in the treatment of depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe9INO5Rp16bVg90H21EOLACvtfcHk0lhotbADvQiKGw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXht1KqtrY%253D&md5=45ef4a17496654912e0bf515ba3fce2a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2899%2900230-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252899%252900230-9%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DR.%2BM.%26aulast%3DCappiello%26aufirst%3DA.%26aulast%3DAnand%26aufirst%3DA.%26aulast%3DOren%26aufirst%3DD.%2BA.%26aulast%3DHeninger%26aufirst%3DG.%2BR.%26aulast%3DCharney%26aufirst%3DD.%2BS.%26aulast%3DKrystal%26aufirst%3DJ.%2BH.%26atitle%3DAntidepressant%2520effects%2520of%2520ketamine%2520in%2520depressed%2520patients%26jtitle%3DBiol.%2520Psychiatry%26date%3D2000%26volume%3D47%26spage%3D351%26epage%3D354%26doi%3D10.1016%2FS0006-3223%2899%2900230-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">aan
het Rot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murrough, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reich, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charney, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, S. J.</span></span> <span> </span><span class="NLM_article-title">Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">139</span>â <span class="NLM_lpage">145</span>, <span class="refDoi">Â DOI: 10.1016/j.biopsych.2009.08.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2Fj.biopsych.2009.08.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=19897179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGrtLvI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=139-145&author=M.+aan%0Ahet+Rotauthor=K.+A.+Collinsauthor=J.+W.+Murroughauthor=A.+M.+Perezauthor=D.+L.+Reichauthor=D.+S.+Charneyauthor=S.+J.+Mathew&title=Safety+and+efficacy+of+repeated-dose+intravenous+ketamine+for+treatment-resistant+depression&doi=10.1016%2Fj.biopsych.2009.08.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression</span></div><div class="casAuthors">aan het Rot, Marije; Collins, Katherine A.; Murrough, James W.; Perez, Andrew M.; Reich, David L.; Charney, Dennis S.; Mathew, Sanjay J.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-145</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A single subanesthetic i.v. dose of ketamine might have rapid but transient antidepressant effects in patients with treatment-resistant depression (TRD).  Here we tested the tolerability, safety, and efficacy of repeated-dose open-label i.v. ketamine (six infusions over 12 days) in 10 medication-free symptomatic patients with TRD who had previously shown a meaningful antidepressant response to a single dose.  On day 1, patients received a 40-min i.v. infusion of ketamine (.5 mg/kg) in an inpatient setting with continuous vital-sign monitoring.  Psychotomimetic effects and adverse events were recorded repeatedly.  The primary efficacy measure was change from baseline in the Montgomery-Ãsberg Depression Rating Scale (MADRS) score.  If patients showed a â¥50% redn. in MADRS scores on day 2, they received five addnl. infusions on an outpatient basis (days 3, 5, 8, 10, and 12).  Follow-up visits were conducted twice-weekly for â¥4 wk or until relapse.  Ketamine elicited minimal pos. psychotic symptoms.  Three patients experienced significant but transient dissociative symptoms.  Side effects during and after each ketamine infusion were generally mild.  The response criterion was met by nine patients after the first infusion as well as after the sixth infusion.  The mean (SD) redn. in MADRS scores after the sixth infusion was 85% (12%).  Postketamine, eight of nine patients relapsed, on av., 19 days after the sixth infusion (range 6 days-45 days).  One patient remained antidepressant-free with minimal depressive symptoms for >3 mo.  These pilot findings suggest feasibility of repeated-dose i.v. ketamine for the acute treatment of TRD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu2kFXrpAgrbVg90H21EOLACvtfcHk0li2dk58MnpuHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGrtLvI&md5=e68b2a1af8cb23477f2b68e0f77bbea6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2009.08.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2009.08.038%26sid%3Dliteratum%253Aachs%26aulast%3Daan%2Bhet%2BRot%26aufirst%3DM.%26aulast%3DCollins%26aufirst%3DK.%2BA.%26aulast%3DMurrough%26aufirst%3DJ.%2BW.%26aulast%3DPerez%26aufirst%3DA.%2BM.%26aulast%3DReich%26aufirst%3DD.%2BL.%26aulast%3DCharney%26aufirst%3DD.%2BS.%26aulast%3DMathew%26aufirst%3DS.%2BJ.%26atitle%3DSafety%2520and%2520efficacy%2520of%2520repeated-dose%2520intravenous%2520ketamine%2520for%2520treatment-resistant%2520depression%26jtitle%3DBiol.%2520Psychiatry%26date%3D2010%26volume%3D67%26spage%3D139%26epage%3D145%26doi%3D10.1016%2Fj.biopsych.2009.08.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santangelo, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katzman, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strong, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span> <span> </span><span class="NLM_article-title">Novel NMDA receptor modulators: an update</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1337</span>â <span class="NLM_lpage">1352</span>, <span class="refDoi">Â DOI: 10.1517/13543776.2012.728587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1517%2F13543776.2012.728587" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=23009122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFeku7rM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1337-1352&author=R.+M.+Santangeloauthor=T.+M.+Ackerauthor=S.+S.+Zimmermanauthor=B.+M.+Katzmanauthor=K.+L.+Strongauthor=S.+F.+Traynelisauthor=D.+C.+Liotta&title=Novel+NMDA+receptor+modulators%3A+an+update&doi=10.1517%2F13543776.2012.728587"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Novel NMDA receptor modulators: an update</span></div><div class="casAuthors">Santangelo, Rose M.; Acker, Timothy M.; Zimmerman, Sommer S.; Katzman, Brooke M.; Strong, Katie L.; Traynelis, Stephen F.; Liotta, Dennis C.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1337-1352</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The NMDA receptor is a ligand-gated ion channel that plays a crit. role in higher level brain processes and has been implicated in a range of neurol. and psychiatric conditions.  Although initial studies for the use of NMDA receptor antagonists in neuroprotection were unsuccessful, more recently, NMDA receptor antagonists have shown clin. promise in other indications such as Alzheimer's disease, Parkinson's disease, pain and depression.  Based on the clin. observations and more recent insights into receptor pharmacol., new modulatory approaches are beginning to emerge, with potential therapeutic benefit.Areas covered: The article covers the known pharmacol. and important features regarding NMDA receptors and their function.  A discussion of pre-clin. and clin. relevance is included, as well.  The subsequent patent literature review highlights the current state of the art targeting the receptor since the last review in 2010.Expert opinion: The complex nature of the NMDA receptor structure and function is becoming better understood.  As knowledge about this receptor increases, it opens up new opportunities for targeting the receptor for many therapeutic indications.  New strategies and advances in older technologies will need to be further developed before clin. success can be achieved.  First-in-class potentiators and subunit-selective agents form the basis for most new strategies, complemented by efforts to limit off-target liability and fine-tune on-target properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCcPFoWECh97Vg90H21EOLACvtfcHk0li2dk58MnpuHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFeku7rM&md5=2f284210f7d50d98bfea33414c72048d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.728587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.728587%26sid%3Dliteratum%253Aachs%26aulast%3DSantangelo%26aufirst%3DR.%2BM.%26aulast%3DAcker%26aufirst%3DT.%2BM.%26aulast%3DZimmerman%26aufirst%3DS.%2BS.%26aulast%3DKatzman%26aufirst%3DB.%2BM.%26aulast%3DStrong%26aufirst%3DK.%2BL.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26atitle%3DNovel%2520NMDA%2520receptor%2520modulators%253A%2520an%2520update%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26spage%3D1337%26epage%3D1352%26doi%3D10.1517%2F13543776.2012.728587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strong, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jing, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prosser, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span> <span> </span><span class="NLM_article-title">NMDA receptor modulators: an updated patent review (2013-2014)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1349</span>â <span class="NLM_lpage">1366</span>, <span class="refDoi">Â DOI: 10.1517/13543776.2014.972938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1517%2F13543776.2014.972938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=25351527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFejsr%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1349-1366&author=K.+L.+Strongauthor=Y.+Jingauthor=A.+R.+Prosserauthor=S.+F.+Traynelisauthor=D.+C.+Liotta&title=NMDA+receptor+modulators%3A+an+updated+patent+review+%282013-2014%29&doi=10.1517%2F13543776.2014.972938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor modulators: an updated patent review (2013 - 2014)</span></div><div class="casAuthors">Strong, Katie L.; Jing, Yao; Prosser, Anthony R.; Traynelis, Stephen F.; Liotta, Dennis C.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1349-1366</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Introduction: The NMDA receptor mediates a slow component of excitatory synaptic transmission, and NMDA receptor dysfunction has been implicated in numerous neurol. disorders.  Thus, interest in developing modulators that are capable of regulating the channel continues to be strong.  Recent research has led to the discovery of a no. of compds. that hold therapeutic and clin. value.  Deeper insight into the NMDA intersubunit interactions and structural motifs gleaned from the recently solved crystal structures of the NMDA receptor should facilitate a deeper understanding of how these compds. modulate the receptor.  Areas covered: This article discusses the known pharmacol. of NMDA receptors.  A discussion of the patent literature since 2012 is also included, with an emphasis on those that claimed new chem. entities as regulators of the NMDA receptor.  Expert opinion: The no. of patents involving novel NMDA receptor modulators suggests a renewed interest in the NMDA receptor as a therapeutic target.  Subunit-selective modulators continue to show promise, and the development of new subunit-selective NMDA receptor modulators appears poised for continued growth.  Although a modest no. of channel blocker patents were published, successful clin. outcomes involving ketamine have led to a resurgent interest in low-affinity channel blockers as therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7rbzQ3H9ZDbVg90H21EOLACvtfcHk0li2dk58MnpuHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFejsr%252FL&md5=2a1ffaa993c76d1f4ddf2cd80a298f04</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.972938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.972938%26sid%3Dliteratum%253Aachs%26aulast%3DStrong%26aufirst%3DK.%2BL.%26aulast%3DJing%26aufirst%3DY.%26aulast%3DProsser%26aufirst%3DA.%2BR.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26atitle%3DNMDA%2520receptor%2520modulators%253A%2520an%2520updated%2520patent%2520review%2520%25282013-2014%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26spage%3D1349%26epage%3D1366%26doi%3D10.1517%2F13543776.2014.972938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregestovski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ascher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prochiantz, A.</span></span> <span> </span><span class="NLM_article-title">Magnesium gates glutamate-activated channels in mouse central neurones</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>307</i></span>,  <span class="NLM_fpage">462</span>â <span class="NLM_lpage">465</span>, <span class="refDoi">Â DOI: 10.1038/307462a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2F307462a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=6320006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaL2cXhtVSktrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=1984&pages=462-465&author=L.+Nowakauthor=P.+Bregestovskiauthor=P.+Ascherauthor=A.+Herbetauthor=A.+Prochiantz&title=Magnesium+gates+glutamate-activated+channels+in+mouse+central+neurones&doi=10.1038%2F307462a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Magnesium gates glutamate-activated channels in mouse central neurons</span></div><div class="casAuthors">Nowak, L.; Bregestovski, P.; Ascher, P.; Herbet, A.; Prochiantz, A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">5950</span>),
    <span class="NLM_cas:pages">462-5</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Studies on mouse embryo mesencephalic or striatal neurons using the patch-clamp technique indicated a link between voltage sensitivity and Mg2+ sensitivity.  In Mg2+-free solns., L-glutamate, L-aspartate, and N-methyl-D-aspartate (NMDA) opened cation channels, the properties of which were voltage independent.  In the presence of Mg2+, the single-channel currents measured at resting potential were chopped in bursts and the probability of opening the channels was reduced.  Both effects increased with hyperpolarization, thereby accounting for the neg. slope of the I-V relation of the glutamate response.  Thus, the voltage dependence of the NMDA receptor-linked conductance appears to be a consequence of the voltage dependence of the Mg2+ block, and its interpretation does not require the implication of an intramembrane voltage-dependent gate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNI5KPbMeMT7Vg90H21EOLACvtfcHk0lgo-ZjV9O1T5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhtVSktrg%253D&md5=cc393236b9af6184c9b936bf2b61c83b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2F307462a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F307462a0%26sid%3Dliteratum%253Aachs%26aulast%3DNowak%26aufirst%3DL.%26aulast%3DBregestovski%26aufirst%3DP.%26aulast%3DAscher%26aufirst%3DP.%26aulast%3DHerbet%26aufirst%3DA.%26aulast%3DProchiantz%26aufirst%3DA.%26atitle%3DMagnesium%2520gates%2520glutamate-activated%2520channels%2520in%2520mouse%2520central%2520neurones%26jtitle%3DNature%26date%3D1984%26volume%3D307%26spage%3D462%26epage%3D465%26doi%3D10.1038%2F307462a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westbrook, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guthrie, P. B.</span></span> <span> </span><span class="NLM_article-title">Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>309</i></span>,  <span class="NLM_fpage">261</span>â <span class="NLM_lpage">263</span>, <span class="refDoi">Â DOI: 10.1038/309261a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2F309261a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=6325946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaL2cXktFyjtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=1984&pages=261-263&author=M.+L.+Mayerauthor=G.+L.+Westbrookauthor=P.+B.+Guthrie&title=Voltage-dependent+block+by+Mg2%2B+of+NMDA+responses+in+spinal+cord+neurones&doi=10.1038%2F309261a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-dependent block by magnesium(2+) of NMDA responses in spinal cord neurons</span></div><div class="casAuthors">Mayer, Mark L.; Westbrook, Gary L.; Guthrie, Peter B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">5965</span>),
    <span class="NLM_cas:pages">261-3</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Voltage-clamp expts. on mouse spinal cord neurons showed that the voltage-sensitivity of N-methyl-D-aspartic acid (NMDA)  [6384-92-5] action is greatly reduced on the withdrawal of physiol. concns. (â¼1 mM) of Mg2+ from the extracellular fluid.  Thus, Mg2+ blocks inward current flow through ion channels linked to NMDA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLE_6GreNx3rVg90H21EOLACvtfcHk0lgo-ZjV9O1T5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXktFyjtrk%253D&md5=5f44b8f339efde1dc09259c308373c8d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2F309261a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F309261a0%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DM.%2BL.%26aulast%3DWestbrook%26aufirst%3DG.%2BL.%26aulast%3DGuthrie%26aufirst%3DP.%2BB.%26atitle%3DVoltage-dependent%2520block%2520by%2520Mg2%252B%2520of%2520NMDA%2520responses%2520in%2520spinal%2520cord%2520neurones%26jtitle%3DNature%26date%3D1984%26volume%3D309%26spage%3D261%26epage%3D263%26doi%3D10.1038%2F309261a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacDermott, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westbrook, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, J. L.</span></span> <span> </span><span class="NLM_article-title">NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>321</i></span>,  <span class="NLM_fpage">519</span>â <span class="NLM_lpage">522</span>, <span class="refDoi">Â DOI: 10.1038/321519a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2F321519a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=3012362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaL28XksFGjs7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=1986&pages=519-522&author=A.+B.+MacDermottauthor=M.+L.+Mayerauthor=G.+L.+Westbrookauthor=S.+J.+Smithauthor=J.+L.+Barker&title=NMDA-receptor+activation+increases+cytoplasmic+calcium+concentration+in+cultured+spinal+cord+neurones&doi=10.1038%2F321519a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurons</span></div><div class="casAuthors">MacDermott, Amy B.; Mayer, Mark L.; Westbrook, Gary L.; Smith, Stephen J.; Barker, Jeffery L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">6069</span>),
    <span class="NLM_cas:pages">519-22</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The intracellular Ca2+ activity in 13-14-day-old mouse embryo spinal neurons was measured by using the indicator dye arsenazo III.  N-Methyl-D-aspartic acid (NMDA)  [6384-92-5] application to spinal cord neurons voltage-clamped at -50 to -60 mV evoked an inward current accompanied by an increase in the intracellular Ca2+ concn.  The increase in Ca2+ levels peaked near +10 mV and declined in amplitude on further depolarization.  L-Glutamate  [56-86-0], a mixed agonist acting at NMDA receptors, also evoked increases in intracellular Ca2+ levels.  A depolarizing shift of the NMDA reversal potential on increasing the extracellular Ca2+ concn. provides direct evidence that NMDA channels have measurable Ca2+ permeability.  In contrast, the reversal potential of the response evoked by kainate  [487-79-6] showed little Ca2+ dependence.  The response to NMDA receptor activation thus provides a 2nd source of Ca2+ flux, distinct from that resulting from conventional voltage-dependent Ca2+ channels, which may have important long-term effects on excitability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqawDa2JDMMBLVg90H21EOLACvtfcHk0lgo-ZjV9O1T5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XksFGjs7g%253D&md5=3867f3a74a88ff4e25421653a495e03e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2F321519a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F321519a0%26sid%3Dliteratum%253Aachs%26aulast%3DMacDermott%26aufirst%3DA.%2BB.%26aulast%3DMayer%26aufirst%3DM.%2BL.%26aulast%3DWestbrook%26aufirst%3DG.%2BL.%26aulast%3DSmith%26aufirst%3DS.%2BJ.%26aulast%3DBarker%26aufirst%3DJ.%2BL.%26atitle%3DNMDA-receptor%2520activation%2520increases%2520cytoplasmic%2520calcium%2520concentration%2520in%2520cultured%2520spinal%2520cord%2520neurones%26jtitle%3DNature%26date%3D1986%26volume%3D321%26spage%3D519%26epage%3D522%26doi%3D10.1038%2F321519a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monyer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnashev, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurie, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeburg, P. H.</span></span> <span> </span><span class="NLM_article-title">Developmental and regional expression in the rat brain and functional properties of four NMDA receptors</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">529</span>â <span class="NLM_lpage">540</span>, <span class="refDoi">Â DOI: 10.1016/0896-6273(94)90210-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2F0896-6273%2894%2990210-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=7512349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaK2cXitlKku7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1994&pages=529-540&author=H.+Monyerauthor=N.+Burnashevauthor=D.+J.+Laurieauthor=B.+Sakmannauthor=P.+H.+Seeburg&title=Developmental+and+regional+expression+in+the+rat+brain+and+functional+properties+of+four+NMDA+receptors&doi=10.1016%2F0896-6273%2894%2990210-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental and regional expression in the rat brain and functional properties of four NMDA receptors</span></div><div class="casAuthors">Monyer, Hannah; Burnashev, Nail; Laurie, David J.; Sakmann, Bert; Seeburg, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">ISS/REP#/MLT:  3</span>),
    <span class="NLM_cas:pages">529-40</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    </div><div class="casAbstract">An in situ study of mRNAs encoding NMDA receptor subunits in the developing rat CNS revealed that, at all stages, the NR1 gene is expressed in virtually all neurons, whereas the four NR2 transcripts display distinct expression patterns.  NR2B and NR2D mRNA occur prenatally, whereas NR2A and NR2C mRNAs are first detected near birth.  All transcripts except NR2D peak around P20.  NR2D mRNA, present mainly in midbrain structures, peaks around P7 and thereafter decreases to adult levels.  Postnatally, NR2B and NR2C transcript levels change in opposite directions in the cerebellar internal granule cell layer.  In the adult hippocampus, NR2A and NR2B mRNAs are prominent in CA1 and CA3 pyramidal cells, but NR2C and NR2D mRNAs occur in different subsets of interneurons.  Recombinant binary NR1-NR2 channels show comparable Ca2+ permeabilities, but marked differences in voltage-dependent Mg2+ block and in offset decay time consts.  Thus, the distinct expression profiles and functional properties of NR2 subunits provide a basis for NMDA channel heterogeneity in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfdrOkgeEJfbVg90H21EOLACvtfcHk0lgo-ZjV9O1T5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlKku7w%253D&md5=9ff9985abba893a28ae4983c5099e913</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2F0896-6273%2894%2990210-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0896-6273%252894%252990210-0%26sid%3Dliteratum%253Aachs%26aulast%3DMonyer%26aufirst%3DH.%26aulast%3DBurnashev%26aufirst%3DN.%26aulast%3DLaurie%26aufirst%3DD.%2BJ.%26aulast%3DSakmann%26aufirst%3DB.%26aulast%3DSeeburg%26aufirst%3DP.%2BH.%26atitle%3DDevelopmental%2520and%2520regional%2520expression%2520in%2520the%2520rat%2520brain%2520and%2520functional%2520properties%2520of%2520four%2520NMDA%2520receptors%26jtitle%3DNeuron%26date%3D1994%26volume%3D12%26spage%3D529%26epage%3D540%26doi%3D10.1016%2F0896-6273%2894%2990210-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akazawa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigemoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessho, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, N.</span></span> <span> </span><span class="NLM_article-title">Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats</span>. <i>J. Comp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">150</span>â <span class="NLM_lpage">160</span>, <span class="refDoi">Â DOI: 10.1002/cne.903470112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1002%2Fcne.903470112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=7798379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaK2cXmt1alt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=1994&pages=150-160&author=C.+Akazawaauthor=R.+Shigemotoauthor=Y.+Besshoauthor=S.+Nakanishiauthor=N.+Mizuno&title=Differential+expression+of+five+N-methyl-D-aspartate+receptor+subunit+mRNAs+in+the+cerebellum+of+developing+and+adult+rats&doi=10.1002%2Fcne.903470112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats</span></div><div class="casAuthors">Akazawa, Chihiro; Shigemoto, Ryuichi; Bessho, Yasumasa; Nakanishi, Shigetada; Mizuno, Noboru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">150-60</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    </div><div class="casAbstract">Five N-methyl-D-aspartate (NMDA) receptor subunits have been identified thus far: NR1, NR2A, NR2B, NR2C, and NR2D.  Here, the authors have analyzed the expression patterns of mRNAs for the NMDA receptor subunits in the developing and adult rats by in situ hybridization.  The developmental changes of the expression patterns were most salient in the cerebellum.  In the external granular layer, hybridization signals of mRNAs for NR1, NR2A, NR2B, and NR2C appeared by postnatal day 3, but no NR2D mRNA was expressed at any developmental stage examd.  The NR1 mRNA was expressed in all cerebellar neurons at all developmental stages examd.  The signals for the NR2A mRNA appeared in Purkinje cells and granule cells during the second postnatal week.  The signals for the NR2B mRNA in granule cells were seen transiently during the first 2 wk after birth.  The signals for NR2C mRNA appeared in granule cells and glial cells during the second postnatal week.  The signals for NR2D mRNA appeared transiently in Purkinje cells during the first 8 postnatal days; in adult rats, these were seen in stellate and Golgi cells.  In the cerebellar nuclei, mRNAs for NR1, NR2A, NR2B, and NR2D were more or less expressed on postnatal day 0, while expression signals for the NR2C mRNA were first detected in postnatal day 14.  Thus, the most conspicuous changes of expression patterns were obsd. in the cerebellar cortex during the first 2 wk after birth, when development and maturation of the cerebellum proceed most rapidly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-3uXAbBlyr7Vg90H21EOLACvtfcHk0liEM5BIxl9n0A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmt1alt74%253D&md5=56ff09fd6667cd9c90a2bc8225261e5a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fcne.903470112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcne.903470112%26sid%3Dliteratum%253Aachs%26aulast%3DAkazawa%26aufirst%3DC.%26aulast%3DShigemoto%26aufirst%3DR.%26aulast%3DBessho%26aufirst%3DY.%26aulast%3DNakanishi%26aufirst%3DS.%26aulast%3DMizuno%26aufirst%3DN.%26atitle%3DDifferential%2520expression%2520of%2520five%2520N-methyl-D-aspartate%2520receptor%2520subunit%2520mRNAs%2520in%2520the%2520cerebellum%2520of%2520developing%2520and%2520adult%2520rats%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D1994%26volume%3D347%26spage%3D150%26epage%3D160%26doi%3D10.1002%2Fcne.903470112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishina, M.</span></span> <span> </span><span class="NLM_article-title">Developmental changes in distribution of NMDA receptor channel subunit mRNAs</span>. <i>NeuroReport</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1138</span>â <span class="NLM_lpage">1140</span>, <span class="refDoi">Â DOI: 10.1097/00001756-199212000-00027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1097%2F00001756-199212000-00027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1493227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaK3sXit1Khs7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1992&pages=1138-1140&author=M.+Watanabeauthor=Y.+Inoueauthor=K.+Sakimuraauthor=M.+Mishina&title=Developmental+changes+in+distribution+of+NMDA+receptor+channel+subunit+mRNAs&doi=10.1097%2F00001756-199212000-00027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental changes in distribution of NMDA receptor channel subunit mRNAs</span></div><div class="casAuthors">Watanabe, Masahiko; Inoue, Yoshiro; Sakimura, Kenji; Mishina, Masayoshi</div><div class="citationInfo"><span class="NLM_cas:title">NeuroReport</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1138-40</span>CODEN:
                <span class="NLM_cas:coden">NERPEZ</span>;
        ISSN:<span class="NLM_cas:issn">0959-4965</span>.
    </div><div class="casAbstract">In situ hybridization analyses revealed drastic changes in expression and distribution of 5 subunit mRNAs of the mouse NMDA receptor channel during brain development.  The Îµ1 subunit mRNA is expressed postnatally and widely in the brain.  On the other hand, the Îµ2 subunit mRNA is found throughout the entire embryonic brain, but its expression becomes restricted to the forebrain at postnatal stages.  The Îµ3 subunit mRNA appears postnatally and predominantly in the cerebellum, whereas the Îµ4 subunit mRNA is abundantly expressed in the diencephalon and the brain stem at embryonic and neonatal stages.  In contrast, the Î¶1 subunit mRNA distributes ubiquitously in the brain throughout development.  These findings suggest that changes in the subunit compn. of the NMDA receptor channel take place during brain development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5mdDqXX5eybVg90H21EOLACvtfcHk0liEM5BIxl9n0A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit1Khs7s%253D&md5=4ed4b0724e33d4432836b8613c020d92</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1097%2F00001756-199212000-00027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-199212000-00027%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DY.%26aulast%3DSakimura%26aufirst%3DK.%26aulast%3DMishina%26aufirst%3DM.%26atitle%3DDevelopmental%2520changes%2520in%2520distribution%2520of%2520NMDA%2520receptor%2520channel%2520subunit%2520mRNAs%26jtitle%3DNeuroReport%26date%3D1992%26volume%3D3%26spage%3D1138%26epage%3D1140%26doi%3D10.1097%2F00001756-199212000-00027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erreger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dravid, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banke, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, D. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signaling profiles</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>563</i></span>,  <span class="NLM_fpage">345</span>â <span class="NLM_lpage">358</span>, <span class="refDoi">Â DOI: 10.1113/jphysiol.2004.080028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1113%2Fjphysiol.2004.080028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=15649985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVWiur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=563&publication_year=2005&pages=345-358&author=K.+Erregerauthor=S.+M.+Dravidauthor=T.+G.+Bankeauthor=D.+J.+A.+Wyllieauthor=S.+F.+Traynelis&title=Subunit-specific+gating+controls+rat+NR1%2FNR2A+and+NR1%2FNR2B+NMDA+channel+kinetics+and+synaptic+signaling+profiles&doi=10.1113%2Fjphysiol.2004.080028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles</span></div><div class="casAuthors">Erreger, Kevin; Dravid, Shashank M.; Banke, Tue G.; Wyllie, David J. A.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">563</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">345-358</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">NR2A and NR2B are the predominant NR2 NMDA receptor subunits expressed in cortex and hippocampus.  The relative expression level of NR2A and NR2B is regulated developmentally and these two subunits have been suggested to play distinct roles in long-term synaptic plasticity.  The authors have used patch-clamp recording of recombinant NMDA receptors expressed in HEK293 cells to characterize the activation properties of both NR1/NR2A and NR1/NR2B receptors.  Recordings from outside-out patches that contain a single active channel show that NR2A-contg. receptors have a higher probability of opening at least once in response to a brief synaptic-like pulse of glutamate than NR2B-contg. receptors (NR2A, 0.80; NR2B, 0.56), a higher peak open probability (NR2A, 0.50; NR2B, 0.12), and a higher open probability within an activation (NR2A, 0.67; NR2B, 0.37).  Anal. of the sequence of single-channel open and closed intervals shows that both NR2A- and NR2B-contg. receptors undergo multiple conformational changes prior to opening of the channel, with at least one of these steps being faster for NR2A than NR2B.  These distinct properties produce profoundly different temporal signaling profiles for NR2A- and NR2B-contg. receptors.  Simulations of synaptic responses demonstrate that at low frequencies typically used to induce long-term depression (LTD; 1 Hz), NR1/NR2B makes a larger contribution to total charge transfer and therefore calcium influx than NR1/NR2A.  However, under high-frequency tetanic stimulation (100 Hz; > 100 ms) typically used to induce long-term potentiation (LTP), the charge transfer mediated by NR1/NR2A considerably exceeds that of NR1/NR2B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRM6ur3MVsKbVg90H21EOLACvtfcHk0liEM5BIxl9n0A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVWiur4%253D&md5=201e62033417cad488f26a1378c6cde1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2004.080028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2004.080028%26sid%3Dliteratum%253Aachs%26aulast%3DErreger%26aufirst%3DK.%26aulast%3DDravid%26aufirst%3DS.%2BM.%26aulast%3DBanke%26aufirst%3DT.%2BG.%26aulast%3DWyllie%26aufirst%3DD.%2BJ.%2BA.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DSubunit-specific%2520gating%2520controls%2520rat%2520NR1%252FNR2A%2520and%2520NR1%252FNR2B%2520NMDA%2520channel%2520kinetics%2520and%2520synaptic%2520signaling%2520profiles%26jtitle%3DJ.%2520Physiol.%26date%3D2005%26volume%3D563%26spage%3D345%26epage%3D358%26doi%3D10.1113%2Fjphysiol.2004.080028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dravid, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">Activation of recombinant NR1/NR2C NMDA receptors</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>586</i></span>,  <span class="NLM_fpage">4425</span>â <span class="NLM_lpage">4439</span>, <span class="refDoi">Â DOI: 10.1113/jphysiol.2008.158634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1113%2Fjphysiol.2008.158634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=18635641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1SnsL3L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=586&publication_year=2008&pages=4425-4439&author=S.+M.+Dravidauthor=A.+Prakashauthor=S.+F.+Traynelis&title=Activation+of+recombinant+NR1%2FNR2C+NMDA+receptors&doi=10.1113%2Fjphysiol.2008.158634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of recombinant NR1/NR2C NMDA receptors</span></div><div class="casAuthors">Dravid, Shashank M.; Prakash, Anand; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">586</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4425-4439</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The N-methyl-D-aspartate (NMDA) subtype of ionotropic glutamate receptors comprises both NR1 and NR2 subunits, and plays numerous roles in both physiol. and pathophysiol. processes in the central nervous system (CNS).  NR2C-contg. NMDA receptors are most abundant in cerebellum, thalamus and olfactory bulb, and are also expressed in oligodendrocytes and hippocampal interneurons.  We have used patch clamp recording to explore the activation properties of recombinant NR1/NR2C receptors expressed in HEK293 cells.  NR1/NR2C receptors activated by a maximally effective concn. of glutamate and glycine had two main conductance levels of 45 pS and 28 pS when the extracellular Ca2+ concn. was 0.5 mM and the holding potential was -80 mV.  The occurrence of the lower subconductance state was reduced in the absence of extracellular Ca2+.  The distribution of closed durations recorded from patches with a high probability of contg. only one active channel were best fitted by five exponential functions; the apparent open duration histogram could be fitted by two exponential functions (n = 10 patches).  The apparent mean open time of NR1/NR2C receptors was brief (0.52 Â± 0.04 ms), suggesting that the stability of the open state of the NR1/NR2C receptors is lower than other NR2-contg. receptors.  NR1/NR2C open probability was exceptionally low, being 0.011 Â± 0.002 in patches contg. a single active receptor (n = 8).  Fast agonist concn. jumps were performed on outside out patches with multiple NR1/NR2C channels, which activated with a 10-90% rise time of 3.9 Â± 0.4 ms, faster than other NR2-contg. receptors.  The deactivation time const. after a brief (5-8 ms) application of a maximally effective concn. of agonists was 319 Â± 34 ms.  The majority of the patches also showed a modest level of desensitization that could be described by either a single or a double exponential time course with the fastest time const. between 15 and 47 ms.  Conceptual models of activation were fitted using the max. interval likelihood (MIL) method to the sequence of open and closed durations recorded from outside-out patches that contained one active NR1/NR2C channel.  NR1/NR2C receptor properties including modest desensitization and low open probability could be described by gating schemes similar to those previously proposed for other NMDA receptor subunit combinations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjw6raHUAlArVg90H21EOLACvtfcHk0lgNu6-g6yzixA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1SnsL3L&md5=e525f3cdd1c15c04d901ef0ef900b262</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2008.158634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2008.158634%26sid%3Dliteratum%253Aachs%26aulast%3DDravid%26aufirst%3DS.%2BM.%26aulast%3DPrakash%26aufirst%3DA.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DActivation%2520of%2520recombinant%2520NR1%252FNR2C%2520NMDA%2520receptors%26jtitle%3DJ.%2520Physiol.%26date%3D2008%26volume%3D586%26spage%3D4425%26epage%3D4439%26doi%3D10.1113%2Fjphysiol.2008.158634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, D. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beheâ², P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colquhoun, D.</span></span> <span> </span><span class="NLM_article-title">Single-channel activations and concentration jumps: comparison of recombinant NR1a/NR2A and NR1a/NR2D NMDA receptors</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>510</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">18</span>, <span class="refDoi">Â DOI: 10.1111/j.1469-7793.1998.001bz.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1111%2Fj.1469-7793.1998.001bz.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=9625862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaK1cXkvVKksro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=510&publication_year=1998&pages=1-18&author=D.+J.+A.+Wyllieauthor=P.+Behe%E2%80%B2author=D.+Colquhoun&title=Single-channel+activations+and+concentration+jumps%3A+comparison+of+recombinant+NR1a%2FNR2A+and+NR1a%2FNR2D+NMDA+receptors&doi=10.1111%2Fj.1469-7793.1998.001bz.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Single-channel activations and concentration jumps: comparison of recombinant NR1a/NR2A and NR1a/NR2D NMDA receptors</span></div><div class="casAuthors">Wyllie, David J. A.; Behe, Philippe; Colquhoun, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">510</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-18</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">The authors have expressed recombinant NR1a/NR2A and NR1a/NR2D N-methyl-D-aspartate (NMDA) receptor channels in Xenopus oocytes and made recordings of single-channel and macroscopic currents in outside-out membrane patches.  For each receptor type the authors measured (a) the individual single-channel activations evoked by low glutamate concns. in steady-state recordings, and (b) the macroscopic responses elicited by brief concn. jumps with high agonist concns., and the authors explore the relationship between these two sorts of observation.  Low concn. (5-100 nM) steady-state recordings of NR1a/NR2A and NR1a/NR2D single-channel activity generated shut-time distributions that were best fitted with a mixt. of five and six exponential components, resp.  Individual activations of either receptor type were resolved as bursts of openings, which the authors refer to as "super-clusters".  During a single activation, NR1a/NR2A receptors were open for 36% of the time, but NR1a/NR2D receptors were open for only 4% of the time.  For both, distributions of super-cluster durations were best fitted with a mixt. of six exponential components.  Their overall mean durations were 35.8 and 1602 ms, resp.  Steady-state super-clusters were aligned on their first openings and averaged.  The av. was well fitted by a sum of exponentials with time consts. taken from fits to super-cluster length distributions.  It is shown that this is what would be expected for a channel that shows simple Markovian behavior.  The current through NR1a/NR2A channels following a concn. jump from zero to 1 mM glutamate for 1 ms was well fitted by three exponential components with time consts. of 13 ms (rising phase), 70 ms and 350 ms (decaying phase).  Similar concn. jumps on NR1a/NR2D channels were well fitted by two exponentials with means of 45 ms (rising phase) and 4408 ms (decaying phase) components.  During prolonged exposure to glutamate, NR1a/NR2A channels desensitized with a time const. of 649 ms, while NR1a/NR2D channels exhibited no apparent desensitization.  The authors show that under certain conditions, the time consts. for the macroscopic jump response should be the same as those for the distribution of super-cluster lengths, though the resoln. of the latter is so much greater that it cannot be expected that all the components will be resolvable in a macroscopic current.  Good agreement was found for jumps on NR1a/NR2D receptors, and for some jump expts. on NR1a/NR2A.  However, the latter were rather variable and some were slower than predicted.  Slow decays were assocd. with patches that had large currents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp06u6poN-ph7Vg90H21EOLACvtfcHk0lgNu6-g6yzixA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvVKksro%253D&md5=7dbdff84304f43105499b0db7816641f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1469-7793.1998.001bz.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1469-7793.1998.001bz.x%26sid%3Dliteratum%253Aachs%26aulast%3DWyllie%26aufirst%3DD.%2BJ.%2BA.%26aulast%3DBehe%25E2%2580%25B2%26aufirst%3DP.%26aulast%3DColquhoun%26aufirst%3DD.%26atitle%3DSingle-channel%2520activations%2520and%2520concentration%2520jumps%253A%2520comparison%2520of%2520recombinant%2520NR1a%252FNR2A%2520and%2520NR1a%252FNR2D%2520NMDA%2520receptors%26jtitle%3DJ.%2520Physiol.%26date%3D1998%26volume%3D510%26spage%3D1%26epage%3D18%26doi%3D10.1111%2Fj.1469-7793.1998.001bz.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vance, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">GluN1 splice variant control of GluN1/GluN2D NMDA receptors</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>590</i></span>,  <span class="NLM_fpage">3857</span>â <span class="NLM_lpage">3875</span>, <span class="refDoi">Â DOI: 10.1113/jphysiol.2012.234062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1113%2Fjphysiol.2012.234062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=22641781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlOjsr%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=590&publication_year=2012&pages=3857-3875&author=K.+M.+Vanceauthor=K.+B.+Hansenauthor=S.+F.+Traynelis&title=GluN1+splice+variant+control+of+GluN1%2FGluN2D+NMDA+receptors&doi=10.1113%2Fjphysiol.2012.234062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">GluN1 splice variant control of GluN1/GluN2D NMDA receptors</span></div><div class="casAuthors">Vance, Katie M.; Hansen, Kasper B.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">590</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3857-3875</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">NMDA receptors are ionotropic glutamate receptors that mediate a slow, Ca2+-permeable component of excitatory synaptic transmission in the central nervous system.  Recombinant GluN1-1a/GluN2D receptors are characterized by low channel open probability and prolonged deactivation time course following the removal of agonist.  The deactivation time course, agonist potency, and single channel properties of GluN2D-contg. NMDA receptors are modulated by alternative RNA splicing of GluN1.  The authors' results demonstrate that GluN1 exon 5, which encodes a 21-amino-acid insert in the N-terminal domain, is a key determinant of GluN1/GluN2D receptor function.  GluN1-1b/GluN2D receptors, which contain the residues encoded by exon 5, deactivate with a dual exponential time course described by a ÏFAST of 410 ms and a ÏSLOW of 1100 ms.  This time course is 3-fold more rapid than that for exon 5-lacking GluN1-1a/GluN2D, which deactivates with a ÏFAST of 1100 ms and a ÏSLOW of 3400 ms.  Exon 5-contg. NMDA receptors also have a two-fold higher open probability (0.037) than exon 5-lacking receptors (0.017).  Furthermore, inclusion of exon 5-encoded residues within the GluN1-1b subunit decreases the potency for the endogenous agonist L-glutamate.  Evaluation of receptor kinetics for NMDA receptors contg. mutated GluN1-1b subunits and wild-type GluN2D identified residue Lys 211 in GluN1-1b as a key determinant of exon 5 control of the deactivation time course and glutamate potency.  Evaluation of a kinetic model of GluN1/GluN2D gating suggests that residues encoded by exon 5 influence several rate-limiting steps.  These data demonstrate that the GluN1 subunit is a key determinant of the kinetic and pharmacol. properties of GluN2D-contg. NMDA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmbUqORgSwVbVg90H21EOLACvtfcHk0lgNu6-g6yzixA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlOjsr%252FL&md5=97b96e89a03b1bdc15afd50d9790b354</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2012.234062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2012.234062%26sid%3Dliteratum%253Aachs%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DGluN1%2520splice%2520variant%2520control%2520of%2520GluN1%252FGluN2D%2520NMDA%2520receptors%26jtitle%3DJ.%2520Physiol.%26date%3D2012%26volume%3D590%26spage%3D3857%26epage%3D3875%26doi%3D10.1113%2Fjphysiol.2012.234062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erreger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geballe, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyuboslavsky, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micale, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">JÃ¸rgensen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, D. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">907</span>â <span class="NLM_lpage">920</span>, <span class="refDoi">Â DOI: 10.1124/mol.107.037333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1124%2Fmol.107.037333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=17622578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFaiu7%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=907-920&author=K.+Erregerauthor=M.+T.+Geballeauthor=A.+Kristensenauthor=P.+E.+Chenauthor=K.+B.+Hansenauthor=C.+J.+Leeauthor=H.+Yuanauthor=P.+Leauthor=P.+N.+Lyuboslavskyauthor=N.+Micaleauthor=L.+J%C3%B8rgensenauthor=R.+P.+Clausenauthor=D.+J.+A.+Wyllieauthor=J.+P.+Snyderauthor=S.+F.+Traynelis&title=Subunit-specific+agonist+activity+at+NR2A-%2C+NR2B-%2C+NR2C-%2C+and+NR2D-containing+N-methyl-D-aspartate+glutamate+receptors&doi=10.1124%2Fmol.107.037333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors</span></div><div class="casAuthors">Erreger, Kevin; Geballe, Matthew T.; Kristensen, Anders; Chen, Philip E.; Hansen, Kasper B.; Lee, C. Justin; Yuan, Hongjie; Le, Phuong; Lyuboslavsky, Polina N.; Micale, Nicola; Jorgensen, Lars; Clausen, Rasmus P.; Wyllie, David J. A.; Snyder, James P.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">907-920</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The four N-methyl-D-aspartate (NMDA) receptor NR2 subunits (NR2A-D) have different developmental, anatomical, and functional profiles that allow them to serve different roles in normal and neuropathol. situations.  Identification of subunit-selective NMDA receptor agonists, antagonists, or modulators could prove to be both valuable pharmacol. tools as well as potential new therapeutic agents.  We evaluated the potency and efficacy of a wide range of glutamate-like compds. at NR1/NR2A, NR1/NR2B, NR1/NR2C, and NR1/NR2D receptors.  Twenty-five of 53 compds. examd. exhibited agonist activity at the glutamate binding site of NMDA receptors.  Concn.-response relationships were detd. for these agonists at each NR2 subunit.  We find consistently higher potency at the NR2D subunit for a wide range of dissimilar structures, with (2S,4R)-4-methylglutamate (SYM2081) showing the greatest differential potency between NR2A- and NR2D-contg. receptors (46-fold).  Anal. of chimeric NR2A/D receptors suggests that enhanced agonist potency for NR2D is controlled by residues in both of the domains (Domain1 and Domain2) that compose the bilobed agonist binding domain.  Mol. dynamics (MD) simulations comparing a crystallog.-based hydrated NR1/NR2A model with a homol.-based NR1/NR2D hydrated model of the agonist binding domains suggest that glutamate exhibits a different binding mode in NR2D compared with NR2A that accommodates a 4-Me substitution in SYM2081.  Mutagenesis of functionally divergent residues supports the conclusions drawn based on the modeling studies.  Despite high homol. and conserved at. contact residues within the agonist binding pocket of NR2A and NR2D, glutamate adopts a different binding orientation that could be exploited for the development of subunit selective agonists and competitive antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9aAIDNF01_rVg90H21EOLACvtfcHk0lgPRGWTdZIhng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFaiu7%252FI&md5=3c3c6f17e71604dbdf14d8e600d12886</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fmol.107.037333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.107.037333%26sid%3Dliteratum%253Aachs%26aulast%3DErreger%26aufirst%3DK.%26aulast%3DGeballe%26aufirst%3DM.%2BT.%26aulast%3DKristensen%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DP.%2BE.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DLee%26aufirst%3DC.%2BJ.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DLyuboslavsky%26aufirst%3DP.%2BN.%26aulast%3DMicale%26aufirst%3DN.%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DL.%26aulast%3DClausen%26aufirst%3DR.%2BP.%26aulast%3DWyllie%26aufirst%3DD.%2BJ.%2BA.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DSubunit-specific%2520agonist%2520activity%2520at%2520NR2A-%252C%2520NR2B-%252C%2520NR2C-%252C%2520and%2520NR2D-containing%2520N-methyl-D-aspartate%2520glutamate%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D72%26spage%3D907%26epage%3D920%26doi%3D10.1124%2Fmol.107.037333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vicini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grayson, D. R.</span></span> <span> </span><span class="NLM_article-title">Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors</span>. <i>J. Neurophysiol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">555</span>â <span class="NLM_lpage">566</span>, <span class="refDoi">Â DOI: 10.1152/jn.1998.79.2.555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1152%2Fjn.1998.79.2.555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=9463421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaK1cXhsVGrurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1998&pages=555-566&author=S.+Viciniauthor=J.+F.+Wangauthor=J.+H.+Liauthor=W.+J.+Zhuauthor=Y.+H.+Wangauthor=J.+H.+Luoauthor=B.+B.+Wolfeauthor=D.+R.+Grayson&title=Functional+and+pharmacological+differences+between+recombinant+N-methyl-D-aspartate+receptors&doi=10.1152%2Fjn.1998.79.2.555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors</span></div><div class="casAuthors">Vicini, Stefano; Wang, Jian Feng; Li, Jin Hong; Zhu, Wei Jian; Wang, Yue Hua; Luo, Jian Hong; Wolfe, Barry B.; Grayson, Dennis R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurophysiology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">555-566</span>CODEN:
                <span class="NLM_cas:coden">JONEA4</span>;
        ISSN:<span class="NLM_cas:issn">0022-3077</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">N-methyl-D-aspartic acid (NMDA) receptors transiently transfected into mammalian HEK-293 cells were characterized with subunit-specific antibodies and electrophysiol. recordings.  Deactivation time course recorded in response to fast L-glutamate pulses were studied in isolated and lifted cells, as well as in outside-out membrane patches excised from cells expressing recombinant NR1 subunits in combination with the NR2A, NR2B, NR2C, or NR2D NMDA receptor subunits.  Transfected cells were preidentified by the fluorescence emitted from the coexpressed Aequorea victoria jellyfish Green Lantern protein.  Currents generated by NR1/NR2A channels displayed double exponential deactivation time course being faster than that in NR1/NR2B or NR1/NR2C channels.  However, a large decay variability was obsd. within each cotransfection, suggesting that mechanisms addnl. to subunit compn. may also regulate deactivation time course.  NR1/NR2D channels displayed slowly deactivating currents.  Channel deactivation was fast and comparable among receptors obtained by cotransfecting five distinct spliced variants of the NR1 subunit, each with the NR2A subunit.  Addnl., recovery from desensitization was slower for NR1/NR2B than for NR1/NR2A channels.  The av. deactivation time course of responses to brief L-glutamate applications in cells where NR1/NR2A/NR2B cDNAs were cotransfected at variable ratio was intermediate between those of the NR1/NR2A and NR1/NR2B channels.  Although immunocytochem. evidence indicates that the majority of cells are cotransfected by all plasmids in triple transfection, our exptl. condition did not allow for a tight control of the expression of NMDA receptor subunits.  This produced the result that many cells were characterized by deactivation time course and haloperidol sensitivities of sep. NR1/NR2A and NR1/NR2B subunit heteromers.  We also speculate on the possible formation of channels resulting from the coassembly in the same receptor of NR1/NR2A/NR2B subunits from a minority of cells that gave responses to brief application of L-glutamate characterized by slow deactivation time course and decreased haloperidol sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdVejBBO3a_bVg90H21EOLACvtfcHk0lgPRGWTdZIhng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsVGrurw%253D&md5=f9970aa9cc3d0d479691aabbfe9242dc</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1152%2Fjn.1998.79.2.555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fjn.1998.79.2.555%26sid%3Dliteratum%253Aachs%26aulast%3DVicini%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%2BF.%26aulast%3DLi%26aufirst%3DJ.%2BH.%26aulast%3DZhu%26aufirst%3DW.%2BJ.%26aulast%3DWang%26aufirst%3DY.%2BH.%26aulast%3DLuo%26aufirst%3DJ.%2BH.%26aulast%3DWolfe%26aufirst%3DB.%2BB.%26aulast%3DGrayson%26aufirst%3DD.%2BR.%26atitle%3DFunctional%2520and%2520pharmacological%2520differences%2520between%2520recombinant%2520N-methyl-D-aspartate%2520receptors%26jtitle%3DJ.%2520Neurophysiol.%26date%3D1998%26volume%3D79%26spage%3D555%26epage%3D566%26doi%3D10.1152%2Fjn.1998.79.2.555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibb, A. J.</span></span> <span> </span><span class="NLM_article-title">Functional NR2B- and NR2D-containing NMDA receptor channels in rat substantia nigra dopaminergic neurones</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>569</i></span>,  <span class="NLM_fpage">209</span>â <span class="NLM_lpage">221</span>, <span class="refDoi">Â DOI: 10.1113/jphysiol.2005.095554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1113%2Fjphysiol.2005.095554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=16141268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSmsrvN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=569&publication_year=2005&pages=209-221&author=S.+Jonesauthor=A.+J.+Gibb&title=Functional+NR2B-+and+NR2D-containing+NMDA+receptor+channels+in+rat+substantia+nigra+dopaminergic+neurones&doi=10.1113%2Fjphysiol.2005.095554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Functional NR2B- and NR2D-containing NMDA receptor channels in rat substantia nigra dopaminergic neurones</span></div><div class="casAuthors">Jones, Susan; Gibb, Alasdair J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">569</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">209-221</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">NMDA receptors regulate burst firing of dopaminergic neurons in the substantia nigra pars compacta (SNc) and may contribute to excitotoxic cell death in Parkinson's disease (PD).  To investigate the subunit compn. of functional NMDA receptors in identified rat SNc dopaminergic neurons, the authors have analyzed the properties of individual NMDA receptor channels in outside-out patches.  NMDA (100 nM) activated channels corresponding to four chord conductances of 18, 30, 41 and 54 pS.  Direct transitions were obsd. between all conductance levels.  Between 18 pS and 41 pS conductance levels, direct transitions were asym., consistent with the presence of NR2D-contg. NMDA receptors.  Channel activity in response to 100 nM or 200 Î¼M NMDA was not affected by zinc or TPEN (N,N,N',N'-tetrakis-[2-pyridylmethyl]-ethylenediamine), indicating that SNc dopaminergic neurons do not contain functional NR2A subunits.  The effect of the NR2B antagonist ifenprodil was complex: 1 Î¼M ifenprodil reduced open probability, while 10 Î¼M reduced channel open time but had no effect on open probability of channels activated by 100 nM NMDA.  When the concn. of NMDA was increased to 200 Î¼M, ifenprodil (10 Î¼M) produced the expected redn. in open probability.  These results indicate that NR2B subunits are present in SNc dopaminergic neurons.  Taken together, these findings indicate that NR2D and NR2B subunits form functional NMDA receptor channels in SNc dopaminergic neurons, and suggest that they may form a triheteromeric NMDA receptor composed of NR1/NR2B/NR2D subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOstcK8ZoIE7Vg90H21EOLACvtfcHk0lgPRGWTdZIhng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSmsrvN&md5=35ec389abfbc8740f11fbdcbc356ed88</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2005.095554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2005.095554%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DS.%26aulast%3DGibb%26aufirst%3DA.%2BJ.%26atitle%3DFunctional%2520NR2B-%2520and%2520NR2D-containing%2520NMDA%2520receptor%2520channels%2520in%2520rat%2520substantia%2520nigra%2520dopaminergic%2520neurones%26jtitle%3DJ.%2520Physiol.%26date%3D2005%26volume%3D569%26spage%3D209%26epage%3D221%26doi%3D10.1113%2Fjphysiol.2005.095554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geballe, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erreger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livesey, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâToole, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, D. J.</span></span> <span> </span><span class="NLM_article-title">Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>586</i></span>,  <span class="NLM_fpage">227</span>â <span class="NLM_lpage">245</span>, <span class="refDoi">Â DOI: 10.1113/jphysiol.2007.143172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1113%2Fjphysiol.2007.143172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=17962328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFaqu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=586&publication_year=2008&pages=227-245&author=P.+E.+Chenauthor=M.+T.+Geballeauthor=E.+Katzauthor=K.+Erregerauthor=M.+R.+Liveseyauthor=K.+K.+O%E2%80%99Tooleauthor=P.+Leauthor=C.+J.+Leeauthor=J.+P.+Snyderauthor=S.+F.+Traynelisauthor=D.+J.+Wyllie&title=Modulation+of+glycine+potency+in+rat+recombinant+NMDA+receptors+containing+chimeric+NR2A%2F2D+subunits+expressed+in+Xenopus+laevis+oocytes&doi=10.1113%2Fjphysiol.2007.143172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes</span></div><div class="casAuthors">Chen, Philip E.; Geballe, Matthew T.; Katz, Elyse; Erreger, Kevin; Livesey, Matthew R.; O'Toole, Kate K.; Le, Phuong; Lee, C. Justin; Snyder, James P.; Traynelis, Stephen F.; Wyllie, David J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">586</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">227-245</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Heteromeric NMDARs are composed of coagonist glycine-binding NR1 subunits and glutamate-binding NR2 subunits.  The majority of functional NMDARs in the mammalian central nervous system (CNS) contain two NR1 subunits and two NR2 subunits of which there are four types (A-D).  The authors show that the potency of a variety of endogenous and synthetic glycine-site coagonists varies between recombinant NMDARs such that the highest potency is seen at NR2D-contg. and the lowest at NR2A-contg. NMDARs.  This heterogeneity is specified by the particular NR2 subunit within the NMDAR complex since the glycine-binding NR1 subunit is common to all NMDARs investigated.  To identify the mol. determinants responsible for this heterogeneity, the authors generated chimeric NR2A/2D subunits where they exchanged the S1 and S2 regions that form the ligand-binding domains and coexpressed these with NR1 subunits in Xenopus laevis oocytes.  Glycine concn.-response curves for NMDARs contg. NR2A subunits including the NR2D S1 region gave mean glycine EC50 values similar to NR2A(WT)-contg. NMDARs.  However, receptors contg. NR2A subunits including the NR2D S2 region or both NR2D S1 and S2 regions gave glycine potencies similar to those seen in NR2D(WT)-contg. NMDARs.  In particular, two residues in the S2 region of the NR2A subunit (Lys 719 and Tyr 735) when mutated to the corresponding residues found in the NR2D subunit influence glycine potency.  The authors conclude that the variation in glycine potency is caused by interactions between the NR1 and NR2 ligand-binding domains that occur following agonist binding and which may be involved in the initial conformation changes that det. channel gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcTrVbGodj6LVg90H21EOLACvtfcHk0lj3ffdM0Uh05Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFaqu7o%253D&md5=ea684497e12cfe93ab0a0d108d7a887f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2007.143172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2007.143172%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%2BE.%26aulast%3DGeballe%26aufirst%3DM.%2BT.%26aulast%3DKatz%26aufirst%3DE.%26aulast%3DErreger%26aufirst%3DK.%26aulast%3DLivesey%26aufirst%3DM.%2BR.%26aulast%3DO%25E2%2580%2599Toole%26aufirst%3DK.%2BK.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DC.%2BJ.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DWyllie%26aufirst%3DD.%2BJ.%26atitle%3DModulation%2520of%2520glycine%2520potency%2520in%2520rat%2520recombinant%2520NMDA%2520receptors%2520containing%2520chimeric%2520NR2A%252F2D%2520subunits%2520expressed%2520in%2520Xenopus%2520laevis%2520oocytes%26jtitle%3DJ.%2520Physiol.%26date%3D2008%26volume%3D586%26spage%3D227%26epage%3D245%26doi%3D10.1113%2Fjphysiol.2007.143172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banke, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">Activation of NR1/NR2B NMDA receptors</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">144</span>â <span class="NLM_lpage">152</span>, <span class="refDoi">Â DOI: 10.1038/nn1000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2Fnn1000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=12524545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFGgtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2003&pages=144-152&author=T.+G.+Bankeauthor=S.+F.+Traynelis&title=Activation+of+NR1%2FNR2B+NMDA+receptors&doi=10.1038%2Fnn1000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of NR1/NR2B NMDA receptors</span></div><div class="casAuthors">Banke, Tue G.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144-152</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate (NMDA) receptors are highly expressed in the central nervous system and are involved in excitatory synaptic transmission as well as synaptic plasticity.  Despite considerable structural and biophys. research, the mechanism behind activation of the NMDA receptor is still poorly understood.  By analyzing patch clamp recordings of one channel activated by glutamate, the authors detd. the burst structure and open probability for recombinant rat NR1/NR2B receptors.  The authors used partial agonists at the glutamate and glycine binding sites to show that at least two kinetically distinct subunit-assocd. conformational changes link co-agonist binding to the opening of the NMDA receptor pore.  These data suggest that NR1 and NR2B subunits, resp., undergo a fast and slow agonist-dependent conformational change that precedes opening of the pore.  The authors propose a new working model of receptor activation that can account for macroscopic as well as microscopic NMDA receptor properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwRF4DBX3gr7Vg90H21EOLACvtfcHk0lj3ffdM0Uh05Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFGgtA%253D%253D&md5=da0f4d8bac701450e59abc590420e968</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnn1000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn1000%26sid%3Dliteratum%253Aachs%26aulast%3DBanke%26aufirst%3DT.%2BG.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DActivation%2520of%2520NR1%252FNR2B%2520NMDA%2520receptors%26jtitle%3DNat.%2520Neurosci.%26date%3D2003%26volume%3D6%26spage%3D144%26epage%3D152%26doi%3D10.1038%2Fnn1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegler
Retchless, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. W.</span></span> <span> </span><span class="NLM_article-title">A single GluN2 subunit residue controls NMDA receptor channel properties via intersubunit interaction</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">406</span>â <span class="NLM_lpage">413</span>, <span class="refDoi">Â DOI: 10.1038/nn.3025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2Fnn.3025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=22246434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BC383lvVGjtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=406-413&author=B.+Siegler%0ARetchlessauthor=W.+Gaoauthor=J.+W.+Johnson&title=A+single+GluN2+subunit+residue+controls+NMDA+receptor+channel+properties+via+intersubunit+interaction&doi=10.1038%2Fnn.3025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A single GluN2 subunit residue controls NMDA receptor channel properties via intersubunit interaction</span></div><div class="casAuthors">Siegler Retchless Beth; Gao Wei; Johnson Jon W</div><div class="citationInfo"><span class="NLM_cas:title">Nature neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">406-13, S1-2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">NMDA receptors (NMDARs) are glutamate-gated ion channels that are present at most excitatory mammalian synapses.  The four GluN2 subunits (GluN2A-D) contribute to four diheteromeric NMDAR subtypes that have divergent physiological and pathological roles.  Channel properties that are fundamental to NMDAR function vary among subtypes.  We investigated the amino acid residues responsible for variations in channel properties by creating and examining NMDARs containing mutant GluN2 subunits.  We found that the NMDAR subtype specificity of three crucial channel properties, Mg(2+) block, selective permeability to Ca(2+) and single-channel conductance, were all controlled primarily by the residue at a single GluN2 site in the M3 transmembrane region.  Mutant cycle analysis guided by molecular modeling revealed that a GluN2-GluN1 subunit interaction mediates the site's effects.  We conclude that a single GluN2 subunit residue couples with the pore-forming loop of the GluN1 subunit to create naturally occurring variations in NMDAR properties that are critical to synaptic plasticity and learning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQhudDPeKwJomLFM_lbR1VmfW6udTcc2eY6T1DVhd3tZLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383lvVGjtQ%253D%253D&md5=d146405b6871e50ad4b9d481e1e0c239</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnn.3025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3025%26sid%3Dliteratum%253Aachs%26aulast%3DSiegler%2BRetchless%26aufirst%3DB.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DJohnson%26aufirst%3DJ.%2BW.%26atitle%3DA%2520single%2520GluN2%2520subunit%2520residue%2520controls%2520NMDA%2520receptor%2520channel%2520properties%2520via%2520intersubunit%2520interaction%26jtitle%3DNat.%2520Neurosci.%26date%3D2012%26volume%3D15%26spage%3D406%26epage%3D413%26doi%3D10.1038%2Fnn.3025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paoletti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiang, Z.</span></span> <span> </span><span class="NLM_article-title">NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">383</span>â <span class="NLM_lpage">400</span>, <span class="refDoi">Â DOI: 10.1038/nrn3504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2Fnrn3504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=23686171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVSit7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=383-400&author=P.+Paolettiauthor=C.+Belloneauthor=Z.+Qiang&title=NMDA+receptor+subunit+diversity%3A+impact+on+receptor+properties%2C+synaptic+plasticity+and+disease&doi=10.1038%2Fnrn3504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease</span></div><div class="casAuthors">Paoletti, Pierre; Bellone, Camilla; Zhou, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">383-400</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  NMDA receptors (NMDARs) are glutamate-gated ion channels and are crucial for neuronal communication.  NMDARs form tetrameric complexes that consist of several homologous subunits.  The subunit compn. of NMDARs is plastic, resulting in a large no. of receptor subtypes.  As each receptor subtype has distinct biophys., pharmacol. and signaling properties, there is great interest in detg. whether individual subtypes carry out specific functions in the CNS in both normal and pathol. conditions.  Here, we review the effects of subunit compn. on NMDAR properties, synaptic plasticity and cellular mechanisms implicated in neuropsychiatric disorders.  Understanding the rules and roles of NMDAR diversity could provide new therapeutic strategies against dysfunctions of glutamatergic transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqubMsb4ZP2U7Vg90H21EOLACvtfcHk0linLWE4u9W6-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVSit7Y%253D&md5=f69790da360242d491bf1a5eb146613d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnrn3504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3504%26sid%3Dliteratum%253Aachs%26aulast%3DPaoletti%26aufirst%3DP.%26aulast%3DBellone%26aufirst%3DC.%26aulast%3DQiang%26aufirst%3DZ.%26atitle%3DNMDA%2520receptor%2520subunit%2520diversity%253A%2520impact%2520on%2520receptor%2520properties%252C%2520synaptic%2520plasticity%2520and%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D383%26epage%3D400%26doi%3D10.1038%2Fnrn3504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipton, S. A.</span></span> <span> </span><span class="NLM_article-title">Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults</span>. <i>NeuroRx</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">101</span>â <span class="NLM_lpage">110</span>, <span class="refDoi">Â DOI: 10.1602/neurorx.1.1.101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1602%2Fneurorx.1.1.101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=15717010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BD2MzntVamsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=101-110&author=S.+A.+Lipton&title=Failures+and+successes+of+NMDA+receptor+antagonists%3A+molecular+basis+for+the+use+of+open-channel+blockers+like+memantine+in+the+treatment+of+acute+and+chronic+neurologic+insults&doi=10.1602%2Fneurorx.1.1.101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults</span></div><div class="casAuthors">Lipton Stuart A</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-10</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Excitotoxicity, defined as excessive exposure to the neurotransmitter glutamate or overstimulation of its membrane receptors, has been implicated as one of the key factors contributing to neuronal injury and death in a wide range of both acute and chronic neurologic disorders.  Excitotoxic cell death is due, at least in part, to excessive activation of N-methyl-D-aspartate (NMDA)-type glutamate receptors and hence excessive Ca2+ influx through the receptor's associated ion channel.  Physiological NMDA receptor activity, however, is also essential for normal neuronal function; potential neuroprotective agents that block virtually all NMDA receptor activity will very likely have unacceptable clinical side effects.  For this reason many NMDA receptor antagonists have disappointingly failed advanced clinical trials for a number of diseases including stroke and neurodegenerative disorders such as Huntington's disease.  In contrast, studies in my laboratory were the first to show that memantine, an adamantane derivative, preferentially blocks excessive NMDA receptor activity without disrupting normal activity.  Memantine does this through its action as an open-channel blocker; it enters the receptor-associated ion channel preferentially when it is excessively open, and, most importantly, its off-rate is relatively fast so that it does not substantially accumulate in the channel to interfere with normal synaptic transmission.  Past clinical use for other indications has demonstrated that memantine is well tolerated, and it has recently been approved in both Europe and the USA for the treatment of dementia of the Alzheimer's type.  Clinical studies of the safety and efficacy of memantine for other neurological disorders, including glaucoma and other forms of dementia, are currently underway.  A series of second-generation memantine derivatives are currently in development and may prove to have even greater neuroprotective properties than does memantine.  These second-generation drugs take advantage of the fact that the NMDA receptor has other modulatory sites, in addition to its ion channel, that could potentially be used for safe but effective clinical intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8zmuJRBq_D4JKJbLTgsvCfW6udTcc2ebrVsyiP1ZRvrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzntVamsQ%253D%253D&md5=8b298d6d2296816681a880ae371ca027</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.1.1.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.1.1.101%26sid%3Dliteratum%253Aachs%26aulast%3DLipton%26aufirst%3DS.%2BA.%26atitle%3DFailures%2520and%2520successes%2520of%2520NMDA%2520receptor%2520antagonists%253A%2520molecular%2520basis%2520for%2520the%2520use%2520of%2520open-channel%2520blockers%2520like%2520memantine%2520in%2520the%2520treatment%2520of%2520acute%2520and%2520chronic%2520neurologic%2520insults%26jtitle%3DNeuroRx%26date%3D2004%26volume%3D1%26spage%3D101%26epage%3D110%26doi%3D10.1602%2Fneurorx.1.1.101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moghaddam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitt, D.</span></span> <span> </span><span class="NLM_article-title">From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">4</span>â <span class="NLM_lpage">15</span>, <span class="refDoi">Â DOI: 10.1038/npp.2011.181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2Fnpp.2011.181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=21956446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ejs77N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=4-15&author=B.+Moghaddamauthor=D.+Javitt&title=From+revolution+to+evolution%3A+the+glutamate+hypothesis+of+schizophrenia+and+its+implication+for+treatment&doi=10.1038%2Fnpp.2011.181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment</span></div><div class="casAuthors">Moghaddam, Bita; Javitt, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-15</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Glutamate is the primary excitatory neurotransmitter in mammalian brain.  Disturbances in glutamate-mediated neurotransmission have been increasingly documented in a range of neuropsychiatric disorders including schizophrenia, substance abuse, mood disorders, Alzheimer's disease, and autism-spectrum disorders.  Glutamatergic theories of schizophrenia are based on the ability of N-methyl--aspartate receptor (NMDAR) antagonists to induce schizophrenia-like symptoms, as well as emergent literature documenting disturbances of NMDAR-related gene expression and metabolic pathways in schizophrenia.  Research over the past two decades has highlighted promising new targets for drug development based on potential pre- and postsynaptic, and glial mechanisms leading to NMDAR dysfunction.  Reduced NMDAR activity on inhibitory neurons leads to disinhibition of glutamate neurons increasing synaptic activity of glutamate, esp. in the prefrontal cortex.  Based on this mechanism, normalizing excess glutamate levels by metabotropic glutamate group 2/3 receptor agonists has led to potential identification of the first non-monoaminergic target with comparable efficacy as conventional antipsychotic drugs for treating pos. and neg. symptoms of schizophrenia.  In addn., NMDAR has intrinsic modulatory sites that are active targets for drug development, several of which show promise in preclin./early clin. trials targeting both symptoms and cognition.  To date, most studies have been done with orthosteric agonists and/or antagonists at specific sites.  However, allosteric modulators, both pos. and neg., may offer superior efficacy with less danger of downregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeNMlez-A7MbVg90H21EOLACvtfcHk0linLWE4u9W6-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ejs77N&md5=0bf82fc0e3cb5c3ad2bed91414672e6f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2011.181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2011.181%26sid%3Dliteratum%253Aachs%26aulast%3DMoghaddam%26aufirst%3DB.%26aulast%3DJavitt%26aufirst%3DD.%26atitle%3DFrom%2520revolution%2520to%2520evolution%253A%2520the%2520glutamate%2520hypothesis%2520of%2520schizophrenia%2520and%2520its%2520implication%2520for%2520treatment%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D4%26epage%3D15%26doi%3D10.1038%2Fnpp.2011.181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goff, D.</span></span> <span> </span><span class="NLM_article-title">Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>1003</i></span>,  <span class="NLM_fpage">318</span>â <span class="NLM_lpage">327</span>, <span class="refDoi">Â DOI: 10.1196/annals.1300.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1196%2Fannals.1300.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=14684455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlGqtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1003&publication_year=2003&pages=318-327&author=J.+T.+Coyleauthor=G.+Tsaiauthor=D.+Goff&title=Converging+evidence+of+NMDA+receptor+hypofunction+in+the+pathophysiology+of+schizophrenia&doi=10.1196%2Fannals.1300.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia</span></div><div class="casAuthors">Coyle, Joseph T.; Tsai, Guochuan; Goff, Donald</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1003</span>
        (<span class="NLM_cas:issue">Glutamate and Disorders of Cognition and Motivation</span>),
    <span class="NLM_cas:pages">318-327</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">New York Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  Numerous clin. studies demonstrate that subanesthetic doses of dissociative anesthetics, which are noncompetitive antagonists at the NMDA receptor, replicate in normal subjects the cognitive impairments, neg. symptoms, and brain functional abnormalities of schizophrenia.  Postmortem and genetic studies have identified several abnormalities assocd. with schizophrenia that would interfere with the activation of the glycine modulatory site on the NMDA receptor.  Placebo-controlled clin. trials with agents that directly or indirectly activate the glycine modulatory site consistently reduce neg. symptoms and frequently improve cognition in patients with chronic schizophrenia who are receiving concurrent typical antipsychotics.  Thus, there is convincing evidence that hypofunction of a subset of NMDA receptors may contribute to the symptomatic features of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfQixZ_xxPHLVg90H21EOLACvtfcHk0lj1D5EV1u6IAA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlGqtQ%253D%253D&md5=0688464460facbf01a7b2ecd701bc87d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1196%2Fannals.1300.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1300.020%26sid%3Dliteratum%253Aachs%26aulast%3DCoyle%26aufirst%3DJ.%2BT.%26aulast%3DTsai%26aufirst%3DG.%26aulast%3DGoff%26aufirst%3DD.%26atitle%3DConverging%2520evidence%2520of%2520NMDA%2520receptor%2520hypofunction%2520in%2520the%2520pathophysiology%2520of%2520schizophrenia%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2003%26volume%3D1003%26spage%3D318%26epage%3D327%26doi%3D10.1196%2Fannals.1300.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Burgos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, D. A.</span></span> <span> </span><span class="NLM_article-title">NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia</span>. <i>Schizophr. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">950</span>â <span class="NLM_lpage">957</span>, <span class="refDoi">Â DOI: 10.1093/schbul/sbs010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1093%2Fschbul%2Fsbs010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=22355184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BC38vjvVKrsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2012&pages=950-957&author=G.+Gonzalez-Burgosauthor=D.+A.+Lewis&title=NMDA+receptor+hypofunction%2C+parvalbumin-positive+neurons%2C+and+cortical+gamma+oscillations+in+schizophrenia&doi=10.1093%2Fschbul%2Fsbs010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia</span></div><div class="casAuthors">Gonzalez-Burgos Guillermo; Lewis David A</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia bulletin</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">950-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Gamma oscillations appear to be dependent on inhibitory neurotransmission from parvalbumin (PV)-containing gamma-amino butyric acid neurons.  Thus, the abnormalities in PV neurons found in schizophrenia may underlie the deficits of gamma-band synchrony in the illness.  Because gamma-band synchrony is thought to be crucial for cognition, cognitive deficits in schizophrenia may reflect PV neuron dysfunction in cortical neural circuits.  Interestingly, it has been suggested that PV alterations in schizophrenia are the consequence of a hypofunction of signaling through N-methyl-D-aspartate (NMDA) receptors (NMDARs).  Here, we review recent findings that address the question of how NMDAR hypofunction might produce deficits of PV neuron-mediated inhibition in schizophrenia.  We conclude that while dysregulation of NMDARs may play an important role in the pathophysiology of schizophrenia, additional research is required to determine the particular cell type(s) that mediate dysfunctional NMDAR signaling in the illness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQrAZ3KfzIjOFVwdslNBF-tfW6udTcc2eZAys_5hFPU-7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vjvVKrsA%253D%253D&md5=9b113bfef5b2597d7927d763006e2a8e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1093%2Fschbul%2Fsbs010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fschbul%252Fsbs010%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Burgos%26aufirst%3DG.%26aulast%3DLewis%26aufirst%3DD.%2BA.%26atitle%3DNMDA%2520receptor%2520hypofunction%252C%2520parvalbumin-positive%2520neurons%252C%2520and%2520cortical%2520gamma%2520oscillations%2520in%2520schizophrenia%26jtitle%3DSchizophr.%2520Bull.%26date%3D2012%26volume%3D38%26spage%3D950%26epage%3D957%26doi%3D10.1093%2Fschbul%2Fsbs010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Won, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gee, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mah, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaang, B.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.</span></span> <span> </span><span class="NLM_article-title">Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>486</i></span>,  <span class="NLM_fpage">261</span>â <span class="NLM_lpage">265</span>, <span class="refDoi">Â DOI: 10.1038/nature11208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2Fnature11208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=22699620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1emtrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=486&publication_year=2012&pages=261-265&author=H.+Wonauthor=H.-R.+Leeauthor=H.+Y.+Geeauthor=W.+Mahauthor=J.-I.+Kimauthor=J.+Leeauthor=S.+Haauthor=C.+Chungauthor=E.+S.+Jungauthor=Y.+S.+Choauthor=S.-G.+Parkauthor=J.-S.+Leeauthor=K.+Leeauthor=D.+Kimauthor=Y.+C.+Baeauthor=B.-K.+Kaangauthor=M.+G.+Leeauthor=E.+Kim&title=Autistic-like+social+behaviour+in+Shank2-mutant+mice+improved+by+restoring+NMDA+receptor+function&doi=10.1038%2Fnature11208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Autistic-like social behavior in Shank2-mutant mice improved by restoring NMDA receptor function</span></div><div class="casAuthors">Won, Hyejung; Lee, Hye-Ryeon; Gee, Heon Yung; Mah, Won; Kim, Jae-Ick; Lee, Jiseok; Ha, Seungmin; Chung, Changuk; Jung, Eun Suk; Cho, Yi Sul; Park, Sae-Geun; Lee, Jung-Soo; Lee, Kyungmin; Kim, Daesoo; Bae, Yong Chul; Kaang, Bong-Kiun; Lee, Min Goo; Kim, Eunjoon</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">486</span>
        (<span class="NLM_cas:issue">7402</span>),
    <span class="NLM_cas:pages">261-265</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autism spectrum disorder (ASD) is a group of conditions characterized by impaired social interaction and communication, and restricted and repetitive behaviors.  ASD is a highly heritable disorder involving various genetic determinants.  Shank2 (also known as ProSAP1) is a multi-domain scaffolding protein and signaling adaptor enriched at excitatory neuronal synapses, and mutations in the human SHANK2 gene have recently been assocd. with ASD and intellectual disablility.  Although ASD-assocd. genes are being increasingly identified and studied using various approaches, including mouse genetics, further efforts are required to delineate important causal mechanisms with the potential for therapeutic application.  Here we show that Shank2-mutant (Shank2-/-) mice carrying a mutation identical to the ASD-assocd. microdeletion in the human SHANK2 gene exhibit ASD-like behaviors including reduced social interaction, reduced social communication by ultrasonic vocalizations, and repetitive jumping.  These mice show a marked decrease in NMDA (N-methyl-d-aspartate) glutamate receptor (NMDAR) function.  Direct stimulation of NMDARs with d-cycloserine, a partial agonist of NMDARs, normalizes NMDAR function and improves social interaction in Shank2-/- mice.  Furthermore, treatment of Shank2-/- mice with a pos. allosteric modulator of metabotropic glutamate receptor 5 (mGluR5), which enhances NMDAR function via mGluR5 activation, also normalizes NMDAR function and markedly enhances social interaction.  These results suggest that reduced NMDAR function may contribute to the development of ASD-like phenotypes in Shank2-/- mice, and mGluR modulation of NMDARs offers a potential strategy to treat ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLS1qTT4nQELVg90H21EOLACvtfcHk0lj1D5EV1u6IAA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1emtrw%253D&md5=0d5478d17f8b572074040b9fe70b64a3</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnature11208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11208%26sid%3Dliteratum%253Aachs%26aulast%3DWon%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DH.-R.%26aulast%3DGee%26aufirst%3DH.%2BY.%26aulast%3DMah%26aufirst%3DW.%26aulast%3DKim%26aufirst%3DJ.-I.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DHa%26aufirst%3DS.%26aulast%3DChung%26aufirst%3DC.%26aulast%3DJung%26aufirst%3DE.%2BS.%26aulast%3DCho%26aufirst%3DY.%2BS.%26aulast%3DPark%26aufirst%3DS.-G.%26aulast%3DLee%26aufirst%3DJ.-S.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DBae%26aufirst%3DY.%2BC.%26aulast%3DKaang%26aufirst%3DB.-K.%26aulast%3DLee%26aufirst%3DM.%2BG.%26aulast%3DKim%26aufirst%3DE.%26atitle%3DAutistic-like%2520social%2520behaviour%2520in%2520Shank2-mutant%2520mice%2520improved%2520by%2520restoring%2520NMDA%2520receptor%2520function%26jtitle%3DNature%26date%3D2012%26volume%3D486%26spage%3D261%26epage%3D265%26doi%3D10.1038%2Fnature11208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmeisser, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ey, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegener, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bockmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stempel, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuebler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, A.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udvardi, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiban, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spilker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balschun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skryabin, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dieck, S. t.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smalla, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montag, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faure, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torquet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Sourd, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabrcuker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutz, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourgeron, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gundelfinger, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boeckers, T. M.</span></span> <span> </span><span class="NLM_article-title">Autistic-liek behaviours and hyperactivity in mice lacking ProSAP1/Shank2</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>486</i></span>,  <span class="NLM_fpage">256</span>â <span class="NLM_lpage">260</span>, <span class="refDoi">Â DOI: 10.1038/nature11015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2Fnature11015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=22699619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1entLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=486&publication_year=2012&pages=256-260&author=M.+J.+Schmeisserauthor=E.+Eyauthor=S.+Wegenerauthor=J.+Bockmannauthor=A.+V.+Stempelauthor=A.+Kueblerauthor=A.-J.+Janssenauthor=P.+T.+Udvardiauthor=E.+Shibanauthor=C.+Spilkerauthor=D.+Balschunauthor=B.+V.+Skryabinauthor=S.+t.+Dieckauthor=K.-H.+Smallaauthor=D.+Montagauthor=C.+S.+Leblondauthor=P.+Faureauthor=N.+Torquetauthor=A.-M.+Le+Sourdauthor=R.+Toroauthor=A.+M.+Grabrcukerauthor=S.+A.+Shoichetauthor=D.+Schmitzauthor=M.+R.+Kreutzauthor=T.+Bourgeronauthor=E.+D.+Gundelfingerauthor=T.+M.+Boeckers&title=Autistic-liek+behaviours+and+hyperactivity+in+mice+lacking+ProSAP1%2FShank2&doi=10.1038%2Fnature11015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Autistic-like behaviors and hyperactivity in mice lacking ProSAP1/Shank2</span></div><div class="casAuthors">Schmeisser, Michael J.; Ey, Elodie; Wegener, Stephanie; Bockmann, Juergen; Stempel, A. Vanessa; Kuebler, Angelika; Janssen, Anna-Lena; Udvardi, Patrick T.; Shiban, Ehab; Spilker, Christina; Balschun, Detlef; Skryabin, Boris V.; Dieck, Susanne tom; Smalla, Karl-Heinz; Montag, Dirk; Leblond, Claire S.; Faure, Philippe; Torquet, Nicolas; Le Sourd, Anne-Marie; Toro, Roberto; Grabrucker, Andreas M.; Shoichet, Sarah A.; Schmitz, Dietmar; Kreutz, Michael R.; Bourgeron, Thomas; Gundelfinger, Eckart D.; Boeckers, Tobias M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">486</span>
        (<span class="NLM_cas:issue">7402</span>),
    <span class="NLM_cas:pages">256-260</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autism spectrum disorders comprise a range of neurodevelopmental disorders characterized by deficits in social interaction and communication, and by repetitive behavior.  Mutations in synaptic proteins such as neuroligins, neurexins, GKAPs/SAPAPs and ProSAPs/Shanks were identified in patients with autism spectrum disorder, but the causative mechanisms remain largely unknown.  ProSAPs/Shanks build large homo- and heteromeric protein complexes at excitatory synapses and organize the complex protein machinery of the postsynaptic d. in a laminar fashion.  Here we demonstrate that genetic deletion of ProSAP1/Shank2 results in an early, brain-region-specific upregulation of ionotropic glutamate receptors at the synapse and increased levels of ProSAP2/Shank3.  Moreover, ProSAP1/Shank2-/- mutants exhibit fewer dendritic spines and show reduced basal synaptic transmission, a reduced frequency of miniature excitatory postsynaptic currents and enhanced N-methyl-d-aspartate receptor-mediated excitatory currents at the physiol. level.  Mutants are extremely hyperactive and display profound autistic-like behavioral alterations including repetitive grooming as well as abnormalities in vocal and social behaviors.  By comparing the data on ProSAP1/Shank2-/- mutants with ProSAP2/Shank3Î±Î²-/- mice, we show that different abnormalities in synaptic glutamate receptor expression can cause alterations in social interactions and communication.  Accordingly, we propose that appropriate therapies for autism spectrum disorders are to be carefully matched to the underlying synaptopathic phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocv7xYASrOwLVg90H21EOLACvtfcHk0lj4TVZO_y_-rQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1entLg%253D&md5=f88f5082cdf90461937c3c8fc2209366</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnature11015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11015%26sid%3Dliteratum%253Aachs%26aulast%3DSchmeisser%26aufirst%3DM.%2BJ.%26aulast%3DEy%26aufirst%3DE.%26aulast%3DWegener%26aufirst%3DS.%26aulast%3DBockmann%26aufirst%3DJ.%26aulast%3DStempel%26aufirst%3DA.%2BV.%26aulast%3DKuebler%26aufirst%3DA.%26aulast%3DJanssen%26aufirst%3DA.-J.%26aulast%3DUdvardi%26aufirst%3DP.%2BT.%26aulast%3DShiban%26aufirst%3DE.%26aulast%3DSpilker%26aufirst%3DC.%26aulast%3DBalschun%26aufirst%3DD.%26aulast%3DSkryabin%26aufirst%3DB.%2BV.%26aulast%3DDieck%26aufirst%3DS.%2Bt.%26aulast%3DSmalla%26aufirst%3DK.-H.%26aulast%3DMontag%26aufirst%3DD.%26aulast%3DLeblond%26aufirst%3DC.%2BS.%26aulast%3DFaure%26aufirst%3DP.%26aulast%3DTorquet%26aufirst%3DN.%26aulast%3DLe%2BSourd%26aufirst%3DA.-M.%26aulast%3DToro%26aufirst%3DR.%26aulast%3DGrabrcuker%26aufirst%3DA.%2BM.%26aulast%3DShoichet%26aufirst%3DS.%2BA.%26aulast%3DSchmitz%26aufirst%3DD.%26aulast%3DKreutz%26aufirst%3DM.%2BR.%26aulast%3DBourgeron%26aufirst%3DT.%26aulast%3DGundelfinger%26aufirst%3DE.%2BD.%26aulast%3DBoeckers%26aufirst%3DT.%2BM.%26atitle%3DAutistic-liek%2520behaviours%2520and%2520hyperactivity%2520in%2520mice%2520lacking%2520ProSAP1%252FShank2%26jtitle%3DNature%26date%3D2012%26volume%3D486%26spage%3D256%26epage%3D260%26doi%3D10.1038%2Fnature11015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalmau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleichman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessain, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenfeld, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balice-Gordon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, D. R.</span></span> <span> </span><span class="NLM_article-title">Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1091</span>â <span class="NLM_lpage">1098</span>, <span class="refDoi">Â DOI: 10.1016/S1474-4422(08)70224-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2FS1474-4422%2808%2970224-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=18851928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFCrsLrF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1091-1098&author=J.+Dalmauauthor=A.+J.+Gleichmanauthor=E.+G.+Hughesauthor=J.+E.+Rossiauthor=X.+Pengauthor=M.+Laiauthor=S.+K.+Dessainauthor=M.+R.+Rosenfeldauthor=R.+Balice-Gordonauthor=D.+R.+Lynch&title=Anti-NMDA-receptor+encephalitis%3A+case+series+and+analysis+of+the+effects+of+antibodies&doi=10.1016%2FS1474-4422%2808%2970224-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies</span></div><div class="casAuthors">Dalmau, Josep; Gleichman, Amy J.; Hughes, Ethan G.; Rossi, Jeffrey E.; Peng, Xiaoyu; Lai, Meizan; Dessain, Scott K.; Rosenfeld, Myrna R.; Balice-Gordon, Rita; Lynch, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1091-1098</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A severe form of encephalitis assocd. with antibodies against NR1-NR2 heteromers of the NMDA receptor was recently identified.  We aimed to analyze the clin. and immunol. features of patients with the disorder and examine the effects of antibodies against NMDA receptors in neuronal cultures.  We describe the clin. characteristics of 100 patients with encephalitis and NR1-NR2 antibodies.  HEK293 cells ectopically expressing single or assembled NR1-NR2 subunits were used to det. the epitope targeted by the antibodies.  Antibody titers were measured with ELISA.  The effect of antibodies on neuronal cultures was detd. by quant. anal. of NMDA-receptor clusters.  Median age of patients was 23 years (range 5-76 years); 91 were women.  All patients presented with psychiatric symptoms or memory problems; 76 had seizures, 88 unresponsiveness (decreased consciousness), 86 dyskinesias, 69 autonomic instability, and 66 hypoventilation.  58 (59%) Of 98 patients for whom results of oncol. assessments were available had tumors, most commonly ovarian teratoma.  Patients who received early tumor treatment (usually with immunotherapy) had better outcome (p=0.004) and fewer neurol. relapses (p=0.009) than the rest of the patients.  Seventy-five patients recovered or had mild deficits and 25 had severe deficits or died.  Improvement was assocd. with a decrease of serum antibody titers.  The main epitope targeted by the antibodies is in the extracellular N-terminal domain of the NR1 subunit.  Patients' antibodies decreased the nos. of cell-surface NMDA receptors and NMDA-receptor clusters in postsynaptic dendrites, an effect that could be reversed by antibody removal.  A well-defined set of clin. characteristics are assocd. with anti-NMDA-receptor encephalitis.  The pathogenesis of the disorder seems to be mediated by antibodies.  Funding National Institutes for Health, University of Pennsylvania Institute for Translational Medicine, Lankenau Institute for Medical Research, Foederer Foundation of the Children's Hospital of Philadelphia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxvbKVlmZeRbVg90H21EOLACvtfcHk0lh0064qqDFtKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFCrsLrF&md5=cfa7bfdcd2c41b075c7f473ea559d10b</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2808%2970224-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252808%252970224-2%26sid%3Dliteratum%253Aachs%26aulast%3DDalmau%26aufirst%3DJ.%26aulast%3DGleichman%26aufirst%3DA.%2BJ.%26aulast%3DHughes%26aufirst%3DE.%2BG.%26aulast%3DRossi%26aufirst%3DJ.%2BE.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DLai%26aufirst%3DM.%26aulast%3DDessain%26aufirst%3DS.%2BK.%26aulast%3DRosenfeld%26aufirst%3DM.%2BR.%26aulast%3DBalice-Gordon%26aufirst%3DR.%26aulast%3DLynch%26aufirst%3DD.%2BR.%26atitle%3DAnti-NMDA-receptor%2520encephalitis%253A%2520case%2520series%2520and%2520analysis%2520of%2520the%2520effects%2520of%2520antibodies%26jtitle%3DLancet%2520Neurol.%26date%3D2008%26volume%3D7%26spage%3D1091%26epage%3D1098%26doi%3D10.1016%2FS1474-4422%2808%2970224-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleichman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsou, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalmau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balice-Gordon, R. J.</span></span> <span> </span><span class="NLM_article-title">Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">5866</span>â <span class="NLM_lpage">5875</span>, <span class="refDoi">Â DOI: 10.1523/JNEUROSCI.0167-10.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1523%2FJNEUROSCI.0167-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=20427647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosFeqs7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=5866-5875&author=E.+G.+Hughesauthor=X.+Pengauthor=A.+J.+Gleichmanauthor=M.+Laiauthor=L.+Zhouauthor=R.+Tsouauthor=T.+D.+Parsonsauthor=D.+R.+Lynchauthor=J.+Dalmauauthor=R.+J.+Balice-Gordon&title=Cellular+and+synaptic+mechanisms+of+anti-NMDA+receptor+encephalitis&doi=10.1523%2FJNEUROSCI.0167-10.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis</span></div><div class="casAuthors">Hughes, Ethan G.; Peng, Xiaoyu; Gleichman, Amy J.; Lai, Meizan; Zhou, Lei; Tsou, Ryan; Parsons, Thomas D.; Lynch, David R.; Dalmau, Josep; Balice-Gordon, Rita J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5866-5875</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">We recently described a severe, potentially lethal, but treatment-responsive encephalitis that assocs. with autoantibodies to the NMDA receptor (NMDAR) and results in behavioral symptoms similar to those obtained with models of genetic or pharmacol. attenuation of NMDAR function.  Here, we demonstrate that patients' NMDAR antibodies cause a selective and reversible decrease in NMDAR surface d. and synaptic localization that correlates with patients' antibody titers.  The mechanism of this decrease is selective antibody-mediated capping and internalization of surface NMDARs, as Fab fragments prepd. from patients' antibodies did not decrease surface receptor d., but subsequent crosslinking with anti-Fab antibodies recapitualted the decrease caused by intact patient NMDAR antibodies.  Moreover, whole-cell patch-clamp recordings of miniature EPSCs in cultured rat hippocampal neurons showed that patients' antibodies specifically decreased synaptic NMDAR-mediated currents, without affecting AMPA receptor-mediated currents.  In contrast to these profound effects on NMDARs, patients' antibodies did not alter the localization or expression of other glutamate receptors or synaptic proteins, no. of synapses, dendritic spines, dendritic complexity, or cell survival.  In addn., NMDAR d. was dramatically reduced in the hippocampus of female Lewis rats infused with patients' antibodies, similar to the decrease obsd. in the hippocampus of autopsied patients.  These studies establish the cellular mechanisms through which antibodies of patients with anti-NMDAR encephalitis cause a specific, titer-dependent, and reversible loss of NMDARs.  The loss of this subtype of glutamate receptors eliminates NMDAR-mediated synaptic function, resulting in the learning, memory, and other behavioral deficits obsd. in patients with anti-NMDAR encephalitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFMBlJAlyshrVg90H21EOLACvtfcHk0lh0064qqDFtKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosFeqs7w%253D&md5=56da6f0dee9d8203d0b26882d77f833a</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0167-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0167-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DE.%2BG.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DGleichman%26aufirst%3DA.%2BJ.%26aulast%3DLai%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DTsou%26aufirst%3DR.%26aulast%3DParsons%26aufirst%3DT.%2BD.%26aulast%3DLynch%26aufirst%3DD.%2BR.%26aulast%3DDalmau%26aufirst%3DJ.%26aulast%3DBalice-Gordon%26aufirst%3DR.%2BJ.%26atitle%3DCellular%2520and%2520synaptic%2520mechanisms%2520of%2520anti-NMDA%2520receptor%2520encephalitis%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D5866%26epage%3D5875%26doi%3D10.1523%2FJNEUROSCI.0167-10.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mikasova, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rossi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouchet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogemond, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didelot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meissirel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honnorat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groc, L.</span></span> <span> </span><span class="NLM_article-title">Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">1606</span>â <span class="NLM_lpage">1621</span>, <span class="refDoi">Â DOI: 10.1093/brain/aws092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1093%2Fbrain%2Faws092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=22544902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BC38rptFSiuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2012&pages=1606-1621&author=L.+D.+Mikasovaauthor=P.+De+Rossiauthor=D.+Bouchetauthor=F.+Georgesauthor=V.+Rogemondauthor=A.+Didelotauthor=C.+Meissirelauthor=J.+Honnoratauthor=L.+Groc&title=Disrupted+surface+cross-talk+between+NMDA+and+Ephrin-B2+receptors+in+anti-NMDA+encephalitis&doi=10.1093%2Fbrain%2Faws092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis</span></div><div class="casAuthors">Mikasova Lenka; De Rossi Pierre; Bouchet Delphine; Georges Francois; Rogemond Veronique; Didelot Adrien; Meissirel Claire; Honnorat Jerome; Groc Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">Pt 5</span>),
    <span class="NLM_cas:pages">1606-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autoimmune synaptic encephalitides are recently described human brain diseases leading to psychiatric and neurological syndromes through inappropriate brain-autoantibody interactions.  The most frequent synaptic autoimmune encephalitis is associated with autoantibodies against extracellular domains of the glutamatergic N-methyl-d-aspartate receptor, with patients developing psychotic and neurological symptoms in an autoantibody titre-dependent manner.  Although N-methyl-d-aspartate receptors are the primary target of these antibodies, the cellular and molecular pathway(s) that rapidly lead to N-methyl-d-aspartate receptor dysfunction remain poorly understood.  In this report, we used a unique combination of high-resolution nanoparticle and bulk live imaging approaches to demonstrate that anti-N-methyl-d-aspartate receptor autoantibodies from patients with encephalitis strongly alter, in a time-dependent manner, the surface content and trafficking of GluN2-NMDA receptor subtypes.  Autoantibodies laterally displaced surface GluN2A-NMDA receptors out of synapses and completely blocked synaptic plasticity.  This loss of extrasynaptic and synaptic N-methyl-d-aspartate receptor is prevented both in vitro and in vivo, by the activation of EPHB2 receptors.  Indeed, the anti-N-methyl-d-aspartate receptor autoantibodies weaken the interaction between the extracellular domains of the N-methyl-d-aspartate and Ephrin-B2 receptors.  Together, we demonstrate that the anti-N-methyl-d-aspartate receptor autoantibodies from patients with encephalitis alter the dynamic retention of synaptic N-methyl-d-aspartate receptor through extracellular domain-dependent mechanism(s), shedding new light on the pathology of the neurological and psychiatric disorders observed in these patients and opening possible new therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHviLGtJ4ez5SWdIdmEou5fW6udTcc2eZ4cIqyAoqt3Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rptFSiuw%253D%253D&md5=dc65600d3c0078388dc1170a519291e6</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Faws092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Faws092%26sid%3Dliteratum%253Aachs%26aulast%3DMikasova%26aufirst%3DL.%2BD.%26aulast%3DDe%2BRossi%26aufirst%3DP.%26aulast%3DBouchet%26aufirst%3DD.%26aulast%3DGeorges%26aufirst%3DF.%26aulast%3DRogemond%26aufirst%3DV.%26aulast%3DDidelot%26aufirst%3DA.%26aulast%3DMeissirel%26aufirst%3DC.%26aulast%3DHonnorat%26aufirst%3DJ.%26aulast%3DGroc%26aufirst%3DL.%26atitle%3DDisrupted%2520surface%2520cross-talk%2520between%2520NMDA%2520and%2520Ephrin-B2%2520receptors%2520in%2520anti-NMDA%2520encephalitis%26jtitle%3DBrain%26date%3D2012%26volume%3D135%26spage%3D1606%26epage%3D1621%26doi%3D10.1093%2Fbrain%2Faws092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bannerman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niewoehner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprengel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeburg, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KÃ¶hr, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawlins, J. N.</span></span> <span> </span><span class="NLM_article-title">NMDA receptor subunit NR2A is required for rapidly acquired spatial working memory but not incremental spatial reference memory</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3623</span>â <span class="NLM_lpage">3630</span>, <span class="refDoi">Â DOI: 10.1523/JNEUROSCI.3639-07.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1523%2FJNEUROSCI.3639-07.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=18385321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkslSjtL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=3623-3630&author=D.+M.+Bannermanauthor=B.+Niewoehnerauthor=L.+Lyonauthor=C.+Rombergauthor=W.+B.+Schmittauthor=A.+Taylorauthor=D.+J.+Sandersonauthor=J.+Cottamauthor=R.+Sprengelauthor=P.+H.+Seeburgauthor=G.+K%C3%B6hrauthor=J.+N.+Rawlins&title=NMDA+receptor+subunit+NR2A+is+required+for+rapidly+acquired+spatial+working+memory+but+not+incremental+spatial+reference+memory&doi=10.1523%2FJNEUROSCI.3639-07.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor subunit NR2A is required for rapidly acquired spatial working memory but not incremental spatial reference memory</span></div><div class="casAuthors">Bannerman, David M.; Niewoehner, Burkhard; Lyon, Louisa; Romberg, Carola; Schmitt, Wolfram B.; Taylor, Amy; Sanderson, David J.; Cottam, James; Sprengel, Rolf; Seeburg, Peter H.; Kohr, Georg; Rawlins, John N. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3623-3630</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">NMDA receptors (NMDARs) contg. NR2A (Îµ1) subunits are key contributors to hippocampal long-term potentiation (LTP) induction in adult animals and have therefore been widely implicated in hippocampus-dependent spatial learning.  Here we show that mice lacking the NR2A subunit or its C-terminal interacellular domain exhibit impaired spatial working memory (SWM) but normal spatial ref. memory (SRM).  Both NR2A mutants acquired the SRM version of the water maze task, and the SRM component of the radial maze, as well as controls.  They were, however, impaired on a non-matching-to-place T-maze task, and on the SWM component of the radial maze.  In addn., NR2A knock-out mice displayed a diminished spatial novelty preference in a spontaneous exploration Y-maze task, and were impaired on a T-maze task in which distinctive inserts present on the floor of the maze detd. which goal arm contained the reward, but only if there was a discontiguity between the conditional cue and the place at which the reward was delivered.  This dissocn. of spatial memory into distinctive components is strikingly similar to results obtained with mice lacking glutamate receptor-A (GluR-A)-contg. AMPA receptors, which support long-term potentiation expression.  These results identify a specific role for a NMDAR-dependent signaling pathway that leads to the activation of a GluR-A-dependent expression mechanism in a rapidly acquired, flexible form of spatial memory.  This mechanism depends on the C-terminal intracellular domain of the NR2A subunit.  In contrast, the ability to assoc. a particular spatial location with the water maze escape platform or food reward is NR2A independent, as well as GluR-A independent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozRr5dwP4DZ7Vg90H21EOLACvtfcHk0lh2HwLyrr0JrQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkslSjtL0%253D&md5=5ebf612af3ce8bf4d82a99c14207f4ef</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3639-07.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3639-07.2008%26sid%3Dliteratum%253Aachs%26aulast%3DBannerman%26aufirst%3DD.%2BM.%26aulast%3DNiewoehner%26aufirst%3DB.%26aulast%3DLyon%26aufirst%3DL.%26aulast%3DRomberg%26aufirst%3DC.%26aulast%3DSchmitt%26aufirst%3DW.%2BB.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DSanderson%26aufirst%3DD.%2BJ.%26aulast%3DCottam%26aufirst%3DJ.%26aulast%3DSprengel%26aufirst%3DR.%26aulast%3DSeeburg%26aufirst%3DP.%2BH.%26aulast%3DK%25C3%25B6hr%26aufirst%3DG.%26aulast%3DRawlins%26aufirst%3DJ.%2BN.%26atitle%3DNMDA%2520receptor%2520subunit%2520NR2A%2520is%2520required%2520for%2520rapidly%2520acquired%2520spatial%2520working%2520memory%2520but%2520not%2520incremental%2520spatial%2520reference%2520memory%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D3623%26epage%3D3630%26doi%3D10.1523%2FJNEUROSCI.3639-07.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsien, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span> <span> </span><span class="NLM_article-title">Genetic enhancement of memory and long-term potentiation but not CA1 long-term depression in NR2B transgenic rats</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e7486</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0007486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1371%2Fjournal.pone.0007486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=19838302" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&author=D.+Wangauthor=Z.+Cuiauthor=Q.+Zengauthor=H.+Kuangauthor=L.+P.+Wangauthor=J.+Z.+Tsienauthor=X.+Cao&title=Genetic+enhancement+of+memory+and+long-term+potentiation+but+not+CA1+long-term+depression+in+NR2B+transgenic+rats&doi=10.1371%2Fjournal.pone.0007486"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0007486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0007486%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.%26aulast%3DCui%26aufirst%3DZ.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DKuang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%2BP.%26aulast%3DTsien%26aufirst%3DJ.%2BZ.%26aulast%3DCao%26aufirst%3DX.%26atitle%3DGenetic%2520enhancement%2520of%2520memory%2520and%2520long-term%2520potentiation%2520but%2520not%2520CA1%2520long-term%2520depression%2520in%2520NR2B%2520transgenic%2520rats%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26doi%3D10.1371%2Fjournal.pone.0007486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khlestova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krystal, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisman, J.</span></span> <span> </span><span class="NLM_article-title">The role of GluN2C-containing NMDA receptors in ketamineâs psychotogenic action and in schizophrenia models</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">11151</span>â <span class="NLM_lpage">11157</span>, <span class="refDoi">Â DOI: 10.1523/JNEUROSCI.1203-16.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1523%2FJNEUROSCI.1203-16.2016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=27807157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Ohurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=11151-11157&author=E.+Khlestovaauthor=J.+W.+Johnsonauthor=J.+H.+Krystalauthor=J.+Lisman&title=The+role+of+GluN2C-containing+NMDA+receptors+in+ketamine%E2%80%99s+psychotogenic+action+and+in+schizophrenia+models&doi=10.1523%2FJNEUROSCI.1203-16.2016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The role of GluN2C-containing NMDA receptors in ketamine's psychotogenic action and in schizophrenia models</span></div><div class="casAuthors">Khlestova, Elizaveta; Johnson, Jon W.; Krystal, John H.; Lisman, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">11151-11157</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The NMDA receptor (NMDAR) hypofunction hypothesis of schizophrenia is supported by multiple lines of evidence.  Notably, administration of the NMDAR antagonist, ketamine, to healthy human subjects has psychotogenic action, producing both pos. and neg. symptoms assocd. with schizophrenia.  NMDARs have multiple subtypes, but the subtypes through which ketamine produces its psychotogenic effects are not known.  Here we address this question using quant. data that characterize ketamine's ability to block different NMDAR subtypes.  Our calcns. indicate that, at a concn. that has psychotogenic action in humans, ketamine blocks a substantial fraction of GluN2C subunit-contg. receptors but has less effect on GluN2A-, GluN2B-, and GluN2D-contg. receptors.  Thus, GluN2C-contg. receptors may have preferential involvement in psychotic states produced by ketamine.  A sep. line of expts. also points to a special role for GluN2C.  That work demonstrates the ability of NMDAR antagonists to mimic the elevation in the awake-state Î´ frequency EEG power that occurs in schizophrenia.  Physiol. expts. in rodents show that NMDAR antagonists generate Î´ oscillations by their action on the GluN2C-contg. NMDARs that are prevalent in the thalamus.  Optogenetic expts. suggest that such oscillations could contribute to symptoms of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5QgRmYO74BrVg90H21EOLACvtfcHk0lgnWTL0d6CU2g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Ohurc%253D&md5=6c30a33b65b2be535bdf07f45a925a05</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1203-16.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1203-16.2016%26sid%3Dliteratum%253Aachs%26aulast%3DKhlestova%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DJ.%2BW.%26aulast%3DKrystal%26aufirst%3DJ.%2BH.%26aulast%3DLisman%26aufirst%3DJ.%26atitle%3DThe%2520role%2520of%2520GluN2C-containing%2520NMDA%2520receptors%2520in%2520ketamine%25E2%2580%2599s%2520psychotogenic%2520action%2520and%2520in%2520schizophrenia%2520models%26jtitle%3DJ.%2520Neurosci.%26date%3D2016%26volume%3D36%26spage%3D11151%26epage%3D11157%26doi%3D10.1523%2FJNEUROSCI.1203-16.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koschel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zink, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sommer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treutlein, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider-Axmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parlapani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rietschel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falkai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henn, F. A.</span></span> <span> </span><span class="NLM_article-title">Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia</span>. <i>Eur. Arch. Psychiatry Clin. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>260</i></span>,  <span class="NLM_fpage">101</span>â <span class="NLM_lpage">111</span>, <span class="refDoi">Â DOI: 10.1007/s00406-009-0017-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1007%2Fs00406-009-0017-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=19856012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BC3c7ksFCjuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=2010&pages=101-111&author=A.+Schmittauthor=J.+Koschelauthor=M.+Zinkauthor=M.+Bauerauthor=C.+Sommerauthor=J.+Frankauthor=T.+Treutleinauthor=T.+Schulzeauthor=T.+Schneider-Axmannauthor=E.+Parlapaniauthor=M.+Rietschelauthor=P.+Falkaiauthor=F.+A.+Henn&title=Gene+expression+of+NMDA+receptor+subunits+in+the+cerebellum+of+elderly+patients+with+schizophrenia&doi=10.1007%2Fs00406-009-0017-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia</span></div><div class="casAuthors">Schmitt Andrea; Koschel Jiri; Zink Mathias; Bauer Manfred; Sommer Clemens; Frank Josef; Treutlein Jens; Schulze Thomas; Schneider-Axmann Thomas; Parlapani Eleni; Rietschel Marcella; Falkai Peter; Henn Fritz A</div><div class="citationInfo"><span class="NLM_cas:title">European archives of psychiatry and clinical neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">260</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-11</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">To determine if NMDA receptor alterations are present in the cerebellum in schizophrenia, we measured NMDA receptor binding and gene expression of the NMDA receptor subunits in a post-mortem study of elderly patients with schizophrenia and non-affected subjects.  Furthermore, we assessed influence of genetic variation in the candidate gene neuregulin-1 (NRG1) on the expression of the NMDA receptor in an exploratory study.  Post-mortem samples from the cerebellar cortex of ten schizophrenic patients were compared with nine normal subjects.  We investigated NMDA receptor binding by receptor autoradiography and gene expression of the NMDA receptor subunits NR1, NR2A, NR2B, NR2C and NR2D by in situ hybridization.  For the genetic study, we genotyped the NRG1 polymorphism rs35753505 (SNP8NRG221533).  Additionally, we treated rats with the antipsychotics haloperidol or clozapine and assessed cerebellar NMDA receptor binding and gene expression of subunits to examine the effects of antipsychotic treatment.  Gene expression of the NR2D subunit was increased in the right cerebellum of schizophrenic patients compared to controls.  Individuals carrying at least one C allele of rs35753505 (SNP8NRG221533) showed decreased expression of the NR2C subunit in the right cerebellum, compared to individuals homozygous for the T allele.  Correlation with medication parameters and the animal model revealed no treatment effects.  In conclusion, increased NR2D expression results in a hyperexcitable NMDA receptor suggesting an adaptive effect due to receptor hypofunction.  The decreased NR2C expression in NRG1 risk variant may cause a deficit in NMDA receptor function.  This supports the hypothesis of an abnormal glutamatergic neurotransmission in the right cerebellum in the pathophysiology of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5PS3sSHjA2waK-_ZudimnfW6udTcc2ebliQkiZJ8Mobntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7ksFCjuw%253D%253D&md5=9cab8cf5f2f2df2cf423b6b25488a13f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1007%2Fs00406-009-0017-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00406-009-0017-1%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DA.%26aulast%3DKoschel%26aufirst%3DJ.%26aulast%3DZink%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DM.%26aulast%3DSommer%26aufirst%3DC.%26aulast%3DFrank%26aufirst%3DJ.%26aulast%3DTreutlein%26aufirst%3DT.%26aulast%3DSchulze%26aufirst%3DT.%26aulast%3DSchneider-Axmann%26aufirst%3DT.%26aulast%3DParlapani%26aufirst%3DE.%26aulast%3DRietschel%26aufirst%3DM.%26aulast%3DFalkai%26aufirst%3DP.%26aulast%3DHenn%26aufirst%3DF.%2BA.%26atitle%3DGene%2520expression%2520of%2520NMDA%2520receptor%2520subunits%2520in%2520the%2520cerebellum%2520of%2520elderly%2520patients%2520with%2520schizophrenia%26jtitle%3DEur.%2520Arch.%2520Psychiatry%2520Clin.%2520Neurosci.%26date%3D2010%26volume%3D260%26spage%3D101%26epage%3D111%26doi%3D10.1007%2Fs00406-009-0017-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meador-Woodruff, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, A. J.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. E.</span></span> <span> </span><span class="NLM_article-title">Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder</span>. <i>Brain Res. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">631</span>â <span class="NLM_lpage">640</span>, <span class="refDoi">Â DOI: 10.1016/S0361-9230(01)00523-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2FS0361-9230%2801%2900523-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=11576760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntVWqtb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2001&pages=631-640&author=J.+H.+Meador-Woodruffauthor=A.+J.+Hoggauthor=R.+E.+Smith&title=Striatal+ionotropic+glutamate+receptor+expression+in+schizophrenia%2C+bipolar+disorder%2C+and+major+depressive+disorder&doi=10.1016%2FS0361-9230%2801%2900523-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder</span></div><div class="casAuthors">Meador-Woodruff, J. H.; Hogg, A. J.; Smith, R. E.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">631-640</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Abnormalities of the ionotropic glutamate receptors (N-methyl-D-aspartate, Î±-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid [AMPA], and kainate) have been reported in the brain in schizophrenia, although in complex, region-specific patterns.  While limbic cortex and medial temporal lobe structures have been most often studied in psychiatric illnesses, glutamate receptors are expressed in other brain regions assocd. with limbic circuitry, esp. the striatum.  In this study, we have detd. striatal ionotropic glutamate receptor expression in brains from persons with schizophrenia, bipolar disorder, major depression, and a comparison group, using samples from the Stanley Foundation Neuropathol. Consortium.  We have detd. the expression of these receptors at multiple levels of gene expression by using both in situ hybridization and receptor autoradiog.  The expression of nearly all of these mols. was not different in these psychiatric conditions.  The only significant changes noted were NR2D and gluR1 transcripts, and [3H]AMPA binding.  This is the first comprehensive study of striatal ionotropic glutamate receptor expression in schizophrenia and affective disorders, and suggests that there are minimal changes in these receptors in this region of the brain in these illnesses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_dwhhuMywirVg90H21EOLACvtfcHk0lgnWTL0d6CU2g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntVWqtb0%253D&md5=8788a4abd8495b68b2a50f033f3986e7</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0361-9230%2801%2900523-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0361-9230%252801%252900523-8%26sid%3Dliteratum%253Aachs%26aulast%3DMeador-Woodruff%26aufirst%3DJ.%2BH.%26aulast%3DHogg%26aufirst%3DA.%2BJ.%26aulast%3DSmith%26aufirst%3DR.%2BE.%26atitle%3DStriatal%2520ionotropic%2520glutamate%2520receptor%2520expression%2520in%2520schizophrenia%252C%2520bipolar%2520disorder%252C%2520and%2520major%2520depressive%2520disorder%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2001%26volume%3D55%26spage%3D631%26epage%3D640%26doi%3D10.1016%2FS0361-9230%2801%2900523-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sapkota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Synowicki, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikezu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gautam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaghan, D. T.</span></span> <span> </span><span class="NLM_article-title">GluN2D N-methyl-D-aspartate receptor subunit contribution to the stimulation of brain activity and gamma oscillations by ketamine: Implications for schizophrenia</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">702</span>â <span class="NLM_lpage">711</span>, <span class="refDoi">Â DOI: 10.1124/jpet.115.230391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1124%2Fjpet.115.230391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=26675679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVelu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2016&pages=702-711&author=K.+Sapkotaauthor=Z.+Maoauthor=P.+Synowickiauthor=D.+Lieberauthor=M.+Liuauthor=T.+Ikezuauthor=V.+Gautamauthor=D.+T.+Monaghan&title=GluN2D+N-methyl-D-aspartate+receptor+subunit+contribution+to+the+stimulation+of+brain+activity+and+gamma+oscillations+by+ketamine%3A+Implications+for+schizophrenia&doi=10.1124%2Fjpet.115.230391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">GluN2D N-Methyl-d-aspartate receptor subunit contribution to the stimulation of brain activity and gamma oscillations by ketamine: implications for schizophrenia</span></div><div class="casAuthors">Sapkota, Kiran; Mao, Zhihao; Synowicki, Paul; Lieber, Dillon; Liu, Meng; Ikezu, Tsuneya; Gautam, Vivek; Monaghan, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">702-711</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The dissociative anesthetic ketamine elicits symptoms of schizophrenia at subanesthetic doses by blocking N-methyl-d-aspartate receptors (NMDARs).  This property led to a variety of studies resulting in the now well-supported theory that hypofunction of NMDARs is responsible for many of the symptoms of schizophrenia.  However, the roles played by specific NMDAR subunits in different symptom components are unknown.  To evaluate the potential contribution of GluN2D NMDAR subunits to antagonist-induced cortical activation and schizophrenia symptoms, we detd. the ability of ketamine to alter regional brain activity and gamma frequency band neuronal oscillations in wild-type (WT) and GluN2D-knockout (GluN2D-KO) mice.  In WT mice, ketamine (30 mg/kg, i.p.) significantly increased [14C]-2-deoxyglucose ([14C]-2DG) uptake in the medial prefrontal cortex (mPFC), entorhinal cortex and other brain regions, and decreased activity in the somatosensory cortex and inferior colliculus.  In GluN2D-KO mice, however, ketamine did not significantly increase [14C]-2DG uptake in any brain region examd., yet still decreased [14C]-2DG uptake in the somatosensory cortex and inferior colliculus.  Ketamine also increased locomotor activity in WT mice but not in GluN2D-KO mice.  In electrocorticog. anal., ketamine induced a 111% Â± 16% increase in cortical gamma-band oscillatory power in WT mice, but only a 15% Â± 12% increase in GluN2D-KO mice.  Consistent with GluN2D involvement in schizophrenia-related neurol. changes, GluN2D-KO mice displayed impaired spatial memory acquisition and reduced parvalbumin (PV)-immunopos. staining compared with control mice.  These results suggest a crit. role of GluN2D-contg. NMDARs in neuronal oscillations and ketamine's psychotomimetic, dissociative effects and hence suggests a crit. role for GluN2D subunits in cognition and perception.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaCNutH8DBErVg90H21EOLACvtfcHk0lgSyPEAzxq05A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVelu70%253D&md5=ca6b37e9ddd9bd0fdac578df6a8df9fa</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.230391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.230391%26sid%3Dliteratum%253Aachs%26aulast%3DSapkota%26aufirst%3DK.%26aulast%3DMao%26aufirst%3DZ.%26aulast%3DSynowicki%26aufirst%3DP.%26aulast%3DLieber%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DIkezu%26aufirst%3DT.%26aulast%3DGautam%26aufirst%3DV.%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26atitle%3DGluN2D%2520N-methyl-D-aspartate%2520receptor%2520subunit%2520contribution%2520to%2520the%2520stimulation%2520of%2520brain%2520activity%2520and%2520gamma%2520oscillations%2520by%2520ketamine%253A%2520Implications%2520for%2520schizophrenia%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D356%26spage%3D702%26epage%3D711%26doi%3D10.1124%2Fjpet.115.230391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ninomiya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukumaki, Y.</span></span> <span> </span><span class="NLM_article-title">Identification of single-nucleotide polymorphisms in the human N-methyl-D-aspartate receptor subunit NR2D gene, GRIN2D, and association study with schizophrenia</span>. <i>Psychiatr. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">215</span>â <span class="NLM_lpage">221</span>, <span class="refDoi">Â DOI: 10.1097/00041444-200509000-00014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1097%2F00041444-200509000-00014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=16094258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BD2MvpvV2isg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=215-221&author=C.+Makinoauthor=H.+Shibataauthor=H.+Ninomiyaauthor=N.+Tashiroauthor=Y.+Fukumaki&title=Identification+of+single-nucleotide+polymorphisms+in+the+human+N-methyl-D-aspartate+receptor+subunit+NR2D+gene%2C+GRIN2D%2C+and+association+study+with+schizophrenia&doi=10.1097%2F00041444-200509000-00014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of single-nucleotide polymorphisms in the human N-methyl-D-aspartate receptor subunit NR2D gene, GRIN2D, and association study with schizophrenia</span></div><div class="casAuthors">Makino Chieko; Shibata Hiroki; Ninomiya Hideaki; Tashiro Nobutada; Fukumaki Yasuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Psychiatric genetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">215-21</span>
        ISSN:<span class="NLM_cas:issn">0955-8829</span>.
    </div><div class="casAbstract">OBJECTIVES:  The glutamatergic dysfunction is one of the main hypotheses for the pathophysiology of schizophrenia.  N-methyl-D-aspartate receptors are of major interest because phencyclidine, a non-competitive antagonist of N-methyl-D-aspartate receptors, produces a schizophrenia-like psychosis.  Therefore, the genes encoding N-methyl-D-aspartate receptor subunits are strong candidates for schizophrenia susceptibility genes.  We focused on the N-methyl-D-aspartate receptor subunit NR2D gene in the case-control study of schizophrenia.  METHODS:  We screened for polymorphisms in exons, exon-intron boundaries and the 5' upstream region of GRIN2D by direct sequencing in 32 Japanese patients.  Out of the total 13 single-nucleotide polymorphisms identified, we genotyped 200-201 Japanese patients and 219-221 controls for nine common single-nucleotide polymorphisms (minor allele frequency over 0.05).  RESULTS:  None of the nine single-nucleotide polymorphisms showed significant differences in genotype and allele frequencies between cases and controls.  We observed significant associations of pairwise haplotypes in three combinations of four single-nucleotide polymorphisms, INT10SNP-EX13SNP2, EX13SNP2-EX13SNP3 and EX6SNP-EX13SNP2, with the disease even after the Bonferroni correction (P=1.094 x 10(-6), Pcorrected=2.297 x 10(-5), P=2.825 x 10(-6), Pcorrected=5.933 x 10(-5) and P=2.02 x 10(-4), Pcorrected=4.242 x 10(-3), respectively).  The same results were also obtained using the false discovery rate (BL) method at the threshold P value, 2.908 x 10(-3).  CONCLUSIONS:  We conclude that the GRIN2D locus is a possible genomic region contributing to schizophrenia susceptibility in the Japanese population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxrMh5nlgqGVvAgqb2vdc5fW6udTcc2eYpe2e-y2Aakbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MvpvV2isg%253D%253D&md5=56a0b5e6deab30f011c9a7fd2c026e1d</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1097%2F00041444-200509000-00014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00041444-200509000-00014%26sid%3Dliteratum%253Aachs%26aulast%3DMakino%26aufirst%3DC.%26aulast%3DShibata%26aufirst%3DH.%26aulast%3DNinomiya%26aufirst%3DH.%26aulast%3DTashiro%26aufirst%3DN.%26aulast%3DFukumaki%26aufirst%3DY.%26atitle%3DIdentification%2520of%2520single-nucleotide%2520polymorphisms%2520in%2520the%2520human%2520N-methyl-D-aspartate%2520receptor%2520subunit%2520NR2D%2520gene%252C%2520GRIN2D%252C%2520and%2520association%2520study%2520with%2520schizophrenia%26jtitle%3DPsychiatr.%2520Genet.%26date%3D2005%26volume%3D15%26spage%3D215%26epage%3D221%26doi%3D10.1097%2F00041444-200509000-00014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lisman, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitt, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benes, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grace, A. A.</span></span> <span> </span><span class="NLM_article-title">Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia</span>. <i>Trends Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">234</span>â <span class="NLM_lpage">242</span>, <span class="refDoi">Â DOI: 10.1016/j.tins.2008.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2Fj.tins.2008.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=18395805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslGjt7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=234-242&author=J.+E.+Lismanauthor=J.+T.+Coyleauthor=R.+W.+Greenauthor=D.+C.+Javittauthor=F.+M.+Benesauthor=S.+Heckersauthor=A.+A.+Grace&title=Circuit-based+framework+for+understanding+neurotransmitter+and+risk+gene+interactions+in+schizophrenia&doi=10.1016%2Fj.tins.2008.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia</span></div><div class="casAuthors">Lisman, John E.; Coyle, Joseph T.; Green, Robert W.; Javitt, Daniel C.; Benes, Francine M.; Heckers, Stephan; Grace, Anthony A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Neurosciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">234-242</span>CODEN:
                <span class="NLM_cas:coden">TNSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-2236</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Many risk genes interact synergistically to produce schizophrenia and many neurotransmitter interactions have been implicated.  We have developed a circuit-based framework for understanding gene and neurotransmitter interactions.  NMDAR hypofunction has been implicated in schizophrenia because NMDAR antagonists reproduce symptoms of the disease.  One action of antagonists is to reduce the excitation of fast-spiking interneurons, resulting in disinhibition of pyramidal cells.  Overactive pyramidal cells, notably those in the hippocampus, can drive a hyperdopaminergic state that produces psychosis.  Addnl. aspects of interneuron function can be understood in this framework, as follows. (i) In animal models, NMDAR antagonists reduce parvalbumin and GAD67, as found in schizophrenia.  These changes produce further disinhibition and can be viewed as the aberrant response of a homeostatic system having a faulty activity sensor (the NMDAR). (ii) Disinhibition decreases the power of gamma oscillation and might thereby produce neg. and cognitive symptoms. (iii) Nicotine enhances the output of interneurons, and might thereby contribute to its therapeutic effect in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonsMASuu2k9rVg90H21EOLACvtfcHk0lgSyPEAzxq05A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslGjt7w%253D&md5=b8eb2d2b371e877022dbcd5920675974</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2008.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2008.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DLisman%26aufirst%3DJ.%2BE.%26aulast%3DCoyle%26aufirst%3DJ.%2BT.%26aulast%3DGreen%26aufirst%3DR.%2BW.%26aulast%3DJavitt%26aufirst%3DD.%2BC.%26aulast%3DBenes%26aufirst%3DF.%2BM.%26aulast%3DHeckers%26aufirst%3DS.%26aulast%3DGrace%26aufirst%3DA.%2BA.%26atitle%3DCircuit-based%2520framework%2520for%2520understanding%2520neurotransmitter%2520and%2520risk%2520gene%2520interactions%2520in%2520schizophrenia%26jtitle%3DTrends%2520Neurosci.%26date%3D2008%26volume%3D31%26spage%3D234%26epage%3D242%26doi%3D10.1016%2Fj.tins.2008.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perszyk, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiRaddo, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strong, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargish, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelkey, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tricoire, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBain, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">GluN2D-containing N-methyl-D-aspartate receptors mediate synaptic transmission in hippocampal interneurons and regulate interneuron activity</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">689</span>â <span class="NLM_lpage">702</span>, <span class="refDoi">Â DOI: 10.1124/mol.116.105130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1124%2Fmol.116.105130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=27625038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitValu7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2016&pages=689-702&author=R.+E.+Perszykauthor=J.+O.+DiRaddoauthor=K.+L.+Strongauthor=C.+M.+Lowauthor=K.+K.+Ogdenauthor=A.+Khatriauthor=G.+A.+Vargishauthor=K.+A.+Pelkeyauthor=L.+Tricoireauthor=D.+C.+Liottaauthor=Y.+Smithauthor=C.+J.+McBainauthor=S.+F.+Traynelis&title=GluN2D-containing+N-methyl-D-aspartate+receptors+mediate+synaptic+transmission+in+hippocampal+interneurons+and+regulate+interneuron+activity&doi=10.1124%2Fmol.116.105130"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">GluN2D-containing N-methyl-D-aspartate receptors mediate synaptic transmission in hippocampal interneurons and regulate interneuron activity</span></div><div class="casAuthors">Perszyk, Riley E.; DiRaddo, John O.; Strong, Katie L.; Low, Chian-Ming; Ogden, Kevin K.; Khatri, Alpa; Vargish, Geoffrey A.; Pelkey, Kenneth A.; Tricoire, Ludovic; Liotta, Dennis C.; Smith, Yoland; McBain, Chris J.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">689-702</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate receptors (NMDARs) are ionotropic glutamatergic receptors that have been implicated in learning, development, and neuropathol. conditions.  They are typically composed of GluN1 and GluN2A-D subunits.  Whereas a great deal is known about the role of GluN2A- and GluN2Bcontaining NMDARs, much less is known about GluN2Dcontaining NMDARs.  Here we explore the subunit compn. of synaptic NMDARs on hippocampal interneurons.  GluN2D mRNA was detected by single-cell PCR and in situ hybridization in diverse interneuron subtypes in the CA1 region of the hippocampus.  The GluN2D subunit was detectable by immunoblotting and immunohistochem. in all subfields of the hippocampus in young and adult mice.  In whole-cell patch-clamp recordings from acute hippocampal slices, (+)-CIQ, the active enantiomer of the pos. allosteric modulator CIQ, significantly enhanced the amplitude of the NMDAR component of miniature excitatory postsynaptic currents (mEPSCs) in CA1 interneurons but not in pyramidal cells. (+)-CIQ had no effect in slices from Grin2d-/- mice, suggesting that GluN2D-contg. NMDARs participate in excitatory synaptic transmission onto hippocampal interneurons.  The time course of the NMDAR component of the mEPSC was unaffected by (+)-CIQ potentiation and was not accelerated in slices from Grin2d-/- mice compared with wild-type, suggesting that GluN2D does not detectably slow the NMDAR EPSC time course at this age. (+)-CIQ increased the activity of CA1 interneurons as detected by the rate and net charge transfer of spontaneous inhibitory postsynaptic currents (sIPSCs) recorded from CA1 pyramidal cells.  These data provide evidence that interneurons contain synaptic NMDARs possessing a GluN2D subunit, which can influence interneuron function and signal processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-PEPLEcqOlbVg90H21EOLACvtfcHk0liTmMgraYU0yA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitValu7k%253D&md5=5c132034fc27420661791a3d8e3839ea</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1124%2Fmol.116.105130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.116.105130%26sid%3Dliteratum%253Aachs%26aulast%3DPerszyk%26aufirst%3DR.%2BE.%26aulast%3DDiRaddo%26aufirst%3DJ.%2BO.%26aulast%3DStrong%26aufirst%3DK.%2BL.%26aulast%3DLow%26aufirst%3DC.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DVargish%26aufirst%3DG.%2BA.%26aulast%3DPelkey%26aufirst%3DK.%2BA.%26aulast%3DTricoire%26aufirst%3DL.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DSmith%26aufirst%3DY.%26aulast%3DMcBain%26aufirst%3DC.%2BJ.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DGluN2D-containing%2520N-methyl-D-aspartate%2520receptors%2520mediate%2520synaptic%2520transmission%2520in%2520hippocampal%2520interneurons%2520and%2520regulate%2520interneuron%2520activity%26jtitle%3DMol.%2520Pharmacol.%26date%3D2016%26volume%3D90%26spage%3D689%26epage%3D702%26doi%3D10.1124%2Fmol.116.105130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">von Engelhardt, J.</span>; <span class="NLM_string-name">Bocklisch, C.</span>; <span class="NLM_string-name">TÃ¶nges, L.</span>; <span class="NLM_string-name">Herb, A.</span>; <span class="NLM_string-name">Mishina, M.</span>; <span class="NLM_string-name">Monyer, H.</span></span> <span> </span><span class="NLM_article-title">GluN2D-containing NMDA receptors-mediate synaptic currents in hippocampal interneurons and pyramidal cells in juvenile mice</span> <i>Front. Cell Neurosci.</i> [Online].<span class="refDoi">Â DOI: 10.3389/fncel.2015.00095</span> . Published Online: Mar 25, <span class="NLM_year">2015</span>, <a href="https://www.frontiersin.org/articles/10.3389/fncel.2015.00095/full" class="extLink">https://www.frontiersin.org/articles/10.3389/fncel.2015.00095/full</a> (accessed Jun 11, 2020).</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.3389%2Ffncel.2015.00095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=25859181" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+von+Engelhardt&author=C.+Bocklisch&author=L.+T%C3%B6nges&author=A.+Herb&author=M.+Mishina&author=H.+Monyer&title=GluN2D-containing+NMDA+receptors-mediate+synaptic+currents+in+hippocampal+interneurons+and+pyramidal+cells+in+juvenile+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2015.00095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.3389%252Ffncel.2015.00095%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BEngelhardt%26aufirst%3DJ.%26atitle%3DGluN2D-containing%2520NMDA%2520receptors-mediate%2520synaptic%2520currents%2520in%2520hippocampal%2520interneurons%2520and%2520pyramidal%2520cells%2520in%2520juvenile%2520mice%26jtitle%3DFront.%2520Cell%2520Neurosci.%26doi%3D10.3389%2Ffncel.2015.00095%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullasseril, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtkaya, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santangelo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellano, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>, <span class="NLM_elocation-id">90</span> <span class="refDoi">Â DOI: 10.1038/ncomms1085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2Fncomms1085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=20981015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BC3cbislehtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&author=P.+Mullasserilauthor=K.+B.+Hansenauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=H.+Yuanauthor=N.+L.+Kurtkayaauthor=R.+Santangeloauthor=A.+G.+Orrauthor=P.+Leauthor=K.+M.+Vellanoauthor=D.+C.+Liottaauthor=S.+F.+Traynelis&title=A+subunit-selective+potentiator+of+NR2C-+and+NR2D-containing+NMDA+receptors&doi=10.1038%2Fncomms1085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors</span></div><div class="casAuthors">Mullasseril Praseeda; Hansen Kasper B; Vance Katie M; Ogden Kevin K; Yuan Hongjie; Kurtkaya Natalie L; Santangelo Rose; Orr Anna G; Le Phuong; Vellano Kimberly M; Liotta Dennis C; Traynelis Stephen F</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">90</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">NMDA receptors are tetrameric complexes of NR1 and NR2A-D subunits that mediate excitatory synaptic transmission and have a role in neurological disorders.  In this article, we identify a novel subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit, which could allow selective modification of circuit function in regions expressing NR2C/D subunits.  The substituted tetrahydroisoquinoline CIQ (3-chlorophenyl)(6,7-dimethoxy-1-((4-methoxyphenoxy)methyl)-3,4-dihydroisoquinolin-2(1H)-yl)methanone) enhances receptor responses two-fold with an EC(50) of 3 Î¼M by increasing channel opening frequency without altering mean open time or EC(50) values for glutamate or glycine.  The actions of CIQ depend on a single residue in the M1 region (NR2D Thr592) and on the linker between the N-terminal domain and agonist binding domain.  CIQ potentiates native NR2D-containing NMDA receptor currents from subthalamic neurons.  Our identification of a subunit-selective NMDA receptor modulator reveals a new class of pharmacological tools with which to probe the role of NR2C- and NR2D-containing NMDA receptors in brain function and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOCqf6rsXbPtyzdcP07UmufW6udTcc2ebssmnMfRnTwrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbislehtA%253D%253D&md5=8cde7c73dc6bf72ea3050c21db4f5ad4</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fncomms1085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1085%26sid%3Dliteratum%253Aachs%26aulast%3DMullasseril%26aufirst%3DP.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DKurtkaya%26aufirst%3DN.%2BL.%26aulast%3DSantangelo%26aufirst%3DR.%26aulast%3DOrr%26aufirst%3DA.%2BG.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DVellano%26aufirst%3DK.%2BM.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DA%2520subunit-selective%2520potentiator%2520of%2520NR2C-%2520and%2520NR2D-containing%2520NMDA%2520receptors%26jtitle%3DNat.%2520Commun.%26date%3D2010%26volume%3D1%26doi%3D10.1038%2Fncomms1085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santangelo
Freel, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strong, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chepiga, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure activity relationship of tetrahydroisoquinoline-based potentiators of GluN2C and GluN2D containing N-methyl-D-aspartate receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5351</span>â <span class="NLM_lpage">5381</span>, <span class="refDoi">Â DOI: 10.1021/jm400177t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400177t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslSntbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5351-5381&author=R.+M.+Santangelo%0AFreelauthor=K.+K.+Ogdenauthor=K.+L.+Strongauthor=A.+Khatriauthor=K.+M.+Chepigaauthor=H.+S.+Jensenauthor=S.+F.+Traynelisauthor=D.+C.+Liotta&title=Synthesis+and+structure+activity+relationship+of+tetrahydroisoquinoline-based+potentiators+of+GluN2C+and+GluN2D+containing+N-methyl-D-aspartate+receptors&doi=10.1021%2Fjm400177t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure Activity Relationship of Tetrahydroisoquinoline-Based Potentiators of GluN2C and GluN2D Containing N-Methyl-D-aspartate Receptors</span></div><div class="casAuthors">Santangelo Freel, Rose M.; Ogden, Kevin K.; Strong, Katie L.; Khatri, Alpa; Chepiga, Kathryn M.; Jensen, Henrik S.; Traynelis, Stephen F.; Liotta, Dennis C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5351-5381</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe here the synthesis and evaluation of a series of tetrahydroisoquinolines (e.g., I) that show subunit-selective potentiation of NMDA receptors contg. the GluN2C or GluN2D subunits.  Bischler-Napieralski conditions were employed in the key step for the conversion of acyclic amides to the corresponding tetrahydroisoquinoline-contg. analogs.  Compds. were evaluated using both two-electrode voltage clamp recordings from Xenopus laevis oocytes and imaging of mammalian BHK cells loaded with Ca2+-sensitive dyes.  The most potent analogs had EC50 values of 300 nM and showed over 2-fold potentiation of the response to maximally effective concns. of glutamate and glycine but had no effect on responses from NMDA receptors contg. the GluN2A or GluN2B subunits AMPA, kainate, and GABA or glycine receptors or a variety of other potential targets.  These compds. represent a potent class of small mol. subunit-selective potentiators of NMDA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo3icU__XjyrVg90H21EOLACvtfcHk0lht_-3QE8JZ4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslSntbY%253D&md5=65951c8ac931b520be03667476ab3aad</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm400177t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400177t%26sid%3Dliteratum%253Aachs%26aulast%3DSantangelo%2BFreel%26aufirst%3DR.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DStrong%26aufirst%3DK.%2BL.%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DChepiga%26aufirst%3DK.%2BM.%26aulast%3DJensen%26aufirst%3DH.%2BS.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26atitle%3DSynthesis%2520and%2520structure%2520activity%2520relationship%2520of%2520tetrahydroisoquinoline-based%2520potentiators%2520of%2520GluN2C%2520and%2520GluN2D%2520containing%2520N-methyl-D-aspartate%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5351%26epage%3D5381%26doi%3D10.1021%2Fjm400177t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nouhi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chergui, K.</span></span> <span> </span><span class="NLM_article-title">CIQ, a positive allosteric modulator of GluN2C/D-containing N-methyl-d-aspartate receptors, rescues striatal synaptic plasticity deficit in a mouse model of Parkinsonâs disease</span>. <i>CNS Neurosci. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">144</span>â <span class="NLM_lpage">153</span>, <span class="refDoi">Â DOI: 10.1111/cns.12784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1111%2Fcns.12784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=29230960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFKju7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=144-153&author=M.+Nouhiauthor=X.+Zhangauthor=N.+Yaoauthor=K.+Chergui&title=CIQ%2C+a+positive+allosteric+modulator+of+GluN2C%2FD-containing+N-methyl-d-aspartate+receptors%2C+rescues+striatal+synaptic+plasticity+deficit+in+a+mouse+model+of+Parkinson%E2%80%99s+disease&doi=10.1111%2Fcns.12784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">CIQ, a positive allosteric modulator of GluN2C/D-containing N-methyl-D-aspartate receptors, rescues striatal synaptic plasticity deficit in a mouse model of Parkinson's disease</span></div><div class="casAuthors">Nouhi, Mona; Zhang, Xiaoqun; Yao, Ning; Chergui, Karima</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144-153</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Aims : To investigate if CIQ, a pos. allosteric modulator of N-methyl-D-aspartate receptors (NMDARs) contg. GluN2C/D subunits, rescues the loss of long-term potentiation (LTP) and forelimb-use asymmetry in a mouse model of Parkinson's disease (PD).  Methods : We have used electrophysiol. in brain slices and the cylinder test to examine the effect of CIQ on glutamatergic synaptic transmission, synaptic plasticity, and forelimb-use in the unilateral 6-hydroxydopamine-lesion mouse model of PD.  Results : CIQ, applied in the perfusion soln., reversibly reduced glutamatergic synaptic transmission in the dopamine-depleted striatum and had no effect in the dopamine-intact striatum.  LTP, a dopamine- and NMDAR-dependent form of synaptic plasticity, was induced in the dopamine-intact striatum but was lost in the dopamine-depleted striatum.  This impaired LTP was restored in the presence of CIQ applied in the perfusion soln.  This treatment, however, prevented LTP induction in control slices.  In brain slices from mice which received single and chronic i.p. injections of CIQ, LTP was restored in the dopamine-depleted striatum and unaffected in the dopamine-intact striatum.  Forelimb-use asymmetry, a test which assesses deficits in paw usage in the unilateral lesion model of PD, was reversed by systemic chronic treatment with CIQ.  Conclusion : A pos. allosteric modulator of GluN2C/D-contg. NMDARs rescues LTP and forelimb-use asymmetry in a mouse model of PD.  This study proposes GluN2D as a potential candidate for therapeutic intervention in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVXh0w-u7o-LVg90H21EOLACvtfcHk0lht_-3QE8JZ4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFKju7w%253D&md5=cbe6e8f4d2808a4c8e913ec16ae00ea7</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1111%2Fcns.12784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcns.12784%26sid%3Dliteratum%253Aachs%26aulast%3DNouhi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DChergui%26aufirst%3DK.%26atitle%3DCIQ%252C%2520a%2520positive%2520allosteric%2520modulator%2520of%2520GluN2C%252FD-containing%2520N-methyl-d-aspartate%2520receptors%252C%2520rescues%2520striatal%2520synaptic%2520plasticity%2520deficit%2520in%2520a%2520mouse%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2018%26volume%3D24%26spage%3D144%26epage%3D153%26doi%3D10.1111%2Fcns.12784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heldt, S. A.</span></span> <span> </span><span class="NLM_article-title">Potentiation of GluN2C/D NMDA receptor subtypes in the amygdala facilitates the retention of fear and extinction learning in mice</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">625</span>â <span class="NLM_lpage">637</span>, <span class="refDoi">Â DOI: 10.1038/npp.2013.241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2Fnpp.2013.241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=24008353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFynurfM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=625-637&author=K.+K.+Ogdenauthor=A.+Khatriauthor=S.+F.+Traynelisauthor=S.+A.+Heldt&title=Potentiation+of+GluN2C%2FD+NMDA+receptor+subtypes+in+the+amygdala+facilitates+the+retention+of+fear+and+extinction+learning+in+mice&doi=10.1038%2Fnpp.2013.241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of GluN2C/D NMDA Receptor Subtypes in the Amygdala Facilitates the Retention of Fear and Extinction Learning in Mice</span></div><div class="casAuthors">Ogden, Kevin K.; Khatri, Alpa; Traynelis, Stephen F.; Heldt, Scott A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">625-637</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">NMDA receptors are glutamate receptor ion channels that contribute to synaptic plasticity and are important for many forms of learning and memory.  In the amygdala, NMDA receptors are crit. for the acquisition, retention, and extinction of classically conditioned fear responses.  Although the GluN2B subunit has been implicated in both the acquisition and extinction of conditioned fear, GluN2C-knockout mice show reduced conditioned fear responses.  Moreover, D-cycloserine (DCS), which facilitates fear extinction, selectively enhances the activity of GluN2C-contg. NMDA receptors.  To further define the contribution of GluN2C receptors to fear learning, we infused the GluN2C/GluN2D-selective potentiator CIQ bilaterally into the basolateral amygdala (3, 10, or 30 Î¼g/side) following either fear conditioning or fear extinction training.  CIQ both increased the expression of conditioned fear 24 h later and enhanced the extinction of the previously conditioned fear response.  These results support a crit. role for GluN2C receptors in the amygdala in the consolidation of learned fear responses and suggest that increased activity of GluN2C receptors may underlie the therapeutic actions of DCS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH3PU52ifV_7Vg90H21EOLACvtfcHk0lhGspNEhxLn4Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFynurfM&md5=20d2789ed3331e5f48d147ac21ec6436</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2013.241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2013.241%26sid%3Dliteratum%253Aachs%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DHeldt%26aufirst%3DS.%2BA.%26atitle%3DPotentiation%2520of%2520GluN2C%252FD%2520NMDA%2520receptor%2520subtypes%2520in%2520the%2520amygdala%2520facilitates%2520the%2520retention%2520of%2520fear%2520and%2520extinction%2520learning%2520in%2520mice%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D625%26epage%3D637%26doi%3D10.1038%2Fnpp.2013.241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shelkar, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavuluri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravikrishnan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gawande, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stairs, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugale, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dravid, S. M.</span></span> <span> </span><span class="NLM_article-title">Differential effect of NMDA receptor GluN2C and GluN2D subunit ablation on behavior and channel blocker-induced schizophrenia phenotypes</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">7572</span> <span class="refDoi">Â DOI: 10.1038/s41598-019-43957-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2Fs41598-019-43957-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=31110197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BB3M7nvV2qug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&author=G.+P.+Shelkarauthor=P.+Pavuluriauthor=P.+J.+Gandhiauthor=A.+Ravikrishnanauthor=D.+Y.+Gawandeauthor=J.+Liuauthor=D.+J.+Stairsauthor=R.+R.+Ugaleauthor=S.+M.+Dravid&title=Differential+effect+of+NMDA+receptor+GluN2C+and+GluN2D+subunit+ablation+on+behavior+and+channel+blocker-induced+schizophrenia+phenotypes&doi=10.1038%2Fs41598-019-43957-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effect of NMDA receptor GluN2C and GluN2D subunit ablation on behavior and channel blocker-induced schizophrenia phenotypes</span></div><div class="casAuthors">Shelkar Gajanan P; Pavuluri Ratnamala; Gandhi Pauravi J; Ravikrishnan Aparna; Gawande Dinesh Y; Liu Jinxu; Dravid Shashank M; Stairs Dustin J; Ugale Rajesh R</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7572</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The GluN2C- and GluN2D-containing NMDA receptors are distinct from GluN2A- and GluN2B-containing receptors in many aspects including lower sensitivity to Mg(2+) block and lack of desensitization.  Recent studies have highlighted the unique contribution of GluN2C and GluN2D subunits in various aspects of neuronal and circuit function and behavior, however a direct comparison of the effect of ablation of these subunits in mice on pure background strain has not been conducted.  Using knockout-first strains for the GRIN2C and GRIN2D produced on pure C57BL/6N strain, we compared the effect of partial or complete ablation of GluN2C and GluN2D subunit on various behaviors relevant to mental disorders.  A large number of behaviors described previously in GluN2C and GluN2D knockout mice were reproduced in these mice, however, some specific differences were also observed possibly representing strain effects.  We also examined the response to NMDA receptor channel blockers in these mouse strains and surprisingly found that unlike previous reports GluN2D knockout mice were not resistant to phencyclidine-induced hyperlocomotion.  Interestingly, the GluN2C knockout mice showed reduced sensitivity to phencyclidine-induced hyperlocomotion.  We also found that NMDA receptor channel blocker produced a deficit in prepulse inhibition which was prevented by a GluN2C/2D potentiator in wildtype and GluN2C heterozygous mice but not in GluN2C knockout mice.  Together these results demonstrate a unique role of GluN2C subunit in schizophrenia-like behaviors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSWYwi-aOJLuR_TJajKxJDfW6udTcc2eZnLE8rqaeAIrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7nvV2qug%253D%253D&md5=548cde7ed4a0ce94721e9e766a5b1b00</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-43957-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-43957-2%26sid%3Dliteratum%253Aachs%26aulast%3DShelkar%26aufirst%3DG.%2BP.%26aulast%3DPavuluri%26aufirst%3DP.%26aulast%3DGandhi%26aufirst%3DP.%2BJ.%26aulast%3DRavikrishnan%26aufirst%3DA.%26aulast%3DGawande%26aufirst%3DD.%2BY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DStairs%26aufirst%3DD.%2BJ.%26aulast%3DUgale%26aufirst%3DR.%2BR.%26aulast%3DDravid%26aufirst%3DS.%2BM.%26atitle%3DDifferential%2520effect%2520of%2520NMDA%2520receptor%2520GluN2C%2520and%2520GluN2D%2520subunit%2520ablation%2520on%2520behavior%2520and%2520channel%2520blocker-induced%2520schizophrenia%2520phenotypes%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26doi%3D10.1038%2Fs41598-019-43957-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strong, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epplin, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacsa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butch, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menaldino, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span> <span> </span><span class="NLM_article-title">The structure-activity relationship of a tetrahydroisoquinoline class of N-methyl-D-aspartate receptor modulators that potentiate GluN2B-containing N-methyl-D-aspartate receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5556</span>â <span class="NLM_lpage">5585</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b00239</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00239" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1KmsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5556-5585&author=K.+L.+Strongauthor=M.+P.+Epplinauthor=J.+Bacsaauthor=C.+J.+Butchauthor=P.+B.+Burgerauthor=D.+S.+Menaldinoauthor=S.+F.+Traynelisauthor=D.+C.+Liotta&title=The+structure-activity+relationship+of+a+tetrahydroisoquinoline+class+of+N-methyl-D-aspartate+receptor+modulators+that+potentiate+GluN2B-containing+N-methyl-D-aspartate+receptors&doi=10.1021%2Facs.jmedchem.7b00239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">The Structure-Activity Relationship of a Tetrahydroisoquinoline Class of N-Methyl-d-Aspartate Receptor Modulators that Potentiates GluN2B-Containing N-Methyl-d-Aspartate Receptors</span></div><div class="casAuthors">Strong, Katie L.; Epplin, Matthew P.; Bacsa, John; Butch, Christopher J.; Burger, Pieter B.; Menaldino, David S.; Traynelis, Stephen F.; Liotta, Dennis C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5556-5585</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have identified a series of pos. allosteric NMDA receptor (NMDAR) modulators derived from a known class of GluN2C/D-selective tetrahydroisoquinoline analogs that includes CIQ.  The prototypical compd. of this series contains a single isopropoxy moiety in place of the two methoxy substituents present in CIQ.  Modifications of this isopropoxy-contg. scaffold led to the identification of analogs with enhanced activity at the GluN2B subunit.  We identified mols. that potentiate the response of GluN2B/GluN2C/GluN2D, GluN2B/GluN2C, and GluN2C/GluN2D-contg. NMDARs to maximally effective concns. of agonist.  Multiple compds. potentiate the response of NMDARs with submicromolar EC50 values.  Anal. of enantiomeric pairs revealed that the S-(-) enantiomer is active at the GluN2B, GluN2C, and/or GluN2D subunits, whereas the R-(+) enantiomer is only active at GluN2C/D subunits.  These results provide a starting point for the development of selective pos. allosteric modulators for GluN2B-contg. receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4Np5ydh-Xh7Vg90H21EOLACvtfcHk0lhGspNEhxLn4Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1KmsL4%253D&md5=08167b1b31e6b26bcfa0a8303d173e14</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00239%26sid%3Dliteratum%253Aachs%26aulast%3DStrong%26aufirst%3DK.%2BL.%26aulast%3DEpplin%26aufirst%3DM.%2BP.%26aulast%3DBacsa%26aufirst%3DJ.%26aulast%3DButch%26aufirst%3DC.%2BJ.%26aulast%3DBurger%26aufirst%3DP.%2BB.%26aulast%3DMenaldino%26aufirst%3DD.%2BS.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26atitle%3DThe%2520structure-activity%2520relationship%2520of%2520a%2520tetrahydroisoquinoline%2520class%2520of%2520N-methyl-D-aspartate%2520receptor%2520modulators%2520that%2520potentiate%2520GluN2B-containing%2520N-methyl-D-aspartate%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5556%26epage%3D5585%26doi%3D10.1021%2Facs.jmedchem.7b00239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volgraf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J. E.</span></span> <span> </span><span class="NLM_article-title">A novel NMDA receptor positive allosteric modulator that acts via the transmembrane domain</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">204</span>â <span class="NLM_lpage">218</span>, <span class="refDoi">Â DOI: 10.1016/j.neuropharm.2017.04.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2Fj.neuropharm.2017.04.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=28457974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsFentLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2017&pages=204-218&author=T.-M.+Wangauthor=B.+M.+Brownauthor=L.+Dengauthor=B.+D.+Sellersauthor=P.+L.+Lupardusauthor=H.+J.+A.+Wallweberauthor=A.+Gustafsonauthor=E.+Wongauthor=M.+Volgrafauthor=J.+B.+Schwarzauthor=D.+H.+Hackosauthor=J.+E.+Hanson&title=A+novel+NMDA+receptor+positive+allosteric+modulator+that+acts+via+the+transmembrane+domain&doi=10.1016%2Fj.neuropharm.2017.04.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">A novel NMDA receptor positive allosteric modulator that acts via the transmembrane domain</span></div><div class="casAuthors">Wang, Tzu-Ming; Brown, Brandon M.; Deng, Lunbin; Sellers, Benjamin D.; Lupardus, Patrick J.; Wallweber, Heidi J. A.; Gustafson, Amy; Wong, Evera; Volgraf, Matthew; Schwarz, Jacob B.; Hackos, David H.; Hanson, Jesse E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">204-218</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ionotropic glutamate receptors (iGluRs) mediate fast excitatory neurotransmission and are key nervous system drug targets.  While diverse pharmacol. tools have yielded insight into iGluR extracellular domain function, less is known about mol. mechanisms underlying the ion conduction gating process within the transmembrane domain (TMD).  We have discovered a novel NMDAR pos. allosteric modulator (PAM), GNE-9278, with a unique binding site on the extracellular surface of the TMD.  Mutation of a single residue near the Lurcher motif on GluN1 M3 can convert GNE-9278 modulation from pos. to neg., and replacing three AMPAR pre-M1 residues with corresponding NMDAR residues can confer GNE-9278 sensitivity to AMPARs.  Modulation by GNE-9278 is state-dependent and significantly alters extracellular domain pharmacol.  The unique properties and structural determinants of GNE-9278 reveal new modulatory potential of the iGluR TMD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlpDlNo3PXSrVg90H21EOLACvtfcHk0liN272f2kN0oA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsFentLk%253D&md5=e868c18884abbb5c63de5adb5873660c</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2017.04.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2017.04.041%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.-M.%26aulast%3DBrown%26aufirst%3DB.%2BM.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DSellers%26aufirst%3DB.%2BD.%26aulast%3DLupardus%26aufirst%3DP.%2BL.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DWong%26aufirst%3DE.%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DHanson%26aufirst%3DJ.%2BE.%26atitle%3DA%2520novel%2520NMDA%2520receptor%2520positive%2520allosteric%2520modulator%2520that%2520acts%2520via%2520the%2520transmembrane%2520domain%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D121%26spage%3D204%26epage%3D218%26doi%3D10.1016%2Fj.neuropharm.2017.04.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ceccon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumbaugh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicini, S.</span></span> <span> </span><span class="NLM_article-title">Distinct effect of pregnenolone sulfate on NMDA receptor subtypes</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">491</span>â <span class="NLM_lpage">500</span>, <span class="refDoi">Â DOI: 10.1016/S0028-3908(00)00197-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2FS0028-3908%2800%2900197-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=11249958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslyltbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=491-500&author=M.+Cecconauthor=G.+Rumbaughauthor=S.+Vicini&title=Distinct+effect+of+pregnenolone+sulfate+on+NMDA+receptor+subtypes&doi=10.1016%2FS0028-3908%2800%2900197-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct effect of pregnenolone sulfate on NMDA receptor subtypes</span></div><div class="casAuthors">Ceccon, M.; Rumbaugh, G.; Vicini, S.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">491-500</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Using rapid agonist applications to transfected HEK-293 cells, the authors investigated pregnenolone sulfate (PS) effects on deactivation and desensitization of recombinant NMDA receptors subtypes.  PS prolonged the deactivation of responses produced by brief applications of L-glutamate with all subunit combinations tested.  The action of PS was larger on NR1a/NR2A than on NR1a/NR2B channels.  PS slowed the rate of macroscopic desensitization of the responses with all subunit combinations tested.  In contrast, PS had little effect on current rise time and had much reduced action on responses with L-cysteate, a low affinity agonist.  The authors' results suggest that PS decreases agonist unbinding.  However, this action is counteracted by decreased desensitization.  Since desensitization produces slow deactivating components, particularly with NR1a/NR2B receptors, this underlies the decreased PS effect with these subtypes.  Indeed PS action was mainly obsd. on the fast component of deactivation.  Furthermore, prolongation of NR1a/NR2A responses was similar to that of responses from NR1b/NR2B receptor, a subtype characterized by reduced desensitization.  PS prolongation of evoked NMDA receptor mediated synaptic currents from cortical neuronal primary culture(s) was not significantly different from that of responses with NR1a/NR2B receptors indicating that native receptors in these neurons comprised at least some heteromeric combinations of these two subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgeasen5m0gbVg90H21EOLACvtfcHk0liN272f2kN0oA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslyltbw%253D&md5=838bf88a82d875e6dd175ead35707e1b</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2800%2900197-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252800%252900197-0%26sid%3Dliteratum%253Aachs%26aulast%3DCeccon%26aufirst%3DM.%26aulast%3DRumbaugh%26aufirst%3DG.%26aulast%3DVicini%26aufirst%3DS.%26atitle%3DDistinct%2520effect%2520of%2520pregnenolone%2520sulfate%2520on%2520NMDA%2520receptor%2520subtypes%26jtitle%3DNeuropharmacology%26date%3D2001%26volume%3D40%26spage%3D491%26epage%3D500%26doi%3D10.1016%2FS0028-3908%2800%2900197-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belfort, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linsenbardt, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izumi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mennerick, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorumski, C. F.</span></span> <span> </span><span class="NLM_article-title">The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">17290</span>â <span class="NLM_lpage">17300</span>, <span class="refDoi">Â DOI: 10.1523/JNEUROSCI.2619-13.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1523%2FJNEUROSCI.2619-13.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=24174662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCjtrbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=17290-17300&author=S.+M.+Paulauthor=J.+J.+Dohertyauthor=A.+J.+Robichaudauthor=G.+M.+Belfortauthor=B.+Y.+Chowauthor=R.+S.+Hammondauthor=D.+C.+Crawfordauthor=A.+J.+Linsenbardtauthor=H.-J.+Shuauthor=Y.+Izumiauthor=S.+J.+Mennerickauthor=C.+F.+Zorumski&title=The+major+brain+cholesterol+metabolite+24%28S%29-hydroxycholesterol+is+a+potent+allosteric+modulator+of+N-methyl-D-aspartate+receptors&doi=10.1523%2FJNEUROSCI.2619-13.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors</span></div><div class="casAuthors">Paul, Steven M.; Doherty, James J.; Robichaud, Albert J.; Belfort, Gabriel M.; Chow, Brian Y.; Hammond, Rebecca S.; Crawford, Devon C.; Linsenbardt, Andrew J.; Shu, Hong-Jin; Izumi, Yukitoshi; Mennerick, Steven J.; Zorumski, Charles F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">17290-17300</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate receptors (NMDARs) are glutamate-gated ion channels that are crit. to the regulation of excitatory synaptic function in the CNS.  NMDARs govern experience-dependent synaptic plasticity and have been implicated in the pathophysiol. of various neuropsychiatric disorders including the cognitive deficits of schizophrenia and certain forms of autism.  Certain neurosteroids modulate NMDARs exptl. but their low potency, poor selectivity, and very low brain concns. make them poor candidates as endogenous ligands or therapeutic agents.  Here we show that the major brain-derived cholesterol metabolite 24(S)-hydroxycholesterol (24(S)-HC) is a very potent, direct, and selective pos. allosteric modulator of NMDARs with a mechanism that does not overlap that of other allosteric modulators.  At submicromolar concns. 24(S)-HC potentiates NMDAR-mediated EPSCs in rat hippocampal neurons but fails to affect AMPAR or GABAA receptors (GABAARs)-mediated responses.  Cholesterol itself and other naturally occurring oxysterols present in brain do not modulate NMDARs at concns. â¤10 Î¼M.  In hippocampal slices, 24(S)-HC enhances the ability of subthreshold stimuli to induce long-term potentiation (LTP).  24(S)-HC also reverses hippocampal LTP deficits induced by the NMDAR channel blocker ketamine.  Finally, we show that synthetic drug-like derivs. of 24(S)-HC, which potently enhance NMDAR-mediated EPSCs and LTP, restore behavioral and cognitive deficits in rodents treated with NMDAR channel blockers.  Thus, 24(S)-HC may function as an endogenous modulator of NMDARs acting at a novel oxysterol modulatory site that also represents a target for therapeutic drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDNdn3JBVmtLVg90H21EOLACvtfcHk0liN272f2kN0oA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCjtrbI&md5=35ab8bb8030a4ac752f224f8cd942fb4</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2619-13.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2619-13.2013%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DDoherty%26aufirst%3DJ.%2BJ.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26aulast%3DBelfort%26aufirst%3DG.%2BM.%26aulast%3DChow%26aufirst%3DB.%2BY.%26aulast%3DHammond%26aufirst%3DR.%2BS.%26aulast%3DCrawford%26aufirst%3DD.%2BC.%26aulast%3DLinsenbardt%26aufirst%3DA.%2BJ.%26aulast%3DShu%26aufirst%3DH.-J.%26aulast%3DIzumi%26aufirst%3DY.%26aulast%3DMennerick%26aufirst%3DS.%2BJ.%26aulast%3DZorumski%26aufirst%3DC.%2BF.%26atitle%3DThe%2520major%2520brain%2520cholesterol%2520metabolite%252024%2528S%2529-hydroxycholesterol%2520is%2520a%2520potent%2520allosteric%2520modulator%2520of%2520N-methyl-D-aspartate%2520receptors%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D17290%26epage%3D17300%26doi%3D10.1523%2FJNEUROSCI.2619-13.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volgraf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villemure, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L. F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liederer, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plise, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirksen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietz, M. G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scearce-Levie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Discovery of GluN2A-selective NMDA receptor positive allosteric modulators (PAMs): tuning deactivation kinetics via structure-based design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2760</span>â <span class="NLM_lpage">2779</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b02010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b02010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1ynt70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2760-2779&author=M.+Volgrafauthor=B.+D.+Sellersauthor=Y.+Jiangauthor=G.+Wuauthor=C.+Q.+Lyauthor=E.+Villemureauthor=R.+M.+Pastorauthor=P.+Yuenauthor=A.+Luauthor=X.+Luoauthor=M.+Liuauthor=S.+Zhangauthor=L.+F.+Y.+Sunauthor=P.+J.+Lupardusauthor=H.+J.+A.+Wallweberauthor=B.+M.+Liedererauthor=G.+Deshmukhauthor=E.+Pliseauthor=S.+Tayauthor=P.+Reynenauthor=J.+Herringtonauthor=A.+Gustafsonauthor=Y.+Liuauthor=A.+Dirksenauthor=M.+G.+A.+Dietzauthor=Y.+Liuauthor=T.-M.+Wangauthor=J.+E.+Hansonauthor=D.+Hackosauthor=K.+Scearce-Levieauthor=J.+B.+Schwarz&title=Discovery+of+GluN2A-selective+NMDA+receptor+positive+allosteric+modulators+%28PAMs%29%3A+tuning+deactivation+kinetics+via+structure-based+design&doi=10.1021%2Facs.jmedchem.5b02010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design</span></div><div class="casAuthors">Volgraf, Matthew; Sellers, Benjamin D.; Jiang, Yu; Wu, Guosheng; Ly, Cuong Q.; Villemure, Elisia; Pastor, Richard M.; Yuen, Po-wai; Lu, Aijun; Luo, Xifeng; Liu, Mingcui; Zhang, Shun; Sun, Liang; Fu, Yuhong; Lupardus, Patrick J.; Wallweber, Heidi J. A.; Liederer, Bianca M.; Deshmukh, Gauri; Plise, Emile; Tay, Suzanne; Reynen, Paul; Herrington, James; Gustafson, Amy; Liu, Yichin; Dirksen, Akim; Dietz, Matthias G. A.; Liu, Yanzhou; Wang, Tzu-Ming; Hanson, Jesse E.; Hackos, David; Scearce-Levie, Kimberly; Schwarz, Jacob B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2760-2779</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The N-methyl-D-aspartate receptor (NMDAR) is a Na+ and Ca2+ permeable ionotropic glutamate receptor that is activated by the coagonists glycine and glutamate.  NMDARs are crit. to synaptic signaling and plasticity, and their dysfunction has been implicated in a no. of neurol. disorders, including schizophrenia, depression, and Alzheimer's disease.  Herein we describe the discovery of potent GluN2A-selective NMDAR pos. allosteric modulators (PAMs) starting from a high-throughput screening hit.  Using structure-based design, we sought to increase potency at the GluN2A subtype, while improving selectivity against related Î±-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs).  The structure-activity relationship of channel deactivation kinetics was studied using a combination of electrophysiol. and protein crystallog.  Effective incorporation of these strategies resulted in the discovery of GNE-0723 (46), a highly potent and brain penetrant GluN2A-selective NMDAR PAM suitable for in vivo characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdza-qdjBnZbVg90H21EOLACvtfcHk0ljQrrZ4DoaPlw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1ynt70%253D&md5=2d9f7199cd3d9d9ac513006612e9bb01</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b02010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b02010%26sid%3Dliteratum%253Aachs%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DB.%2BD.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DLy%26aufirst%3DC.%2BQ.%26aulast%3DVillemure%26aufirst%3DE.%26aulast%3DPastor%26aufirst%3DR.%2BM.%26aulast%3DYuen%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DL.%2BF.%2BY.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DLiederer%26aufirst%3DB.%2BM.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DReynen%26aufirst%3DP.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDirksen%26aufirst%3DA.%26aulast%3DDietz%26aufirst%3DM.%2BG.%2BA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DT.-M.%26aulast%3DHanson%26aufirst%3DJ.%2BE.%26aulast%3DHackos%26aufirst%3DD.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520of%2520GluN2A-selective%2520NMDA%2520receptor%2520positive%2520allosteric%2520modulators%2520%2528PAMs%2529%253A%2520tuning%2520deactivation%2520kinetics%2520via%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2760%26epage%3D2779%26doi%3D10.1021%2Facs.jmedchem.5b02010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grand, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volgraf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paoletti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J. E.</span></span> <span> </span><span class="NLM_article-title">Positive allosteric modulators of GluN2A-containing NMDARs with distinct modes of action and impacts on circuit function</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">983</span>â <span class="NLM_lpage">999</span>, <span class="refDoi">Â DOI: 10.1016/j.neuron.2016.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2Fj.neuron.2016.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=26875626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFSrtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2016&pages=983-999&author=D.+H.+Hackosauthor=P.+J.+Lupardusauthor=T.+Grandauthor=Y.+Chenauthor=T.-M.+Wangauthor=P.+Reynenauthor=A.+Gustafsonauthor=H.+J.+A.+Wallweberauthor=M.+Volgrafauthor=B.+D.+Sellersauthor=J.+B.+Schwarzauthor=P.+Paolettiauthor=M.+Shengauthor=Q.+Zhouauthor=J.+E.+Hanson&title=Positive+allosteric+modulators+of+GluN2A-containing+NMDARs+with+distinct+modes+of+action+and+impacts+on+circuit+function&doi=10.1016%2Fj.neuron.2016.01.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function</span></div><div class="casAuthors">Hackos, David H.; Lupardus, Patrick J.; Grand, Teddy; Chen, Yelin; Wang, Tzu-Ming; Reynen, Paul; Gustafson, Amy; Wallweber, Heidi J. A.; Volgraf, Matthew; Sellers, Benjamin D.; Schwarz, Jacob B.; Paoletti, Pierre; Sheng, Morgan; Zhou, Qiang; Hanson, Jesse E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">983-999</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">To enhance physiol. function of NMDA receptors (NMDARs), we identified pos. allosteric modulators (PAMs) of NMDARs with selectivity for GluN2A subunit-contg. receptors.  X-ray crystallog. revealed a binding site at the GluN1-GluN2A dimer interface of the extracellular ligand-binding domains (LBDs).  Despite the similarity between the LBDs of NMDARs and AMPA receptors (AMPARs), GluN2A PAMs with good selectivity against AMPARs were identified.  Potentiation was obsd. with recombinant triheteromeric GluN1/GluN2A/GluN2B NMDARs and with synaptically activated NMDARs in brain slices from wild-type (WT), but not GluN2A knockout (KO), mice.  Individual GluN2A PAMs exhibited variable degrees of glutamate (Glu) dependence, impact on NMDAR Glu EC50, and slowing of channel deactivation.  These distinct PAMs also exhibited differential impacts during synaptic plasticity induction.  The identification of a new NMDAR modulatory site and characterization of GluN2A-selective PAMs provide powerful mol. tools to dissect NMDAR function and demonstrate the feasibility of a therapeutically desirable type of NMDAR enhancement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGros48fNAsozLVg90H21EOLACvtfcHk0ljQrrZ4DoaPlw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFSrtbw%253D&md5=38661a9f898df39ba616e77f0bdf34e9</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2016.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2016.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DGrand%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DT.-M.%26aulast%3DReynen%26aufirst%3DP.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DB.%2BD.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26aulast%3DPaoletti%26aufirst%3DP.%26aulast%3DSheng%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DHanson%26aufirst%3DJ.%2BE.%26atitle%3DPositive%2520allosteric%2520modulators%2520of%2520GluN2A-containing%2520NMDARs%2520with%2520distinct%2520modes%2520of%2520action%2520and%2520impacts%2520on%2520circuit%2520function%26jtitle%3DNeuron%26date%3D2016%26volume%3D89%26spage%3D983%26epage%3D999%26doi%3D10.1016%2Fj.neuron.2016.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villemure, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volgraf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liederer, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plise, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scearce-Levie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, B. D.</span></span> <span> </span><span class="NLM_article-title">GluN2A-selective pyridopyrimidinone series of NMDAR positive allosteric modulators with an improved in vivo profile</span>. <i>ACS. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">84</span>â <span class="NLM_lpage">89</span>, <span class="refDoi">Â DOI: 10.1021/acsmedchemlett.6b00388</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00388" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslKgsbbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=84-89&author=E.+Villemureauthor=M.+Volgrafauthor=Y.+Jiangauthor=G.+Wuauthor=C.+Q.+Lyauthor=P.+W.+Yuenauthor=A.+Luauthor=X.+Luoauthor=M.+Liuauthor=S.+Zhangauthor=P.+J.+Lupardusauthor=H.+J.+Wallweberauthor=B.+M.+Liedererauthor=G.+Deshmukhauthor=E.+Pliseauthor=S.+Tayauthor=T.+M.+Wangauthor=J.+E.+Hansonauthor=D.+H.+Hackosauthor=K.+Scearce-Levieauthor=J.+B.+Schwarzauthor=B.+D.+Sellers&title=GluN2A-selective+pyridopyrimidinone+series+of+NMDAR+positive+allosteric+modulators+with+an+improved+in+vivo+profile&doi=10.1021%2Facsmedchemlett.6b00388"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">GluN2A-Selective Pyridopyrimidinone Series of NMDAR Positive Allosteric Modulators with an Improved in Vivo Profile</span></div><div class="casAuthors">Villemure, Elisia; Volgraf, Matthew; Jiang, Yu; Wu, Guosheng; Ly, Cuong Q.; Yuen, Po-wai; Lu, Aijun; Luo, Xifeng; Liu, Mingcui; Zhang, Shun; Lupardus, Patrick J.; Wallweber, Heidi J. A.; Liederer, Bianca M.; Deshmukh, Gauri; Plise, Emile; Tay, Suzanne; Wang, Tzu-Ming; Hanson, Jesse E.; Hackos, David H.; Scearce-Levie, Kimberly; Schwarz, Jacob B.; Sellers, Benjamin D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-89</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The N-methyl-D-aspartate receptor (NMDAR) is an ionotropic glutamate receptor, gated by the endogenous coagonists glutamate and glycine, permeable to Ca2+ and Na+.  NMDAR dysfunction is assocd. with numerous neurol. and psychiatric disorders, including schizophrenia, depression, and Alzheimer's disease.  Recently, the authors have disclosed GNE-0723, a GluN2A subunit-selective and brain-penetrant pos. allosteric modulator (PAM) of NMDARs.  This work highlights the discovery of a related pyridopyrimidinone core with distinct structure-activity relationships, despite the structural similarity to GNE-0723.  GNE-5729, a pyridopyrimidinone-based NMDAR PAM, was identified with both an improved pharmacokinetic profile and increased selectivity against AMPARs.  The authors also include x-ray structure anal. and modeling to propose hypotheses for the activity and selectivity differences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoLJ_nCpoJTLVg90H21EOLACvtfcHk0lgpbLAlRXSuXA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslKgsbbI&md5=8c49858ca424d034efc1f8a9e6c00409</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00388%26sid%3Dliteratum%253Aachs%26aulast%3DVillemure%26aufirst%3DE.%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DLy%26aufirst%3DC.%2BQ.%26aulast%3DYuen%26aufirst%3DP.%2BW.%26aulast%3DLu%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DLiederer%26aufirst%3DB.%2BM.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.%2BM.%26aulast%3DHanson%26aufirst%3DJ.%2BE.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26aulast%3DSellers%26aufirst%3DB.%2BD.%26atitle%3DGluN2A-selective%2520pyridopyrimidinone%2520series%2520of%2520NMDAR%2520positive%2520allosteric%2520modulators%2520with%2520an%2520improved%2520in%2520vivo%2520profile%26jtitle%3DACS.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D84%26epage%3D89%26doi%3D10.1021%2Facsmedchemlett.6b00388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnier-Amblard, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullasseril, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtkaya, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyoneva, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and structure-activity relationship of a novel series of GluN2C-seective potentiators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2334</span>â <span class="NLM_lpage">2356</span>, <span class="refDoi">Â DOI: 10.1021/jm401695d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401695d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKns7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2334-2356&author=S.+S.+Zimmermanauthor=A.+Khatriauthor=E.+C.+Garnier-Amblardauthor=P.+Mullasserilauthor=N.+L.+Kurtkayaauthor=S.+Gyonevaauthor=K.+B.+Hansenauthor=S.+F.+Traynelisauthor=D.+C.+Liotta&title=Design%2C+synthesis%2C+and+structure-activity+relationship+of+a+novel+series+of+GluN2C-seective+potentiators&doi=10.1021%2Fjm401695d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Structure-Activity Relationship of a Novel Series of GluN2C-Selective Potentiators</span></div><div class="casAuthors">Zimmerman, Sommer S.; Khatri, Alpa; Garnier-Amblard, Ethel C.; Mullasseril, Praseeda; Kurtkaya, Natalie L.; Gyoneva, Stefka; Hansen, Kasper B.; Traynelis, Stephen F.; Liotta, Dennis C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2334-2356</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">NMDA receptors are tetrameric complexes composed of GluN1 and GluN2A-D subunits that mediate a slow Ca2+-permeable component of excitatory synaptic transmission.  NMDA receptors have been implicated in a wide range of neurol. diseases and thus represent an important therapeutic target.  We herein describe a novel series of pyrrolidinones, e.g., I, that selectively potentiate only NMDA receptors that contain the GluN2C subunit.  The most active analogs tested were over 100-fold selective for recombinant GluN2C-contg. receptors over GluN2A/B/D-contg. NMDA receptors as well as AMPA and kainate receptors.  This series represents the first class of allosteric potentiators that are selective for diheteromeric GluN2C-contg. NMDA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMrwwwTno41rVg90H21EOLACvtfcHk0lgpbLAlRXSuXA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKns7c%253D&md5=24bfccc53190b69254cf7542fad5966c</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm401695d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401695d%26sid%3Dliteratum%253Aachs%26aulast%3DZimmerman%26aufirst%3DS.%2BS.%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DGarnier-Amblard%26aufirst%3DE.%2BC.%26aulast%3DMullasseril%26aufirst%3DP.%26aulast%3DKurtkaya%26aufirst%3DN.%2BL.%26aulast%3DGyoneva%26aufirst%3DS.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structure-activity%2520relationship%2520of%2520a%2520novel%2520series%2520of%2520GluN2C-seective%2520potentiators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2334%26epage%3D2356%26doi%3D10.1021%2Fjm401695d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanger, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karakas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furukawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">548</span>â <span class="NLM_lpage">560</span>, <span class="refDoi">Â DOI: 10.1124/mol.114.094516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1124%2Fmol.114.094516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=25205677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFSlur3F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=548-560&author=A.+Khatriauthor=P.+B.+Burgerauthor=S.+A.+Swangerauthor=K.+B.+Hansenauthor=S.+Zimmermanauthor=E.+Karakasauthor=D.+C.+Liottaauthor=H.+Furukawaauthor=J.+P.+Snyderauthor=S.+F.+Traynelis&title=Structural+determinants+and+mechanism+of+action+of+a+GluN2C-selective+NMDA+receptor+positive+allosteric+modulator&doi=10.1124%2Fmol.114.094516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator</span></div><div class="casAuthors">Khatri, Alpa; Burger, Pieter B.; Swanger, Sharon A.; Hansen, Kasper B.; Zimmerman, Sommer; Karakas, Erkan; Liotta, Dennis C.; Furukawa, Hiro; Snyder, James P.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">548-560, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">NMDA receptors are tetrameric complexes of GluN1, GluN2A-D, and GluN3A-B subunits and are involved in normal brain function and neurol. disorders.  We identified a novel class of stereoselective pyrrolidinone (PYD) pos. allosteric modulators for GluN2C-contg. NMDA receptors, exemplified by Me 4-(3-acetyl-4-hydroxy-1-[2-(2-methyl-1H-indol-3-yl)ethyl]-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)benzoate.  Here we explore the site and mechanism of action of a prototypical analog, PYD-106, which at 30 Î¼M does not alter responses of NMDA receptors contg. GluN2A, GluN2B, and GluN2D and has no effect on AMPA [Î±-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid] and kainate receptors.  Coapplication of 50 Î¼M PYD-106 with a maximally effective concn. of glutamate and glycine increases the response of GluN1/GluN2C NMDA receptors in HEK-293 cells to 221% of that obtained in the absence of PYD (taken as 100%).  Evaluation of the concn. dependence of this enhancement revealed an EC50 value for PYD of 13 Î¼M.  PYD-106 increased opening frequency and open time of single channel currents activated by maximally effective concns. of agonist but only had modest effects on glutamate and glycine EC50.  PYD-106 selectively enhanced the responses of diheteromeric GluN1/GluN2C receptors but not triheteromeric GluN1/GluN2A/GluN2C receptors.  Inclusion of residues encoded by GluN1-exon 5 attenuated the effects of PYD.  Three GluN2C residues (Arg194, Ser470, Lys470), at which mutagenesis virtually eliminated PYD function, line a cavity at the interface of the ligand binding and the amino terminal domains in a homol. model of GluN1/GluN2C built from crystallog. data on GluN1/GluN2B.  We propose that this domain interface constitutes a new allosteric modulatory site on the NMDA receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO8Jlk1LXDrrVg90H21EOLACvtfcHk0lidNyMVr3bb2A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFSlur3F&md5=ebc48a2c667046b1adab7037868278e1</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1124%2Fmol.114.094516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.114.094516%26sid%3Dliteratum%253Aachs%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DBurger%26aufirst%3DP.%2BB.%26aulast%3DSwanger%26aufirst%3DS.%2BA.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DZimmerman%26aufirst%3DS.%26aulast%3DKarakas%26aufirst%3DE.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DFurukawa%26aufirst%3DH.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DStructural%2520determinants%2520and%2520mechanism%2520of%2520action%2520of%2520a%2520GluN2C-selective%2520NMDA%2520receptor%2520positive%2520allosteric%2520modulator%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D86%26spage%3D548%26epage%3D560%26doi%3D10.1124%2Fmol.114.094516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buttar, D.</span>; <span class="NLM_string-name">Foote, K. M.</span>; <span class="NLM_string-name">Nowak, T.</span>; <span class="NLM_string-name">Rudge, D. A.</span>; <span class="NLM_string-name">Theoclitou, M.-E.</span>; <span class="NLM_string-name">Thomas, A. P.</span></span> <span> </span><span class="NLM_article-title">Pyrimidine derivatives useful in the treatment of cancer</span>. International Patent <span class="NLM_patent">WO2008001070A1</span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=D.+Buttar&author=K.+M.+Foote&author=T.+Nowak&author=D.+A.+Rudge&author=M.-E.+Theoclitou&author=A.+P.+Thomas&title=Pyrimidine+derivatives+useful+in+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DButtar%26aufirst%3DD.%26atitle%3DPyrimidine%2520derivatives%2520useful%2520in%2520the%2520treatment%2520of%2520cancer%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span> <span> </span><span class="NLM_article-title">Lipophilicity in drug discovery</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">235</span>â <span class="NLM_lpage">248</span>, <span class="refDoi">Â DOI: 10.1517/17460441003605098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1517%2F17460441003605098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=22823020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=235-248&author=M.+J.+Waring&title=Lipophilicity+in+drug+discovery&doi=10.1517%2F17460441003605098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in drug discovery</span></div><div class="casAuthors">Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The role of lipophilicity in detg. the overall quality of candidate drug mols. is of paramount importance.  Recent developments suggest that, as well as detg. pre-clin. ADMET (absorption, distribution, metab., elimination and toxicol.) properties, compds. of optimal lipophilicity might have increased chances of success in development.  Areas covered in this review: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compd.  Quality' with lipophilicity.  What the reader will gain: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region.  Take home message: The review of the data shows that this optimal space is defined by a narrow range of logD between â¼ 1 and 3.  Some of the implications of this for medicinal chem. optimization are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJrmVgvPaZLVg90H21EOLACvtfcHk0lidNyMVr3bb2A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D&md5=94424042ea49fcf5fcc7f1e4b17c10d6</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1517%2F17460441003605098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441003605098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DLipophilicity%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26spage%3D235%26epage%3D248%26doi%3D10.1517%2F17460441003605098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dress, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M.</span></span> <span> </span><span class="NLM_article-title">Using the golden triangle to optimize clearance and oral absorption</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">5560</span>â <span class="NLM_lpage">5564</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2009.08.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2Fj.bmcl.2009.08.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=19720530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFaktbfE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5560-5564&author=T.+W.+Johnsonauthor=K.+R.+Dressauthor=M.+Edwards&title=Using+the+golden+triangle+to+optimize+clearance+and+oral+absorption&doi=10.1016%2Fj.bmcl.2009.08.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Using the Golden Triangle to optimize clearance and oral absorption</span></div><div class="casAuthors">Johnson, Ted W.; Dress, Klaus R.; Edwards, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5560-5564</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Golden Triangle is a visualization tool developed from in vitro permeability, in vitro clearance and computational data designed to aid medicinal chemists in achieving metabolically stable, permeable and potent drug candidates.  Classifying compds. as permeable and stable and plotting mol. wt. (MW) vs. octanol:buffer (pH 7.4) distribution coeffs. (log D) or estd. octanol:buffer (pH 7.4) distribution coeffs. (elog D) reveals useful trends.  Anal. of at least 2 orthogonal trends, such as permeability and clearance, can be extremely effective in balancing and optimizing multiple properties.  In addn., mol. wt. and log D impact potency-efficiency calcns., allowing potency, clearance and permeability to be optimized simultaneously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjGjEaOp0237Vg90H21EOLACvtfcHk0likdNfFJBBeZw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFaktbfE&md5=3cfed1288ec451eb4419f1db753ae4b4</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.045%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DUsing%2520the%2520golden%2520triangle%2520to%2520optimize%2520clearance%2520and%2520oral%2520absorption%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5560%26epage%3D5564%26doi%3D10.1016%2Fj.bmcl.2009.08.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahr, A.</span></span> <span> </span><span class="NLM_article-title">Lipophilicity and its relationship with passive drug permeation</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">962</span>â <span class="NLM_lpage">977</span>, <span class="refDoi">Â DOI: 10.1007/s11095-010-0303-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1007%2Fs11095-010-0303-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=21052797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlOqtrzK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2011&pages=962-977&author=X.+Liuauthor=B.+Testaauthor=A.+Fahr&title=Lipophilicity+and+its+relationship+with+passive+drug+permeation&doi=10.1007%2Fs11095-010-0303-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity and Its Relationship with Passive Drug Permeation</span></div><div class="casAuthors">Liu, Xiangli; Testa, Bernard; Fahr, Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">962-977</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In this review, we first summarize the structure and properties of biol. membranes and the routes of passive drug transfer through physiol. barriers.  Lipophilicity is then introduced in terms of the intermol. interactions it encodes.  Finally, lipophilicity indexes from isotropic solvent systems and from anisotropic membrane-like systems are discussed for their capacity to predict passive drug permeation across biol. membranes such as the intestinal epithelium, the blood-brain barrier (BBB) or the skin.  The broad evidence presented here shows that beyond the predictive power of lipophilicity parameters, the various intermol. forces they encode allow a mechanistic interpretation of passive drug permeation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxn2Ic1yX8SbVg90H21EOLACvtfcHk0likdNfFJBBeZw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlOqtrzK&md5=6bd2bb54a14574f31b046204f260595a</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1007%2Fs11095-010-0303-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-010-0303-7%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DFahr%26aufirst%3DA.%26atitle%3DLipophilicity%2520and%2520its%2520relationship%2520with%2520passive%2520drug%2520permeation%26jtitle%3DPharm.%2520Res.%26date%3D2011%26volume%3D28%26spage%3D962%26epage%3D977%26doi%3D10.1007%2Fs11095-010-0303-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topliss, J. G.</span></span> <span> </span><span class="NLM_article-title">QSAR Model for Drug Human Oral Bioavailability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2575</span>â <span class="NLM_lpage">2585</span>, <span class="refDoi">Â DOI: 10.1021/jm0000564</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0000564" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjslGluro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2575-2585&author=F.+Yoshidaauthor=J.+G.+Topliss&title=QSAR+Model+for+Drug+Human+Oral+Bioavailability&doi=10.1021%2Fjm0000564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">QSAR Model for Drug Human Oral Bioavailability</span></div><div class="casAuthors">Yoshida, Fumitaka; Topliss, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2575-2585</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The quant. structure-bioavailability relationship of 232 structurally diverse drugs was studied to evaluate the feasibility of constructing a predictive model for the human oral bioavailability of prospective new medicinal agents.  The oral bioavailability detd. in human adults was assigned one of four ratings and analyzed in relation to physicochem. and structural factors by the ORMUCS (ordered multicategorical classification method using the simplex technique) method.  A systematic examn. of various physicochem. parameters relating primarily to absorption, and structural elements which could influence metab., was carried out to analyze their effects on the bioavailability classification of drugs in the data set.  Lipophilicity, expressed as the distribution coeff. at pH 6.5, was found to be a significant factor influencing bioavailability.  The observation that acids generally had better bioavailability characteristics than bases, with neutral compds. between, led to the formulation of a new parameter, Î log D (log D6.5 - log D7.4), which proved to be an important contributor in improving the classification results.  The addn. of 15 structural descriptors relating primarily to well-known metabolic processes yielded a satisfactory QSAR equation which had a correct classification rate of 71% (97% within one class) and a Spearman rank correlation coeff. (Rs) of 0.851, despite the diversity of structure and pharmacol. activity in the compd. set.  In leave-one-out tests, an av. of 67% of drugs were correctly classified (96% within one class) with an Rs of 0.812.  The relationship formulated identified significant factors influencing bioavailability and assigned them quant. values expressing their contribution.  The predictive power of the model was evaluated using a sep. test set of 40 compds., of which 60% (95% within one class) were correctly classified.  Since the necessary physicochem. parameters can be calcd. or estd. and the structural descriptors are obtained from an inspection of the structure, the model enables a rough est. to be made of the prospective human oral bioavailability of unsynthesized compds.  Also, the model has the advantage of transparency in that it indicates which factors may affect bioavailability and the extent of that effect.  This could be useful in designing compds. which are more bioavailable.  Refinement of the model is possible as more bioavailability data becomes available.  Potential uses are in drug design, prioritization of compds. for synthesis, and selection for detailed studies of early compd. leads in drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrCuiR5_SKw7Vg90H21EOLACvtfcHk0likdNfFJBBeZw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjslGluro%253D&md5=79075f57b7f47c7290d7e8ee14a564bc</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm0000564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0000564%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DF.%26aulast%3DTopliss%26aufirst%3DJ.%2BG.%26atitle%3DQSAR%2520Model%2520for%2520Drug%2520Human%2520Oral%2520Bioavailability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2575%26epage%3D2585%26doi%3D10.1021%2Fjm0000564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moldavski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bading, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bengtson, C. P.</span></span> <span> </span><span class="NLM_article-title">A novel method using ambient glutamate for the electrophysiological quantification of extrasynaptic NMDA receptor function in acute brain slices</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>598</i></span>,  <span class="NLM_fpage">633</span>â <span class="NLM_lpage">650</span>, <span class="refDoi">Â DOI: 10.1113/JP278362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1113%2FJP278362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=31876958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFOku7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=598&publication_year=2020&pages=633-650&author=A.+Moldavskiauthor=J.+Behrauthor=H.+Badingauthor=C.+P.+Bengtson&title=A+novel+method+using+ambient+glutamate+for+the+electrophysiological+quantification+of+extrasynaptic+NMDA+receptor+function+in+acute+brain+slices&doi=10.1113%2FJP278362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">A novel method using ambient glutamate for the electrophysiological quantification of extrasynaptic NMDA receptor function in acute brain slices</span></div><div class="casAuthors">Moldavski, Alexander; Behr, Joachim; Bading, Hilmar; Bengtson, C. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">598</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">633-650</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">1469-7793</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Key points : We present a novel protocol to quantify extrasynaptic NMDA receptor function utilizing the semi-selective activation of extrasynaptic receptors by ambient extracellular glutamate in acute brain slices from adult rats.  We use whole cell patch clamp to measure the effect of the NMDA receptor antagonist MK-801 on both synaptic and brief, local agonist application-evoked responses.  The level of ambient glutamate was estd. from tonic NMDA receptor activity to be â¼77 nM and an equiv. concn. of NMDA was used to est. the degree of extrasynaptic blockade (>82%) by our MK-801 protocol.  The extrasynaptic component of the total NMDA receptor pool can be math. derived from these data and was estd. to be 29-39% in the stratum radiatum of the CA1 region of the rat hippocampus.  This technique could be used to quantify extrasynaptic NMDA receptor function in rodent models of diseases where extrasynaptic NMDA receptors are implicated in neuron death.  Synaptic NMDA receptors (NMDARs) play a central role in pro-survival signalling and synaptic plasticity in the majority of excitatory synapses in the central nervous system whereas extrasynaptic NMDARs (ES-NMDARs) activate pro-death pathways and have been implicated in many neurodegenerative diseases.  ES-NMDARs have been characterized in acute brain slice prepns. using the largely irreversible, activity-dependent NMDAR antagonist MK-801 to block synaptic NMDARs.  This approach is limited by the concomitant MK-801 blockade of ES-NMDARs activated by ambient extracellular glutamate, which is largely absent from the synaptic cleft due to the high d. of nearby glutamate transporters.  In acute hippocampal slices from rats aged 35-42 postnatal days, we estd. ambient glutamate to be 72-83 nM resulting in a block of more than 82% of ES-NMDARs during a 5 min MK-801 application.  This paper describes a novel electrophysiol. and math. method to quantify the proportion of NMDARs located at extrasynaptic locations in a confined region of an acute brain slice prepn. using MK-801 to preferentially block ES-NMDARs.  The protocol uses whole cell patch clamp measurement of NMDAR responses to synaptic stimulation and brief local pressure application of NMDA before and after MK-801 application.  After math. correcting for the relative block of both synaptic and extrasynaptic receptors, ES-NMDARs were estd. to comprise 29-39% of the total NMDAR pool in the apical dendrites of hippocampal CA1 pyramidal neurons.  This new method may prove useful for accurate quantification of NMDAR distributions in neurodegenerative diseases that are assocd. with increased toxic ES-NMDAR signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP4lNB5DzbfbVg90H21EOLACvtfcHk0likdNfFJBBeZw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFOku7o%253D&md5=b3769c179ccbc44a54f5daa7084c89c7</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1113%2FJP278362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252FJP278362%26sid%3Dliteratum%253Aachs%26aulast%3DMoldavski%26aufirst%3DA.%26aulast%3DBehr%26aufirst%3DJ.%26aulast%3DBading%26aufirst%3DH.%26aulast%3DBengtson%26aufirst%3DC.%2BP.%26atitle%3DA%2520novel%2520method%2520using%2520ambient%2520glutamate%2520for%2520the%2520electrophysiological%2520quantification%2520of%2520extrasynaptic%2520NMDA%2520receptor%2520function%2520in%2520acute%2520brain%2520slices%26jtitle%3DJ.%2520Physiol.%26date%3D2020%26volume%3D598%26spage%3D633%26epage%3D650%26doi%3D10.1113%2FJP278362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span>The
active enantiomers
of this series have been previously shown to be brain penetrant:<span class="NLM_contrib-group"><span class="NLM_string-name">Gawai, P.</span>; <span class="NLM_string-name">Upadhyay, R.</span>; <span class="NLM_string-name">Gakare, S. G.</span>; <span class="NLM_string-name">Sarode, L.</span>; <span class="NLM_string-name">Dravid, S.</span>; <span class="NLM_string-name">Ugale, R. R.</span></span> <span> </span><span class="NLM_article-title">Antipsychotic-like profile of CIQ isomers in animal models of schizophrenia</span> <i>Behav. Pharmacol.</i> [Online early access].<span class="refDoi">Â DOI: 10.1097/FBP.0000000000000532</span> . Published Online: Dec 18, <span class="NLM_year">2019</span>. <a href="https://journals.lww.com/behaviouralpharm/Abstract/9000/Antipsychotic_like_profile_of_CIQ_isomers_in.99204.aspx" class="extLink">https://journals.lww.com/behaviouralpharm/Abstract/9000/Antipsychotic_like_profile_of_CIQ_isomers_in.99204.aspx</a> (accessed May 7, 2020).</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1097%2FFBP.0000000000000532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=31860561" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=P.+Gawai&author=R.+Upadhyay&author=S.+G.+Gakare&author=L.+Sarode&author=S.+Dravid&author=R.+R.+Ugale&title=Antipsychotic-like+profile+of+CIQ+isomers+in+animal+models+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1097%2FFBP.0000000000000532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.1097%252FFBP.0000000000000532%26sid%3Dliteratum%253Aachs%26aulast%3DGawai%26aufirst%3DP.%26atitle%3DAntipsychotic-like%2520profile%2520of%2520CIQ%2520isomers%2520in%2520animal%2520models%2520of%2520schizophrenia%26jtitle%3DBehav.%2520Pharmacol.%26doi%3D10.1097%2FFBP.0000000000000532%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dravid, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erreger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyuboslavsky, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almonte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">Subunit-Specific Mechanisms and Proton Sensitivity of NMDA Receptor Channel Block</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>581</i></span>,  <span class="NLM_fpage">107</span>â <span class="NLM_lpage">128</span>, <span class="refDoi">Â DOI: 10.1113/jphysiol.2006.124958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1113%2Fjphysiol.2006.124958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=17303642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BD2s3ovVyguw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2007&pages=107-128&author=S.+M.+Dravidauthor=K.+Erregerauthor=H.+Yuanauthor=K.+Nicholsonauthor=P.+Leauthor=P.+Lyuboslavskyauthor=A.+Almonteauthor=E.+Murrayauthor=C.+Mosleyauthor=J.+Barberauthor=A.+Frenchauthor=R.+Balsterauthor=T.+F.+Murrayauthor=S.+F.+Traynelis&title=Subunit-Specific+Mechanisms+and+Proton+Sensitivity+of+NMDA+Receptor+Channel+Block&doi=10.1113%2Fjphysiol.2006.124958"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block</span></div><div class="casAuthors">Dravid Shashank M; Erreger Kevin; Yuan Hongjie; Nicholson Katherine; Le Phuong; Lyuboslavsky Polina; Almonte Antoine; Murray Ernest; Mosely Cara; Barber Jeremy; French Adam; Balster Robert; Murray Thomas F; Traynelis Stephen F</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of physiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">581</span>
        (<span class="NLM_cas:issue">Pt 1</span>),
    <span class="NLM_cas:pages">107-28</span>
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    </div><div class="casAbstract">We have compared the potencies of structurally distinct channel blockers at recombinant NR1/NR2A, NR1/NR2B, NR1/NR2C and NR1/NR2D receptors.  The IC50 values varied with stereochemistry and subunit composition, suggesting that it may be possible to design subunit-selective channel blockers.  For dizocilpine (MK-801), the differential potency of MK-801 stereoisomers determined at recombinant NMDA receptors was confirmed at native receptors in vitro and in vivo.  Since the proton sensor is tightly linked both structurally and functionally to channel gating, we examined whether blocking molecules that interact in the channel pore with the gating machinery can differentially sense protonation of the receptor.  Blockers capable of remaining trapped in the pore during agonist unbinding showed the strongest dependence on extracellular pH, appearing more potent at acidic pH values that promote channel closure.  Determination of pK(a) values for channel blockers suggests that the ionization of ketamine but not of other blockers can influence its pH-dependent potency.  Kinetic modelling and single channel studies suggest that the pH-dependent block of NR1/NR2A by (-)MK-801 but not (+)MK-801 reflects an increase in the MK-801 association rate even though protons reduce channel open probability and thus MK-801 access to its binding site.  Allosteric modulators that alter pH sensitivity alter the potency of MK-801, supporting the interpretation that the pH sensitivity of MK-801 binding reflects the changes at the proton sensor rather than a secondary effect of pH.  These data suggest a tight coupling between the proton sensor and the ion channel gate as well as unique subunit-specific mechanisms of channel block.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcStu9_z3ViyDvIW7hznt0zpfW6udTcc2eZlSS8h1UyHP7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3ovVyguw%253D%253D&md5=925d12d73740bf616173011163f9945b</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2006.124958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2006.124958%26sid%3Dliteratum%253Aachs%26aulast%3DDravid%26aufirst%3DS.%2BM.%26aulast%3DErreger%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DNicholson%26aufirst%3DK.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DLyuboslavsky%26aufirst%3DP.%26aulast%3DAlmonte%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DE.%26aulast%3DMosley%26aufirst%3DC.%26aulast%3DBarber%26aufirst%3DJ.%26aulast%3DFrench%26aufirst%3DA.%26aulast%3DBalster%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DT.%2BF.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DSubunit-Specific%2520Mechanisms%2520and%2520Proton%2520Sensitivity%2520of%2520NMDA%2520Receptor%2520Channel%2520Block%26jtitle%3DJ.%2520Physiol.%26date%3D2007%26volume%3D581%26spage%3D107%26epage%3D128%26doi%3D10.1113%2Fjphysiol.2006.124958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallego, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. P.</span></span> <span> </span><span class="NLM_article-title">Lipophilic efficiency as an important metric in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6401</span>â <span class="NLM_lpage">6420</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b00077</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00077" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsVahsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6401-6420&author=T.+W.+Johnsonauthor=R.+A.+Gallegoauthor=M.+P.+Edwards&title=Lipophilic+efficiency+as+an+important+metric+in+drug+design&doi=10.1021%2Facs.jmedchem.8b00077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilic Efficiency as an Important Metric in Drug Design</span></div><div class="casAuthors">Johnson, Ted W.; Gallego, Rebecca A.; Edwards, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6401-6420</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Lipophilic efficiency (LipE) is an important metric that has been increasingly applied in drug discovery medicinal chem. lead optimization programs.  In this perspective, using literature drug discovery examples, we discuss the concept of rigorously applying LipE to guide medicinal chem. lead optimization toward drug candidates with potential for superior in vivo efficacy and safety, esp. when guided by physiochem. property-based optimization (PPBO).  Also highlighted are examples of small structural modifications such as addn. of single atoms, small functional groups, and cyclizations that produce large increases in LipE.  Understanding the factors that may contribute to LipE changes through anal. of ligand-protein crystal structures and using structure-based drug design (SBDD) to increase LipE by design is also discussed.  Herein we advocate for use of LipE anal. coupled with PPBO and SBDD as an efficient mechanism for drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXQ8DOcOj6GrVg90H21EOLACvtfcHk0liUPWig_7r4Qw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsVahsbg%253D&md5=29f38880914fa75c33be3a640ace4309</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00077%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DGallego%26aufirst%3DR.%2BA.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DLipophilic%2520efficiency%2520as%2520an%2520important%2520metric%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6401%26epage%3D6420%26doi%3D10.1021%2Facs.jmedchem.8b00077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawryluk, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieters, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rech, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sales, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velter, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaventure, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contreras, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morton, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickenden, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Pharmacological Characterization of Two Novel, Brain Penetrating P2X7 Antagonists</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">419</span>â <span class="NLM_lpage">422</span>, <span class="refDoi">Â DOI: 10.1021/ml400040v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400040v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVahtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=419-422&author=M.+A.+Letavicauthor=B.+Lordauthor=F.+Bischoffauthor=N.+A.+Hawrylukauthor=S.+Pietersauthor=J.+C.+Rechauthor=Z.+Salesauthor=A.+I.+Velterauthor=H.+Aoauthor=P.+Bonaventureauthor=V.+Contrerasauthor=X.+Jiangauthor=K.+L.+Mortonauthor=B.+Scottauthor=Q.+Wangauthor=A.+D.+Wickendenauthor=N.+I.+Carruthersauthor=A.+Bhattacharya&title=Synthesis+and+Pharmacological+Characterization+of+Two+Novel%2C+Brain+Penetrating+P2X7+Antagonists&doi=10.1021%2Fml400040v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Pharmacological Characterization of Two Novel, Brain Penetrating P2X7 Antagonists</span></div><div class="casAuthors">Letavic, Michael A.; Lord, Brian; Bischoff, Francois; Hawryluk, Natalie A.; Pieters, Serge; Rech, Jason C.; Sales, Zachary; Velter, Adriana I.; Ao, Hong; Bonaventure, Pascal; Contreras, Victor; Jiang, Xiaohui; Morton, Kirsten L.; Scott, Brian; Wang, Qi; Wickenden, Alan D.; Carruthers, Nicholas I.; Bhattacharya, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">419-422</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and preclin. characterization of two novel, brain penetrating P2X7 compds. will be described.  Both compds. are shown to be high potency P2X7 antagonists in human, rat, and mouse cell lines and both were shown to have high brain concns. and robust receptor occupancy in rat.  Compd. I is of particular interest as a probe compd. for the preclin. assessment of P2X7 blockade in animal models of neuro-inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFnpKdjd4_XLVg90H21EOLACvtfcHk0ljCAQpP4BCkug"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVahtbw%253D&md5=7c1d0561aad7338b75840181756c9295</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fml400040v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400040v%26sid%3Dliteratum%253Aachs%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DBischoff%26aufirst%3DF.%26aulast%3DHawryluk%26aufirst%3DN.%2BA.%26aulast%3DPieters%26aufirst%3DS.%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DSales%26aufirst%3DZ.%26aulast%3DVelter%26aufirst%3DA.%2BI.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DContreras%26aufirst%3DV.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DMorton%26aufirst%3DK.%2BL.%26aulast%3DScott%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWickenden%26aufirst%3DA.%2BD.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DBhattacharya%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520Pharmacological%2520Characterization%2520of%2520Two%2520Novel%252C%2520Brain%2520Penetrating%2520P2X7%2520Antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D419%26epage%3D422%26doi%3D10.1021%2Fml400040v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 1 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianwei  Xie</span>, <span class="hlFld-ContribAuthor ">Muhammad  Suleman</span>, <span class="hlFld-ContribAuthor ">Zaibin  Wang</span>, <span class="hlFld-ContribAuthor ">Xinfei  Mao</span>, <span class="hlFld-ContribAuthor ">Beibei  Mao</span>, <span class="hlFld-ContribAuthor ">Jiale  Fan</span>, <span class="hlFld-ContribAuthor ">Ping  Lu</span>, <span class="hlFld-ContribAuthor ">Yanguang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Syntheses of 4-allyl-/4-allenyl-4-(arylthio)-1,4-dihydroisoquinolin-3-ones
              via
              the photochemical DoyleâKirmse reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (28)
                                     , 6341-6345. <a href="https://doi.org/10.1039/D1OB00859E" title="DOI URL">https://doi.org/10.1039/D1OB00859E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB00859E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB00859E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSyntheses%252Bof%252B4-allyl-%25252F4-allenyl-4-%252528arylthio%252529-1%25252C4-dihydroisoquinolin-3-ones%252Bvia%252Bthe%252Bphotochemical%252BDoyle%2525E2%252580%252593Kirmse%252Breaction%26aulast%3DXie%26aufirst%3DJianwei%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D28%26spage%3D6341%26epage%3D6345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01733&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. PAMs of the NMDAR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01733&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Labeled 1,4-dihydroisoquinolin-3(2<i>H</i>)-one (left) and dihydropyrrolo[1,2-<i>a</i>]pyrazin-3(4<i>H</i>)-one (right) to distinguish between the A-, B-, and C-rings.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01733&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Model of the steric encumbrance upon translocation of the carbonyl in the 1,4-dihydroisoquinolin-3(2<i>H</i>)-one series. The s-cis conformation was hypothesized to create steric clash between the carbonyl and A-ring, creating preference for the more active s-trans conformation (left). This is visualized on this scaffold through a crystal structure of <b><i>R</i>-(+)-EU-1180-453</b> (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01733&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Dihydroisoquinolinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01733&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) chloroacetyl chloride, SnCl<sub>4</sub>, 1,2-dichloroethane (DCE), reflux, 90 min; (b) 4-methoxyphenol, KI, K<sub>2</sub>CO<sub>3</sub>, reflux, 4 h; (c) substituted primary amines, Ti(O<i>i</i>Pr)<sub>4</sub>, NaBH(OAc)<sub>3</sub>, DCE, 120 Â°C, mw, 20 min; (d) (i) PtO<sub>2</sub>, H<sub>2</sub> (balloon), EtOH, rt, 10 h, (ii) Pd/C, H<sub>2</sub> (50 psi), EtOH, rt, 24 h; (e) NaN<sub>3</sub>, CH<sub>2</sub>O (37% in H<sub>2</sub>O), AcOH, cat. sodium ascorbate, cat. CuSO<sub>4</sub>, tetrahydrofuran (THF), rt, 24 h.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of B-Ring Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01733&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) chloroacetyl chloride, Et<sub>3</sub>N, dichloromethane (DCM), 0 Â°C, 30 min; (b) R<sub>1</sub>OH, NaH or Cs<sub>2</sub>CO<sub>3</sub>; (c) POCl<sub>3</sub>, ACN, reflux then NaBH<sub>4</sub>, MeOH, 0 Â°C, 10 min; (d) substituted benzoyl chloride, Et<sub>3</sub>N, DCM, rt, 1 h; (e) Pd/C, H<sub>2</sub> (50 psi), MeOH, o/n; (f) methane sulfonic acid, DCM, rt, 6 h; (g) heteroaryl fluoride, NaH, THF, reflux, o/n, (ii) heteroaryl iodide, 1,10-Phen, CuI, Cs<sub>2</sub>CO<sub>3</sub>, PhMe, 80 Â°C, o/n.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Heterocyclic C-Rings<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01733&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) cat. butylamine, cat. AcOH, 4 Ã MS, MeNO<sub>2</sub>, reflux, 30 min; (b) LiAlH<sub>4</sub>/H<sub>2</sub>SO<sub>4</sub>, THF, 0 Â°C to reflux, 5 min; (c) chloroacetyl chloride, Et<sub>3</sub>N, DCM, 0 Â°C, 30 min; (d) 4-methoxyphenol, Cs<sub>2</sub>CO<sub>3</sub>, o/n, 79â93%; (e) POCl<sub>3</sub>, ACN, reflux, o/n then NaBH<sub>4</sub>, MeOH, 0 Â°C, 10 min; (f) (i) acid chloride, Et<sub>3</sub>N, DCM, rt, 1 h, (ii) carboxylic acid, EDCI, 4-dimethylaminopyridine (DMAP), rt, o/n; (g) Lawessonâs reagent, PhMe, 150 Â°C, mw, 2 h.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/medium/jm9b01733_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Pyrrolopyrazinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01733/20200716/images/large/jm9b01733_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01733&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2,5-dimethoxytetrahydrofuran, NaOAc, 2:1 v/v AcOH:water, reflux, 4 h; (b) chloroacetyl chloride, DBN, PhMe, 115 Â°C, 4 h; (c) 4-methoxyphenol, KI, K<sub>2</sub>CO<sub>3</sub>, acetone, rt, o/n; (d) substituted primary amines, Ti(O<i>i</i>Pr)<sub>4</sub>, sodium triacetoxyborohydride (STAB), DCE, 120 Â°C, mw, 2 h; (e) Pd/C, H<sub>2</sub> (1 atm), EtOAc, rt, o/n; (f) Lawessonâs reagent, PhMe, 150 Â°C, mw, 2 h.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i166">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53162" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53162" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 81 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wollmuth, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBain, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menniti, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingledine, R.</span></span> <span> </span><span class="NLM_article-title">Glutamate receptor ion channels: structure, regulation, and function</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">405</span>â <span class="NLM_lpage">496</span>, <span class="refDoi">Â DOI: 10.1124/pr.109.002451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1124%2Fpr.109.002451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=20716669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=405-496&author=S.+F.+Traynelisauthor=L.+P.+Wollmuthauthor=C.+J.+McBainauthor=F.+S.+Mennitiauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=K.+B.+Hansenauthor=H.+Yuanauthor=S.+J.+Myersauthor=R.+Dingledine&title=Glutamate+receptor+ion+channels%3A+structure%2C+regulation%2C+and+function&doi=10.1124%2Fpr.109.002451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate receptor ion channels: structure, regulation, and function</span></div><div class="casAuthors">Traynelis, Stephen F.; Wollmuth, Lonnie P.; McBain, Chris J.; Menniti, Frank S.; Vance, Katie M.; Ogden, Kevin K.; Hansen, Kasper B.; Yuan, Hongjie; Myers, Scott J.; Dingledine, Ray</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">405-496</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The mammalian ionotropic glutamate receptor family encodes 18 gene products that coassemble to form ligand-gated ion channels contg. an agonist recognition site, a transmembrane ion permeation pathway, and gating elements that couple agonist-induced conformational changes to the opening or closing of the permeation pore.  Glutamate receptors mediate fast excitatory synaptic transmission in the central nervous system and are localized on neuronal and non-neuronal cells.  These receptors regulate a broad spectrum of processes in the brain, spinal cord, retina, and peripheral nervous system.  Glutamate receptors are postulated to play important roles in numerous neurol. diseases and have attracted intense scrutiny.  The description of glutamate receptor structure, including its transmembrane elements, reveals a complex assembly of multiple semiautonomous extracellular domains linked to a pore-forming element with striking resemblance to an inverted potassium channel.  In this review we discuss International Union of Basic and Clin. Pharmacol. glutamate receptor nomenclature, structure, assembly, accessory subunits, interacting proteins, gene expression and translation, post-translational modifications, agonist and antagonist pharmacol., allosteric modulation, mechanisms of gating and permeation, roles in normal physiol. function, as well as the potential therapeutic use of pharmacol. agents acting at glutamate receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov0rj4nMr5ObVg90H21EOLACvtfcHk0lgI5CLz86eexw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ&md5=5d0a7945b5ad99113adf9f6312bafe13</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.109.002451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.109.002451%26sid%3Dliteratum%253Aachs%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DWollmuth%26aufirst%3DL.%2BP.%26aulast%3DMcBain%26aufirst%3DC.%2BJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DMyers%26aufirst%3DS.%2BJ.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DGlutamate%2520receptor%2520ion%2520channels%253A%2520structure%252C%2520regulation%252C%2520and%2520function%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D405%26epage%3D496%26doi%3D10.1124%2Fpr.109.002451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dube, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerchner, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsien, J. Z.</span></span> <span> </span><span class="NLM_article-title">Genetic enhancement of learning and memory in mice</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>401</i></span>,  <span class="NLM_fpage">63</span>â <span class="NLM_lpage">69</span>, <span class="refDoi">Â DOI: 10.1038/43432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2F43432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10485705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaK1MXlvVGms70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=1999&pages=63-69&author=Y.-P.+Tangauthor=E.+Shimizuauthor=G.+R.+Dubeauthor=C.+Ramponauthor=G.+A.+Kerchnerauthor=M.+Zhuoauthor=G.+Liuauthor=J.+Z.+Tsien&title=Genetic+enhancement+of+learning+and+memory+in+mice&doi=10.1038%2F43432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic enhancement of learning and memory in mice</span></div><div class="casAuthors">Tang, Ya-Ping; Shimizu, Eiji; Dube, Gilles, R.; Rampon, Claire; Kerchner, Geoffrey; Zhuo, Min; Liu, Guosong; Tsien, Joe Z.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">6748</span>),
    <span class="NLM_cas:pages">63-69</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Hebb's rule (1949) states that learning and memory are based on modifications of synaptic strength among neurons that are simultaneously active.  This implies that enhanced synaptic coincidence detection would lead to better learning and memory.  If the NMDA (N-methyl-D-aspartate) receptor, a synaptic coincidence detection would lead to better learning and memory.  If the NMDA (N-methyl-D-aspartate) receptor, a synaptic coincidence detector, acts as a graded switch for memory formation, enhanced signal detection by NMDA receptors should enhance learning and memory.  Here we show that overexpression of NMDA receptor 2B (NR2B) in the forebrains of transgenic mice leads to enhanced activation of NMDA receptors, facilitating synaptic potentiation in response to stimulation at 10-100 Hz.  These mice exhibit superior ability in learning and memory in various behavioral tasks, showing that NR2B is crit. in gating the age-dependent threshold for plasticity and memory formation.  NMDA-receptor-dependent modifications of synaptic efficacy, therefore, represent a unifying mechanism for associative learning and memory.  Our results suggest that genetic enhancement of mental and cognitive attributes such as intelligence and memory in mammals is feasible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpztBLI9qsOIbVg90H21EOLACvtfcHk0lgI5CLz86eexw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvVGms70%253D&md5=b2ef8b0610c3c070063f869f82a838e6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F43432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F43432%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DY.-P.%26aulast%3DShimizu%26aufirst%3DE.%26aulast%3DDube%26aufirst%3DG.%2BR.%26aulast%3DRampon%26aufirst%3DC.%26aulast%3DKerchner%26aufirst%3DG.%2BA.%26aulast%3DZhuo%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DTsien%26aufirst%3DJ.%2BZ.%26atitle%3DGenetic%2520enhancement%2520of%2520learning%2520and%2520memory%2520in%2520mice%26jtitle%3DNature%26date%3D1999%26volume%3D401%26spage%3D63%26epage%3D69%26doi%3D10.1038%2F43432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collingridge, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volianskis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">France, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidball, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaghan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolotto, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molnar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodge, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jane, D. E.</span></span> <span> </span><span class="NLM_article-title">The NMDA receptor as a target for cognitive enhacement</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">13</span>â <span class="NLM_lpage">26</span>, <span class="refDoi">Â DOI: 10.1016/j.neuropharm.2012.06.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2Fj.neuropharm.2012.06.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=22796429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFahsL3P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=13-26&author=G.+L.+Collingridgeauthor=A.+Volianskisauthor=N.+Bannisterauthor=G.+Franceauthor=L.+Hannaauthor=M.+Mercierauthor=P.+Tidballauthor=G.+Fangauthor=M.+W.+Irvineauthor=B.+M.+Costaauthor=D.+T.+Monaghanauthor=Z.+A.+Bortolottoauthor=E.+Molnarauthor=D.+Lodgeauthor=D.+E.+Jane&title=The+NMDA+receptor+as+a+target+for+cognitive+enhacement&doi=10.1016%2Fj.neuropharm.2012.06.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The NMDA receptor as a target for cognitive enhancement</span></div><div class="casAuthors">Collingridge, Graham L.; Volianskis, Arturas; Bannister, Neil; France, Grace; Hanna, Lydia; Mercier, Marion; Tidball, Patrick; Fang, Guangyu; Irvine, Mark W.; Costa, Blaise M.; Monaghan, Daniel T.; Bortolotto, Zuner A.; Molnar, Elek; Lodge, David; Jane, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-26</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  NMDA receptors (NMDARs) play an important role in neural plasticity including long-term potentiation and long-term depression, which are likely to explain their importance for learning and memory.  Cognitive decline is a major problem facing an aging human population, so much so that its reversal has become an important goal for scientific research and pharmaceutical development.  Enhancement of NMDAR function is a core strategy toward this goal.  In this review we indicate some of the major ways of potentiating NMDAR function by both direct and indirect modulation.  There is good evidence that both pos. and neg. modulation can enhance function suggesting that a subtle approach correcting imbalances in particular clin. situations will be required.  Excessive activation and the resultant deleterious effects will need to be carefully avoided.  Finally we describe some novel pos. allosteric modulators of NMDARs, with some subunit selectivity, and show initial evidence of their ability to affect NMDAR mediated events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwosQmB8cQb7Vg90H21EOLACvtfcHk0lgI5CLz86eexw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFahsL3P&md5=4d63552250a5bb940a8d0a7a2d51fd75</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2012.06.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2012.06.051%26sid%3Dliteratum%253Aachs%26aulast%3DCollingridge%26aufirst%3DG.%2BL.%26aulast%3DVolianskis%26aufirst%3DA.%26aulast%3DBannister%26aufirst%3DN.%26aulast%3DFrance%26aufirst%3DG.%26aulast%3DHanna%26aufirst%3DL.%26aulast%3DMercier%26aufirst%3DM.%26aulast%3DTidball%26aufirst%3DP.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DCosta%26aufirst%3DB.%2BM.%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26aulast%3DBortolotto%26aufirst%3DZ.%2BA.%26aulast%3DMolnar%26aufirst%3DE.%26aulast%3DLodge%26aufirst%3DD.%26aulast%3DJane%26aufirst%3DD.%2BE.%26atitle%3DThe%2520NMDA%2520receptor%2520as%2520a%2520target%2520for%2520cognitive%2520enhacement%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D13%26epage%3D26%26doi%3D10.1016%2Fj.neuropharm.2012.06.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rezvani, A. M.</span></span> <span> </span><span class="NLM_article-title">Involvement of the NMDA System in Learning and Memory</span>. In  <i>Animal Models of Cognitive Impairment</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, E. D.</span>; <span class="NLM_string-name">Buccafusco, J. J.</span></span>, Eds.; <span class="NLM_publisher-name">CRC Press/Taylor & Francis</span>: <span class="NLM_publisher-loc">Boca Raton (FL)</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1201%2F9781420004335.ch4" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=A.+M.+Rezvaniauthor=E.+D.+Levin&author=J.+J.+Buccafusco&title=Animal+Models+of+Cognitive+Impairment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1201%2F9781420004335.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1201%252F9781420004335.ch4%26sid%3Dliteratum%253Aachs%26aulast%3DRezvani%26aufirst%3DA.%2BM.%26atitle%3DInvolvement%2520of%2520the%2520NMDA%2520System%2520in%2520Learning%2520and%2520Memory%26btitle%3DAnimal%2520Models%2520of%2520Cognitive%2520Impairment%26aulast%3DLevin%26aufirst%3DE.%2BD.%26pub%3DCRC%2520Press%252FTaylor%2520%2526%2520Francis%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ewald, R. C.</span>; <span class="NLM_string-name">Cline, H. T.</span></span> <span> </span><span class="NLM_article-title">NMDA Receptors and Brain Development</span>. In  <i>Biology of the NMDA Receptor</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Dongen, A. M.</span></span>, Ed.; <span class="NLM_publisher-name">CRC Press/Taylor & Francis</span>: <span class="NLM_publisher-loc">Boca Raton (FL)</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=R.+C.+Ewald&author=H.+T.+Clineauthor=A.+M.+Van+Dongen&title=Biology+of+the+NMDA+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DEwald%26aufirst%3DR.%2BC.%26atitle%3DNMDA%2520Receptors%2520and%2520Brain%2520Development%26btitle%3DBiology%2520of%2520the%2520NMDA%2520Receptor%26aulast%3DVan%2BDongen%26aufirst%3DA.%2BM.%26pub%3DCRC%2520Press%252FTaylor%2520%2526%2520Francis%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auerbach, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meiri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bengzon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, R. D. G.</span></span> <span> </span><span class="NLM_article-title">Hippocampal synaptic Plasticity in mice overexpresssing an embryonic subunit of the NMDA receptor</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">4177</span>â <span class="NLM_lpage">4188</span>, <span class="refDoi">Â DOI: 10.1523/JNEUROSCI.18-11-04177.1998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1523%2FJNEUROSCI.18-11-04177.1998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=9592097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaK1cXjsV2qt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=4177-4188&author=S.+Okabeauthor=C.+Collinauthor=J.+M.+Auerbachauthor=N.+Meiriauthor=J.+Bengzonauthor=M.+B.+Kennedyauthor=M.+Segalauthor=R.+D.+G.+McKay&title=Hippocampal+synaptic+Plasticity+in+mice+overexpresssing+an+embryonic+subunit+of+the+NMDA+receptor&doi=10.1523%2FJNEUROSCI.18-11-04177.1998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Hippocampal synaptic plasticity in mice overexpressing an embryonic subunit of the NMDA receptor</span></div><div class="casAuthors">Okabe, Shigeo; Collin, Carlos; Auerbach, Jonathan M.; Meiri, Noam; Bengzon, Johan; Kennedy, Mary B.; Segal, Menahem; Mckay, Ronald D. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4177-4188</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The effects of changing NMDA receptor subunit compn. on synaptic plasticity in the hippocampus were analyzed by creating transgenic mice overexpressing NR2D, a predominantly embryonic NMDA receptor subunit.  NMDA-evoked currents in the transgenic mice had smaller amplitudes and slower kinetics.  The transgenics also displayed age-dependent deficits in synaptic plasticity in area CA1 of the hippocampus.  Long-term depression was selectively impaired in juvenile mice when NR2D overexpression was moderate.  In mature mice, overexpression of NR2D was assocd. with a redn. of both NR2B and Ca2+-independent activity of Ca2+- and calmodulin-dependent protein kinase II.  These biochem. changes were correlated with a marked impairment of NMDA-dependent long-term potentiation, but spatial behavior was normal in these mice.  These results show that the developmental regulation of NMDA receptor subunit compn. alters the frequency at which modification of synaptic responses occur after afferent stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtTcwOC9Oju7Vg90H21EOLACvtfcHk0lg9vuuo3RcKiw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsV2qt7k%253D&md5=db180bf444a50a64fde6dba0a822c92f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.18-11-04177.1998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.18-11-04177.1998%26sid%3Dliteratum%253Aachs%26aulast%3DOkabe%26aufirst%3DS.%26aulast%3DCollin%26aufirst%3DC.%26aulast%3DAuerbach%26aufirst%3DJ.%2BM.%26aulast%3DMeiri%26aufirst%3DN.%26aulast%3DBengzon%26aufirst%3DJ.%26aulast%3DKennedy%26aufirst%3DM.%2BB.%26aulast%3DSegal%26aufirst%3DM.%26aulast%3DMcKay%26aufirst%3DR.%2BD.%2BG.%26atitle%3DHippocampal%2520synaptic%2520Plasticity%2520in%2520mice%2520overexpresssing%2520an%2520embryonic%2520subunit%2520of%2520the%2520NMDA%2520receptor%26jtitle%3DJ.%2520Neurosci.%26date%3D1998%26volume%3D18%26spage%3D4177%26epage%3D4188%26doi%3D10.1523%2FJNEUROSCI.18-11-04177.1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bliss, T. V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collingridge, G. L.</span></span> <span> </span><span class="NLM_article-title">A synapti model of memory: long-term potentiation in the hippocampus</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">31</span>â <span class="NLM_lpage">39</span>, <span class="refDoi">Â DOI: 10.1038/361031a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2F361031a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=8421494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaK3sXntlOntw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=1993&pages=31-39&author=T.+V.+P.+Blissauthor=G.+L.+Collingridge&title=A+synapti+model+of+memory%3A+long-term+potentiation+in+the+hippocampus&doi=10.1038%2F361031a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A synaptic model of memory:  long-term potentiation in the hippocampus</span></div><div class="casAuthors">Bliss, T. V. P.; Collingridge, G. L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">6407</span>),
    <span class="NLM_cas:pages">31-9</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">A review, with 174 refs., of long-term potentiation (LTP) of synaptic transmission in the hippocampus as the primary exptl. model for investigating the synaptic basis of learning and memory in vertebrates.  Topics discussed were: properties of hippocampal LTP; induction of LTP; and expression of LTP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD1tHZif2aP7Vg90H21EOLACvtfcHk0lg9vuuo3RcKiw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXntlOntw%253D%253D&md5=285f5a175da5a77f4f57a3f5236e3e0a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F361031a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F361031a0%26sid%3Dliteratum%253Aachs%26aulast%3DBliss%26aufirst%3DT.%2BV.%2BP.%26aulast%3DCollingridge%26aufirst%3DG.%2BL.%26atitle%3DA%2520synapti%2520model%2520of%2520memory%253A%2520long-term%2520potentiation%2520in%2520the%2520hippocampus%26jtitle%3DNature%26date%3D1993%26volume%3D361%26spage%3D31%26epage%3D39%26doi%3D10.1038%2F361031a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. T.</span></span> <span> </span><span class="NLM_article-title">NMDA receptor and schizophrenia: a brief history</span>. <i>Schizophr. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">920</span>â <span class="NLM_lpage">926</span>, <span class="refDoi">Â DOI: 10.1093/schbul/sbs076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1093%2Fschbul%2Fsbs076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=22987850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BC38bnvFaltw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2012&pages=920-926&author=J.+T.+Coyle&title=NMDA+receptor+and+schizophrenia%3A+a+brief+history&doi=10.1093%2Fschbul%2Fsbs076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor and schizophrenia: a brief history</span></div><div class="casAuthors">Coyle Joseph T</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia bulletin</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">920-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although glutamate was first hypothesized to be involved in the pathophysiology of schizophrenia in the 1980s, it was the demonstration that N-methyl-D-aspartate (NMDA) receptor antagonists, the dissociative anesthetics, could replicate the full range of psychotic, negative, cognitive, and physiologic features of schizophrenia in normal subjects that placed the "NMDA receptor hypofunction hypothesis" on firm footing.  Additional support came from the demonstration that a variety of agents that enhanced NMDA receptor function at the glycine modulatory site significantly reduced negative symptoms and variably improved cognition in patients with schizophrenia receiving antipsychotic drugs.  Finally, persistent blockade of NMDA receptors recreates in experimental animals the critical pathologic features of schizophrenia including downregulation of  parvalbumin-positive cortical GABAergic neurons,  pyramidal neuron dendritic dysgenesis, and reduced spine density.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR_w6r8iGW247mQt-ICR3qNfW6udTcc2ebTvlFDmg-47Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bnvFaltw%253D%253D&md5=fe18091248ba019a2c9e83b55401a55d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fschbul%2Fsbs076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fschbul%252Fsbs076%26sid%3Dliteratum%253Aachs%26aulast%3DCoyle%26aufirst%3DJ.%2BT.%26atitle%3DNMDA%2520receptor%2520and%2520schizophrenia%253A%2520a%2520brief%2520history%26jtitle%3DSchizophr.%2520Bull.%26date%3D2012%26volume%3D38%26spage%3D920%26epage%3D926%26doi%3D10.1093%2Fschbul%2Fsbs076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olney, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomer, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farber, N. B.</span></span> <span> </span><span class="NLM_article-title">NMDA receptor hypofunction model of schizophrenia</span>. <i>J. Psychiatr. Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">523</span>â <span class="NLM_lpage">533</span>, <span class="refDoi">Â DOI: 10.1016/S0022-3956(99)00029-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2FS0022-3956%2899%2900029-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10628529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BD3c%252Fpt1Wisg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1999&pages=523-533&author=J.+W.+Olneyauthor=J.+W.+Newcomerauthor=N.+B.+Farber&title=NMDA+receptor+hypofunction+model+of+schizophrenia&doi=10.1016%2FS0022-3956%2899%2900029-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor hypofunction model of schizophrenia</span></div><div class="casAuthors">Olney J W; Newcomer J W; Farber N B</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatric research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">523-33</span>
        ISSN:<span class="NLM_cas:issn">0022-3956</span>.
    </div><div class="casAbstract">Several decades of research attempting to explain schizophrenia in terms of the dopamine hyperactivity hypothesis have produced disappointing results.  A new hypothesis focusing on hypofunction of the NMDA glutamate transmitter system is emerging as a potentially more promising concept.  In this article, we present a version of the NMDA receptor hypofunction hypothesis that has evolved from our recent studies pertaining to the neurotoxic and psychotomimetic effects of PCP and related NMDA antagonist drugs.  In this article, we examine this hypothesis in terms of its strengths and weaknesses, its therapeutic implications and ways in which it can be further tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8PJv1HPbUrDEC-75aqa5AfW6udTcc2ebTvlFDmg-47Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c%252Fpt1Wisg%253D%253D&md5=1450b1d092fbd5075e730c8aa68f1153</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0022-3956%2899%2900029-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-3956%252899%252900029-1%26sid%3Dliteratum%253Aachs%26aulast%3DOlney%26aufirst%3DJ.%2BW.%26aulast%3DNewcomer%26aufirst%3DJ.%2BW.%26aulast%3DFarber%26aufirst%3DN.%2BB.%26atitle%3DNMDA%2520receptor%2520hypofunction%2520model%2520of%2520schizophrenia%26jtitle%3DJ.%2520Psychiatr.%2520Res.%26date%3D1999%26volume%3D33%26spage%3D523%26epage%3D533%26doi%3D10.1016%2FS0022-3956%2899%2900029-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reisberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doody, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">StÃ¶ffler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¶bius, H. J.</span></span> <span> </span><span class="NLM_article-title">Memantine in moderate-to-severe Alzheimerâs disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">1333</span>â <span class="NLM_lpage">1341</span>, <span class="refDoi">Â DOI: 10.1056/NEJMoa013128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1056%2FNEJMoa013128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=12672860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1egt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=1333-1341&author=B.+Reisbergauthor=R.+Doodyauthor=A.+St%C3%B6fflerauthor=F.+Schmittauthor=S.+Ferrisauthor=H.+J.+M%C3%B6bius&title=Memantine+in+moderate-to-severe+Alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMoa013128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Memantine in moderate-to-severe Alzheimer's disease</span></div><div class="casAuthors">Reisberg, Barry; Doody, Rachelle; Stoeffler, Albrecht; Schmitt, Frederick; Ferris, Steven; Moebius, Hans Joerg; Apter, J. T.; Baumel, B.; Bernick, C.; Carman, J. S.; Charles, L. P.; Corey-Bloom, J.; DeCarli, C.; Duara, R.; DuBoff, E.; Edwards, N.; Eisner, L.; Farlow, M. R.; Flitman, S.; Hubbard, R. H.; Jacobson, A.; Jurkowski, C. L.; Kiev, A.; Kirby, L. C.; Margolin, D.; Merideth, C.; Mintzer, J. E.; Pfeiffer, E.; Richter, R.; Sadowsky, C. H.; Solomon, P.; Targum, S.; Tilker, H.; Usman, M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1333-1341</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Memantine, an NMDA antagonist, was investigated for the treatment of Alzheimer's disease.  Patients with moderate-to-severe Alzheimer's disease were randomly assigned to receive placebo or 20 mg memantine daily for 28 wk.  Two hundred fifty-two patients (67% women; mean age, 76 yr) from 32 U.S. centers were enrolled.  Of these, 181 (72%) completed the study and were evaluated at week 28.  Seventy-one patients discontinued treatment prematurely (42 taking placebo and 29 taking memantine).  Patients receiving memantine had a better outcome than those receiving placebo, according to the results of several tests.  Memantine treatment was not assocd. with a significant frequency of adverse events.  Thus, antiglutamatergic treatment reduced clin. deterioration in moderate-to-severe Alzheimer's disease, a phase assocd. with distress for patients and burden on caregivers, for which no other treatments are available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouAMuYZycKVrVg90H21EOLACvtfcHk0lhjeKru7SYEAA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1egt7k%253D&md5=f25ba456c00ead51c0a6426ca8701c5b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa013128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa013128%26sid%3Dliteratum%253Aachs%26aulast%3DReisberg%26aufirst%3DB.%26aulast%3DDoody%26aufirst%3DR.%26aulast%3DSt%25C3%25B6ffler%26aufirst%3DA.%26aulast%3DSchmitt%26aufirst%3DF.%26aulast%3DFerris%26aufirst%3DS.%26aulast%3DM%25C3%25B6bius%26aufirst%3DH.%2BJ.%26atitle%3DMemantine%2520in%2520moderate-to-severe%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D348%26spage%3D1333%26epage%3D1341%26doi%3D10.1056%2FNEJMoa013128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hallett, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Standaert, D. G.</span></span> <span> </span><span class="NLM_article-title">Rationale for and use of NMDA receptor antagonists in Parkinonâs disease</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">155</span>â <span class="NLM_lpage">174</span>, <span class="refDoi">Â DOI: 10.1016/j.pharmthera.2004.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2Fj.pharmthera.2004.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=15163596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVCiur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2004&pages=155-174&author=P.+J.+Hallettauthor=D.+G.+Standaert&title=Rationale+for+and+use+of+NMDA+receptor+antagonists+in+Parkinon%E2%80%99s+disease&doi=10.1016%2Fj.pharmthera.2004.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Rationale for and use of NMDA receptor antagonists in Parkinson's disease</span></div><div class="casAuthors">Hallett, Penelope J.; Standaert, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-174</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  N-Methyl-D-aspartate (NMDA) glutamate receptors are a class of excitatory amino acid receptors, which have several important functions in the motor circuits of the basal ganglia, and are viewed as important targets for the development of new drugs to prevent or treat Parkinson's disease (PD).  NMDA receptors are ligand-gated ion channels composed of multiple subunits, each of which has distinct cellular and regional patterns of expression.  They have complex regulatory properties, with both agonist and co-agonist binding sites and regulation by phosphorylation and protein-protein interactions.  They are found in all of the structures of the basal ganglia, although the subunit compn. in the various structures is different.  NMDA receptors present in the striatum are crucial for dopamine-glutamate interactions.  The abundance, structure, and function of striatal receptors are altered by the dopamine depletion and further modified by the pharmacol. treatments used in PD.  In animal models, NMDA receptor antagonists are effective antiparkinsonian agents and can reduce the complications of chronic dopaminergic therapy (wearing off and dyskinesias).  Use of these agents in humans has been limited because of the adverse effects assocd. with nonselective blockade of NMDA receptor function, but the development of more potent and selective pharmaceuticals holds the promise of an important new therapeutic approach for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3ar05ZbM9e7Vg90H21EOLACvtfcHk0lgUEHqoepmJrQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVCiur4%253D&md5=9a8db709281a9e22c8d77438d6862562</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2004.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2004.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DHallett%26aufirst%3DP.%2BJ.%26aulast%3DStandaert%26aufirst%3DD.%2BG.%26atitle%3DRationale%2520for%2520and%2520use%2520of%2520NMDA%2520receptor%2520antagonists%2520in%2520Parkinon%25E2%2580%2599s%2520disease%26jtitle%3DPharmacol.%2520Ther.%26date%3D2004%26volume%3D102%26spage%3D155%26epage%3D174%26doi%3D10.1016%2Fj.pharmthera.2004.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Milnerwood, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raymond, L. A.</span></span> <span> </span><span class="NLM_article-title">Early synaptic pathophysiology in neurodegeneration: insights from Huntingtonâs disease</span>. <i>Trends Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">513</span>â <span class="NLM_lpage">523</span>, <span class="refDoi">Â DOI: 10.1016/j.tins.2010.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2Fj.tins.2010.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=20850189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlensb7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=513-523&author=A.+J.+Milnerwoodauthor=L.+A.+Raymond&title=Early+synaptic+pathophysiology+in+neurodegeneration%3A+insights+from+Huntington%E2%80%99s+disease&doi=10.1016%2Fj.tins.2010.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease</span></div><div class="casAuthors">Milnerwood, Austen J.; Raymond, Lynn A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Neurosciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">513-523</span>CODEN:
                <span class="NLM_cas:coden">TNSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-2236</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Investigations of synaptic transmission and plasticity in mouse models of Huntington's disease (HD) demonstrate neuronal dysfunction long before the onset of classical disease indicators.  Similarly, recent human studies reveal synaptic dysfunction decades before predicted clin. diagnosis in HD gene carriers.  These studies guide premanifest tracking of disease and the development of treatment assessment tools.  New discoveries of mechanisms underlying early neuronal dysfunction, including elevated pathogenic extrasynaptic NMDA receptor signaling, reduced synaptic connectivity and loss of brain-derived neurotrophic factor (BDNF) support have led to pharmacol. interventions that can reverse or delay phenotype onset and disease progression in HD mice.  Further understanding the primary effects of gene mutations assocd. with late-onset neurodegeneration should translate to novel treatments for HD families and guide therapeutic strategies for other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_uV2DR-YcILVg90H21EOLACvtfcHk0lgUEHqoepmJrQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlensb7M&md5=f7ac827cd01948f918d0f19815c49d53</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2010.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2010.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DMilnerwood%26aufirst%3DA.%2BJ.%26aulast%3DRaymond%26aufirst%3DL.%2BA.%26atitle%3DEarly%2520synaptic%2520pathophysiology%2520in%2520neurodegeneration%253A%2520insights%2520from%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Neurosci.%26date%3D2010%26volume%3D33%26spage%3D513%26epage%3D523%26doi%3D10.1016%2Fj.tins.2010.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">XiangWei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span> <span> </span><span class="NLM_article-title">De novo mutations and rare variants occurring in NMDA receptors</span>. <i>Curr. Opin. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">27</span>â <span class="NLM_lpage">35</span>, <span class="refDoi">Â DOI: 10.1016/j.cophys.2017.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2Fj.cophys.2017.12.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=29756080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BC1MfislGnug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2018&pages=27-35&author=W.+XiangWeiauthor=Y.+Jiangauthor=H.+Yuan&title=De+novo+mutations+and+rare+variants+occurring+in+NMDA+receptors&doi=10.1016%2Fj.cophys.2017.12.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">De Novo Mutations and Rare Variants Occurring in NMDA Receptors</span></div><div class="casAuthors">XiangWei Wenshu; Jiang Yuwu; Jiang Yuwu; Yuan Hongjie; Yuan Hongjie</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in physiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27-35</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A significant number of variants/mutations in the N-methyl-D-aspartate glutamatergic receptor (NMDAR) gene family (GRIN) have been identified along with stunning advances in the technologies of next generation of whole-exome sequencing.  Mutations in human GRIN genes are distributed throughout the entire gene, from amino terminal domain to C-terminal domain, in patients with various neuropsychiatric disorders, including autism spectrum disorders, epilepsy, intellectual disability, attention deficit hyperactivity disorder, and schizophrenia.  Analyzing the currently available human genetic variations illustrates the genetic variation intolerance to missense mutations differs significantly among domains within the GRIN genes.  Functional analyses of these mutations and their pharmacological profiles provide the first opportunity to understand the molecular mechanism and targeted therapeutic strategies for these neurological and psychiatric disorders, as well as unfold novel clues to channel function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQdzJKhR8JOSqqcneEtCi92fW6udTcc2eapsyWV_1oh27ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MfislGnug%253D%253D&md5=80f8773fdfd10eaadeb57d47028e55e3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cophys.2017.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cophys.2017.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DXiangWei%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DH.%26atitle%3DDe%2520novo%2520mutations%2520and%2520rare%2520variants%2520occurring%2520in%2520NMDA%2520receptors%26jtitle%3DCurr.%2520Opin.%2520Physiol.%26date%3D2018%26volume%3D2%26spage%3D27%26epage%3D35%26doi%3D10.1016%2Fj.cophys.2017.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, M.</span></span> <span> </span><span class="NLM_article-title">Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">693</span>â <span class="NLM_lpage">702</span>, <span class="refDoi">Â DOI: 10.1016/j.nurt.2009.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2Fj.nurt.2009.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=19789073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVKqu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=693-702&author=L.+J.+Wuauthor=M.+Zhuo&title=Targeting+the+NMDA+receptor+subunit+NR2B+for+the+treatment+of+neuropathic+pain&doi=10.1016%2Fj.nurt.2009.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain</span></div><div class="casAuthors">Wu, Long-Jun; Zhuo, Min</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">693-702</span>CODEN:
                <span class="NLM_cas:coden">NEURNV</span>;
        ISSN:<span class="NLM_cas:issn">1933-7213</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Neuropathic pain is generally defined as a chronic pain state resulting from peripheral or central nerve injury, or both.  An effective treatment for neuropathic pain is still lacking.  The NMDA receptor, one type of the ionotropic glutamate receptors, is known to be important for triggering long-lasting changes in synapses.  NMDA receptor-dependent synaptic plasticity plays roles not only in physiol. functions such as learning and memory, but also in unwanted pathol. conditions such as chronic pain.  This review addresses recent progress on NMDA receptors in neuropathic pain, with particular emphasis on the NR2B-subunit-contg. receptors.  The expression and function of NMDA receptors in synaptic plasticity in the pain transmission pathway from dorsal root ganglia to the anterior cingulate cortex is reviewed, and preclin. and clin. investigations of selective NMDA receptor in neuropathic pain are discussed.  The NMDA receptors, in particular NR2B-contg. NMDA receptors, serve as promising targets for treatment of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJj_EcDQHnR7Vg90H21EOLACvtfcHk0lgUEHqoepmJrQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVKqu7g%253D&md5=b68285897a56e8c4e2b02233cf2c8de7</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.nurt.2009.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nurt.2009.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DL.%2BJ.%26aulast%3DZhuo%26aufirst%3DM.%26atitle%3DTargeting%2520the%2520NMDA%2520receptor%2520subunit%2520NR2B%2520for%2520the%2520treatment%2520of%2520neuropathic%2520pain%26jtitle%3DNeurotherapeutics%26date%3D2009%26volume%3D6%26spage%3D693%26epage%3D702%26doi%3D10.1016%2Fj.nurt.2009.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehls, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teasdale, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCulloch, J.</span></span> <span> </span><span class="NLM_article-title">The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">543</span>â <span class="NLM_lpage">551</span>, <span class="refDoi">Â DOI: 10.1002/ana.410240411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1002%2Fana.410240411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=2853604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaL1cXmt1agtLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1988&pages=543-551&author=C.+K.+Parkauthor=D.+G.+Nehlsauthor=D.+I.+Grahamauthor=G.+M.+Teasdaleauthor=J.+McCulloch&title=The+glutamate+antagonist+MK-801+reduces+focal+ischemic+brain+damage+in+the+rat&doi=10.1002%2Fana.410240411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat</span></div><div class="casAuthors">Park, C. K.; Nehls, D. G.; Graham, D. I.; Teasdale, G. M.; McCulloch, J.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">543-51</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">Focal cerebral ischemia was produced by the permanent occlusion of one middle cerebral artery (MCA), and the animals were killed 3 h after the arterial occlusion.  MK-801 (0.5 mg/kg) was administered i.v. either 30 min prior to MCA occlusion or 30 min after the induction of ischemia.  Pretreatment with MK-801 reduced the vol. of ischemic damage both in the cerebral cortex (by 38% compared with untreated rats with MCA occlusion, and in the caudate nucleus (by 18% compared with controls).  Treatment with MK-801, initiated 30 min after MCA occlusion, reduced the vol. of ischemic damage in the cerebral cortex (by 52% compared with controls).  The vol. of ischemic damage in the caudate nucleus was minimally influenced by MK-801 treatment initiated after MCA occlusion.  The antiischemic effects of MK-801 were readily demonstrable despite the hypotension that MK-801 induced in rats anesthetized with halothane (0.5%), N2O (70%), and O (30%).  The potency of MK-801 in reducing ischemic brain damage, even when administered after the induction of ischemia, highlights the potential use of N-methyl-D-aspartate receptor antagonists for the treatment of focal cerebral ischemia in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg60Bc9vNYHrVg90H21EOLACvtfcHk0lhKTItmbnJS6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXmt1agtLc%253D&md5=113494a1ddee98d9ee935b322c06e7b0</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fana.410240411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410240411%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DC.%2BK.%26aulast%3DNehls%26aufirst%3DD.%2BG.%26aulast%3DGraham%26aufirst%3DD.%2BI.%26aulast%3DTeasdale%26aufirst%3DG.%2BM.%26aulast%3DMcCulloch%26aufirst%3DJ.%26atitle%3DThe%2520glutamate%2520antagonist%2520MK-801%2520reduces%2520focal%2520ischemic%2520brain%2520damage%2520in%2520the%2520rat%26jtitle%3DAnn.%2520Neurol.%26date%3D1988%26volume%3D24%26spage%3D543%26epage%3D551%26doi%3D10.1002%2Fana.410240411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simon, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swan, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meldrum, B. S.</span></span> <span> </span><span class="NLM_article-title">Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>226</i></span>,  <span class="NLM_fpage">850</span>â <span class="NLM_lpage">852</span>, <span class="refDoi">Â DOI: 10.1126/science.6093256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1126%2Fscience.6093256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=6093256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaL2MXjsl0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=1984&pages=850-852&author=R.+P.+Simonauthor=J.+H.+Swanauthor=T.+Griffithsauthor=B.+S.+Meldrum&title=Blockade+of+N-methyl-D-aspartate+receptors+may+protect+against+ischemic+damage+in+the+brain&doi=10.1126%2Fscience.6093256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain</span></div><div class="casAuthors">Simon, R. P.; Swan, J. H.; Griffiths, T.; Meldrum, B. S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">4676</span>),
    <span class="NLM_cas:pages">850-2</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">In rats ischemia of the forebrain induced by a 30-min occlusion of the carotid artery followed by 120 min of arterial reperfusion produced ischemic lesions of selectively vulnerable pyramidal cells in both hippocampi.  Focal microinfusion into the dorsal hippocampus of 2-amino-7-phosphonoheptanoic acid  [85797-13-3], an antagonist of excitation at the N-methyl-D-aspartate-preferring receptor, before ischemia was induced protected against the development of ischemic damage.  Apparently, excitatory neurotransmission plays an important role in selective neuronal loss due to cerebral ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZAGwtHGrEWrVg90H21EOLACvtfcHk0lhKTItmbnJS6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXjsl0%253D&md5=057560bcd8ee07a6a4bc35862e4b4424</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.6093256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.6093256%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DR.%2BP.%26aulast%3DSwan%26aufirst%3DJ.%2BH.%26aulast%3DGriffiths%26aufirst%3DT.%26aulast%3DMeldrum%26aufirst%3DB.%2BS.%26atitle%3DBlockade%2520of%2520N-methyl-D-aspartate%2520receptors%2520may%2520protect%2520against%2520ischemic%2520damage%2520in%2520the%2520brain%26jtitle%3DScience%26date%3D1984%26volume%3D226%26spage%3D850%26epage%3D852%26doi%3D10.1126%2Fscience.6093256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morikawa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirino, T.</span></span> <span> </span><span class="NLM_article-title">Attenuation of focal ischemic brain injury in mice deficient in the epsilon1 (NR2A) subunit of NMDA receptor</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">9727</span>â <span class="NLM_lpage">9732</span>, <span class="refDoi">Â DOI: 10.1523/JNEUROSCI.18-23-09727.1998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1523%2FJNEUROSCI.18-23-09727.1998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=9822733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaK1cXnslyru7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=9727-9732&author=E.+Morikawaauthor=H.+Moriauthor=Y.+Kiyamaauthor=M.+Mishinaauthor=T.+Asanoauthor=T.+Kirino&title=Attenuation+of+focal+ischemic+brain+injury+in+mice+deficient+in+the+epsilon1+%28NR2A%29+subunit+of+NMDA+receptor&doi=10.1523%2FJNEUROSCI.18-23-09727.1998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation of focal ischemic brain injury in mice deficient in the Îµ1 (NR2A) subunit of NMDA receptor</span></div><div class="casAuthors">Morikawa, Eiharu; Mori, Hisashi; Kiyama, Yuji; Mishina, Masayoshi; Asano, Takao; Kirino, Takaaki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9727-9732</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The role of glutamate neurotoxicity in cerebral ischemia has long been advocated but still remains controversial, because various glutamate receptor (GluR) antagonists showed inconsistent protective efficacy in brain ischemia models.  To address this central issue of ischemic brain damage more directly, the authors used mutant mice deficient in the GluRÎµ1 (NR2A) subunit of NMDA receptor with or without addnl. heterozygous mutation in the GluRÎµ2 (NR2B) subunit.  Those mutant mice, as well as their littermates, were subjected to focal cerebral ischemia by introducing a 6-0 nylon suture from left common carotid artery.  Brain injury vols. after 2 h of suture insertion, as evaluated by 2,3,5-triphenyltetrazolium chloride staining at 24 h after ischemia, revealed significantly smaller injury size in GluRÎµ1 subunit knock-out mice compared with their wild-type littermates.  The redn. in injury vol. was not attributable to differences in body temp. or in blood flow during ischemia.  Addnl. heterozygous GluRÎµ2 subunit disruption did not result in further redn. in injury vol.  These data directly demonstrate relevance of NMDA receptor-mediated tissue injury after brain ischemia and provide evidence that GluRÎµ1 subunit is involved in these injurious mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0UGwap3Z-r7Vg90H21EOLACvtfcHk0lhKTItmbnJS6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnslyru7o%253D&md5=8a952c73015b06db44d4a8d53abac22b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.18-23-09727.1998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.18-23-09727.1998%26sid%3Dliteratum%253Aachs%26aulast%3DMorikawa%26aufirst%3DE.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DY.%26aulast%3DMishina%26aufirst%3DM.%26aulast%3DAsano%26aufirst%3DT.%26aulast%3DKirino%26aufirst%3DT.%26atitle%3DAttenuation%2520of%2520focal%2520ischemic%2520brain%2520injury%2520in%2520mice%2520deficient%2520in%2520the%2520epsilon1%2520%2528NR2A%2529%2520subunit%2520of%2520NMDA%2520receptor%26jtitle%3DJ.%2520Neurosci.%26date%3D1998%26volume%3D18%26spage%3D9727%26epage%3D9732%26doi%3D10.1523%2FJNEUROSCI.18-23-09727.1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berman, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappiello, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oren, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heninger, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charney, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krystal, J. H.</span></span> <span> </span><span class="NLM_article-title">Antidepressant effects of ketamine in depressed patients</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">351</span>â <span class="NLM_lpage">354</span>, <span class="refDoi">Â DOI: 10.1016/S0006-3223(99)00230-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2FS0006-3223%2899%2900230-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10686270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD3cXht1KqtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2000&pages=351-354&author=R.+M.+Bermanauthor=A.+Cappielloauthor=A.+Anandauthor=D.+A.+Orenauthor=G.+R.+Heningerauthor=D.+S.+Charneyauthor=J.+H.+Krystal&title=Antidepressant+effects+of+ketamine+in+depressed+patients&doi=10.1016%2FS0006-3223%2899%2900230-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant effects of ketamine in depressed patients</span></div><div class="casAuthors">Berman, R. M.; Cappiello, A.; Anand, A.; Oren, D. A.; Heninger, G. R.; Charney, D. S.; Krystal, J. H.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">351-354</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Subjects with major depression completed 2 test days that involved i.v. treatment with ketamine-HCl [an N-methyl-D-aspartate (NMDA) receptor antagonist] (0.5 mg/kg) or saline solns. under randomized, double-blind conditions. The subjects evidenced significant improvement in depressive symptoms within 72 h after ketamine but not placebo infusion. These results suggest a potential role for NMDA receptor-modulating drugs in the treatment of depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe9INO5Rp16bVg90H21EOLACvtfcHk0lgGwJhWhSJFVg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXht1KqtrY%253D&md5=45ef4a17496654912e0bf515ba3fce2a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2899%2900230-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252899%252900230-9%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DR.%2BM.%26aulast%3DCappiello%26aufirst%3DA.%26aulast%3DAnand%26aufirst%3DA.%26aulast%3DOren%26aufirst%3DD.%2BA.%26aulast%3DHeninger%26aufirst%3DG.%2BR.%26aulast%3DCharney%26aufirst%3DD.%2BS.%26aulast%3DKrystal%26aufirst%3DJ.%2BH.%26atitle%3DAntidepressant%2520effects%2520of%2520ketamine%2520in%2520depressed%2520patients%26jtitle%3DBiol.%2520Psychiatry%26date%3D2000%26volume%3D47%26spage%3D351%26epage%3D354%26doi%3D10.1016%2FS0006-3223%2899%2900230-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">aan
het Rot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murrough, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reich, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charney, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, S. J.</span></span> <span> </span><span class="NLM_article-title">Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">139</span>â <span class="NLM_lpage">145</span>, <span class="refDoi">Â DOI: 10.1016/j.biopsych.2009.08.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2Fj.biopsych.2009.08.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=19897179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGrtLvI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=139-145&author=M.+aan%0Ahet+Rotauthor=K.+A.+Collinsauthor=J.+W.+Murroughauthor=A.+M.+Perezauthor=D.+L.+Reichauthor=D.+S.+Charneyauthor=S.+J.+Mathew&title=Safety+and+efficacy+of+repeated-dose+intravenous+ketamine+for+treatment-resistant+depression&doi=10.1016%2Fj.biopsych.2009.08.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression</span></div><div class="casAuthors">aan het Rot, Marije; Collins, Katherine A.; Murrough, James W.; Perez, Andrew M.; Reich, David L.; Charney, Dennis S.; Mathew, Sanjay J.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-145</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A single subanesthetic i.v. dose of ketamine might have rapid but transient antidepressant effects in patients with treatment-resistant depression (TRD).  Here we tested the tolerability, safety, and efficacy of repeated-dose open-label i.v. ketamine (six infusions over 12 days) in 10 medication-free symptomatic patients with TRD who had previously shown a meaningful antidepressant response to a single dose.  On day 1, patients received a 40-min i.v. infusion of ketamine (.5 mg/kg) in an inpatient setting with continuous vital-sign monitoring.  Psychotomimetic effects and adverse events were recorded repeatedly.  The primary efficacy measure was change from baseline in the Montgomery-Ãsberg Depression Rating Scale (MADRS) score.  If patients showed a â¥50% redn. in MADRS scores on day 2, they received five addnl. infusions on an outpatient basis (days 3, 5, 8, 10, and 12).  Follow-up visits were conducted twice-weekly for â¥4 wk or until relapse.  Ketamine elicited minimal pos. psychotic symptoms.  Three patients experienced significant but transient dissociative symptoms.  Side effects during and after each ketamine infusion were generally mild.  The response criterion was met by nine patients after the first infusion as well as after the sixth infusion.  The mean (SD) redn. in MADRS scores after the sixth infusion was 85% (12%).  Postketamine, eight of nine patients relapsed, on av., 19 days after the sixth infusion (range 6 days-45 days).  One patient remained antidepressant-free with minimal depressive symptoms for >3 mo.  These pilot findings suggest feasibility of repeated-dose i.v. ketamine for the acute treatment of TRD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu2kFXrpAgrbVg90H21EOLACvtfcHk0lgGwJhWhSJFVg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGrtLvI&md5=e68b2a1af8cb23477f2b68e0f77bbea6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2009.08.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2009.08.038%26sid%3Dliteratum%253Aachs%26aulast%3Daan%2Bhet%2BRot%26aufirst%3DM.%26aulast%3DCollins%26aufirst%3DK.%2BA.%26aulast%3DMurrough%26aufirst%3DJ.%2BW.%26aulast%3DPerez%26aufirst%3DA.%2BM.%26aulast%3DReich%26aufirst%3DD.%2BL.%26aulast%3DCharney%26aufirst%3DD.%2BS.%26aulast%3DMathew%26aufirst%3DS.%2BJ.%26atitle%3DSafety%2520and%2520efficacy%2520of%2520repeated-dose%2520intravenous%2520ketamine%2520for%2520treatment-resistant%2520depression%26jtitle%3DBiol.%2520Psychiatry%26date%3D2010%26volume%3D67%26spage%3D139%26epage%3D145%26doi%3D10.1016%2Fj.biopsych.2009.08.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santangelo, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katzman, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strong, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span> <span> </span><span class="NLM_article-title">Novel NMDA receptor modulators: an update</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1337</span>â <span class="NLM_lpage">1352</span>, <span class="refDoi">Â DOI: 10.1517/13543776.2012.728587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1517%2F13543776.2012.728587" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=23009122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFeku7rM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1337-1352&author=R.+M.+Santangeloauthor=T.+M.+Ackerauthor=S.+S.+Zimmermanauthor=B.+M.+Katzmanauthor=K.+L.+Strongauthor=S.+F.+Traynelisauthor=D.+C.+Liotta&title=Novel+NMDA+receptor+modulators%3A+an+update&doi=10.1517%2F13543776.2012.728587"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Novel NMDA receptor modulators: an update</span></div><div class="casAuthors">Santangelo, Rose M.; Acker, Timothy M.; Zimmerman, Sommer S.; Katzman, Brooke M.; Strong, Katie L.; Traynelis, Stephen F.; Liotta, Dennis C.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1337-1352</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The NMDA receptor is a ligand-gated ion channel that plays a crit. role in higher level brain processes and has been implicated in a range of neurol. and psychiatric conditions.  Although initial studies for the use of NMDA receptor antagonists in neuroprotection were unsuccessful, more recently, NMDA receptor antagonists have shown clin. promise in other indications such as Alzheimer's disease, Parkinson's disease, pain and depression.  Based on the clin. observations and more recent insights into receptor pharmacol., new modulatory approaches are beginning to emerge, with potential therapeutic benefit.Areas covered: The article covers the known pharmacol. and important features regarding NMDA receptors and their function.  A discussion of pre-clin. and clin. relevance is included, as well.  The subsequent patent literature review highlights the current state of the art targeting the receptor since the last review in 2010.Expert opinion: The complex nature of the NMDA receptor structure and function is becoming better understood.  As knowledge about this receptor increases, it opens up new opportunities for targeting the receptor for many therapeutic indications.  New strategies and advances in older technologies will need to be further developed before clin. success can be achieved.  First-in-class potentiators and subunit-selective agents form the basis for most new strategies, complemented by efforts to limit off-target liability and fine-tune on-target properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCcPFoWECh97Vg90H21EOLACvtfcHk0lgGwJhWhSJFVg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFeku7rM&md5=2f284210f7d50d98bfea33414c72048d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.728587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.728587%26sid%3Dliteratum%253Aachs%26aulast%3DSantangelo%26aufirst%3DR.%2BM.%26aulast%3DAcker%26aufirst%3DT.%2BM.%26aulast%3DZimmerman%26aufirst%3DS.%2BS.%26aulast%3DKatzman%26aufirst%3DB.%2BM.%26aulast%3DStrong%26aufirst%3DK.%2BL.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26atitle%3DNovel%2520NMDA%2520receptor%2520modulators%253A%2520an%2520update%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26spage%3D1337%26epage%3D1352%26doi%3D10.1517%2F13543776.2012.728587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strong, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jing, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prosser, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span> <span> </span><span class="NLM_article-title">NMDA receptor modulators: an updated patent review (2013-2014)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1349</span>â <span class="NLM_lpage">1366</span>, <span class="refDoi">Â DOI: 10.1517/13543776.2014.972938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1517%2F13543776.2014.972938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=25351527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFejsr%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1349-1366&author=K.+L.+Strongauthor=Y.+Jingauthor=A.+R.+Prosserauthor=S.+F.+Traynelisauthor=D.+C.+Liotta&title=NMDA+receptor+modulators%3A+an+updated+patent+review+%282013-2014%29&doi=10.1517%2F13543776.2014.972938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor modulators: an updated patent review (2013 - 2014)</span></div><div class="casAuthors">Strong, Katie L.; Jing, Yao; Prosser, Anthony R.; Traynelis, Stephen F.; Liotta, Dennis C.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1349-1366</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Introduction: The NMDA receptor mediates a slow component of excitatory synaptic transmission, and NMDA receptor dysfunction has been implicated in numerous neurol. disorders.  Thus, interest in developing modulators that are capable of regulating the channel continues to be strong.  Recent research has led to the discovery of a no. of compds. that hold therapeutic and clin. value.  Deeper insight into the NMDA intersubunit interactions and structural motifs gleaned from the recently solved crystal structures of the NMDA receptor should facilitate a deeper understanding of how these compds. modulate the receptor.  Areas covered: This article discusses the known pharmacol. of NMDA receptors.  A discussion of the patent literature since 2012 is also included, with an emphasis on those that claimed new chem. entities as regulators of the NMDA receptor.  Expert opinion: The no. of patents involving novel NMDA receptor modulators suggests a renewed interest in the NMDA receptor as a therapeutic target.  Subunit-selective modulators continue to show promise, and the development of new subunit-selective NMDA receptor modulators appears poised for continued growth.  Although a modest no. of channel blocker patents were published, successful clin. outcomes involving ketamine have led to a resurgent interest in low-affinity channel blockers as therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7rbzQ3H9ZDbVg90H21EOLACvtfcHk0ljpU-rvVmFyTQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFejsr%252FL&md5=2a1ffaa993c76d1f4ddf2cd80a298f04</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.972938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.972938%26sid%3Dliteratum%253Aachs%26aulast%3DStrong%26aufirst%3DK.%2BL.%26aulast%3DJing%26aufirst%3DY.%26aulast%3DProsser%26aufirst%3DA.%2BR.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26atitle%3DNMDA%2520receptor%2520modulators%253A%2520an%2520updated%2520patent%2520review%2520%25282013-2014%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26spage%3D1349%26epage%3D1366%26doi%3D10.1517%2F13543776.2014.972938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregestovski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ascher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prochiantz, A.</span></span> <span> </span><span class="NLM_article-title">Magnesium gates glutamate-activated channels in mouse central neurones</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>307</i></span>,  <span class="NLM_fpage">462</span>â <span class="NLM_lpage">465</span>, <span class="refDoi">Â DOI: 10.1038/307462a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2F307462a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=6320006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaL2cXhtVSktrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=1984&pages=462-465&author=L.+Nowakauthor=P.+Bregestovskiauthor=P.+Ascherauthor=A.+Herbetauthor=A.+Prochiantz&title=Magnesium+gates+glutamate-activated+channels+in+mouse+central+neurones&doi=10.1038%2F307462a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Magnesium gates glutamate-activated channels in mouse central neurons</span></div><div class="casAuthors">Nowak, L.; Bregestovski, P.; Ascher, P.; Herbet, A.; Prochiantz, A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">5950</span>),
    <span class="NLM_cas:pages">462-5</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Studies on mouse embryo mesencephalic or striatal neurons using the patch-clamp technique indicated a link between voltage sensitivity and Mg2+ sensitivity.  In Mg2+-free solns., L-glutamate, L-aspartate, and N-methyl-D-aspartate (NMDA) opened cation channels, the properties of which were voltage independent.  In the presence of Mg2+, the single-channel currents measured at resting potential were chopped in bursts and the probability of opening the channels was reduced.  Both effects increased with hyperpolarization, thereby accounting for the neg. slope of the I-V relation of the glutamate response.  Thus, the voltage dependence of the NMDA receptor-linked conductance appears to be a consequence of the voltage dependence of the Mg2+ block, and its interpretation does not require the implication of an intramembrane voltage-dependent gate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNI5KPbMeMT7Vg90H21EOLACvtfcHk0ljpU-rvVmFyTQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhtVSktrg%253D&md5=cc393236b9af6184c9b936bf2b61c83b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2F307462a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F307462a0%26sid%3Dliteratum%253Aachs%26aulast%3DNowak%26aufirst%3DL.%26aulast%3DBregestovski%26aufirst%3DP.%26aulast%3DAscher%26aufirst%3DP.%26aulast%3DHerbet%26aufirst%3DA.%26aulast%3DProchiantz%26aufirst%3DA.%26atitle%3DMagnesium%2520gates%2520glutamate-activated%2520channels%2520in%2520mouse%2520central%2520neurones%26jtitle%3DNature%26date%3D1984%26volume%3D307%26spage%3D462%26epage%3D465%26doi%3D10.1038%2F307462a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westbrook, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guthrie, P. B.</span></span> <span> </span><span class="NLM_article-title">Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>309</i></span>,  <span class="NLM_fpage">261</span>â <span class="NLM_lpage">263</span>, <span class="refDoi">Â DOI: 10.1038/309261a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2F309261a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=6325946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaL2cXktFyjtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=1984&pages=261-263&author=M.+L.+Mayerauthor=G.+L.+Westbrookauthor=P.+B.+Guthrie&title=Voltage-dependent+block+by+Mg2%2B+of+NMDA+responses+in+spinal+cord+neurones&doi=10.1038%2F309261a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-dependent block by magnesium(2+) of NMDA responses in spinal cord neurons</span></div><div class="casAuthors">Mayer, Mark L.; Westbrook, Gary L.; Guthrie, Peter B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">5965</span>),
    <span class="NLM_cas:pages">261-3</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Voltage-clamp expts. on mouse spinal cord neurons showed that the voltage-sensitivity of N-methyl-D-aspartic acid (NMDA)  [6384-92-5] action is greatly reduced on the withdrawal of physiol. concns. (â¼1 mM) of Mg2+ from the extracellular fluid.  Thus, Mg2+ blocks inward current flow through ion channels linked to NMDA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLE_6GreNx3rVg90H21EOLACvtfcHk0ljpU-rvVmFyTQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXktFyjtrk%253D&md5=5f44b8f339efde1dc09259c308373c8d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2F309261a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F309261a0%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DM.%2BL.%26aulast%3DWestbrook%26aufirst%3DG.%2BL.%26aulast%3DGuthrie%26aufirst%3DP.%2BB.%26atitle%3DVoltage-dependent%2520block%2520by%2520Mg2%252B%2520of%2520NMDA%2520responses%2520in%2520spinal%2520cord%2520neurones%26jtitle%3DNature%26date%3D1984%26volume%3D309%26spage%3D261%26epage%3D263%26doi%3D10.1038%2F309261a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacDermott, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westbrook, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, J. L.</span></span> <span> </span><span class="NLM_article-title">NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>321</i></span>,  <span class="NLM_fpage">519</span>â <span class="NLM_lpage">522</span>, <span class="refDoi">Â DOI: 10.1038/321519a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2F321519a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=3012362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaL28XksFGjs7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=1986&pages=519-522&author=A.+B.+MacDermottauthor=M.+L.+Mayerauthor=G.+L.+Westbrookauthor=S.+J.+Smithauthor=J.+L.+Barker&title=NMDA-receptor+activation+increases+cytoplasmic+calcium+concentration+in+cultured+spinal+cord+neurones&doi=10.1038%2F321519a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurons</span></div><div class="casAuthors">MacDermott, Amy B.; Mayer, Mark L.; Westbrook, Gary L.; Smith, Stephen J.; Barker, Jeffery L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">6069</span>),
    <span class="NLM_cas:pages">519-22</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The intracellular Ca2+ activity in 13-14-day-old mouse embryo spinal neurons was measured by using the indicator dye arsenazo III.  N-Methyl-D-aspartic acid (NMDA)  [6384-92-5] application to spinal cord neurons voltage-clamped at -50 to -60 mV evoked an inward current accompanied by an increase in the intracellular Ca2+ concn.  The increase in Ca2+ levels peaked near +10 mV and declined in amplitude on further depolarization.  L-Glutamate  [56-86-0], a mixed agonist acting at NMDA receptors, also evoked increases in intracellular Ca2+ levels.  A depolarizing shift of the NMDA reversal potential on increasing the extracellular Ca2+ concn. provides direct evidence that NMDA channels have measurable Ca2+ permeability.  In contrast, the reversal potential of the response evoked by kainate  [487-79-6] showed little Ca2+ dependence.  The response to NMDA receptor activation thus provides a 2nd source of Ca2+ flux, distinct from that resulting from conventional voltage-dependent Ca2+ channels, which may have important long-term effects on excitability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqawDa2JDMMBLVg90H21EOLACvtfcHk0ljpU-rvVmFyTQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XksFGjs7g%253D&md5=3867f3a74a88ff4e25421653a495e03e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2F321519a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F321519a0%26sid%3Dliteratum%253Aachs%26aulast%3DMacDermott%26aufirst%3DA.%2BB.%26aulast%3DMayer%26aufirst%3DM.%2BL.%26aulast%3DWestbrook%26aufirst%3DG.%2BL.%26aulast%3DSmith%26aufirst%3DS.%2BJ.%26aulast%3DBarker%26aufirst%3DJ.%2BL.%26atitle%3DNMDA-receptor%2520activation%2520increases%2520cytoplasmic%2520calcium%2520concentration%2520in%2520cultured%2520spinal%2520cord%2520neurones%26jtitle%3DNature%26date%3D1986%26volume%3D321%26spage%3D519%26epage%3D522%26doi%3D10.1038%2F321519a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monyer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnashev, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurie, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeburg, P. H.</span></span> <span> </span><span class="NLM_article-title">Developmental and regional expression in the rat brain and functional properties of four NMDA receptors</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">529</span>â <span class="NLM_lpage">540</span>, <span class="refDoi">Â DOI: 10.1016/0896-6273(94)90210-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2F0896-6273%2894%2990210-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=7512349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaK2cXitlKku7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1994&pages=529-540&author=H.+Monyerauthor=N.+Burnashevauthor=D.+J.+Laurieauthor=B.+Sakmannauthor=P.+H.+Seeburg&title=Developmental+and+regional+expression+in+the+rat+brain+and+functional+properties+of+four+NMDA+receptors&doi=10.1016%2F0896-6273%2894%2990210-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental and regional expression in the rat brain and functional properties of four NMDA receptors</span></div><div class="casAuthors">Monyer, Hannah; Burnashev, Nail; Laurie, David J.; Sakmann, Bert; Seeburg, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">ISS/REP#/MLT:  3</span>),
    <span class="NLM_cas:pages">529-40</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    </div><div class="casAbstract">An in situ study of mRNAs encoding NMDA receptor subunits in the developing rat CNS revealed that, at all stages, the NR1 gene is expressed in virtually all neurons, whereas the four NR2 transcripts display distinct expression patterns.  NR2B and NR2D mRNA occur prenatally, whereas NR2A and NR2C mRNAs are first detected near birth.  All transcripts except NR2D peak around P20.  NR2D mRNA, present mainly in midbrain structures, peaks around P7 and thereafter decreases to adult levels.  Postnatally, NR2B and NR2C transcript levels change in opposite directions in the cerebellar internal granule cell layer.  In the adult hippocampus, NR2A and NR2B mRNAs are prominent in CA1 and CA3 pyramidal cells, but NR2C and NR2D mRNAs occur in different subsets of interneurons.  Recombinant binary NR1-NR2 channels show comparable Ca2+ permeabilities, but marked differences in voltage-dependent Mg2+ block and in offset decay time consts.  Thus, the distinct expression profiles and functional properties of NR2 subunits provide a basis for NMDA channel heterogeneity in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfdrOkgeEJfbVg90H21EOLACvtfcHk0lgm7-lrrnadWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlKku7w%253D&md5=9ff9985abba893a28ae4983c5099e913</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2F0896-6273%2894%2990210-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0896-6273%252894%252990210-0%26sid%3Dliteratum%253Aachs%26aulast%3DMonyer%26aufirst%3DH.%26aulast%3DBurnashev%26aufirst%3DN.%26aulast%3DLaurie%26aufirst%3DD.%2BJ.%26aulast%3DSakmann%26aufirst%3DB.%26aulast%3DSeeburg%26aufirst%3DP.%2BH.%26atitle%3DDevelopmental%2520and%2520regional%2520expression%2520in%2520the%2520rat%2520brain%2520and%2520functional%2520properties%2520of%2520four%2520NMDA%2520receptors%26jtitle%3DNeuron%26date%3D1994%26volume%3D12%26spage%3D529%26epage%3D540%26doi%3D10.1016%2F0896-6273%2894%2990210-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akazawa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigemoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessho, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, N.</span></span> <span> </span><span class="NLM_article-title">Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats</span>. <i>J. Comp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">150</span>â <span class="NLM_lpage">160</span>, <span class="refDoi">Â DOI: 10.1002/cne.903470112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1002%2Fcne.903470112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=7798379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaK2cXmt1alt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=1994&pages=150-160&author=C.+Akazawaauthor=R.+Shigemotoauthor=Y.+Besshoauthor=S.+Nakanishiauthor=N.+Mizuno&title=Differential+expression+of+five+N-methyl-D-aspartate+receptor+subunit+mRNAs+in+the+cerebellum+of+developing+and+adult+rats&doi=10.1002%2Fcne.903470112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats</span></div><div class="casAuthors">Akazawa, Chihiro; Shigemoto, Ryuichi; Bessho, Yasumasa; Nakanishi, Shigetada; Mizuno, Noboru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">150-60</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    </div><div class="casAbstract">Five N-methyl-D-aspartate (NMDA) receptor subunits have been identified thus far: NR1, NR2A, NR2B, NR2C, and NR2D.  Here, the authors have analyzed the expression patterns of mRNAs for the NMDA receptor subunits in the developing and adult rats by in situ hybridization.  The developmental changes of the expression patterns were most salient in the cerebellum.  In the external granular layer, hybridization signals of mRNAs for NR1, NR2A, NR2B, and NR2C appeared by postnatal day 3, but no NR2D mRNA was expressed at any developmental stage examd.  The NR1 mRNA was expressed in all cerebellar neurons at all developmental stages examd.  The signals for the NR2A mRNA appeared in Purkinje cells and granule cells during the second postnatal week.  The signals for the NR2B mRNA in granule cells were seen transiently during the first 2 wk after birth.  The signals for NR2C mRNA appeared in granule cells and glial cells during the second postnatal week.  The signals for NR2D mRNA appeared transiently in Purkinje cells during the first 8 postnatal days; in adult rats, these were seen in stellate and Golgi cells.  In the cerebellar nuclei, mRNAs for NR1, NR2A, NR2B, and NR2D were more or less expressed on postnatal day 0, while expression signals for the NR2C mRNA were first detected in postnatal day 14.  Thus, the most conspicuous changes of expression patterns were obsd. in the cerebellar cortex during the first 2 wk after birth, when development and maturation of the cerebellum proceed most rapidly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-3uXAbBlyr7Vg90H21EOLACvtfcHk0lgm7-lrrnadWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmt1alt74%253D&md5=56ff09fd6667cd9c90a2bc8225261e5a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fcne.903470112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcne.903470112%26sid%3Dliteratum%253Aachs%26aulast%3DAkazawa%26aufirst%3DC.%26aulast%3DShigemoto%26aufirst%3DR.%26aulast%3DBessho%26aufirst%3DY.%26aulast%3DNakanishi%26aufirst%3DS.%26aulast%3DMizuno%26aufirst%3DN.%26atitle%3DDifferential%2520expression%2520of%2520five%2520N-methyl-D-aspartate%2520receptor%2520subunit%2520mRNAs%2520in%2520the%2520cerebellum%2520of%2520developing%2520and%2520adult%2520rats%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D1994%26volume%3D347%26spage%3D150%26epage%3D160%26doi%3D10.1002%2Fcne.903470112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishina, M.</span></span> <span> </span><span class="NLM_article-title">Developmental changes in distribution of NMDA receptor channel subunit mRNAs</span>. <i>NeuroReport</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1138</span>â <span class="NLM_lpage">1140</span>, <span class="refDoi">Â DOI: 10.1097/00001756-199212000-00027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1097%2F00001756-199212000-00027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1493227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaK3sXit1Khs7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1992&pages=1138-1140&author=M.+Watanabeauthor=Y.+Inoueauthor=K.+Sakimuraauthor=M.+Mishina&title=Developmental+changes+in+distribution+of+NMDA+receptor+channel+subunit+mRNAs&doi=10.1097%2F00001756-199212000-00027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental changes in distribution of NMDA receptor channel subunit mRNAs</span></div><div class="casAuthors">Watanabe, Masahiko; Inoue, Yoshiro; Sakimura, Kenji; Mishina, Masayoshi</div><div class="citationInfo"><span class="NLM_cas:title">NeuroReport</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1138-40</span>CODEN:
                <span class="NLM_cas:coden">NERPEZ</span>;
        ISSN:<span class="NLM_cas:issn">0959-4965</span>.
    </div><div class="casAbstract">In situ hybridization analyses revealed drastic changes in expression and distribution of 5 subunit mRNAs of the mouse NMDA receptor channel during brain development.  The Îµ1 subunit mRNA is expressed postnatally and widely in the brain.  On the other hand, the Îµ2 subunit mRNA is found throughout the entire embryonic brain, but its expression becomes restricted to the forebrain at postnatal stages.  The Îµ3 subunit mRNA appears postnatally and predominantly in the cerebellum, whereas the Îµ4 subunit mRNA is abundantly expressed in the diencephalon and the brain stem at embryonic and neonatal stages.  In contrast, the Î¶1 subunit mRNA distributes ubiquitously in the brain throughout development.  These findings suggest that changes in the subunit compn. of the NMDA receptor channel take place during brain development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5mdDqXX5eybVg90H21EOLACvtfcHk0lgm7-lrrnadWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit1Khs7s%253D&md5=4ed4b0724e33d4432836b8613c020d92</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1097%2F00001756-199212000-00027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-199212000-00027%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DY.%26aulast%3DSakimura%26aufirst%3DK.%26aulast%3DMishina%26aufirst%3DM.%26atitle%3DDevelopmental%2520changes%2520in%2520distribution%2520of%2520NMDA%2520receptor%2520channel%2520subunit%2520mRNAs%26jtitle%3DNeuroReport%26date%3D1992%26volume%3D3%26spage%3D1138%26epage%3D1140%26doi%3D10.1097%2F00001756-199212000-00027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erreger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dravid, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banke, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, D. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signaling profiles</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>563</i></span>,  <span class="NLM_fpage">345</span>â <span class="NLM_lpage">358</span>, <span class="refDoi">Â DOI: 10.1113/jphysiol.2004.080028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1113%2Fjphysiol.2004.080028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=15649985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVWiur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=563&publication_year=2005&pages=345-358&author=K.+Erregerauthor=S.+M.+Dravidauthor=T.+G.+Bankeauthor=D.+J.+A.+Wyllieauthor=S.+F.+Traynelis&title=Subunit-specific+gating+controls+rat+NR1%2FNR2A+and+NR1%2FNR2B+NMDA+channel+kinetics+and+synaptic+signaling+profiles&doi=10.1113%2Fjphysiol.2004.080028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles</span></div><div class="casAuthors">Erreger, Kevin; Dravid, Shashank M.; Banke, Tue G.; Wyllie, David J. A.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">563</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">345-358</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">NR2A and NR2B are the predominant NR2 NMDA receptor subunits expressed in cortex and hippocampus.  The relative expression level of NR2A and NR2B is regulated developmentally and these two subunits have been suggested to play distinct roles in long-term synaptic plasticity.  The authors have used patch-clamp recording of recombinant NMDA receptors expressed in HEK293 cells to characterize the activation properties of both NR1/NR2A and NR1/NR2B receptors.  Recordings from outside-out patches that contain a single active channel show that NR2A-contg. receptors have a higher probability of opening at least once in response to a brief synaptic-like pulse of glutamate than NR2B-contg. receptors (NR2A, 0.80; NR2B, 0.56), a higher peak open probability (NR2A, 0.50; NR2B, 0.12), and a higher open probability within an activation (NR2A, 0.67; NR2B, 0.37).  Anal. of the sequence of single-channel open and closed intervals shows that both NR2A- and NR2B-contg. receptors undergo multiple conformational changes prior to opening of the channel, with at least one of these steps being faster for NR2A than NR2B.  These distinct properties produce profoundly different temporal signaling profiles for NR2A- and NR2B-contg. receptors.  Simulations of synaptic responses demonstrate that at low frequencies typically used to induce long-term depression (LTD; 1 Hz), NR1/NR2B makes a larger contribution to total charge transfer and therefore calcium influx than NR1/NR2A.  However, under high-frequency tetanic stimulation (100 Hz; > 100 ms) typically used to induce long-term potentiation (LTP), the charge transfer mediated by NR1/NR2A considerably exceeds that of NR1/NR2B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRM6ur3MVsKbVg90H21EOLACvtfcHk0liVc_aGTvN2TA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVWiur4%253D&md5=201e62033417cad488f26a1378c6cde1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2004.080028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2004.080028%26sid%3Dliteratum%253Aachs%26aulast%3DErreger%26aufirst%3DK.%26aulast%3DDravid%26aufirst%3DS.%2BM.%26aulast%3DBanke%26aufirst%3DT.%2BG.%26aulast%3DWyllie%26aufirst%3DD.%2BJ.%2BA.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DSubunit-specific%2520gating%2520controls%2520rat%2520NR1%252FNR2A%2520and%2520NR1%252FNR2B%2520NMDA%2520channel%2520kinetics%2520and%2520synaptic%2520signaling%2520profiles%26jtitle%3DJ.%2520Physiol.%26date%3D2005%26volume%3D563%26spage%3D345%26epage%3D358%26doi%3D10.1113%2Fjphysiol.2004.080028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dravid, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">Activation of recombinant NR1/NR2C NMDA receptors</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>586</i></span>,  <span class="NLM_fpage">4425</span>â <span class="NLM_lpage">4439</span>, <span class="refDoi">Â DOI: 10.1113/jphysiol.2008.158634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1113%2Fjphysiol.2008.158634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=18635641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1SnsL3L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=586&publication_year=2008&pages=4425-4439&author=S.+M.+Dravidauthor=A.+Prakashauthor=S.+F.+Traynelis&title=Activation+of+recombinant+NR1%2FNR2C+NMDA+receptors&doi=10.1113%2Fjphysiol.2008.158634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of recombinant NR1/NR2C NMDA receptors</span></div><div class="casAuthors">Dravid, Shashank M.; Prakash, Anand; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">586</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4425-4439</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The N-methyl-D-aspartate (NMDA) subtype of ionotropic glutamate receptors comprises both NR1 and NR2 subunits, and plays numerous roles in both physiol. and pathophysiol. processes in the central nervous system (CNS).  NR2C-contg. NMDA receptors are most abundant in cerebellum, thalamus and olfactory bulb, and are also expressed in oligodendrocytes and hippocampal interneurons.  We have used patch clamp recording to explore the activation properties of recombinant NR1/NR2C receptors expressed in HEK293 cells.  NR1/NR2C receptors activated by a maximally effective concn. of glutamate and glycine had two main conductance levels of 45 pS and 28 pS when the extracellular Ca2+ concn. was 0.5 mM and the holding potential was -80 mV.  The occurrence of the lower subconductance state was reduced in the absence of extracellular Ca2+.  The distribution of closed durations recorded from patches with a high probability of contg. only one active channel were best fitted by five exponential functions; the apparent open duration histogram could be fitted by two exponential functions (n = 10 patches).  The apparent mean open time of NR1/NR2C receptors was brief (0.52 Â± 0.04 ms), suggesting that the stability of the open state of the NR1/NR2C receptors is lower than other NR2-contg. receptors.  NR1/NR2C open probability was exceptionally low, being 0.011 Â± 0.002 in patches contg. a single active receptor (n = 8).  Fast agonist concn. jumps were performed on outside out patches with multiple NR1/NR2C channels, which activated with a 10-90% rise time of 3.9 Â± 0.4 ms, faster than other NR2-contg. receptors.  The deactivation time const. after a brief (5-8 ms) application of a maximally effective concn. of agonists was 319 Â± 34 ms.  The majority of the patches also showed a modest level of desensitization that could be described by either a single or a double exponential time course with the fastest time const. between 15 and 47 ms.  Conceptual models of activation were fitted using the max. interval likelihood (MIL) method to the sequence of open and closed durations recorded from outside-out patches that contained one active NR1/NR2C channel.  NR1/NR2C receptor properties including modest desensitization and low open probability could be described by gating schemes similar to those previously proposed for other NMDA receptor subunit combinations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjw6raHUAlArVg90H21EOLACvtfcHk0liVc_aGTvN2TA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1SnsL3L&md5=e525f3cdd1c15c04d901ef0ef900b262</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2008.158634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2008.158634%26sid%3Dliteratum%253Aachs%26aulast%3DDravid%26aufirst%3DS.%2BM.%26aulast%3DPrakash%26aufirst%3DA.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DActivation%2520of%2520recombinant%2520NR1%252FNR2C%2520NMDA%2520receptors%26jtitle%3DJ.%2520Physiol.%26date%3D2008%26volume%3D586%26spage%3D4425%26epage%3D4439%26doi%3D10.1113%2Fjphysiol.2008.158634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, D. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beheâ², P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colquhoun, D.</span></span> <span> </span><span class="NLM_article-title">Single-channel activations and concentration jumps: comparison of recombinant NR1a/NR2A and NR1a/NR2D NMDA receptors</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>510</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">18</span>, <span class="refDoi">Â DOI: 10.1111/j.1469-7793.1998.001bz.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1111%2Fj.1469-7793.1998.001bz.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=9625862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaK1cXkvVKksro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=510&publication_year=1998&pages=1-18&author=D.+J.+A.+Wyllieauthor=P.+Behe%E2%80%B2author=D.+Colquhoun&title=Single-channel+activations+and+concentration+jumps%3A+comparison+of+recombinant+NR1a%2FNR2A+and+NR1a%2FNR2D+NMDA+receptors&doi=10.1111%2Fj.1469-7793.1998.001bz.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Single-channel activations and concentration jumps: comparison of recombinant NR1a/NR2A and NR1a/NR2D NMDA receptors</span></div><div class="casAuthors">Wyllie, David J. A.; Behe, Philippe; Colquhoun, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">510</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-18</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">The authors have expressed recombinant NR1a/NR2A and NR1a/NR2D N-methyl-D-aspartate (NMDA) receptor channels in Xenopus oocytes and made recordings of single-channel and macroscopic currents in outside-out membrane patches.  For each receptor type the authors measured (a) the individual single-channel activations evoked by low glutamate concns. in steady-state recordings, and (b) the macroscopic responses elicited by brief concn. jumps with high agonist concns., and the authors explore the relationship between these two sorts of observation.  Low concn. (5-100 nM) steady-state recordings of NR1a/NR2A and NR1a/NR2D single-channel activity generated shut-time distributions that were best fitted with a mixt. of five and six exponential components, resp.  Individual activations of either receptor type were resolved as bursts of openings, which the authors refer to as "super-clusters".  During a single activation, NR1a/NR2A receptors were open for 36% of the time, but NR1a/NR2D receptors were open for only 4% of the time.  For both, distributions of super-cluster durations were best fitted with a mixt. of six exponential components.  Their overall mean durations were 35.8 and 1602 ms, resp.  Steady-state super-clusters were aligned on their first openings and averaged.  The av. was well fitted by a sum of exponentials with time consts. taken from fits to super-cluster length distributions.  It is shown that this is what would be expected for a channel that shows simple Markovian behavior.  The current through NR1a/NR2A channels following a concn. jump from zero to 1 mM glutamate for 1 ms was well fitted by three exponential components with time consts. of 13 ms (rising phase), 70 ms and 350 ms (decaying phase).  Similar concn. jumps on NR1a/NR2D channels were well fitted by two exponentials with means of 45 ms (rising phase) and 4408 ms (decaying phase) components.  During prolonged exposure to glutamate, NR1a/NR2A channels desensitized with a time const. of 649 ms, while NR1a/NR2D channels exhibited no apparent desensitization.  The authors show that under certain conditions, the time consts. for the macroscopic jump response should be the same as those for the distribution of super-cluster lengths, though the resoln. of the latter is so much greater that it cannot be expected that all the components will be resolvable in a macroscopic current.  Good agreement was found for jumps on NR1a/NR2D receptors, and for some jump expts. on NR1a/NR2A.  However, the latter were rather variable and some were slower than predicted.  Slow decays were assocd. with patches that had large currents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp06u6poN-ph7Vg90H21EOLACvtfcHk0liVc_aGTvN2TA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvVKksro%253D&md5=7dbdff84304f43105499b0db7816641f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1469-7793.1998.001bz.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1469-7793.1998.001bz.x%26sid%3Dliteratum%253Aachs%26aulast%3DWyllie%26aufirst%3DD.%2BJ.%2BA.%26aulast%3DBehe%25E2%2580%25B2%26aufirst%3DP.%26aulast%3DColquhoun%26aufirst%3DD.%26atitle%3DSingle-channel%2520activations%2520and%2520concentration%2520jumps%253A%2520comparison%2520of%2520recombinant%2520NR1a%252FNR2A%2520and%2520NR1a%252FNR2D%2520NMDA%2520receptors%26jtitle%3DJ.%2520Physiol.%26date%3D1998%26volume%3D510%26spage%3D1%26epage%3D18%26doi%3D10.1111%2Fj.1469-7793.1998.001bz.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vance, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">GluN1 splice variant control of GluN1/GluN2D NMDA receptors</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>590</i></span>,  <span class="NLM_fpage">3857</span>â <span class="NLM_lpage">3875</span>, <span class="refDoi">Â DOI: 10.1113/jphysiol.2012.234062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1113%2Fjphysiol.2012.234062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=22641781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlOjsr%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=590&publication_year=2012&pages=3857-3875&author=K.+M.+Vanceauthor=K.+B.+Hansenauthor=S.+F.+Traynelis&title=GluN1+splice+variant+control+of+GluN1%2FGluN2D+NMDA+receptors&doi=10.1113%2Fjphysiol.2012.234062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">GluN1 splice variant control of GluN1/GluN2D NMDA receptors</span></div><div class="casAuthors">Vance, Katie M.; Hansen, Kasper B.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">590</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3857-3875</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">NMDA receptors are ionotropic glutamate receptors that mediate a slow, Ca2+-permeable component of excitatory synaptic transmission in the central nervous system.  Recombinant GluN1-1a/GluN2D receptors are characterized by low channel open probability and prolonged deactivation time course following the removal of agonist.  The deactivation time course, agonist potency, and single channel properties of GluN2D-contg. NMDA receptors are modulated by alternative RNA splicing of GluN1.  The authors' results demonstrate that GluN1 exon 5, which encodes a 21-amino-acid insert in the N-terminal domain, is a key determinant of GluN1/GluN2D receptor function.  GluN1-1b/GluN2D receptors, which contain the residues encoded by exon 5, deactivate with a dual exponential time course described by a ÏFAST of 410 ms and a ÏSLOW of 1100 ms.  This time course is 3-fold more rapid than that for exon 5-lacking GluN1-1a/GluN2D, which deactivates with a ÏFAST of 1100 ms and a ÏSLOW of 3400 ms.  Exon 5-contg. NMDA receptors also have a two-fold higher open probability (0.037) than exon 5-lacking receptors (0.017).  Furthermore, inclusion of exon 5-encoded residues within the GluN1-1b subunit decreases the potency for the endogenous agonist L-glutamate.  Evaluation of receptor kinetics for NMDA receptors contg. mutated GluN1-1b subunits and wild-type GluN2D identified residue Lys 211 in GluN1-1b as a key determinant of exon 5 control of the deactivation time course and glutamate potency.  Evaluation of a kinetic model of GluN1/GluN2D gating suggests that residues encoded by exon 5 influence several rate-limiting steps.  These data demonstrate that the GluN1 subunit is a key determinant of the kinetic and pharmacol. properties of GluN2D-contg. NMDA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmbUqORgSwVbVg90H21EOLACvtfcHk0lj_TgmDxjj8sA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlOjsr%252FL&md5=97b96e89a03b1bdc15afd50d9790b354</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2012.234062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2012.234062%26sid%3Dliteratum%253Aachs%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DGluN1%2520splice%2520variant%2520control%2520of%2520GluN1%252FGluN2D%2520NMDA%2520receptors%26jtitle%3DJ.%2520Physiol.%26date%3D2012%26volume%3D590%26spage%3D3857%26epage%3D3875%26doi%3D10.1113%2Fjphysiol.2012.234062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erreger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geballe, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyuboslavsky, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micale, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">JÃ¸rgensen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, D. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">907</span>â <span class="NLM_lpage">920</span>, <span class="refDoi">Â DOI: 10.1124/mol.107.037333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1124%2Fmol.107.037333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=17622578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFaiu7%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=907-920&author=K.+Erregerauthor=M.+T.+Geballeauthor=A.+Kristensenauthor=P.+E.+Chenauthor=K.+B.+Hansenauthor=C.+J.+Leeauthor=H.+Yuanauthor=P.+Leauthor=P.+N.+Lyuboslavskyauthor=N.+Micaleauthor=L.+J%C3%B8rgensenauthor=R.+P.+Clausenauthor=D.+J.+A.+Wyllieauthor=J.+P.+Snyderauthor=S.+F.+Traynelis&title=Subunit-specific+agonist+activity+at+NR2A-%2C+NR2B-%2C+NR2C-%2C+and+NR2D-containing+N-methyl-D-aspartate+glutamate+receptors&doi=10.1124%2Fmol.107.037333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors</span></div><div class="casAuthors">Erreger, Kevin; Geballe, Matthew T.; Kristensen, Anders; Chen, Philip E.; Hansen, Kasper B.; Lee, C. Justin; Yuan, Hongjie; Le, Phuong; Lyuboslavsky, Polina N.; Micale, Nicola; Jorgensen, Lars; Clausen, Rasmus P.; Wyllie, David J. A.; Snyder, James P.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">907-920</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The four N-methyl-D-aspartate (NMDA) receptor NR2 subunits (NR2A-D) have different developmental, anatomical, and functional profiles that allow them to serve different roles in normal and neuropathol. situations.  Identification of subunit-selective NMDA receptor agonists, antagonists, or modulators could prove to be both valuable pharmacol. tools as well as potential new therapeutic agents.  We evaluated the potency and efficacy of a wide range of glutamate-like compds. at NR1/NR2A, NR1/NR2B, NR1/NR2C, and NR1/NR2D receptors.  Twenty-five of 53 compds. examd. exhibited agonist activity at the glutamate binding site of NMDA receptors.  Concn.-response relationships were detd. for these agonists at each NR2 subunit.  We find consistently higher potency at the NR2D subunit for a wide range of dissimilar structures, with (2S,4R)-4-methylglutamate (SYM2081) showing the greatest differential potency between NR2A- and NR2D-contg. receptors (46-fold).  Anal. of chimeric NR2A/D receptors suggests that enhanced agonist potency for NR2D is controlled by residues in both of the domains (Domain1 and Domain2) that compose the bilobed agonist binding domain.  Mol. dynamics (MD) simulations comparing a crystallog.-based hydrated NR1/NR2A model with a homol.-based NR1/NR2D hydrated model of the agonist binding domains suggest that glutamate exhibits a different binding mode in NR2D compared with NR2A that accommodates a 4-Me substitution in SYM2081.  Mutagenesis of functionally divergent residues supports the conclusions drawn based on the modeling studies.  Despite high homol. and conserved at. contact residues within the agonist binding pocket of NR2A and NR2D, glutamate adopts a different binding orientation that could be exploited for the development of subunit selective agonists and competitive antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9aAIDNF01_rVg90H21EOLACvtfcHk0lj_TgmDxjj8sA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFaiu7%252FI&md5=3c3c6f17e71604dbdf14d8e600d12886</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fmol.107.037333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.107.037333%26sid%3Dliteratum%253Aachs%26aulast%3DErreger%26aufirst%3DK.%26aulast%3DGeballe%26aufirst%3DM.%2BT.%26aulast%3DKristensen%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DP.%2BE.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DLee%26aufirst%3DC.%2BJ.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DLyuboslavsky%26aufirst%3DP.%2BN.%26aulast%3DMicale%26aufirst%3DN.%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DL.%26aulast%3DClausen%26aufirst%3DR.%2BP.%26aulast%3DWyllie%26aufirst%3DD.%2BJ.%2BA.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DSubunit-specific%2520agonist%2520activity%2520at%2520NR2A-%252C%2520NR2B-%252C%2520NR2C-%252C%2520and%2520NR2D-containing%2520N-methyl-D-aspartate%2520glutamate%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D72%26spage%3D907%26epage%3D920%26doi%3D10.1124%2Fmol.107.037333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vicini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grayson, D. R.</span></span> <span> </span><span class="NLM_article-title">Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors</span>. <i>J. Neurophysiol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">555</span>â <span class="NLM_lpage">566</span>, <span class="refDoi">Â DOI: 10.1152/jn.1998.79.2.555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1152%2Fjn.1998.79.2.555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=9463421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADyaK1cXhsVGrurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1998&pages=555-566&author=S.+Viciniauthor=J.+F.+Wangauthor=J.+H.+Liauthor=W.+J.+Zhuauthor=Y.+H.+Wangauthor=J.+H.+Luoauthor=B.+B.+Wolfeauthor=D.+R.+Grayson&title=Functional+and+pharmacological+differences+between+recombinant+N-methyl-D-aspartate+receptors&doi=10.1152%2Fjn.1998.79.2.555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors</span></div><div class="casAuthors">Vicini, Stefano; Wang, Jian Feng; Li, Jin Hong; Zhu, Wei Jian; Wang, Yue Hua; Luo, Jian Hong; Wolfe, Barry B.; Grayson, Dennis R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurophysiology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">555-566</span>CODEN:
                <span class="NLM_cas:coden">JONEA4</span>;
        ISSN:<span class="NLM_cas:issn">0022-3077</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">N-methyl-D-aspartic acid (NMDA) receptors transiently transfected into mammalian HEK-293 cells were characterized with subunit-specific antibodies and electrophysiol. recordings.  Deactivation time course recorded in response to fast L-glutamate pulses were studied in isolated and lifted cells, as well as in outside-out membrane patches excised from cells expressing recombinant NR1 subunits in combination with the NR2A, NR2B, NR2C, or NR2D NMDA receptor subunits.  Transfected cells were preidentified by the fluorescence emitted from the coexpressed Aequorea victoria jellyfish Green Lantern protein.  Currents generated by NR1/NR2A channels displayed double exponential deactivation time course being faster than that in NR1/NR2B or NR1/NR2C channels.  However, a large decay variability was obsd. within each cotransfection, suggesting that mechanisms addnl. to subunit compn. may also regulate deactivation time course.  NR1/NR2D channels displayed slowly deactivating currents.  Channel deactivation was fast and comparable among receptors obtained by cotransfecting five distinct spliced variants of the NR1 subunit, each with the NR2A subunit.  Addnl., recovery from desensitization was slower for NR1/NR2B than for NR1/NR2A channels.  The av. deactivation time course of responses to brief L-glutamate applications in cells where NR1/NR2A/NR2B cDNAs were cotransfected at variable ratio was intermediate between those of the NR1/NR2A and NR1/NR2B channels.  Although immunocytochem. evidence indicates that the majority of cells are cotransfected by all plasmids in triple transfection, our exptl. condition did not allow for a tight control of the expression of NMDA receptor subunits.  This produced the result that many cells were characterized by deactivation time course and haloperidol sensitivities of sep. NR1/NR2A and NR1/NR2B subunit heteromers.  We also speculate on the possible formation of channels resulting from the coassembly in the same receptor of NR1/NR2A/NR2B subunits from a minority of cells that gave responses to brief application of L-glutamate characterized by slow deactivation time course and decreased haloperidol sensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdVejBBO3a_bVg90H21EOLACvtfcHk0liyuFj9NmDfbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsVGrurw%253D&md5=f9970aa9cc3d0d479691aabbfe9242dc</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1152%2Fjn.1998.79.2.555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fjn.1998.79.2.555%26sid%3Dliteratum%253Aachs%26aulast%3DVicini%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%2BF.%26aulast%3DLi%26aufirst%3DJ.%2BH.%26aulast%3DZhu%26aufirst%3DW.%2BJ.%26aulast%3DWang%26aufirst%3DY.%2BH.%26aulast%3DLuo%26aufirst%3DJ.%2BH.%26aulast%3DWolfe%26aufirst%3DB.%2BB.%26aulast%3DGrayson%26aufirst%3DD.%2BR.%26atitle%3DFunctional%2520and%2520pharmacological%2520differences%2520between%2520recombinant%2520N-methyl-D-aspartate%2520receptors%26jtitle%3DJ.%2520Neurophysiol.%26date%3D1998%26volume%3D79%26spage%3D555%26epage%3D566%26doi%3D10.1152%2Fjn.1998.79.2.555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibb, A. J.</span></span> <span> </span><span class="NLM_article-title">Functional NR2B- and NR2D-containing NMDA receptor channels in rat substantia nigra dopaminergic neurones</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>569</i></span>,  <span class="NLM_fpage">209</span>â <span class="NLM_lpage">221</span>, <span class="refDoi">Â DOI: 10.1113/jphysiol.2005.095554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1113%2Fjphysiol.2005.095554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=16141268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSmsrvN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=569&publication_year=2005&pages=209-221&author=S.+Jonesauthor=A.+J.+Gibb&title=Functional+NR2B-+and+NR2D-containing+NMDA+receptor+channels+in+rat+substantia+nigra+dopaminergic+neurones&doi=10.1113%2Fjphysiol.2005.095554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Functional NR2B- and NR2D-containing NMDA receptor channels in rat substantia nigra dopaminergic neurones</span></div><div class="casAuthors">Jones, Susan; Gibb, Alasdair J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">569</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">209-221</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">NMDA receptors regulate burst firing of dopaminergic neurons in the substantia nigra pars compacta (SNc) and may contribute to excitotoxic cell death in Parkinson's disease (PD).  To investigate the subunit compn. of functional NMDA receptors in identified rat SNc dopaminergic neurons, the authors have analyzed the properties of individual NMDA receptor channels in outside-out patches.  NMDA (100 nM) activated channels corresponding to four chord conductances of 18, 30, 41 and 54 pS.  Direct transitions were obsd. between all conductance levels.  Between 18 pS and 41 pS conductance levels, direct transitions were asym., consistent with the presence of NR2D-contg. NMDA receptors.  Channel activity in response to 100 nM or 200 Î¼M NMDA was not affected by zinc or TPEN (N,N,N',N'-tetrakis-[2-pyridylmethyl]-ethylenediamine), indicating that SNc dopaminergic neurons do not contain functional NR2A subunits.  The effect of the NR2B antagonist ifenprodil was complex: 1 Î¼M ifenprodil reduced open probability, while 10 Î¼M reduced channel open time but had no effect on open probability of channels activated by 100 nM NMDA.  When the concn. of NMDA was increased to 200 Î¼M, ifenprodil (10 Î¼M) produced the expected redn. in open probability.  These results indicate that NR2B subunits are present in SNc dopaminergic neurons.  Taken together, these findings indicate that NR2D and NR2B subunits form functional NMDA receptor channels in SNc dopaminergic neurons, and suggest that they may form a triheteromeric NMDA receptor composed of NR1/NR2B/NR2D subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOstcK8ZoIE7Vg90H21EOLACvtfcHk0liyuFj9NmDfbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSmsrvN&md5=35ec389abfbc8740f11fbdcbc356ed88</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2005.095554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2005.095554%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DS.%26aulast%3DGibb%26aufirst%3DA.%2BJ.%26atitle%3DFunctional%2520NR2B-%2520and%2520NR2D-containing%2520NMDA%2520receptor%2520channels%2520in%2520rat%2520substantia%2520nigra%2520dopaminergic%2520neurones%26jtitle%3DJ.%2520Physiol.%26date%3D2005%26volume%3D569%26spage%3D209%26epage%3D221%26doi%3D10.1113%2Fjphysiol.2005.095554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geballe, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erreger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livesey, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâToole, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, D. J.</span></span> <span> </span><span class="NLM_article-title">Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>586</i></span>,  <span class="NLM_fpage">227</span>â <span class="NLM_lpage">245</span>, <span class="refDoi">Â DOI: 10.1113/jphysiol.2007.143172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1113%2Fjphysiol.2007.143172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=17962328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFaqu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=586&publication_year=2008&pages=227-245&author=P.+E.+Chenauthor=M.+T.+Geballeauthor=E.+Katzauthor=K.+Erregerauthor=M.+R.+Liveseyauthor=K.+K.+O%E2%80%99Tooleauthor=P.+Leauthor=C.+J.+Leeauthor=J.+P.+Snyderauthor=S.+F.+Traynelisauthor=D.+J.+Wyllie&title=Modulation+of+glycine+potency+in+rat+recombinant+NMDA+receptors+containing+chimeric+NR2A%2F2D+subunits+expressed+in+Xenopus+laevis+oocytes&doi=10.1113%2Fjphysiol.2007.143172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes</span></div><div class="casAuthors">Chen, Philip E.; Geballe, Matthew T.; Katz, Elyse; Erreger, Kevin; Livesey, Matthew R.; O'Toole, Kate K.; Le, Phuong; Lee, C. Justin; Snyder, James P.; Traynelis, Stephen F.; Wyllie, David J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">586</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">227-245</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Heteromeric NMDARs are composed of coagonist glycine-binding NR1 subunits and glutamate-binding NR2 subunits.  The majority of functional NMDARs in the mammalian central nervous system (CNS) contain two NR1 subunits and two NR2 subunits of which there are four types (A-D).  The authors show that the potency of a variety of endogenous and synthetic glycine-site coagonists varies between recombinant NMDARs such that the highest potency is seen at NR2D-contg. and the lowest at NR2A-contg. NMDARs.  This heterogeneity is specified by the particular NR2 subunit within the NMDAR complex since the glycine-binding NR1 subunit is common to all NMDARs investigated.  To identify the mol. determinants responsible for this heterogeneity, the authors generated chimeric NR2A/2D subunits where they exchanged the S1 and S2 regions that form the ligand-binding domains and coexpressed these with NR1 subunits in Xenopus laevis oocytes.  Glycine concn.-response curves for NMDARs contg. NR2A subunits including the NR2D S1 region gave mean glycine EC50 values similar to NR2A(WT)-contg. NMDARs.  However, receptors contg. NR2A subunits including the NR2D S2 region or both NR2D S1 and S2 regions gave glycine potencies similar to those seen in NR2D(WT)-contg. NMDARs.  In particular, two residues in the S2 region of the NR2A subunit (Lys 719 and Tyr 735) when mutated to the corresponding residues found in the NR2D subunit influence glycine potency.  The authors conclude that the variation in glycine potency is caused by interactions between the NR1 and NR2 ligand-binding domains that occur following agonist binding and which may be involved in the initial conformation changes that det. channel gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcTrVbGodj6LVg90H21EOLACvtfcHk0lheNyVfvk2BNg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFaqu7o%253D&md5=ea684497e12cfe93ab0a0d108d7a887f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2007.143172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2007.143172%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%2BE.%26aulast%3DGeballe%26aufirst%3DM.%2BT.%26aulast%3DKatz%26aufirst%3DE.%26aulast%3DErreger%26aufirst%3DK.%26aulast%3DLivesey%26aufirst%3DM.%2BR.%26aulast%3DO%25E2%2580%2599Toole%26aufirst%3DK.%2BK.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DC.%2BJ.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DWyllie%26aufirst%3DD.%2BJ.%26atitle%3DModulation%2520of%2520glycine%2520potency%2520in%2520rat%2520recombinant%2520NMDA%2520receptors%2520containing%2520chimeric%2520NR2A%252F2D%2520subunits%2520expressed%2520in%2520Xenopus%2520laevis%2520oocytes%26jtitle%3DJ.%2520Physiol.%26date%3D2008%26volume%3D586%26spage%3D227%26epage%3D245%26doi%3D10.1113%2Fjphysiol.2007.143172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banke, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">Activation of NR1/NR2B NMDA receptors</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">144</span>â <span class="NLM_lpage">152</span>, <span class="refDoi">Â DOI: 10.1038/nn1000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2Fnn1000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=12524545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFGgtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2003&pages=144-152&author=T.+G.+Bankeauthor=S.+F.+Traynelis&title=Activation+of+NR1%2FNR2B+NMDA+receptors&doi=10.1038%2Fnn1000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of NR1/NR2B NMDA receptors</span></div><div class="casAuthors">Banke, Tue G.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144-152</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate (NMDA) receptors are highly expressed in the central nervous system and are involved in excitatory synaptic transmission as well as synaptic plasticity.  Despite considerable structural and biophys. research, the mechanism behind activation of the NMDA receptor is still poorly understood.  By analyzing patch clamp recordings of one channel activated by glutamate, the authors detd. the burst structure and open probability for recombinant rat NR1/NR2B receptors.  The authors used partial agonists at the glutamate and glycine binding sites to show that at least two kinetically distinct subunit-assocd. conformational changes link co-agonist binding to the opening of the NMDA receptor pore.  These data suggest that NR1 and NR2B subunits, resp., undergo a fast and slow agonist-dependent conformational change that precedes opening of the pore.  The authors propose a new working model of receptor activation that can account for macroscopic as well as microscopic NMDA receptor properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwRF4DBX3gr7Vg90H21EOLACvtfcHk0lheNyVfvk2BNg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFGgtA%253D%253D&md5=da0f4d8bac701450e59abc590420e968</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnn1000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn1000%26sid%3Dliteratum%253Aachs%26aulast%3DBanke%26aufirst%3DT.%2BG.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DActivation%2520of%2520NR1%252FNR2B%2520NMDA%2520receptors%26jtitle%3DNat.%2520Neurosci.%26date%3D2003%26volume%3D6%26spage%3D144%26epage%3D152%26doi%3D10.1038%2Fnn1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegler
Retchless, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. W.</span></span> <span> </span><span class="NLM_article-title">A single GluN2 subunit residue controls NMDA receptor channel properties via intersubunit interaction</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">406</span>â <span class="NLM_lpage">413</span>, <span class="refDoi">Â DOI: 10.1038/nn.3025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2Fnn.3025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=22246434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BC383lvVGjtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=406-413&author=B.+Siegler%0ARetchlessauthor=W.+Gaoauthor=J.+W.+Johnson&title=A+single+GluN2+subunit+residue+controls+NMDA+receptor+channel+properties+via+intersubunit+interaction&doi=10.1038%2Fnn.3025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A single GluN2 subunit residue controls NMDA receptor channel properties via intersubunit interaction</span></div><div class="casAuthors">Siegler Retchless Beth; Gao Wei; Johnson Jon W</div><div class="citationInfo"><span class="NLM_cas:title">Nature neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">406-13, S1-2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">NMDA receptors (NMDARs) are glutamate-gated ion channels that are present at most excitatory mammalian synapses.  The four GluN2 subunits (GluN2A-D) contribute to four diheteromeric NMDAR subtypes that have divergent physiological and pathological roles.  Channel properties that are fundamental to NMDAR function vary among subtypes.  We investigated the amino acid residues responsible for variations in channel properties by creating and examining NMDARs containing mutant GluN2 subunits.  We found that the NMDAR subtype specificity of three crucial channel properties, Mg(2+) block, selective permeability to Ca(2+) and single-channel conductance, were all controlled primarily by the residue at a single GluN2 site in the M3 transmembrane region.  Mutant cycle analysis guided by molecular modeling revealed that a GluN2-GluN1 subunit interaction mediates the site's effects.  We conclude that a single GluN2 subunit residue couples with the pore-forming loop of the GluN1 subunit to create naturally occurring variations in NMDAR properties that are critical to synaptic plasticity and learning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQhudDPeKwJomLFM_lbR1VmfW6udTcc2eaavbCbbUBUDLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383lvVGjtQ%253D%253D&md5=d146405b6871e50ad4b9d481e1e0c239</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnn.3025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3025%26sid%3Dliteratum%253Aachs%26aulast%3DSiegler%2BRetchless%26aufirst%3DB.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DJohnson%26aufirst%3DJ.%2BW.%26atitle%3DA%2520single%2520GluN2%2520subunit%2520residue%2520controls%2520NMDA%2520receptor%2520channel%2520properties%2520via%2520intersubunit%2520interaction%26jtitle%3DNat.%2520Neurosci.%26date%3D2012%26volume%3D15%26spage%3D406%26epage%3D413%26doi%3D10.1038%2Fnn.3025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paoletti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiang, Z.</span></span> <span> </span><span class="NLM_article-title">NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">383</span>â <span class="NLM_lpage">400</span>, <span class="refDoi">Â DOI: 10.1038/nrn3504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2Fnrn3504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=23686171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVSit7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=383-400&author=P.+Paolettiauthor=C.+Belloneauthor=Z.+Qiang&title=NMDA+receptor+subunit+diversity%3A+impact+on+receptor+properties%2C+synaptic+plasticity+and+disease&doi=10.1038%2Fnrn3504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease</span></div><div class="casAuthors">Paoletti, Pierre; Bellone, Camilla; Zhou, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">383-400</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  NMDA receptors (NMDARs) are glutamate-gated ion channels and are crucial for neuronal communication.  NMDARs form tetrameric complexes that consist of several homologous subunits.  The subunit compn. of NMDARs is plastic, resulting in a large no. of receptor subtypes.  As each receptor subtype has distinct biophys., pharmacol. and signaling properties, there is great interest in detg. whether individual subtypes carry out specific functions in the CNS in both normal and pathol. conditions.  Here, we review the effects of subunit compn. on NMDAR properties, synaptic plasticity and cellular mechanisms implicated in neuropsychiatric disorders.  Understanding the rules and roles of NMDAR diversity could provide new therapeutic strategies against dysfunctions of glutamatergic transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqubMsb4ZP2U7Vg90H21EOLACvtfcHk0lj9-U12h4oEKA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVSit7Y%253D&md5=f69790da360242d491bf1a5eb146613d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnrn3504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3504%26sid%3Dliteratum%253Aachs%26aulast%3DPaoletti%26aufirst%3DP.%26aulast%3DBellone%26aufirst%3DC.%26aulast%3DQiang%26aufirst%3DZ.%26atitle%3DNMDA%2520receptor%2520subunit%2520diversity%253A%2520impact%2520on%2520receptor%2520properties%252C%2520synaptic%2520plasticity%2520and%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D383%26epage%3D400%26doi%3D10.1038%2Fnrn3504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipton, S. A.</span></span> <span> </span><span class="NLM_article-title">Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults</span>. <i>NeuroRx</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">101</span>â <span class="NLM_lpage">110</span>, <span class="refDoi">Â DOI: 10.1602/neurorx.1.1.101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1602%2Fneurorx.1.1.101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=15717010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BD2MzntVamsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=101-110&author=S.+A.+Lipton&title=Failures+and+successes+of+NMDA+receptor+antagonists%3A+molecular+basis+for+the+use+of+open-channel+blockers+like+memantine+in+the+treatment+of+acute+and+chronic+neurologic+insults&doi=10.1602%2Fneurorx.1.1.101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults</span></div><div class="casAuthors">Lipton Stuart A</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-10</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Excitotoxicity, defined as excessive exposure to the neurotransmitter glutamate or overstimulation of its membrane receptors, has been implicated as one of the key factors contributing to neuronal injury and death in a wide range of both acute and chronic neurologic disorders.  Excitotoxic cell death is due, at least in part, to excessive activation of N-methyl-D-aspartate (NMDA)-type glutamate receptors and hence excessive Ca2+ influx through the receptor's associated ion channel.  Physiological NMDA receptor activity, however, is also essential for normal neuronal function; potential neuroprotective agents that block virtually all NMDA receptor activity will very likely have unacceptable clinical side effects.  For this reason many NMDA receptor antagonists have disappointingly failed advanced clinical trials for a number of diseases including stroke and neurodegenerative disorders such as Huntington's disease.  In contrast, studies in my laboratory were the first to show that memantine, an adamantane derivative, preferentially blocks excessive NMDA receptor activity without disrupting normal activity.  Memantine does this through its action as an open-channel blocker; it enters the receptor-associated ion channel preferentially when it is excessively open, and, most importantly, its off-rate is relatively fast so that it does not substantially accumulate in the channel to interfere with normal synaptic transmission.  Past clinical use for other indications has demonstrated that memantine is well tolerated, and it has recently been approved in both Europe and the USA for the treatment of dementia of the Alzheimer's type.  Clinical studies of the safety and efficacy of memantine for other neurological disorders, including glaucoma and other forms of dementia, are currently underway.  A series of second-generation memantine derivatives are currently in development and may prove to have even greater neuroprotective properties than does memantine.  These second-generation drugs take advantage of the fact that the NMDA receptor has other modulatory sites, in addition to its ion channel, that could potentially be used for safe but effective clinical intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8zmuJRBq_D4JKJbLTgsvCfW6udTcc2eYqPdHEXt3-Bbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzntVamsQ%253D%253D&md5=8b298d6d2296816681a880ae371ca027</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.1.1.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.1.1.101%26sid%3Dliteratum%253Aachs%26aulast%3DLipton%26aufirst%3DS.%2BA.%26atitle%3DFailures%2520and%2520successes%2520of%2520NMDA%2520receptor%2520antagonists%253A%2520molecular%2520basis%2520for%2520the%2520use%2520of%2520open-channel%2520blockers%2520like%2520memantine%2520in%2520the%2520treatment%2520of%2520acute%2520and%2520chronic%2520neurologic%2520insults%26jtitle%3DNeuroRx%26date%3D2004%26volume%3D1%26spage%3D101%26epage%3D110%26doi%3D10.1602%2Fneurorx.1.1.101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moghaddam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitt, D.</span></span> <span> </span><span class="NLM_article-title">From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">4</span>â <span class="NLM_lpage">15</span>, <span class="refDoi">Â DOI: 10.1038/npp.2011.181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2Fnpp.2011.181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=21956446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ejs77N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=4-15&author=B.+Moghaddamauthor=D.+Javitt&title=From+revolution+to+evolution%3A+the+glutamate+hypothesis+of+schizophrenia+and+its+implication+for+treatment&doi=10.1038%2Fnpp.2011.181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment</span></div><div class="casAuthors">Moghaddam, Bita; Javitt, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-15</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Glutamate is the primary excitatory neurotransmitter in mammalian brain.  Disturbances in glutamate-mediated neurotransmission have been increasingly documented in a range of neuropsychiatric disorders including schizophrenia, substance abuse, mood disorders, Alzheimer's disease, and autism-spectrum disorders.  Glutamatergic theories of schizophrenia are based on the ability of N-methyl--aspartate receptor (NMDAR) antagonists to induce schizophrenia-like symptoms, as well as emergent literature documenting disturbances of NMDAR-related gene expression and metabolic pathways in schizophrenia.  Research over the past two decades has highlighted promising new targets for drug development based on potential pre- and postsynaptic, and glial mechanisms leading to NMDAR dysfunction.  Reduced NMDAR activity on inhibitory neurons leads to disinhibition of glutamate neurons increasing synaptic activity of glutamate, esp. in the prefrontal cortex.  Based on this mechanism, normalizing excess glutamate levels by metabotropic glutamate group 2/3 receptor agonists has led to potential identification of the first non-monoaminergic target with comparable efficacy as conventional antipsychotic drugs for treating pos. and neg. symptoms of schizophrenia.  In addn., NMDAR has intrinsic modulatory sites that are active targets for drug development, several of which show promise in preclin./early clin. trials targeting both symptoms and cognition.  To date, most studies have been done with orthosteric agonists and/or antagonists at specific sites.  However, allosteric modulators, both pos. and neg., may offer superior efficacy with less danger of downregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeNMlez-A7MbVg90H21EOLACvtfcHk0ljiru5UUpqV9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ejs77N&md5=0bf82fc0e3cb5c3ad2bed91414672e6f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2011.181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2011.181%26sid%3Dliteratum%253Aachs%26aulast%3DMoghaddam%26aufirst%3DB.%26aulast%3DJavitt%26aufirst%3DD.%26atitle%3DFrom%2520revolution%2520to%2520evolution%253A%2520the%2520glutamate%2520hypothesis%2520of%2520schizophrenia%2520and%2520its%2520implication%2520for%2520treatment%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D4%26epage%3D15%26doi%3D10.1038%2Fnpp.2011.181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goff, D.</span></span> <span> </span><span class="NLM_article-title">Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>1003</i></span>,  <span class="NLM_fpage">318</span>â <span class="NLM_lpage">327</span>, <span class="refDoi">Â DOI: 10.1196/annals.1300.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1196%2Fannals.1300.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=14684455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlGqtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1003&publication_year=2003&pages=318-327&author=J.+T.+Coyleauthor=G.+Tsaiauthor=D.+Goff&title=Converging+evidence+of+NMDA+receptor+hypofunction+in+the+pathophysiology+of+schizophrenia&doi=10.1196%2Fannals.1300.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia</span></div><div class="casAuthors">Coyle, Joseph T.; Tsai, Guochuan; Goff, Donald</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1003</span>
        (<span class="NLM_cas:issue">Glutamate and Disorders of Cognition and Motivation</span>),
    <span class="NLM_cas:pages">318-327</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">New York Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  Numerous clin. studies demonstrate that subanesthetic doses of dissociative anesthetics, which are noncompetitive antagonists at the NMDA receptor, replicate in normal subjects the cognitive impairments, neg. symptoms, and brain functional abnormalities of schizophrenia.  Postmortem and genetic studies have identified several abnormalities assocd. with schizophrenia that would interfere with the activation of the glycine modulatory site on the NMDA receptor.  Placebo-controlled clin. trials with agents that directly or indirectly activate the glycine modulatory site consistently reduce neg. symptoms and frequently improve cognition in patients with chronic schizophrenia who are receiving concurrent typical antipsychotics.  Thus, there is convincing evidence that hypofunction of a subset of NMDA receptors may contribute to the symptomatic features of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfQixZ_xxPHLVg90H21EOLACvtfcHk0ljiru5UUpqV9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlGqtQ%253D%253D&md5=0688464460facbf01a7b2ecd701bc87d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1196%2Fannals.1300.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1300.020%26sid%3Dliteratum%253Aachs%26aulast%3DCoyle%26aufirst%3DJ.%2BT.%26aulast%3DTsai%26aufirst%3DG.%26aulast%3DGoff%26aufirst%3DD.%26atitle%3DConverging%2520evidence%2520of%2520NMDA%2520receptor%2520hypofunction%2520in%2520the%2520pathophysiology%2520of%2520schizophrenia%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2003%26volume%3D1003%26spage%3D318%26epage%3D327%26doi%3D10.1196%2Fannals.1300.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Burgos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, D. A.</span></span> <span> </span><span class="NLM_article-title">NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia</span>. <i>Schizophr. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">950</span>â <span class="NLM_lpage">957</span>, <span class="refDoi">Â DOI: 10.1093/schbul/sbs010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1093%2Fschbul%2Fsbs010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=22355184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BC38vjvVKrsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2012&pages=950-957&author=G.+Gonzalez-Burgosauthor=D.+A.+Lewis&title=NMDA+receptor+hypofunction%2C+parvalbumin-positive+neurons%2C+and+cortical+gamma+oscillations+in+schizophrenia&doi=10.1093%2Fschbul%2Fsbs010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia</span></div><div class="casAuthors">Gonzalez-Burgos Guillermo; Lewis David A</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia bulletin</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">950-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Gamma oscillations appear to be dependent on inhibitory neurotransmission from parvalbumin (PV)-containing gamma-amino butyric acid neurons.  Thus, the abnormalities in PV neurons found in schizophrenia may underlie the deficits of gamma-band synchrony in the illness.  Because gamma-band synchrony is thought to be crucial for cognition, cognitive deficits in schizophrenia may reflect PV neuron dysfunction in cortical neural circuits.  Interestingly, it has been suggested that PV alterations in schizophrenia are the consequence of a hypofunction of signaling through N-methyl-D-aspartate (NMDA) receptors (NMDARs).  Here, we review recent findings that address the question of how NMDAR hypofunction might produce deficits of PV neuron-mediated inhibition in schizophrenia.  We conclude that while dysregulation of NMDARs may play an important role in the pathophysiology of schizophrenia, additional research is required to determine the particular cell type(s) that mediate dysfunctional NMDAR signaling in the illness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQrAZ3KfzIjOFVwdslNBF-tfW6udTcc2eY1celfZH_1Jrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vjvVKrsA%253D%253D&md5=9b113bfef5b2597d7927d763006e2a8e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1093%2Fschbul%2Fsbs010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fschbul%252Fsbs010%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Burgos%26aufirst%3DG.%26aulast%3DLewis%26aufirst%3DD.%2BA.%26atitle%3DNMDA%2520receptor%2520hypofunction%252C%2520parvalbumin-positive%2520neurons%252C%2520and%2520cortical%2520gamma%2520oscillations%2520in%2520schizophrenia%26jtitle%3DSchizophr.%2520Bull.%26date%3D2012%26volume%3D38%26spage%3D950%26epage%3D957%26doi%3D10.1093%2Fschbul%2Fsbs010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Won, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gee, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mah, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaang, B.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.</span></span> <span> </span><span class="NLM_article-title">Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>486</i></span>,  <span class="NLM_fpage">261</span>â <span class="NLM_lpage">265</span>, <span class="refDoi">Â DOI: 10.1038/nature11208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2Fnature11208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=22699620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1emtrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=486&publication_year=2012&pages=261-265&author=H.+Wonauthor=H.-R.+Leeauthor=H.+Y.+Geeauthor=W.+Mahauthor=J.-I.+Kimauthor=J.+Leeauthor=S.+Haauthor=C.+Chungauthor=E.+S.+Jungauthor=Y.+S.+Choauthor=S.-G.+Parkauthor=J.-S.+Leeauthor=K.+Leeauthor=D.+Kimauthor=Y.+C.+Baeauthor=B.-K.+Kaangauthor=M.+G.+Leeauthor=E.+Kim&title=Autistic-like+social+behaviour+in+Shank2-mutant+mice+improved+by+restoring+NMDA+receptor+function&doi=10.1038%2Fnature11208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Autistic-like social behavior in Shank2-mutant mice improved by restoring NMDA receptor function</span></div><div class="casAuthors">Won, Hyejung; Lee, Hye-Ryeon; Gee, Heon Yung; Mah, Won; Kim, Jae-Ick; Lee, Jiseok; Ha, Seungmin; Chung, Changuk; Jung, Eun Suk; Cho, Yi Sul; Park, Sae-Geun; Lee, Jung-Soo; Lee, Kyungmin; Kim, Daesoo; Bae, Yong Chul; Kaang, Bong-Kiun; Lee, Min Goo; Kim, Eunjoon</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">486</span>
        (<span class="NLM_cas:issue">7402</span>),
    <span class="NLM_cas:pages">261-265</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autism spectrum disorder (ASD) is a group of conditions characterized by impaired social interaction and communication, and restricted and repetitive behaviors.  ASD is a highly heritable disorder involving various genetic determinants.  Shank2 (also known as ProSAP1) is a multi-domain scaffolding protein and signaling adaptor enriched at excitatory neuronal synapses, and mutations in the human SHANK2 gene have recently been assocd. with ASD and intellectual disablility.  Although ASD-assocd. genes are being increasingly identified and studied using various approaches, including mouse genetics, further efforts are required to delineate important causal mechanisms with the potential for therapeutic application.  Here we show that Shank2-mutant (Shank2-/-) mice carrying a mutation identical to the ASD-assocd. microdeletion in the human SHANK2 gene exhibit ASD-like behaviors including reduced social interaction, reduced social communication by ultrasonic vocalizations, and repetitive jumping.  These mice show a marked decrease in NMDA (N-methyl-d-aspartate) glutamate receptor (NMDAR) function.  Direct stimulation of NMDARs with d-cycloserine, a partial agonist of NMDARs, normalizes NMDAR function and improves social interaction in Shank2-/- mice.  Furthermore, treatment of Shank2-/- mice with a pos. allosteric modulator of metabotropic glutamate receptor 5 (mGluR5), which enhances NMDAR function via mGluR5 activation, also normalizes NMDAR function and markedly enhances social interaction.  These results suggest that reduced NMDAR function may contribute to the development of ASD-like phenotypes in Shank2-/- mice, and mGluR modulation of NMDARs offers a potential strategy to treat ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLS1qTT4nQELVg90H21EOLACvtfcHk0li_SBC0QZTv3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1emtrw%253D&md5=0d5478d17f8b572074040b9fe70b64a3</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnature11208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11208%26sid%3Dliteratum%253Aachs%26aulast%3DWon%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DH.-R.%26aulast%3DGee%26aufirst%3DH.%2BY.%26aulast%3DMah%26aufirst%3DW.%26aulast%3DKim%26aufirst%3DJ.-I.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DHa%26aufirst%3DS.%26aulast%3DChung%26aufirst%3DC.%26aulast%3DJung%26aufirst%3DE.%2BS.%26aulast%3DCho%26aufirst%3DY.%2BS.%26aulast%3DPark%26aufirst%3DS.-G.%26aulast%3DLee%26aufirst%3DJ.-S.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DBae%26aufirst%3DY.%2BC.%26aulast%3DKaang%26aufirst%3DB.-K.%26aulast%3DLee%26aufirst%3DM.%2BG.%26aulast%3DKim%26aufirst%3DE.%26atitle%3DAutistic-like%2520social%2520behaviour%2520in%2520Shank2-mutant%2520mice%2520improved%2520by%2520restoring%2520NMDA%2520receptor%2520function%26jtitle%3DNature%26date%3D2012%26volume%3D486%26spage%3D261%26epage%3D265%26doi%3D10.1038%2Fnature11208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmeisser, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ey, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegener, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bockmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stempel, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuebler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, A.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udvardi, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiban, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spilker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balschun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skryabin, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dieck, S. t.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smalla, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montag, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faure, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torquet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Sourd, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabrcuker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutz, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourgeron, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gundelfinger, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boeckers, T. M.</span></span> <span> </span><span class="NLM_article-title">Autistic-liek behaviours and hyperactivity in mice lacking ProSAP1/Shank2</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>486</i></span>,  <span class="NLM_fpage">256</span>â <span class="NLM_lpage">260</span>, <span class="refDoi">Â DOI: 10.1038/nature11015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2Fnature11015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=22699619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1entLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=486&publication_year=2012&pages=256-260&author=M.+J.+Schmeisserauthor=E.+Eyauthor=S.+Wegenerauthor=J.+Bockmannauthor=A.+V.+Stempelauthor=A.+Kueblerauthor=A.-J.+Janssenauthor=P.+T.+Udvardiauthor=E.+Shibanauthor=C.+Spilkerauthor=D.+Balschunauthor=B.+V.+Skryabinauthor=S.+t.+Dieckauthor=K.-H.+Smallaauthor=D.+Montagauthor=C.+S.+Leblondauthor=P.+Faureauthor=N.+Torquetauthor=A.-M.+Le+Sourdauthor=R.+Toroauthor=A.+M.+Grabrcukerauthor=S.+A.+Shoichetauthor=D.+Schmitzauthor=M.+R.+Kreutzauthor=T.+Bourgeronauthor=E.+D.+Gundelfingerauthor=T.+M.+Boeckers&title=Autistic-liek+behaviours+and+hyperactivity+in+mice+lacking+ProSAP1%2FShank2&doi=10.1038%2Fnature11015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Autistic-like behaviors and hyperactivity in mice lacking ProSAP1/Shank2</span></div><div class="casAuthors">Schmeisser, Michael J.; Ey, Elodie; Wegener, Stephanie; Bockmann, Juergen; Stempel, A. Vanessa; Kuebler, Angelika; Janssen, Anna-Lena; Udvardi, Patrick T.; Shiban, Ehab; Spilker, Christina; Balschun, Detlef; Skryabin, Boris V.; Dieck, Susanne tom; Smalla, Karl-Heinz; Montag, Dirk; Leblond, Claire S.; Faure, Philippe; Torquet, Nicolas; Le Sourd, Anne-Marie; Toro, Roberto; Grabrucker, Andreas M.; Shoichet, Sarah A.; Schmitz, Dietmar; Kreutz, Michael R.; Bourgeron, Thomas; Gundelfinger, Eckart D.; Boeckers, Tobias M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">486</span>
        (<span class="NLM_cas:issue">7402</span>),
    <span class="NLM_cas:pages">256-260</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autism spectrum disorders comprise a range of neurodevelopmental disorders characterized by deficits in social interaction and communication, and by repetitive behavior.  Mutations in synaptic proteins such as neuroligins, neurexins, GKAPs/SAPAPs and ProSAPs/Shanks were identified in patients with autism spectrum disorder, but the causative mechanisms remain largely unknown.  ProSAPs/Shanks build large homo- and heteromeric protein complexes at excitatory synapses and organize the complex protein machinery of the postsynaptic d. in a laminar fashion.  Here we demonstrate that genetic deletion of ProSAP1/Shank2 results in an early, brain-region-specific upregulation of ionotropic glutamate receptors at the synapse and increased levels of ProSAP2/Shank3.  Moreover, ProSAP1/Shank2-/- mutants exhibit fewer dendritic spines and show reduced basal synaptic transmission, a reduced frequency of miniature excitatory postsynaptic currents and enhanced N-methyl-d-aspartate receptor-mediated excitatory currents at the physiol. level.  Mutants are extremely hyperactive and display profound autistic-like behavioral alterations including repetitive grooming as well as abnormalities in vocal and social behaviors.  By comparing the data on ProSAP1/Shank2-/- mutants with ProSAP2/Shank3Î±Î²-/- mice, we show that different abnormalities in synaptic glutamate receptor expression can cause alterations in social interactions and communication.  Accordingly, we propose that appropriate therapies for autism spectrum disorders are to be carefully matched to the underlying synaptopathic phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocv7xYASrOwLVg90H21EOLACvtfcHk0li_SBC0QZTv3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1entLg%253D&md5=f88f5082cdf90461937c3c8fc2209366</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnature11015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11015%26sid%3Dliteratum%253Aachs%26aulast%3DSchmeisser%26aufirst%3DM.%2BJ.%26aulast%3DEy%26aufirst%3DE.%26aulast%3DWegener%26aufirst%3DS.%26aulast%3DBockmann%26aufirst%3DJ.%26aulast%3DStempel%26aufirst%3DA.%2BV.%26aulast%3DKuebler%26aufirst%3DA.%26aulast%3DJanssen%26aufirst%3DA.-J.%26aulast%3DUdvardi%26aufirst%3DP.%2BT.%26aulast%3DShiban%26aufirst%3DE.%26aulast%3DSpilker%26aufirst%3DC.%26aulast%3DBalschun%26aufirst%3DD.%26aulast%3DSkryabin%26aufirst%3DB.%2BV.%26aulast%3DDieck%26aufirst%3DS.%2Bt.%26aulast%3DSmalla%26aufirst%3DK.-H.%26aulast%3DMontag%26aufirst%3DD.%26aulast%3DLeblond%26aufirst%3DC.%2BS.%26aulast%3DFaure%26aufirst%3DP.%26aulast%3DTorquet%26aufirst%3DN.%26aulast%3DLe%2BSourd%26aufirst%3DA.-M.%26aulast%3DToro%26aufirst%3DR.%26aulast%3DGrabrcuker%26aufirst%3DA.%2BM.%26aulast%3DShoichet%26aufirst%3DS.%2BA.%26aulast%3DSchmitz%26aufirst%3DD.%26aulast%3DKreutz%26aufirst%3DM.%2BR.%26aulast%3DBourgeron%26aufirst%3DT.%26aulast%3DGundelfinger%26aufirst%3DE.%2BD.%26aulast%3DBoeckers%26aufirst%3DT.%2BM.%26atitle%3DAutistic-liek%2520behaviours%2520and%2520hyperactivity%2520in%2520mice%2520lacking%2520ProSAP1%252FShank2%26jtitle%3DNature%26date%3D2012%26volume%3D486%26spage%3D256%26epage%3D260%26doi%3D10.1038%2Fnature11015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalmau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleichman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessain, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenfeld, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balice-Gordon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, D. R.</span></span> <span> </span><span class="NLM_article-title">Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1091</span>â <span class="NLM_lpage">1098</span>, <span class="refDoi">Â DOI: 10.1016/S1474-4422(08)70224-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2FS1474-4422%2808%2970224-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=18851928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFCrsLrF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1091-1098&author=J.+Dalmauauthor=A.+J.+Gleichmanauthor=E.+G.+Hughesauthor=J.+E.+Rossiauthor=X.+Pengauthor=M.+Laiauthor=S.+K.+Dessainauthor=M.+R.+Rosenfeldauthor=R.+Balice-Gordonauthor=D.+R.+Lynch&title=Anti-NMDA-receptor+encephalitis%3A+case+series+and+analysis+of+the+effects+of+antibodies&doi=10.1016%2FS1474-4422%2808%2970224-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies</span></div><div class="casAuthors">Dalmau, Josep; Gleichman, Amy J.; Hughes, Ethan G.; Rossi, Jeffrey E.; Peng, Xiaoyu; Lai, Meizan; Dessain, Scott K.; Rosenfeld, Myrna R.; Balice-Gordon, Rita; Lynch, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1091-1098</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A severe form of encephalitis assocd. with antibodies against NR1-NR2 heteromers of the NMDA receptor was recently identified.  We aimed to analyze the clin. and immunol. features of patients with the disorder and examine the effects of antibodies against NMDA receptors in neuronal cultures.  We describe the clin. characteristics of 100 patients with encephalitis and NR1-NR2 antibodies.  HEK293 cells ectopically expressing single or assembled NR1-NR2 subunits were used to det. the epitope targeted by the antibodies.  Antibody titers were measured with ELISA.  The effect of antibodies on neuronal cultures was detd. by quant. anal. of NMDA-receptor clusters.  Median age of patients was 23 years (range 5-76 years); 91 were women.  All patients presented with psychiatric symptoms or memory problems; 76 had seizures, 88 unresponsiveness (decreased consciousness), 86 dyskinesias, 69 autonomic instability, and 66 hypoventilation.  58 (59%) Of 98 patients for whom results of oncol. assessments were available had tumors, most commonly ovarian teratoma.  Patients who received early tumor treatment (usually with immunotherapy) had better outcome (p=0.004) and fewer neurol. relapses (p=0.009) than the rest of the patients.  Seventy-five patients recovered or had mild deficits and 25 had severe deficits or died.  Improvement was assocd. with a decrease of serum antibody titers.  The main epitope targeted by the antibodies is in the extracellular N-terminal domain of the NR1 subunit.  Patients' antibodies decreased the nos. of cell-surface NMDA receptors and NMDA-receptor clusters in postsynaptic dendrites, an effect that could be reversed by antibody removal.  A well-defined set of clin. characteristics are assocd. with anti-NMDA-receptor encephalitis.  The pathogenesis of the disorder seems to be mediated by antibodies.  Funding National Institutes for Health, University of Pennsylvania Institute for Translational Medicine, Lankenau Institute for Medical Research, Foederer Foundation of the Children's Hospital of Philadelphia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxvbKVlmZeRbVg90H21EOLACvtfcHk0lhKN3sPgdUW9Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFCrsLrF&md5=cfa7bfdcd2c41b075c7f473ea559d10b</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2808%2970224-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252808%252970224-2%26sid%3Dliteratum%253Aachs%26aulast%3DDalmau%26aufirst%3DJ.%26aulast%3DGleichman%26aufirst%3DA.%2BJ.%26aulast%3DHughes%26aufirst%3DE.%2BG.%26aulast%3DRossi%26aufirst%3DJ.%2BE.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DLai%26aufirst%3DM.%26aulast%3DDessain%26aufirst%3DS.%2BK.%26aulast%3DRosenfeld%26aufirst%3DM.%2BR.%26aulast%3DBalice-Gordon%26aufirst%3DR.%26aulast%3DLynch%26aufirst%3DD.%2BR.%26atitle%3DAnti-NMDA-receptor%2520encephalitis%253A%2520case%2520series%2520and%2520analysis%2520of%2520the%2520effects%2520of%2520antibodies%26jtitle%3DLancet%2520Neurol.%26date%3D2008%26volume%3D7%26spage%3D1091%26epage%3D1098%26doi%3D10.1016%2FS1474-4422%2808%2970224-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleichman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsou, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalmau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balice-Gordon, R. J.</span></span> <span> </span><span class="NLM_article-title">Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">5866</span>â <span class="NLM_lpage">5875</span>, <span class="refDoi">Â DOI: 10.1523/JNEUROSCI.0167-10.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1523%2FJNEUROSCI.0167-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=20427647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosFeqs7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=5866-5875&author=E.+G.+Hughesauthor=X.+Pengauthor=A.+J.+Gleichmanauthor=M.+Laiauthor=L.+Zhouauthor=R.+Tsouauthor=T.+D.+Parsonsauthor=D.+R.+Lynchauthor=J.+Dalmauauthor=R.+J.+Balice-Gordon&title=Cellular+and+synaptic+mechanisms+of+anti-NMDA+receptor+encephalitis&doi=10.1523%2FJNEUROSCI.0167-10.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis</span></div><div class="casAuthors">Hughes, Ethan G.; Peng, Xiaoyu; Gleichman, Amy J.; Lai, Meizan; Zhou, Lei; Tsou, Ryan; Parsons, Thomas D.; Lynch, David R.; Dalmau, Josep; Balice-Gordon, Rita J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5866-5875</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">We recently described a severe, potentially lethal, but treatment-responsive encephalitis that assocs. with autoantibodies to the NMDA receptor (NMDAR) and results in behavioral symptoms similar to those obtained with models of genetic or pharmacol. attenuation of NMDAR function.  Here, we demonstrate that patients' NMDAR antibodies cause a selective and reversible decrease in NMDAR surface d. and synaptic localization that correlates with patients' antibody titers.  The mechanism of this decrease is selective antibody-mediated capping and internalization of surface NMDARs, as Fab fragments prepd. from patients' antibodies did not decrease surface receptor d., but subsequent crosslinking with anti-Fab antibodies recapitualted the decrease caused by intact patient NMDAR antibodies.  Moreover, whole-cell patch-clamp recordings of miniature EPSCs in cultured rat hippocampal neurons showed that patients' antibodies specifically decreased synaptic NMDAR-mediated currents, without affecting AMPA receptor-mediated currents.  In contrast to these profound effects on NMDARs, patients' antibodies did not alter the localization or expression of other glutamate receptors or synaptic proteins, no. of synapses, dendritic spines, dendritic complexity, or cell survival.  In addn., NMDAR d. was dramatically reduced in the hippocampus of female Lewis rats infused with patients' antibodies, similar to the decrease obsd. in the hippocampus of autopsied patients.  These studies establish the cellular mechanisms through which antibodies of patients with anti-NMDAR encephalitis cause a specific, titer-dependent, and reversible loss of NMDARs.  The loss of this subtype of glutamate receptors eliminates NMDAR-mediated synaptic function, resulting in the learning, memory, and other behavioral deficits obsd. in patients with anti-NMDAR encephalitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFMBlJAlyshrVg90H21EOLACvtfcHk0lhKN3sPgdUW9Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosFeqs7w%253D&md5=56da6f0dee9d8203d0b26882d77f833a</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0167-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0167-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DE.%2BG.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DGleichman%26aufirst%3DA.%2BJ.%26aulast%3DLai%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DTsou%26aufirst%3DR.%26aulast%3DParsons%26aufirst%3DT.%2BD.%26aulast%3DLynch%26aufirst%3DD.%2BR.%26aulast%3DDalmau%26aufirst%3DJ.%26aulast%3DBalice-Gordon%26aufirst%3DR.%2BJ.%26atitle%3DCellular%2520and%2520synaptic%2520mechanisms%2520of%2520anti-NMDA%2520receptor%2520encephalitis%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D5866%26epage%3D5875%26doi%3D10.1523%2FJNEUROSCI.0167-10.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mikasova, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rossi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouchet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogemond, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didelot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meissirel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honnorat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groc, L.</span></span> <span> </span><span class="NLM_article-title">Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">1606</span>â <span class="NLM_lpage">1621</span>, <span class="refDoi">Â DOI: 10.1093/brain/aws092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1093%2Fbrain%2Faws092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=22544902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BC38rptFSiuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2012&pages=1606-1621&author=L.+D.+Mikasovaauthor=P.+De+Rossiauthor=D.+Bouchetauthor=F.+Georgesauthor=V.+Rogemondauthor=A.+Didelotauthor=C.+Meissirelauthor=J.+Honnoratauthor=L.+Groc&title=Disrupted+surface+cross-talk+between+NMDA+and+Ephrin-B2+receptors+in+anti-NMDA+encephalitis&doi=10.1093%2Fbrain%2Faws092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis</span></div><div class="casAuthors">Mikasova Lenka; De Rossi Pierre; Bouchet Delphine; Georges Francois; Rogemond Veronique; Didelot Adrien; Meissirel Claire; Honnorat Jerome; Groc Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">Pt 5</span>),
    <span class="NLM_cas:pages">1606-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autoimmune synaptic encephalitides are recently described human brain diseases leading to psychiatric and neurological syndromes through inappropriate brain-autoantibody interactions.  The most frequent synaptic autoimmune encephalitis is associated with autoantibodies against extracellular domains of the glutamatergic N-methyl-d-aspartate receptor, with patients developing psychotic and neurological symptoms in an autoantibody titre-dependent manner.  Although N-methyl-d-aspartate receptors are the primary target of these antibodies, the cellular and molecular pathway(s) that rapidly lead to N-methyl-d-aspartate receptor dysfunction remain poorly understood.  In this report, we used a unique combination of high-resolution nanoparticle and bulk live imaging approaches to demonstrate that anti-N-methyl-d-aspartate receptor autoantibodies from patients with encephalitis strongly alter, in a time-dependent manner, the surface content and trafficking of GluN2-NMDA receptor subtypes.  Autoantibodies laterally displaced surface GluN2A-NMDA receptors out of synapses and completely blocked synaptic plasticity.  This loss of extrasynaptic and synaptic N-methyl-d-aspartate receptor is prevented both in vitro and in vivo, by the activation of EPHB2 receptors.  Indeed, the anti-N-methyl-d-aspartate receptor autoantibodies weaken the interaction between the extracellular domains of the N-methyl-d-aspartate and Ephrin-B2 receptors.  Together, we demonstrate that the anti-N-methyl-d-aspartate receptor autoantibodies from patients with encephalitis alter the dynamic retention of synaptic N-methyl-d-aspartate receptor through extracellular domain-dependent mechanism(s), shedding new light on the pathology of the neurological and psychiatric disorders observed in these patients and opening possible new therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHviLGtJ4ez5SWdIdmEou5fW6udTcc2eawH2zhOspPsLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rptFSiuw%253D%253D&md5=dc65600d3c0078388dc1170a519291e6</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Faws092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Faws092%26sid%3Dliteratum%253Aachs%26aulast%3DMikasova%26aufirst%3DL.%2BD.%26aulast%3DDe%2BRossi%26aufirst%3DP.%26aulast%3DBouchet%26aufirst%3DD.%26aulast%3DGeorges%26aufirst%3DF.%26aulast%3DRogemond%26aufirst%3DV.%26aulast%3DDidelot%26aufirst%3DA.%26aulast%3DMeissirel%26aufirst%3DC.%26aulast%3DHonnorat%26aufirst%3DJ.%26aulast%3DGroc%26aufirst%3DL.%26atitle%3DDisrupted%2520surface%2520cross-talk%2520between%2520NMDA%2520and%2520Ephrin-B2%2520receptors%2520in%2520anti-NMDA%2520encephalitis%26jtitle%3DBrain%26date%3D2012%26volume%3D135%26spage%3D1606%26epage%3D1621%26doi%3D10.1093%2Fbrain%2Faws092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bannerman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niewoehner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprengel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeburg, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KÃ¶hr, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawlins, J. N.</span></span> <span> </span><span class="NLM_article-title">NMDA receptor subunit NR2A is required for rapidly acquired spatial working memory but not incremental spatial reference memory</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3623</span>â <span class="NLM_lpage">3630</span>, <span class="refDoi">Â DOI: 10.1523/JNEUROSCI.3639-07.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1523%2FJNEUROSCI.3639-07.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=18385321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkslSjtL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=3623-3630&author=D.+M.+Bannermanauthor=B.+Niewoehnerauthor=L.+Lyonauthor=C.+Rombergauthor=W.+B.+Schmittauthor=A.+Taylorauthor=D.+J.+Sandersonauthor=J.+Cottamauthor=R.+Sprengelauthor=P.+H.+Seeburgauthor=G.+K%C3%B6hrauthor=J.+N.+Rawlins&title=NMDA+receptor+subunit+NR2A+is+required+for+rapidly+acquired+spatial+working+memory+but+not+incremental+spatial+reference+memory&doi=10.1523%2FJNEUROSCI.3639-07.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor subunit NR2A is required for rapidly acquired spatial working memory but not incremental spatial reference memory</span></div><div class="casAuthors">Bannerman, David M.; Niewoehner, Burkhard; Lyon, Louisa; Romberg, Carola; Schmitt, Wolfram B.; Taylor, Amy; Sanderson, David J.; Cottam, James; Sprengel, Rolf; Seeburg, Peter H.; Kohr, Georg; Rawlins, John N. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3623-3630</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">NMDA receptors (NMDARs) contg. NR2A (Îµ1) subunits are key contributors to hippocampal long-term potentiation (LTP) induction in adult animals and have therefore been widely implicated in hippocampus-dependent spatial learning.  Here we show that mice lacking the NR2A subunit or its C-terminal interacellular domain exhibit impaired spatial working memory (SWM) but normal spatial ref. memory (SRM).  Both NR2A mutants acquired the SRM version of the water maze task, and the SRM component of the radial maze, as well as controls.  They were, however, impaired on a non-matching-to-place T-maze task, and on the SWM component of the radial maze.  In addn., NR2A knock-out mice displayed a diminished spatial novelty preference in a spontaneous exploration Y-maze task, and were impaired on a T-maze task in which distinctive inserts present on the floor of the maze detd. which goal arm contained the reward, but only if there was a discontiguity between the conditional cue and the place at which the reward was delivered.  This dissocn. of spatial memory into distinctive components is strikingly similar to results obtained with mice lacking glutamate receptor-A (GluR-A)-contg. AMPA receptors, which support long-term potentiation expression.  These results identify a specific role for a NMDAR-dependent signaling pathway that leads to the activation of a GluR-A-dependent expression mechanism in a rapidly acquired, flexible form of spatial memory.  This mechanism depends on the C-terminal intracellular domain of the NR2A subunit.  In contrast, the ability to assoc. a particular spatial location with the water maze escape platform or food reward is NR2A independent, as well as GluR-A independent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozRr5dwP4DZ7Vg90H21EOLACvtfcHk0ljRTt8TnV9WTw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkslSjtL0%253D&md5=5ebf612af3ce8bf4d82a99c14207f4ef</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3639-07.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3639-07.2008%26sid%3Dliteratum%253Aachs%26aulast%3DBannerman%26aufirst%3DD.%2BM.%26aulast%3DNiewoehner%26aufirst%3DB.%26aulast%3DLyon%26aufirst%3DL.%26aulast%3DRomberg%26aufirst%3DC.%26aulast%3DSchmitt%26aufirst%3DW.%2BB.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DSanderson%26aufirst%3DD.%2BJ.%26aulast%3DCottam%26aufirst%3DJ.%26aulast%3DSprengel%26aufirst%3DR.%26aulast%3DSeeburg%26aufirst%3DP.%2BH.%26aulast%3DK%25C3%25B6hr%26aufirst%3DG.%26aulast%3DRawlins%26aufirst%3DJ.%2BN.%26atitle%3DNMDA%2520receptor%2520subunit%2520NR2A%2520is%2520required%2520for%2520rapidly%2520acquired%2520spatial%2520working%2520memory%2520but%2520not%2520incremental%2520spatial%2520reference%2520memory%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D3623%26epage%3D3630%26doi%3D10.1523%2FJNEUROSCI.3639-07.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsien, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span> <span> </span><span class="NLM_article-title">Genetic enhancement of memory and long-term potentiation but not CA1 long-term depression in NR2B transgenic rats</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e7486</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0007486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1371%2Fjournal.pone.0007486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=19838302" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&author=D.+Wangauthor=Z.+Cuiauthor=Q.+Zengauthor=H.+Kuangauthor=L.+P.+Wangauthor=J.+Z.+Tsienauthor=X.+Cao&title=Genetic+enhancement+of+memory+and+long-term+potentiation+but+not+CA1+long-term+depression+in+NR2B+transgenic+rats&doi=10.1371%2Fjournal.pone.0007486"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0007486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0007486%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.%26aulast%3DCui%26aufirst%3DZ.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DKuang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%2BP.%26aulast%3DTsien%26aufirst%3DJ.%2BZ.%26aulast%3DCao%26aufirst%3DX.%26atitle%3DGenetic%2520enhancement%2520of%2520memory%2520and%2520long-term%2520potentiation%2520but%2520not%2520CA1%2520long-term%2520depression%2520in%2520NR2B%2520transgenic%2520rats%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26doi%3D10.1371%2Fjournal.pone.0007486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khlestova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krystal, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisman, J.</span></span> <span> </span><span class="NLM_article-title">The role of GluN2C-containing NMDA receptors in ketamineâs psychotogenic action and in schizophrenia models</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">11151</span>â <span class="NLM_lpage">11157</span>, <span class="refDoi">Â DOI: 10.1523/JNEUROSCI.1203-16.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1523%2FJNEUROSCI.1203-16.2016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=27807157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Ohurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=11151-11157&author=E.+Khlestovaauthor=J.+W.+Johnsonauthor=J.+H.+Krystalauthor=J.+Lisman&title=The+role+of+GluN2C-containing+NMDA+receptors+in+ketamine%E2%80%99s+psychotogenic+action+and+in+schizophrenia+models&doi=10.1523%2FJNEUROSCI.1203-16.2016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The role of GluN2C-containing NMDA receptors in ketamine's psychotogenic action and in schizophrenia models</span></div><div class="casAuthors">Khlestova, Elizaveta; Johnson, Jon W.; Krystal, John H.; Lisman, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">11151-11157</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The NMDA receptor (NMDAR) hypofunction hypothesis of schizophrenia is supported by multiple lines of evidence.  Notably, administration of the NMDAR antagonist, ketamine, to healthy human subjects has psychotogenic action, producing both pos. and neg. symptoms assocd. with schizophrenia.  NMDARs have multiple subtypes, but the subtypes through which ketamine produces its psychotogenic effects are not known.  Here we address this question using quant. data that characterize ketamine's ability to block different NMDAR subtypes.  Our calcns. indicate that, at a concn. that has psychotogenic action in humans, ketamine blocks a substantial fraction of GluN2C subunit-contg. receptors but has less effect on GluN2A-, GluN2B-, and GluN2D-contg. receptors.  Thus, GluN2C-contg. receptors may have preferential involvement in psychotic states produced by ketamine.  A sep. line of expts. also points to a special role for GluN2C.  That work demonstrates the ability of NMDAR antagonists to mimic the elevation in the awake-state Î´ frequency EEG power that occurs in schizophrenia.  Physiol. expts. in rodents show that NMDAR antagonists generate Î´ oscillations by their action on the GluN2C-contg. NMDARs that are prevalent in the thalamus.  Optogenetic expts. suggest that such oscillations could contribute to symptoms of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5QgRmYO74BrVg90H21EOLACvtfcHk0ljRTt8TnV9WTw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Ohurc%253D&md5=6c30a33b65b2be535bdf07f45a925a05</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1203-16.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1203-16.2016%26sid%3Dliteratum%253Aachs%26aulast%3DKhlestova%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DJ.%2BW.%26aulast%3DKrystal%26aufirst%3DJ.%2BH.%26aulast%3DLisman%26aufirst%3DJ.%26atitle%3DThe%2520role%2520of%2520GluN2C-containing%2520NMDA%2520receptors%2520in%2520ketamine%25E2%2580%2599s%2520psychotogenic%2520action%2520and%2520in%2520schizophrenia%2520models%26jtitle%3DJ.%2520Neurosci.%26date%3D2016%26volume%3D36%26spage%3D11151%26epage%3D11157%26doi%3D10.1523%2FJNEUROSCI.1203-16.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koschel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zink, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sommer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treutlein, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider-Axmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parlapani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rietschel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falkai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henn, F. A.</span></span> <span> </span><span class="NLM_article-title">Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia</span>. <i>Eur. Arch. Psychiatry Clin. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>260</i></span>,  <span class="NLM_fpage">101</span>â <span class="NLM_lpage">111</span>, <span class="refDoi">Â DOI: 10.1007/s00406-009-0017-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1007%2Fs00406-009-0017-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=19856012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BC3c7ksFCjuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=2010&pages=101-111&author=A.+Schmittauthor=J.+Koschelauthor=M.+Zinkauthor=M.+Bauerauthor=C.+Sommerauthor=J.+Frankauthor=T.+Treutleinauthor=T.+Schulzeauthor=T.+Schneider-Axmannauthor=E.+Parlapaniauthor=M.+Rietschelauthor=P.+Falkaiauthor=F.+A.+Henn&title=Gene+expression+of+NMDA+receptor+subunits+in+the+cerebellum+of+elderly+patients+with+schizophrenia&doi=10.1007%2Fs00406-009-0017-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia</span></div><div class="casAuthors">Schmitt Andrea; Koschel Jiri; Zink Mathias; Bauer Manfred; Sommer Clemens; Frank Josef; Treutlein Jens; Schulze Thomas; Schneider-Axmann Thomas; Parlapani Eleni; Rietschel Marcella; Falkai Peter; Henn Fritz A</div><div class="citationInfo"><span class="NLM_cas:title">European archives of psychiatry and clinical neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">260</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-11</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">To determine if NMDA receptor alterations are present in the cerebellum in schizophrenia, we measured NMDA receptor binding and gene expression of the NMDA receptor subunits in a post-mortem study of elderly patients with schizophrenia and non-affected subjects.  Furthermore, we assessed influence of genetic variation in the candidate gene neuregulin-1 (NRG1) on the expression of the NMDA receptor in an exploratory study.  Post-mortem samples from the cerebellar cortex of ten schizophrenic patients were compared with nine normal subjects.  We investigated NMDA receptor binding by receptor autoradiography and gene expression of the NMDA receptor subunits NR1, NR2A, NR2B, NR2C and NR2D by in situ hybridization.  For the genetic study, we genotyped the NRG1 polymorphism rs35753505 (SNP8NRG221533).  Additionally, we treated rats with the antipsychotics haloperidol or clozapine and assessed cerebellar NMDA receptor binding and gene expression of subunits to examine the effects of antipsychotic treatment.  Gene expression of the NR2D subunit was increased in the right cerebellum of schizophrenic patients compared to controls.  Individuals carrying at least one C allele of rs35753505 (SNP8NRG221533) showed decreased expression of the NR2C subunit in the right cerebellum, compared to individuals homozygous for the T allele.  Correlation with medication parameters and the animal model revealed no treatment effects.  In conclusion, increased NR2D expression results in a hyperexcitable NMDA receptor suggesting an adaptive effect due to receptor hypofunction.  The decreased NR2C expression in NRG1 risk variant may cause a deficit in NMDA receptor function.  This supports the hypothesis of an abnormal glutamatergic neurotransmission in the right cerebellum in the pathophysiology of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5PS3sSHjA2waK-_ZudimnfW6udTcc2eak7tNLWwd5Fbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7ksFCjuw%253D%253D&md5=9cab8cf5f2f2df2cf423b6b25488a13f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1007%2Fs00406-009-0017-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00406-009-0017-1%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DA.%26aulast%3DKoschel%26aufirst%3DJ.%26aulast%3DZink%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DM.%26aulast%3DSommer%26aufirst%3DC.%26aulast%3DFrank%26aufirst%3DJ.%26aulast%3DTreutlein%26aufirst%3DT.%26aulast%3DSchulze%26aufirst%3DT.%26aulast%3DSchneider-Axmann%26aufirst%3DT.%26aulast%3DParlapani%26aufirst%3DE.%26aulast%3DRietschel%26aufirst%3DM.%26aulast%3DFalkai%26aufirst%3DP.%26aulast%3DHenn%26aufirst%3DF.%2BA.%26atitle%3DGene%2520expression%2520of%2520NMDA%2520receptor%2520subunits%2520in%2520the%2520cerebellum%2520of%2520elderly%2520patients%2520with%2520schizophrenia%26jtitle%3DEur.%2520Arch.%2520Psychiatry%2520Clin.%2520Neurosci.%26date%3D2010%26volume%3D260%26spage%3D101%26epage%3D111%26doi%3D10.1007%2Fs00406-009-0017-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meador-Woodruff, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, A. J.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. E.</span></span> <span> </span><span class="NLM_article-title">Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder</span>. <i>Brain Res. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">631</span>â <span class="NLM_lpage">640</span>, <span class="refDoi">Â DOI: 10.1016/S0361-9230(01)00523-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2FS0361-9230%2801%2900523-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=11576760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntVWqtb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2001&pages=631-640&author=J.+H.+Meador-Woodruffauthor=A.+J.+Hoggauthor=R.+E.+Smith&title=Striatal+ionotropic+glutamate+receptor+expression+in+schizophrenia%2C+bipolar+disorder%2C+and+major+depressive+disorder&doi=10.1016%2FS0361-9230%2801%2900523-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder</span></div><div class="casAuthors">Meador-Woodruff, J. H.; Hogg, A. J.; Smith, R. E.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">631-640</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Abnormalities of the ionotropic glutamate receptors (N-methyl-D-aspartate, Î±-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid [AMPA], and kainate) have been reported in the brain in schizophrenia, although in complex, region-specific patterns.  While limbic cortex and medial temporal lobe structures have been most often studied in psychiatric illnesses, glutamate receptors are expressed in other brain regions assocd. with limbic circuitry, esp. the striatum.  In this study, we have detd. striatal ionotropic glutamate receptor expression in brains from persons with schizophrenia, bipolar disorder, major depression, and a comparison group, using samples from the Stanley Foundation Neuropathol. Consortium.  We have detd. the expression of these receptors at multiple levels of gene expression by using both in situ hybridization and receptor autoradiog.  The expression of nearly all of these mols. was not different in these psychiatric conditions.  The only significant changes noted were NR2D and gluR1 transcripts, and [3H]AMPA binding.  This is the first comprehensive study of striatal ionotropic glutamate receptor expression in schizophrenia and affective disorders, and suggests that there are minimal changes in these receptors in this region of the brain in these illnesses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_dwhhuMywirVg90H21EOLACvtfcHk0lhRJKWII7bmvg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntVWqtb0%253D&md5=8788a4abd8495b68b2a50f033f3986e7</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0361-9230%2801%2900523-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0361-9230%252801%252900523-8%26sid%3Dliteratum%253Aachs%26aulast%3DMeador-Woodruff%26aufirst%3DJ.%2BH.%26aulast%3DHogg%26aufirst%3DA.%2BJ.%26aulast%3DSmith%26aufirst%3DR.%2BE.%26atitle%3DStriatal%2520ionotropic%2520glutamate%2520receptor%2520expression%2520in%2520schizophrenia%252C%2520bipolar%2520disorder%252C%2520and%2520major%2520depressive%2520disorder%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2001%26volume%3D55%26spage%3D631%26epage%3D640%26doi%3D10.1016%2FS0361-9230%2801%2900523-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sapkota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Synowicki, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikezu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gautam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaghan, D. T.</span></span> <span> </span><span class="NLM_article-title">GluN2D N-methyl-D-aspartate receptor subunit contribution to the stimulation of brain activity and gamma oscillations by ketamine: Implications for schizophrenia</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">702</span>â <span class="NLM_lpage">711</span>, <span class="refDoi">Â DOI: 10.1124/jpet.115.230391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1124%2Fjpet.115.230391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=26675679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVelu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2016&pages=702-711&author=K.+Sapkotaauthor=Z.+Maoauthor=P.+Synowickiauthor=D.+Lieberauthor=M.+Liuauthor=T.+Ikezuauthor=V.+Gautamauthor=D.+T.+Monaghan&title=GluN2D+N-methyl-D-aspartate+receptor+subunit+contribution+to+the+stimulation+of+brain+activity+and+gamma+oscillations+by+ketamine%3A+Implications+for+schizophrenia&doi=10.1124%2Fjpet.115.230391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">GluN2D N-Methyl-d-aspartate receptor subunit contribution to the stimulation of brain activity and gamma oscillations by ketamine: implications for schizophrenia</span></div><div class="casAuthors">Sapkota, Kiran; Mao, Zhihao; Synowicki, Paul; Lieber, Dillon; Liu, Meng; Ikezu, Tsuneya; Gautam, Vivek; Monaghan, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">702-711</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The dissociative anesthetic ketamine elicits symptoms of schizophrenia at subanesthetic doses by blocking N-methyl-d-aspartate receptors (NMDARs).  This property led to a variety of studies resulting in the now well-supported theory that hypofunction of NMDARs is responsible for many of the symptoms of schizophrenia.  However, the roles played by specific NMDAR subunits in different symptom components are unknown.  To evaluate the potential contribution of GluN2D NMDAR subunits to antagonist-induced cortical activation and schizophrenia symptoms, we detd. the ability of ketamine to alter regional brain activity and gamma frequency band neuronal oscillations in wild-type (WT) and GluN2D-knockout (GluN2D-KO) mice.  In WT mice, ketamine (30 mg/kg, i.p.) significantly increased [14C]-2-deoxyglucose ([14C]-2DG) uptake in the medial prefrontal cortex (mPFC), entorhinal cortex and other brain regions, and decreased activity in the somatosensory cortex and inferior colliculus.  In GluN2D-KO mice, however, ketamine did not significantly increase [14C]-2DG uptake in any brain region examd., yet still decreased [14C]-2DG uptake in the somatosensory cortex and inferior colliculus.  Ketamine also increased locomotor activity in WT mice but not in GluN2D-KO mice.  In electrocorticog. anal., ketamine induced a 111% Â± 16% increase in cortical gamma-band oscillatory power in WT mice, but only a 15% Â± 12% increase in GluN2D-KO mice.  Consistent with GluN2D involvement in schizophrenia-related neurol. changes, GluN2D-KO mice displayed impaired spatial memory acquisition and reduced parvalbumin (PV)-immunopos. staining compared with control mice.  These results suggest a crit. role of GluN2D-contg. NMDARs in neuronal oscillations and ketamine's psychotomimetic, dissociative effects and hence suggests a crit. role for GluN2D subunits in cognition and perception.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaCNutH8DBErVg90H21EOLACvtfcHk0lhRJKWII7bmvg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVelu70%253D&md5=ca6b37e9ddd9bd0fdac578df6a8df9fa</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.230391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.230391%26sid%3Dliteratum%253Aachs%26aulast%3DSapkota%26aufirst%3DK.%26aulast%3DMao%26aufirst%3DZ.%26aulast%3DSynowicki%26aufirst%3DP.%26aulast%3DLieber%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DIkezu%26aufirst%3DT.%26aulast%3DGautam%26aufirst%3DV.%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26atitle%3DGluN2D%2520N-methyl-D-aspartate%2520receptor%2520subunit%2520contribution%2520to%2520the%2520stimulation%2520of%2520brain%2520activity%2520and%2520gamma%2520oscillations%2520by%2520ketamine%253A%2520Implications%2520for%2520schizophrenia%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D356%26spage%3D702%26epage%3D711%26doi%3D10.1124%2Fjpet.115.230391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ninomiya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukumaki, Y.</span></span> <span> </span><span class="NLM_article-title">Identification of single-nucleotide polymorphisms in the human N-methyl-D-aspartate receptor subunit NR2D gene, GRIN2D, and association study with schizophrenia</span>. <i>Psychiatr. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">215</span>â <span class="NLM_lpage">221</span>, <span class="refDoi">Â DOI: 10.1097/00041444-200509000-00014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1097%2F00041444-200509000-00014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=16094258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BD2MvpvV2isg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=215-221&author=C.+Makinoauthor=H.+Shibataauthor=H.+Ninomiyaauthor=N.+Tashiroauthor=Y.+Fukumaki&title=Identification+of+single-nucleotide+polymorphisms+in+the+human+N-methyl-D-aspartate+receptor+subunit+NR2D+gene%2C+GRIN2D%2C+and+association+study+with+schizophrenia&doi=10.1097%2F00041444-200509000-00014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of single-nucleotide polymorphisms in the human N-methyl-D-aspartate receptor subunit NR2D gene, GRIN2D, and association study with schizophrenia</span></div><div class="casAuthors">Makino Chieko; Shibata Hiroki; Ninomiya Hideaki; Tashiro Nobutada; Fukumaki Yasuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Psychiatric genetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">215-21</span>
        ISSN:<span class="NLM_cas:issn">0955-8829</span>.
    </div><div class="casAbstract">OBJECTIVES:  The glutamatergic dysfunction is one of the main hypotheses for the pathophysiology of schizophrenia.  N-methyl-D-aspartate receptors are of major interest because phencyclidine, a non-competitive antagonist of N-methyl-D-aspartate receptors, produces a schizophrenia-like psychosis.  Therefore, the genes encoding N-methyl-D-aspartate receptor subunits are strong candidates for schizophrenia susceptibility genes.  We focused on the N-methyl-D-aspartate receptor subunit NR2D gene in the case-control study of schizophrenia.  METHODS:  We screened for polymorphisms in exons, exon-intron boundaries and the 5' upstream region of GRIN2D by direct sequencing in 32 Japanese patients.  Out of the total 13 single-nucleotide polymorphisms identified, we genotyped 200-201 Japanese patients and 219-221 controls for nine common single-nucleotide polymorphisms (minor allele frequency over 0.05).  RESULTS:  None of the nine single-nucleotide polymorphisms showed significant differences in genotype and allele frequencies between cases and controls.  We observed significant associations of pairwise haplotypes in three combinations of four single-nucleotide polymorphisms, INT10SNP-EX13SNP2, EX13SNP2-EX13SNP3 and EX6SNP-EX13SNP2, with the disease even after the Bonferroni correction (P=1.094 x 10(-6), Pcorrected=2.297 x 10(-5), P=2.825 x 10(-6), Pcorrected=5.933 x 10(-5) and P=2.02 x 10(-4), Pcorrected=4.242 x 10(-3), respectively).  The same results were also obtained using the false discovery rate (BL) method at the threshold P value, 2.908 x 10(-3).  CONCLUSIONS:  We conclude that the GRIN2D locus is a possible genomic region contributing to schizophrenia susceptibility in the Japanese population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxrMh5nlgqGVvAgqb2vdc5fW6udTcc2eabHnsiQ1iYuLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MvpvV2isg%253D%253D&md5=56a0b5e6deab30f011c9a7fd2c026e1d</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1097%2F00041444-200509000-00014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00041444-200509000-00014%26sid%3Dliteratum%253Aachs%26aulast%3DMakino%26aufirst%3DC.%26aulast%3DShibata%26aufirst%3DH.%26aulast%3DNinomiya%26aufirst%3DH.%26aulast%3DTashiro%26aufirst%3DN.%26aulast%3DFukumaki%26aufirst%3DY.%26atitle%3DIdentification%2520of%2520single-nucleotide%2520polymorphisms%2520in%2520the%2520human%2520N-methyl-D-aspartate%2520receptor%2520subunit%2520NR2D%2520gene%252C%2520GRIN2D%252C%2520and%2520association%2520study%2520with%2520schizophrenia%26jtitle%3DPsychiatr.%2520Genet.%26date%3D2005%26volume%3D15%26spage%3D215%26epage%3D221%26doi%3D10.1097%2F00041444-200509000-00014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lisman, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javitt, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benes, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grace, A. A.</span></span> <span> </span><span class="NLM_article-title">Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia</span>. <i>Trends Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">234</span>â <span class="NLM_lpage">242</span>, <span class="refDoi">Â DOI: 10.1016/j.tins.2008.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2Fj.tins.2008.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=18395805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslGjt7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=234-242&author=J.+E.+Lismanauthor=J.+T.+Coyleauthor=R.+W.+Greenauthor=D.+C.+Javittauthor=F.+M.+Benesauthor=S.+Heckersauthor=A.+A.+Grace&title=Circuit-based+framework+for+understanding+neurotransmitter+and+risk+gene+interactions+in+schizophrenia&doi=10.1016%2Fj.tins.2008.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia</span></div><div class="casAuthors">Lisman, John E.; Coyle, Joseph T.; Green, Robert W.; Javitt, Daniel C.; Benes, Francine M.; Heckers, Stephan; Grace, Anthony A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Neurosciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">234-242</span>CODEN:
                <span class="NLM_cas:coden">TNSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-2236</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Many risk genes interact synergistically to produce schizophrenia and many neurotransmitter interactions have been implicated.  We have developed a circuit-based framework for understanding gene and neurotransmitter interactions.  NMDAR hypofunction has been implicated in schizophrenia because NMDAR antagonists reproduce symptoms of the disease.  One action of antagonists is to reduce the excitation of fast-spiking interneurons, resulting in disinhibition of pyramidal cells.  Overactive pyramidal cells, notably those in the hippocampus, can drive a hyperdopaminergic state that produces psychosis.  Addnl. aspects of interneuron function can be understood in this framework, as follows. (i) In animal models, NMDAR antagonists reduce parvalbumin and GAD67, as found in schizophrenia.  These changes produce further disinhibition and can be viewed as the aberrant response of a homeostatic system having a faulty activity sensor (the NMDAR). (ii) Disinhibition decreases the power of gamma oscillation and might thereby produce neg. and cognitive symptoms. (iii) Nicotine enhances the output of interneurons, and might thereby contribute to its therapeutic effect in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonsMASuu2k9rVg90H21EOLACvtfcHk0lhhvgmanx6ADA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslGjt7w%253D&md5=b8eb2d2b371e877022dbcd5920675974</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2008.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2008.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DLisman%26aufirst%3DJ.%2BE.%26aulast%3DCoyle%26aufirst%3DJ.%2BT.%26aulast%3DGreen%26aufirst%3DR.%2BW.%26aulast%3DJavitt%26aufirst%3DD.%2BC.%26aulast%3DBenes%26aufirst%3DF.%2BM.%26aulast%3DHeckers%26aufirst%3DS.%26aulast%3DGrace%26aufirst%3DA.%2BA.%26atitle%3DCircuit-based%2520framework%2520for%2520understanding%2520neurotransmitter%2520and%2520risk%2520gene%2520interactions%2520in%2520schizophrenia%26jtitle%3DTrends%2520Neurosci.%26date%3D2008%26volume%3D31%26spage%3D234%26epage%3D242%26doi%3D10.1016%2Fj.tins.2008.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perszyk, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiRaddo, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strong, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargish, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelkey, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tricoire, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBain, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">GluN2D-containing N-methyl-D-aspartate receptors mediate synaptic transmission in hippocampal interneurons and regulate interneuron activity</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">689</span>â <span class="NLM_lpage">702</span>, <span class="refDoi">Â DOI: 10.1124/mol.116.105130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1124%2Fmol.116.105130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=27625038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitValu7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2016&pages=689-702&author=R.+E.+Perszykauthor=J.+O.+DiRaddoauthor=K.+L.+Strongauthor=C.+M.+Lowauthor=K.+K.+Ogdenauthor=A.+Khatriauthor=G.+A.+Vargishauthor=K.+A.+Pelkeyauthor=L.+Tricoireauthor=D.+C.+Liottaauthor=Y.+Smithauthor=C.+J.+McBainauthor=S.+F.+Traynelis&title=GluN2D-containing+N-methyl-D-aspartate+receptors+mediate+synaptic+transmission+in+hippocampal+interneurons+and+regulate+interneuron+activity&doi=10.1124%2Fmol.116.105130"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">GluN2D-containing N-methyl-D-aspartate receptors mediate synaptic transmission in hippocampal interneurons and regulate interneuron activity</span></div><div class="casAuthors">Perszyk, Riley E.; DiRaddo, John O.; Strong, Katie L.; Low, Chian-Ming; Ogden, Kevin K.; Khatri, Alpa; Vargish, Geoffrey A.; Pelkey, Kenneth A.; Tricoire, Ludovic; Liotta, Dennis C.; Smith, Yoland; McBain, Chris J.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">689-702</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate receptors (NMDARs) are ionotropic glutamatergic receptors that have been implicated in learning, development, and neuropathol. conditions.  They are typically composed of GluN1 and GluN2A-D subunits.  Whereas a great deal is known about the role of GluN2A- and GluN2Bcontaining NMDARs, much less is known about GluN2Dcontaining NMDARs.  Here we explore the subunit compn. of synaptic NMDARs on hippocampal interneurons.  GluN2D mRNA was detected by single-cell PCR and in situ hybridization in diverse interneuron subtypes in the CA1 region of the hippocampus.  The GluN2D subunit was detectable by immunoblotting and immunohistochem. in all subfields of the hippocampus in young and adult mice.  In whole-cell patch-clamp recordings from acute hippocampal slices, (+)-CIQ, the active enantiomer of the pos. allosteric modulator CIQ, significantly enhanced the amplitude of the NMDAR component of miniature excitatory postsynaptic currents (mEPSCs) in CA1 interneurons but not in pyramidal cells. (+)-CIQ had no effect in slices from Grin2d-/- mice, suggesting that GluN2D-contg. NMDARs participate in excitatory synaptic transmission onto hippocampal interneurons.  The time course of the NMDAR component of the mEPSC was unaffected by (+)-CIQ potentiation and was not accelerated in slices from Grin2d-/- mice compared with wild-type, suggesting that GluN2D does not detectably slow the NMDAR EPSC time course at this age. (+)-CIQ increased the activity of CA1 interneurons as detected by the rate and net charge transfer of spontaneous inhibitory postsynaptic currents (sIPSCs) recorded from CA1 pyramidal cells.  These data provide evidence that interneurons contain synaptic NMDARs possessing a GluN2D subunit, which can influence interneuron function and signal processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-PEPLEcqOlbVg90H21EOLACvtfcHk0liB-CUrz8Lg_g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitValu7k%253D&md5=5c132034fc27420661791a3d8e3839ea</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1124%2Fmol.116.105130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.116.105130%26sid%3Dliteratum%253Aachs%26aulast%3DPerszyk%26aufirst%3DR.%2BE.%26aulast%3DDiRaddo%26aufirst%3DJ.%2BO.%26aulast%3DStrong%26aufirst%3DK.%2BL.%26aulast%3DLow%26aufirst%3DC.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DVargish%26aufirst%3DG.%2BA.%26aulast%3DPelkey%26aufirst%3DK.%2BA.%26aulast%3DTricoire%26aufirst%3DL.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DSmith%26aufirst%3DY.%26aulast%3DMcBain%26aufirst%3DC.%2BJ.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DGluN2D-containing%2520N-methyl-D-aspartate%2520receptors%2520mediate%2520synaptic%2520transmission%2520in%2520hippocampal%2520interneurons%2520and%2520regulate%2520interneuron%2520activity%26jtitle%3DMol.%2520Pharmacol.%26date%3D2016%26volume%3D90%26spage%3D689%26epage%3D702%26doi%3D10.1124%2Fmol.116.105130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">von Engelhardt, J.</span>; <span class="NLM_string-name">Bocklisch, C.</span>; <span class="NLM_string-name">TÃ¶nges, L.</span>; <span class="NLM_string-name">Herb, A.</span>; <span class="NLM_string-name">Mishina, M.</span>; <span class="NLM_string-name">Monyer, H.</span></span> <span> </span><span class="NLM_article-title">GluN2D-containing NMDA receptors-mediate synaptic currents in hippocampal interneurons and pyramidal cells in juvenile mice</span> <i>Front. Cell Neurosci.</i> [Online].<span class="refDoi">Â DOI: 10.3389/fncel.2015.00095</span> . Published Online: Mar 25, <span class="NLM_year">2015</span>, <a href="https://www.frontiersin.org/articles/10.3389/fncel.2015.00095/full" class="extLink">https://www.frontiersin.org/articles/10.3389/fncel.2015.00095/full</a> (accessed Jun 11, 2020).</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.3389%2Ffncel.2015.00095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=25859181" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+von+Engelhardt&author=C.+Bocklisch&author=L.+T%C3%B6nges&author=A.+Herb&author=M.+Mishina&author=H.+Monyer&title=GluN2D-containing+NMDA+receptors-mediate+synaptic+currents+in+hippocampal+interneurons+and+pyramidal+cells+in+juvenile+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2015.00095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.3389%252Ffncel.2015.00095%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BEngelhardt%26aufirst%3DJ.%26atitle%3DGluN2D-containing%2520NMDA%2520receptors-mediate%2520synaptic%2520currents%2520in%2520hippocampal%2520interneurons%2520and%2520pyramidal%2520cells%2520in%2520juvenile%2520mice%26jtitle%3DFront.%2520Cell%2520Neurosci.%26doi%3D10.3389%2Ffncel.2015.00095%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullasseril, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtkaya, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santangelo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellano, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>, <span class="NLM_elocation-id">90</span> <span class="refDoi">Â DOI: 10.1038/ncomms1085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2Fncomms1085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=20981015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BC3cbislehtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&author=P.+Mullasserilauthor=K.+B.+Hansenauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=H.+Yuanauthor=N.+L.+Kurtkayaauthor=R.+Santangeloauthor=A.+G.+Orrauthor=P.+Leauthor=K.+M.+Vellanoauthor=D.+C.+Liottaauthor=S.+F.+Traynelis&title=A+subunit-selective+potentiator+of+NR2C-+and+NR2D-containing+NMDA+receptors&doi=10.1038%2Fncomms1085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors</span></div><div class="casAuthors">Mullasseril Praseeda; Hansen Kasper B; Vance Katie M; Ogden Kevin K; Yuan Hongjie; Kurtkaya Natalie L; Santangelo Rose; Orr Anna G; Le Phuong; Vellano Kimberly M; Liotta Dennis C; Traynelis Stephen F</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">90</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">NMDA receptors are tetrameric complexes of NR1 and NR2A-D subunits that mediate excitatory synaptic transmission and have a role in neurological disorders.  In this article, we identify a novel subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit, which could allow selective modification of circuit function in regions expressing NR2C/D subunits.  The substituted tetrahydroisoquinoline CIQ (3-chlorophenyl)(6,7-dimethoxy-1-((4-methoxyphenoxy)methyl)-3,4-dihydroisoquinolin-2(1H)-yl)methanone) enhances receptor responses two-fold with an EC(50) of 3 Î¼M by increasing channel opening frequency without altering mean open time or EC(50) values for glutamate or glycine.  The actions of CIQ depend on a single residue in the M1 region (NR2D Thr592) and on the linker between the N-terminal domain and agonist binding domain.  CIQ potentiates native NR2D-containing NMDA receptor currents from subthalamic neurons.  Our identification of a subunit-selective NMDA receptor modulator reveals a new class of pharmacological tools with which to probe the role of NR2C- and NR2D-containing NMDA receptors in brain function and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOCqf6rsXbPtyzdcP07UmufW6udTcc2eY6LPtOVjvLCrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbislehtA%253D%253D&md5=8cde7c73dc6bf72ea3050c21db4f5ad4</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fncomms1085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1085%26sid%3Dliteratum%253Aachs%26aulast%3DMullasseril%26aufirst%3DP.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DKurtkaya%26aufirst%3DN.%2BL.%26aulast%3DSantangelo%26aufirst%3DR.%26aulast%3DOrr%26aufirst%3DA.%2BG.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DVellano%26aufirst%3DK.%2BM.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DA%2520subunit-selective%2520potentiator%2520of%2520NR2C-%2520and%2520NR2D-containing%2520NMDA%2520receptors%26jtitle%3DNat.%2520Commun.%26date%3D2010%26volume%3D1%26doi%3D10.1038%2Fncomms1085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santangelo
Freel, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strong, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chepiga, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure activity relationship of tetrahydroisoquinoline-based potentiators of GluN2C and GluN2D containing N-methyl-D-aspartate receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5351</span>â <span class="NLM_lpage">5381</span>, <span class="refDoi">Â DOI: 10.1021/jm400177t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400177t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslSntbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5351-5381&author=R.+M.+Santangelo%0AFreelauthor=K.+K.+Ogdenauthor=K.+L.+Strongauthor=A.+Khatriauthor=K.+M.+Chepigaauthor=H.+S.+Jensenauthor=S.+F.+Traynelisauthor=D.+C.+Liotta&title=Synthesis+and+structure+activity+relationship+of+tetrahydroisoquinoline-based+potentiators+of+GluN2C+and+GluN2D+containing+N-methyl-D-aspartate+receptors&doi=10.1021%2Fjm400177t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure Activity Relationship of Tetrahydroisoquinoline-Based Potentiators of GluN2C and GluN2D Containing N-Methyl-D-aspartate Receptors</span></div><div class="casAuthors">Santangelo Freel, Rose M.; Ogden, Kevin K.; Strong, Katie L.; Khatri, Alpa; Chepiga, Kathryn M.; Jensen, Henrik S.; Traynelis, Stephen F.; Liotta, Dennis C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5351-5381</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe here the synthesis and evaluation of a series of tetrahydroisoquinolines (e.g., I) that show subunit-selective potentiation of NMDA receptors contg. the GluN2C or GluN2D subunits.  Bischler-Napieralski conditions were employed in the key step for the conversion of acyclic amides to the corresponding tetrahydroisoquinoline-contg. analogs.  Compds. were evaluated using both two-electrode voltage clamp recordings from Xenopus laevis oocytes and imaging of mammalian BHK cells loaded with Ca2+-sensitive dyes.  The most potent analogs had EC50 values of 300 nM and showed over 2-fold potentiation of the response to maximally effective concns. of glutamate and glycine but had no effect on responses from NMDA receptors contg. the GluN2A or GluN2B subunits AMPA, kainate, and GABA or glycine receptors or a variety of other potential targets.  These compds. represent a potent class of small mol. subunit-selective potentiators of NMDA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo3icU__XjyrVg90H21EOLACvtfcHk0lg9bUW5w1qP9Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslSntbY%253D&md5=65951c8ac931b520be03667476ab3aad</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm400177t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400177t%26sid%3Dliteratum%253Aachs%26aulast%3DSantangelo%2BFreel%26aufirst%3DR.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DStrong%26aufirst%3DK.%2BL.%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DChepiga%26aufirst%3DK.%2BM.%26aulast%3DJensen%26aufirst%3DH.%2BS.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26atitle%3DSynthesis%2520and%2520structure%2520activity%2520relationship%2520of%2520tetrahydroisoquinoline-based%2520potentiators%2520of%2520GluN2C%2520and%2520GluN2D%2520containing%2520N-methyl-D-aspartate%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5351%26epage%3D5381%26doi%3D10.1021%2Fjm400177t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nouhi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chergui, K.</span></span> <span> </span><span class="NLM_article-title">CIQ, a positive allosteric modulator of GluN2C/D-containing N-methyl-d-aspartate receptors, rescues striatal synaptic plasticity deficit in a mouse model of Parkinsonâs disease</span>. <i>CNS Neurosci. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">144</span>â <span class="NLM_lpage">153</span>, <span class="refDoi">Â DOI: 10.1111/cns.12784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1111%2Fcns.12784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=29230960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFKju7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=144-153&author=M.+Nouhiauthor=X.+Zhangauthor=N.+Yaoauthor=K.+Chergui&title=CIQ%2C+a+positive+allosteric+modulator+of+GluN2C%2FD-containing+N-methyl-d-aspartate+receptors%2C+rescues+striatal+synaptic+plasticity+deficit+in+a+mouse+model+of+Parkinson%E2%80%99s+disease&doi=10.1111%2Fcns.12784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">CIQ, a positive allosteric modulator of GluN2C/D-containing N-methyl-D-aspartate receptors, rescues striatal synaptic plasticity deficit in a mouse model of Parkinson's disease</span></div><div class="casAuthors">Nouhi, Mona; Zhang, Xiaoqun; Yao, Ning; Chergui, Karima</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144-153</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Aims : To investigate if CIQ, a pos. allosteric modulator of N-methyl-D-aspartate receptors (NMDARs) contg. GluN2C/D subunits, rescues the loss of long-term potentiation (LTP) and forelimb-use asymmetry in a mouse model of Parkinson's disease (PD).  Methods : We have used electrophysiol. in brain slices and the cylinder test to examine the effect of CIQ on glutamatergic synaptic transmission, synaptic plasticity, and forelimb-use in the unilateral 6-hydroxydopamine-lesion mouse model of PD.  Results : CIQ, applied in the perfusion soln., reversibly reduced glutamatergic synaptic transmission in the dopamine-depleted striatum and had no effect in the dopamine-intact striatum.  LTP, a dopamine- and NMDAR-dependent form of synaptic plasticity, was induced in the dopamine-intact striatum but was lost in the dopamine-depleted striatum.  This impaired LTP was restored in the presence of CIQ applied in the perfusion soln.  This treatment, however, prevented LTP induction in control slices.  In brain slices from mice which received single and chronic i.p. injections of CIQ, LTP was restored in the dopamine-depleted striatum and unaffected in the dopamine-intact striatum.  Forelimb-use asymmetry, a test which assesses deficits in paw usage in the unilateral lesion model of PD, was reversed by systemic chronic treatment with CIQ.  Conclusion : A pos. allosteric modulator of GluN2C/D-contg. NMDARs rescues LTP and forelimb-use asymmetry in a mouse model of PD.  This study proposes GluN2D as a potential candidate for therapeutic intervention in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVXh0w-u7o-LVg90H21EOLACvtfcHk0lg9bUW5w1qP9Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFKju7w%253D&md5=cbe6e8f4d2808a4c8e913ec16ae00ea7</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1111%2Fcns.12784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcns.12784%26sid%3Dliteratum%253Aachs%26aulast%3DNouhi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DChergui%26aufirst%3DK.%26atitle%3DCIQ%252C%2520a%2520positive%2520allosteric%2520modulator%2520of%2520GluN2C%252FD-containing%2520N-methyl-d-aspartate%2520receptors%252C%2520rescues%2520striatal%2520synaptic%2520plasticity%2520deficit%2520in%2520a%2520mouse%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2018%26volume%3D24%26spage%3D144%26epage%3D153%26doi%3D10.1111%2Fcns.12784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heldt, S. A.</span></span> <span> </span><span class="NLM_article-title">Potentiation of GluN2C/D NMDA receptor subtypes in the amygdala facilitates the retention of fear and extinction learning in mice</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">625</span>â <span class="NLM_lpage">637</span>, <span class="refDoi">Â DOI: 10.1038/npp.2013.241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2Fnpp.2013.241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=24008353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFynurfM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=625-637&author=K.+K.+Ogdenauthor=A.+Khatriauthor=S.+F.+Traynelisauthor=S.+A.+Heldt&title=Potentiation+of+GluN2C%2FD+NMDA+receptor+subtypes+in+the+amygdala+facilitates+the+retention+of+fear+and+extinction+learning+in+mice&doi=10.1038%2Fnpp.2013.241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of GluN2C/D NMDA Receptor Subtypes in the Amygdala Facilitates the Retention of Fear and Extinction Learning in Mice</span></div><div class="casAuthors">Ogden, Kevin K.; Khatri, Alpa; Traynelis, Stephen F.; Heldt, Scott A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">625-637</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">NMDA receptors are glutamate receptor ion channels that contribute to synaptic plasticity and are important for many forms of learning and memory.  In the amygdala, NMDA receptors are crit. for the acquisition, retention, and extinction of classically conditioned fear responses.  Although the GluN2B subunit has been implicated in both the acquisition and extinction of conditioned fear, GluN2C-knockout mice show reduced conditioned fear responses.  Moreover, D-cycloserine (DCS), which facilitates fear extinction, selectively enhances the activity of GluN2C-contg. NMDA receptors.  To further define the contribution of GluN2C receptors to fear learning, we infused the GluN2C/GluN2D-selective potentiator CIQ bilaterally into the basolateral amygdala (3, 10, or 30 Î¼g/side) following either fear conditioning or fear extinction training.  CIQ both increased the expression of conditioned fear 24 h later and enhanced the extinction of the previously conditioned fear response.  These results support a crit. role for GluN2C receptors in the amygdala in the consolidation of learned fear responses and suggest that increased activity of GluN2C receptors may underlie the therapeutic actions of DCS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH3PU52ifV_7Vg90H21EOLACvtfcHk0lg9bUW5w1qP9Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFynurfM&md5=20d2789ed3331e5f48d147ac21ec6436</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2013.241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2013.241%26sid%3Dliteratum%253Aachs%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DHeldt%26aufirst%3DS.%2BA.%26atitle%3DPotentiation%2520of%2520GluN2C%252FD%2520NMDA%2520receptor%2520subtypes%2520in%2520the%2520amygdala%2520facilitates%2520the%2520retention%2520of%2520fear%2520and%2520extinction%2520learning%2520in%2520mice%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D625%26epage%3D637%26doi%3D10.1038%2Fnpp.2013.241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shelkar, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavuluri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravikrishnan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gawande, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stairs, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugale, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dravid, S. M.</span></span> <span> </span><span class="NLM_article-title">Differential effect of NMDA receptor GluN2C and GluN2D subunit ablation on behavior and channel blocker-induced schizophrenia phenotypes</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">7572</span> <span class="refDoi">Â DOI: 10.1038/s41598-019-43957-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1038%2Fs41598-019-43957-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=31110197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BB3M7nvV2qug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&author=G.+P.+Shelkarauthor=P.+Pavuluriauthor=P.+J.+Gandhiauthor=A.+Ravikrishnanauthor=D.+Y.+Gawandeauthor=J.+Liuauthor=D.+J.+Stairsauthor=R.+R.+Ugaleauthor=S.+M.+Dravid&title=Differential+effect+of+NMDA+receptor+GluN2C+and+GluN2D+subunit+ablation+on+behavior+and+channel+blocker-induced+schizophrenia+phenotypes&doi=10.1038%2Fs41598-019-43957-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effect of NMDA receptor GluN2C and GluN2D subunit ablation on behavior and channel blocker-induced schizophrenia phenotypes</span></div><div class="casAuthors">Shelkar Gajanan P; Pavuluri Ratnamala; Gandhi Pauravi J; Ravikrishnan Aparna; Gawande Dinesh Y; Liu Jinxu; Dravid Shashank M; Stairs Dustin J; Ugale Rajesh R</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7572</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The GluN2C- and GluN2D-containing NMDA receptors are distinct from GluN2A- and GluN2B-containing receptors in many aspects including lower sensitivity to Mg(2+) block and lack of desensitization.  Recent studies have highlighted the unique contribution of GluN2C and GluN2D subunits in various aspects of neuronal and circuit function and behavior, however a direct comparison of the effect of ablation of these subunits in mice on pure background strain has not been conducted.  Using knockout-first strains for the GRIN2C and GRIN2D produced on pure C57BL/6N strain, we compared the effect of partial or complete ablation of GluN2C and GluN2D subunit on various behaviors relevant to mental disorders.  A large number of behaviors described previously in GluN2C and GluN2D knockout mice were reproduced in these mice, however, some specific differences were also observed possibly representing strain effects.  We also examined the response to NMDA receptor channel blockers in these mouse strains and surprisingly found that unlike previous reports GluN2D knockout mice were not resistant to phencyclidine-induced hyperlocomotion.  Interestingly, the GluN2C knockout mice showed reduced sensitivity to phencyclidine-induced hyperlocomotion.  We also found that NMDA receptor channel blocker produced a deficit in prepulse inhibition which was prevented by a GluN2C/2D potentiator in wildtype and GluN2C heterozygous mice but not in GluN2C knockout mice.  Together these results demonstrate a unique role of GluN2C subunit in schizophrenia-like behaviors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSWYwi-aOJLuR_TJajKxJDfW6udTcc2eYmGdhC3WYuPbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7nvV2qug%253D%253D&md5=548cde7ed4a0ce94721e9e766a5b1b00</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-43957-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-43957-2%26sid%3Dliteratum%253Aachs%26aulast%3DShelkar%26aufirst%3DG.%2BP.%26aulast%3DPavuluri%26aufirst%3DP.%26aulast%3DGandhi%26aufirst%3DP.%2BJ.%26aulast%3DRavikrishnan%26aufirst%3DA.%26aulast%3DGawande%26aufirst%3DD.%2BY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DStairs%26aufirst%3DD.%2BJ.%26aulast%3DUgale%26aufirst%3DR.%2BR.%26aulast%3DDravid%26aufirst%3DS.%2BM.%26atitle%3DDifferential%2520effect%2520of%2520NMDA%2520receptor%2520GluN2C%2520and%2520GluN2D%2520subunit%2520ablation%2520on%2520behavior%2520and%2520channel%2520blocker-induced%2520schizophrenia%2520phenotypes%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26doi%3D10.1038%2Fs41598-019-43957-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strong, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epplin, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacsa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butch, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menaldino, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span> <span> </span><span class="NLM_article-title">The structure-activity relationship of a tetrahydroisoquinoline class of N-methyl-D-aspartate receptor modulators that potentiate GluN2B-containing N-methyl-D-aspartate receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5556</span>â <span class="NLM_lpage">5585</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b00239</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00239" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1KmsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5556-5585&author=K.+L.+Strongauthor=M.+P.+Epplinauthor=J.+Bacsaauthor=C.+J.+Butchauthor=P.+B.+Burgerauthor=D.+S.+Menaldinoauthor=S.+F.+Traynelisauthor=D.+C.+Liotta&title=The+structure-activity+relationship+of+a+tetrahydroisoquinoline+class+of+N-methyl-D-aspartate+receptor+modulators+that+potentiate+GluN2B-containing+N-methyl-D-aspartate+receptors&doi=10.1021%2Facs.jmedchem.7b00239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">The Structure-Activity Relationship of a Tetrahydroisoquinoline Class of N-Methyl-d-Aspartate Receptor Modulators that Potentiates GluN2B-Containing N-Methyl-d-Aspartate Receptors</span></div><div class="casAuthors">Strong, Katie L.; Epplin, Matthew P.; Bacsa, John; Butch, Christopher J.; Burger, Pieter B.; Menaldino, David S.; Traynelis, Stephen F.; Liotta, Dennis C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5556-5585</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have identified a series of pos. allosteric NMDA receptor (NMDAR) modulators derived from a known class of GluN2C/D-selective tetrahydroisoquinoline analogs that includes CIQ.  The prototypical compd. of this series contains a single isopropoxy moiety in place of the two methoxy substituents present in CIQ.  Modifications of this isopropoxy-contg. scaffold led to the identification of analogs with enhanced activity at the GluN2B subunit.  We identified mols. that potentiate the response of GluN2B/GluN2C/GluN2D, GluN2B/GluN2C, and GluN2C/GluN2D-contg. NMDARs to maximally effective concns. of agonist.  Multiple compds. potentiate the response of NMDARs with submicromolar EC50 values.  Anal. of enantiomeric pairs revealed that the S-(-) enantiomer is active at the GluN2B, GluN2C, and/or GluN2D subunits, whereas the R-(+) enantiomer is only active at GluN2C/D subunits.  These results provide a starting point for the development of selective pos. allosteric modulators for GluN2B-contg. receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4Np5ydh-Xh7Vg90H21EOLACvtfcHk0lhCfvBDAykGHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1KmsL4%253D&md5=08167b1b31e6b26bcfa0a8303d173e14</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00239%26sid%3Dliteratum%253Aachs%26aulast%3DStrong%26aufirst%3DK.%2BL.%26aulast%3DEpplin%26aufirst%3DM.%2BP.%26aulast%3DBacsa%26aufirst%3DJ.%26aulast%3DButch%26aufirst%3DC.%2BJ.%26aulast%3DBurger%26aufirst%3DP.%2BB.%26aulast%3DMenaldino%26aufirst%3DD.%2BS.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26atitle%3DThe%2520structure-activity%2520relationship%2520of%2520a%2520tetrahydroisoquinoline%2520class%2520of%2520N-methyl-D-aspartate%2520receptor%2520modulators%2520that%2520potentiate%2520GluN2B-containing%2520N-methyl-D-aspartate%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5556%26epage%3D5585%26doi%3D10.1021%2Facs.jmedchem.7b00239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volgraf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J. E.</span></span> <span> </span><span class="NLM_article-title">A novel NMDA receptor positive allosteric modulator that acts via the transmembrane domain</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">204</span>â <span class="NLM_lpage">218</span>, <span class="refDoi">Â DOI: 10.1016/j.neuropharm.2017.04.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2Fj.neuropharm.2017.04.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=28457974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsFentLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2017&pages=204-218&author=T.-M.+Wangauthor=B.+M.+Brownauthor=L.+Dengauthor=B.+D.+Sellersauthor=P.+L.+Lupardusauthor=H.+J.+A.+Wallweberauthor=A.+Gustafsonauthor=E.+Wongauthor=M.+Volgrafauthor=J.+B.+Schwarzauthor=D.+H.+Hackosauthor=J.+E.+Hanson&title=A+novel+NMDA+receptor+positive+allosteric+modulator+that+acts+via+the+transmembrane+domain&doi=10.1016%2Fj.neuropharm.2017.04.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">A novel NMDA receptor positive allosteric modulator that acts via the transmembrane domain</span></div><div class="casAuthors">Wang, Tzu-Ming; Brown, Brandon M.; Deng, Lunbin; Sellers, Benjamin D.; Lupardus, Patrick J.; Wallweber, Heidi J. A.; Gustafson, Amy; Wong, Evera; Volgraf, Matthew; Schwarz, Jacob B.; Hackos, David H.; Hanson, Jesse E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">204-218</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ionotropic glutamate receptors (iGluRs) mediate fast excitatory neurotransmission and are key nervous system drug targets.  While diverse pharmacol. tools have yielded insight into iGluR extracellular domain function, less is known about mol. mechanisms underlying the ion conduction gating process within the transmembrane domain (TMD).  We have discovered a novel NMDAR pos. allosteric modulator (PAM), GNE-9278, with a unique binding site on the extracellular surface of the TMD.  Mutation of a single residue near the Lurcher motif on GluN1 M3 can convert GNE-9278 modulation from pos. to neg., and replacing three AMPAR pre-M1 residues with corresponding NMDAR residues can confer GNE-9278 sensitivity to AMPARs.  Modulation by GNE-9278 is state-dependent and significantly alters extracellular domain pharmacol.  The unique properties and structural determinants of GNE-9278 reveal new modulatory potential of the iGluR TMD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlpDlNo3PXSrVg90H21EOLACvtfcHk0lixruY_q7JqGg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsFentLk%253D&md5=e868c18884abbb5c63de5adb5873660c</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2017.04.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2017.04.041%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.-M.%26aulast%3DBrown%26aufirst%3DB.%2BM.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DSellers%26aufirst%3DB.%2BD.%26aulast%3DLupardus%26aufirst%3DP.%2BL.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DWong%26aufirst%3DE.%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DHanson%26aufirst%3DJ.%2BE.%26atitle%3DA%2520novel%2520NMDA%2520receptor%2520positive%2520allosteric%2520modulator%2520that%2520acts%2520via%2520the%2520transmembrane%2520domain%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D121%26spage%3D204%26epage%3D218%26doi%3D10.1016%2Fj.neuropharm.2017.04.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ceccon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumbaugh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicini, S.</span></span> <span> </span><span class="NLM_article-title">Distinct effect of pregnenolone sulfate on NMDA receptor subtypes</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">491</span>â <span class="NLM_lpage">500</span>, <span class="refDoi">Â DOI: 10.1016/S0028-3908(00)00197-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2FS0028-3908%2800%2900197-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=11249958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslyltbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=491-500&author=M.+Cecconauthor=G.+Rumbaughauthor=S.+Vicini&title=Distinct+effect+of+pregnenolone+sulfate+on+NMDA+receptor+subtypes&doi=10.1016%2FS0028-3908%2800%2900197-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct effect of pregnenolone sulfate on NMDA receptor subtypes</span></div><div class="casAuthors">Ceccon, M.; Rumbaugh, G.; Vicini, S.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">491-500</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Using rapid agonist applications to transfected HEK-293 cells, the authors investigated pregnenolone sulfate (PS) effects on deactivation and desensitization of recombinant NMDA receptors subtypes.  PS prolonged the deactivation of responses produced by brief applications of L-glutamate with all subunit combinations tested.  The action of PS was larger on NR1a/NR2A than on NR1a/NR2B channels.  PS slowed the rate of macroscopic desensitization of the responses with all subunit combinations tested.  In contrast, PS had little effect on current rise time and had much reduced action on responses with L-cysteate, a low affinity agonist.  The authors' results suggest that PS decreases agonist unbinding.  However, this action is counteracted by decreased desensitization.  Since desensitization produces slow deactivating components, particularly with NR1a/NR2B receptors, this underlies the decreased PS effect with these subtypes.  Indeed PS action was mainly obsd. on the fast component of deactivation.  Furthermore, prolongation of NR1a/NR2A responses was similar to that of responses from NR1b/NR2B receptor, a subtype characterized by reduced desensitization.  PS prolongation of evoked NMDA receptor mediated synaptic currents from cortical neuronal primary culture(s) was not significantly different from that of responses with NR1a/NR2B receptors indicating that native receptors in these neurons comprised at least some heteromeric combinations of these two subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgeasen5m0gbVg90H21EOLACvtfcHk0lixruY_q7JqGg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslyltbw%253D&md5=838bf88a82d875e6dd175ead35707e1b</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2800%2900197-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252800%252900197-0%26sid%3Dliteratum%253Aachs%26aulast%3DCeccon%26aufirst%3DM.%26aulast%3DRumbaugh%26aufirst%3DG.%26aulast%3DVicini%26aufirst%3DS.%26atitle%3DDistinct%2520effect%2520of%2520pregnenolone%2520sulfate%2520on%2520NMDA%2520receptor%2520subtypes%26jtitle%3DNeuropharmacology%26date%3D2001%26volume%3D40%26spage%3D491%26epage%3D500%26doi%3D10.1016%2FS0028-3908%2800%2900197-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belfort, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linsenbardt, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izumi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mennerick, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorumski, C. F.</span></span> <span> </span><span class="NLM_article-title">The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">17290</span>â <span class="NLM_lpage">17300</span>, <span class="refDoi">Â DOI: 10.1523/JNEUROSCI.2619-13.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1523%2FJNEUROSCI.2619-13.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=24174662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCjtrbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=17290-17300&author=S.+M.+Paulauthor=J.+J.+Dohertyauthor=A.+J.+Robichaudauthor=G.+M.+Belfortauthor=B.+Y.+Chowauthor=R.+S.+Hammondauthor=D.+C.+Crawfordauthor=A.+J.+Linsenbardtauthor=H.-J.+Shuauthor=Y.+Izumiauthor=S.+J.+Mennerickauthor=C.+F.+Zorumski&title=The+major+brain+cholesterol+metabolite+24%28S%29-hydroxycholesterol+is+a+potent+allosteric+modulator+of+N-methyl-D-aspartate+receptors&doi=10.1523%2FJNEUROSCI.2619-13.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors</span></div><div class="casAuthors">Paul, Steven M.; Doherty, James J.; Robichaud, Albert J.; Belfort, Gabriel M.; Chow, Brian Y.; Hammond, Rebecca S.; Crawford, Devon C.; Linsenbardt, Andrew J.; Shu, Hong-Jin; Izumi, Yukitoshi; Mennerick, Steven J.; Zorumski, Charles F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">17290-17300</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate receptors (NMDARs) are glutamate-gated ion channels that are crit. to the regulation of excitatory synaptic function in the CNS.  NMDARs govern experience-dependent synaptic plasticity and have been implicated in the pathophysiol. of various neuropsychiatric disorders including the cognitive deficits of schizophrenia and certain forms of autism.  Certain neurosteroids modulate NMDARs exptl. but their low potency, poor selectivity, and very low brain concns. make them poor candidates as endogenous ligands or therapeutic agents.  Here we show that the major brain-derived cholesterol metabolite 24(S)-hydroxycholesterol (24(S)-HC) is a very potent, direct, and selective pos. allosteric modulator of NMDARs with a mechanism that does not overlap that of other allosteric modulators.  At submicromolar concns. 24(S)-HC potentiates NMDAR-mediated EPSCs in rat hippocampal neurons but fails to affect AMPAR or GABAA receptors (GABAARs)-mediated responses.  Cholesterol itself and other naturally occurring oxysterols present in brain do not modulate NMDARs at concns. â¤10 Î¼M.  In hippocampal slices, 24(S)-HC enhances the ability of subthreshold stimuli to induce long-term potentiation (LTP).  24(S)-HC also reverses hippocampal LTP deficits induced by the NMDAR channel blocker ketamine.  Finally, we show that synthetic drug-like derivs. of 24(S)-HC, which potently enhance NMDAR-mediated EPSCs and LTP, restore behavioral and cognitive deficits in rodents treated with NMDAR channel blockers.  Thus, 24(S)-HC may function as an endogenous modulator of NMDARs acting at a novel oxysterol modulatory site that also represents a target for therapeutic drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDNdn3JBVmtLVg90H21EOLACvtfcHk0lixruY_q7JqGg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCjtrbI&md5=35ab8bb8030a4ac752f224f8cd942fb4</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2619-13.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2619-13.2013%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DDoherty%26aufirst%3DJ.%2BJ.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26aulast%3DBelfort%26aufirst%3DG.%2BM.%26aulast%3DChow%26aufirst%3DB.%2BY.%26aulast%3DHammond%26aufirst%3DR.%2BS.%26aulast%3DCrawford%26aufirst%3DD.%2BC.%26aulast%3DLinsenbardt%26aufirst%3DA.%2BJ.%26aulast%3DShu%26aufirst%3DH.-J.%26aulast%3DIzumi%26aufirst%3DY.%26aulast%3DMennerick%26aufirst%3DS.%2BJ.%26aulast%3DZorumski%26aufirst%3DC.%2BF.%26atitle%3DThe%2520major%2520brain%2520cholesterol%2520metabolite%252024%2528S%2529-hydroxycholesterol%2520is%2520a%2520potent%2520allosteric%2520modulator%2520of%2520N-methyl-D-aspartate%2520receptors%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D17290%26epage%3D17300%26doi%3D10.1523%2FJNEUROSCI.2619-13.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volgraf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villemure, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L. F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liederer, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plise, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirksen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietz, M. G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scearce-Levie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Discovery of GluN2A-selective NMDA receptor positive allosteric modulators (PAMs): tuning deactivation kinetics via structure-based design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2760</span>â <span class="NLM_lpage">2779</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b02010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b02010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1ynt70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2760-2779&author=M.+Volgrafauthor=B.+D.+Sellersauthor=Y.+Jiangauthor=G.+Wuauthor=C.+Q.+Lyauthor=E.+Villemureauthor=R.+M.+Pastorauthor=P.+Yuenauthor=A.+Luauthor=X.+Luoauthor=M.+Liuauthor=S.+Zhangauthor=L.+F.+Y.+Sunauthor=P.+J.+Lupardusauthor=H.+J.+A.+Wallweberauthor=B.+M.+Liedererauthor=G.+Deshmukhauthor=E.+Pliseauthor=S.+Tayauthor=P.+Reynenauthor=J.+Herringtonauthor=A.+Gustafsonauthor=Y.+Liuauthor=A.+Dirksenauthor=M.+G.+A.+Dietzauthor=Y.+Liuauthor=T.-M.+Wangauthor=J.+E.+Hansonauthor=D.+Hackosauthor=K.+Scearce-Levieauthor=J.+B.+Schwarz&title=Discovery+of+GluN2A-selective+NMDA+receptor+positive+allosteric+modulators+%28PAMs%29%3A+tuning+deactivation+kinetics+via+structure-based+design&doi=10.1021%2Facs.jmedchem.5b02010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design</span></div><div class="casAuthors">Volgraf, Matthew; Sellers, Benjamin D.; Jiang, Yu; Wu, Guosheng; Ly, Cuong Q.; Villemure, Elisia; Pastor, Richard M.; Yuen, Po-wai; Lu, Aijun; Luo, Xifeng; Liu, Mingcui; Zhang, Shun; Sun, Liang; Fu, Yuhong; Lupardus, Patrick J.; Wallweber, Heidi J. A.; Liederer, Bianca M.; Deshmukh, Gauri; Plise, Emile; Tay, Suzanne; Reynen, Paul; Herrington, James; Gustafson, Amy; Liu, Yichin; Dirksen, Akim; Dietz, Matthias G. A.; Liu, Yanzhou; Wang, Tzu-Ming; Hanson, Jesse E.; Hackos, David; Scearce-Levie, Kimberly; Schwarz, Jacob B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2760-2779</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The N-methyl-D-aspartate receptor (NMDAR) is a Na+ and Ca2+ permeable ionotropic glutamate receptor that is activated by the coagonists glycine and glutamate.  NMDARs are crit. to synaptic signaling and plasticity, and their dysfunction has been implicated in a no. of neurol. disorders, including schizophrenia, depression, and Alzheimer's disease.  Herein we describe the discovery of potent GluN2A-selective NMDAR pos. allosteric modulators (PAMs) starting from a high-throughput screening hit.  Using structure-based design, we sought to increase potency at the GluN2A subtype, while improving selectivity against related Î±-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs).  The structure-activity relationship of channel deactivation kinetics was studied using a combination of electrophysiol. and protein crystallog.  Effective incorporation of these strategies resulted in the discovery of GNE-0723 (46), a highly potent and brain penetrant GluN2A-selective NMDAR PAM suitable for in vivo characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdza-qdjBnZbVg90H21EOLACvtfcHk0ljIm10Xj2pyvQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1ynt70%253D&md5=2d9f7199cd3d9d9ac513006612e9bb01</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b02010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b02010%26sid%3Dliteratum%253Aachs%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DB.%2BD.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DLy%26aufirst%3DC.%2BQ.%26aulast%3DVillemure%26aufirst%3DE.%26aulast%3DPastor%26aufirst%3DR.%2BM.%26aulast%3DYuen%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DL.%2BF.%2BY.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DLiederer%26aufirst%3DB.%2BM.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DReynen%26aufirst%3DP.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDirksen%26aufirst%3DA.%26aulast%3DDietz%26aufirst%3DM.%2BG.%2BA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DT.-M.%26aulast%3DHanson%26aufirst%3DJ.%2BE.%26aulast%3DHackos%26aufirst%3DD.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520of%2520GluN2A-selective%2520NMDA%2520receptor%2520positive%2520allosteric%2520modulators%2520%2528PAMs%2529%253A%2520tuning%2520deactivation%2520kinetics%2520via%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2760%26epage%3D2779%26doi%3D10.1021%2Facs.jmedchem.5b02010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grand, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volgraf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paoletti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J. E.</span></span> <span> </span><span class="NLM_article-title">Positive allosteric modulators of GluN2A-containing NMDARs with distinct modes of action and impacts on circuit function</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">983</span>â <span class="NLM_lpage">999</span>, <span class="refDoi">Â DOI: 10.1016/j.neuron.2016.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2Fj.neuron.2016.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=26875626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFSrtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2016&pages=983-999&author=D.+H.+Hackosauthor=P.+J.+Lupardusauthor=T.+Grandauthor=Y.+Chenauthor=T.-M.+Wangauthor=P.+Reynenauthor=A.+Gustafsonauthor=H.+J.+A.+Wallweberauthor=M.+Volgrafauthor=B.+D.+Sellersauthor=J.+B.+Schwarzauthor=P.+Paolettiauthor=M.+Shengauthor=Q.+Zhouauthor=J.+E.+Hanson&title=Positive+allosteric+modulators+of+GluN2A-containing+NMDARs+with+distinct+modes+of+action+and+impacts+on+circuit+function&doi=10.1016%2Fj.neuron.2016.01.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function</span></div><div class="casAuthors">Hackos, David H.; Lupardus, Patrick J.; Grand, Teddy; Chen, Yelin; Wang, Tzu-Ming; Reynen, Paul; Gustafson, Amy; Wallweber, Heidi J. A.; Volgraf, Matthew; Sellers, Benjamin D.; Schwarz, Jacob B.; Paoletti, Pierre; Sheng, Morgan; Zhou, Qiang; Hanson, Jesse E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">983-999</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">To enhance physiol. function of NMDA receptors (NMDARs), we identified pos. allosteric modulators (PAMs) of NMDARs with selectivity for GluN2A subunit-contg. receptors.  X-ray crystallog. revealed a binding site at the GluN1-GluN2A dimer interface of the extracellular ligand-binding domains (LBDs).  Despite the similarity between the LBDs of NMDARs and AMPA receptors (AMPARs), GluN2A PAMs with good selectivity against AMPARs were identified.  Potentiation was obsd. with recombinant triheteromeric GluN1/GluN2A/GluN2B NMDARs and with synaptically activated NMDARs in brain slices from wild-type (WT), but not GluN2A knockout (KO), mice.  Individual GluN2A PAMs exhibited variable degrees of glutamate (Glu) dependence, impact on NMDAR Glu EC50, and slowing of channel deactivation.  These distinct PAMs also exhibited differential impacts during synaptic plasticity induction.  The identification of a new NMDAR modulatory site and characterization of GluN2A-selective PAMs provide powerful mol. tools to dissect NMDAR function and demonstrate the feasibility of a therapeutically desirable type of NMDAR enhancement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGros48fNAsozLVg90H21EOLACvtfcHk0ljIm10Xj2pyvQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFSrtbw%253D&md5=38661a9f898df39ba616e77f0bdf34e9</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2016.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2016.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DGrand%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DT.-M.%26aulast%3DReynen%26aufirst%3DP.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DB.%2BD.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26aulast%3DPaoletti%26aufirst%3DP.%26aulast%3DSheng%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DHanson%26aufirst%3DJ.%2BE.%26atitle%3DPositive%2520allosteric%2520modulators%2520of%2520GluN2A-containing%2520NMDARs%2520with%2520distinct%2520modes%2520of%2520action%2520and%2520impacts%2520on%2520circuit%2520function%26jtitle%3DNeuron%26date%3D2016%26volume%3D89%26spage%3D983%26epage%3D999%26doi%3D10.1016%2Fj.neuron.2016.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villemure, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volgraf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liederer, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plise, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scearce-Levie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, B. D.</span></span> <span> </span><span class="NLM_article-title">GluN2A-selective pyridopyrimidinone series of NMDAR positive allosteric modulators with an improved in vivo profile</span>. <i>ACS. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">84</span>â <span class="NLM_lpage">89</span>, <span class="refDoi">Â DOI: 10.1021/acsmedchemlett.6b00388</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00388" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslKgsbbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=84-89&author=E.+Villemureauthor=M.+Volgrafauthor=Y.+Jiangauthor=G.+Wuauthor=C.+Q.+Lyauthor=P.+W.+Yuenauthor=A.+Luauthor=X.+Luoauthor=M.+Liuauthor=S.+Zhangauthor=P.+J.+Lupardusauthor=H.+J.+Wallweberauthor=B.+M.+Liedererauthor=G.+Deshmukhauthor=E.+Pliseauthor=S.+Tayauthor=T.+M.+Wangauthor=J.+E.+Hansonauthor=D.+H.+Hackosauthor=K.+Scearce-Levieauthor=J.+B.+Schwarzauthor=B.+D.+Sellers&title=GluN2A-selective+pyridopyrimidinone+series+of+NMDAR+positive+allosteric+modulators+with+an+improved+in+vivo+profile&doi=10.1021%2Facsmedchemlett.6b00388"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">GluN2A-Selective Pyridopyrimidinone Series of NMDAR Positive Allosteric Modulators with an Improved in Vivo Profile</span></div><div class="casAuthors">Villemure, Elisia; Volgraf, Matthew; Jiang, Yu; Wu, Guosheng; Ly, Cuong Q.; Yuen, Po-wai; Lu, Aijun; Luo, Xifeng; Liu, Mingcui; Zhang, Shun; Lupardus, Patrick J.; Wallweber, Heidi J. A.; Liederer, Bianca M.; Deshmukh, Gauri; Plise, Emile; Tay, Suzanne; Wang, Tzu-Ming; Hanson, Jesse E.; Hackos, David H.; Scearce-Levie, Kimberly; Schwarz, Jacob B.; Sellers, Benjamin D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-89</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The N-methyl-D-aspartate receptor (NMDAR) is an ionotropic glutamate receptor, gated by the endogenous coagonists glutamate and glycine, permeable to Ca2+ and Na+.  NMDAR dysfunction is assocd. with numerous neurol. and psychiatric disorders, including schizophrenia, depression, and Alzheimer's disease.  Recently, the authors have disclosed GNE-0723, a GluN2A subunit-selective and brain-penetrant pos. allosteric modulator (PAM) of NMDARs.  This work highlights the discovery of a related pyridopyrimidinone core with distinct structure-activity relationships, despite the structural similarity to GNE-0723.  GNE-5729, a pyridopyrimidinone-based NMDAR PAM, was identified with both an improved pharmacokinetic profile and increased selectivity against AMPARs.  The authors also include x-ray structure anal. and modeling to propose hypotheses for the activity and selectivity differences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoLJ_nCpoJTLVg90H21EOLACvtfcHk0lhN-WDHhRqWIQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslKgsbbI&md5=8c49858ca424d034efc1f8a9e6c00409</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00388%26sid%3Dliteratum%253Aachs%26aulast%3DVillemure%26aufirst%3DE.%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DLy%26aufirst%3DC.%2BQ.%26aulast%3DYuen%26aufirst%3DP.%2BW.%26aulast%3DLu%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DLiederer%26aufirst%3DB.%2BM.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.%2BM.%26aulast%3DHanson%26aufirst%3DJ.%2BE.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26aulast%3DSellers%26aufirst%3DB.%2BD.%26atitle%3DGluN2A-selective%2520pyridopyrimidinone%2520series%2520of%2520NMDAR%2520positive%2520allosteric%2520modulators%2520with%2520an%2520improved%2520in%2520vivo%2520profile%26jtitle%3DACS.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D84%26epage%3D89%26doi%3D10.1021%2Facsmedchemlett.6b00388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnier-Amblard, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullasseril, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtkaya, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyoneva, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and structure-activity relationship of a novel series of GluN2C-seective potentiators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2334</span>â <span class="NLM_lpage">2356</span>, <span class="refDoi">Â DOI: 10.1021/jm401695d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401695d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKns7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2334-2356&author=S.+S.+Zimmermanauthor=A.+Khatriauthor=E.+C.+Garnier-Amblardauthor=P.+Mullasserilauthor=N.+L.+Kurtkayaauthor=S.+Gyonevaauthor=K.+B.+Hansenauthor=S.+F.+Traynelisauthor=D.+C.+Liotta&title=Design%2C+synthesis%2C+and+structure-activity+relationship+of+a+novel+series+of+GluN2C-seective+potentiators&doi=10.1021%2Fjm401695d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Structure-Activity Relationship of a Novel Series of GluN2C-Selective Potentiators</span></div><div class="casAuthors">Zimmerman, Sommer S.; Khatri, Alpa; Garnier-Amblard, Ethel C.; Mullasseril, Praseeda; Kurtkaya, Natalie L.; Gyoneva, Stefka; Hansen, Kasper B.; Traynelis, Stephen F.; Liotta, Dennis C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2334-2356</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">NMDA receptors are tetrameric complexes composed of GluN1 and GluN2A-D subunits that mediate a slow Ca2+-permeable component of excitatory synaptic transmission.  NMDA receptors have been implicated in a wide range of neurol. diseases and thus represent an important therapeutic target.  We herein describe a novel series of pyrrolidinones, e.g., I, that selectively potentiate only NMDA receptors that contain the GluN2C subunit.  The most active analogs tested were over 100-fold selective for recombinant GluN2C-contg. receptors over GluN2A/B/D-contg. NMDA receptors as well as AMPA and kainate receptors.  This series represents the first class of allosteric potentiators that are selective for diheteromeric GluN2C-contg. NMDA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMrwwwTno41rVg90H21EOLACvtfcHk0lhN-WDHhRqWIQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKns7c%253D&md5=24bfccc53190b69254cf7542fad5966c</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm401695d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401695d%26sid%3Dliteratum%253Aachs%26aulast%3DZimmerman%26aufirst%3DS.%2BS.%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DGarnier-Amblard%26aufirst%3DE.%2BC.%26aulast%3DMullasseril%26aufirst%3DP.%26aulast%3DKurtkaya%26aufirst%3DN.%2BL.%26aulast%3DGyoneva%26aufirst%3DS.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structure-activity%2520relationship%2520of%2520a%2520novel%2520series%2520of%2520GluN2C-seective%2520potentiators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2334%26epage%3D2356%26doi%3D10.1021%2Fjm401695d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanger, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karakas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furukawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">548</span>â <span class="NLM_lpage">560</span>, <span class="refDoi">Â DOI: 10.1124/mol.114.094516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1124%2Fmol.114.094516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=25205677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFSlur3F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=548-560&author=A.+Khatriauthor=P.+B.+Burgerauthor=S.+A.+Swangerauthor=K.+B.+Hansenauthor=S.+Zimmermanauthor=E.+Karakasauthor=D.+C.+Liottaauthor=H.+Furukawaauthor=J.+P.+Snyderauthor=S.+F.+Traynelis&title=Structural+determinants+and+mechanism+of+action+of+a+GluN2C-selective+NMDA+receptor+positive+allosteric+modulator&doi=10.1124%2Fmol.114.094516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator</span></div><div class="casAuthors">Khatri, Alpa; Burger, Pieter B.; Swanger, Sharon A.; Hansen, Kasper B.; Zimmerman, Sommer; Karakas, Erkan; Liotta, Dennis C.; Furukawa, Hiro; Snyder, James P.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">548-560, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">NMDA receptors are tetrameric complexes of GluN1, GluN2A-D, and GluN3A-B subunits and are involved in normal brain function and neurol. disorders.  We identified a novel class of stereoselective pyrrolidinone (PYD) pos. allosteric modulators for GluN2C-contg. NMDA receptors, exemplified by Me 4-(3-acetyl-4-hydroxy-1-[2-(2-methyl-1H-indol-3-yl)ethyl]-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)benzoate.  Here we explore the site and mechanism of action of a prototypical analog, PYD-106, which at 30 Î¼M does not alter responses of NMDA receptors contg. GluN2A, GluN2B, and GluN2D and has no effect on AMPA [Î±-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid] and kainate receptors.  Coapplication of 50 Î¼M PYD-106 with a maximally effective concn. of glutamate and glycine increases the response of GluN1/GluN2C NMDA receptors in HEK-293 cells to 221% of that obtained in the absence of PYD (taken as 100%).  Evaluation of the concn. dependence of this enhancement revealed an EC50 value for PYD of 13 Î¼M.  PYD-106 increased opening frequency and open time of single channel currents activated by maximally effective concns. of agonist but only had modest effects on glutamate and glycine EC50.  PYD-106 selectively enhanced the responses of diheteromeric GluN1/GluN2C receptors but not triheteromeric GluN1/GluN2A/GluN2C receptors.  Inclusion of residues encoded by GluN1-exon 5 attenuated the effects of PYD.  Three GluN2C residues (Arg194, Ser470, Lys470), at which mutagenesis virtually eliminated PYD function, line a cavity at the interface of the ligand binding and the amino terminal domains in a homol. model of GluN1/GluN2C built from crystallog. data on GluN1/GluN2B.  We propose that this domain interface constitutes a new allosteric modulatory site on the NMDA receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO8Jlk1LXDrrVg90H21EOLACvtfcHk0lhN-WDHhRqWIQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFSlur3F&md5=ebc48a2c667046b1adab7037868278e1</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1124%2Fmol.114.094516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.114.094516%26sid%3Dliteratum%253Aachs%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DBurger%26aufirst%3DP.%2BB.%26aulast%3DSwanger%26aufirst%3DS.%2BA.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DZimmerman%26aufirst%3DS.%26aulast%3DKarakas%26aufirst%3DE.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DFurukawa%26aufirst%3DH.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DStructural%2520determinants%2520and%2520mechanism%2520of%2520action%2520of%2520a%2520GluN2C-selective%2520NMDA%2520receptor%2520positive%2520allosteric%2520modulator%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D86%26spage%3D548%26epage%3D560%26doi%3D10.1124%2Fmol.114.094516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buttar, D.</span>; <span class="NLM_string-name">Foote, K. M.</span>; <span class="NLM_string-name">Nowak, T.</span>; <span class="NLM_string-name">Rudge, D. A.</span>; <span class="NLM_string-name">Theoclitou, M.-E.</span>; <span class="NLM_string-name">Thomas, A. P.</span></span> <span> </span><span class="NLM_article-title">Pyrimidine derivatives useful in the treatment of cancer</span>. International Patent <span class="NLM_patent">WO2008001070A1</span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=D.+Buttar&author=K.+M.+Foote&author=T.+Nowak&author=D.+A.+Rudge&author=M.-E.+Theoclitou&author=A.+P.+Thomas&title=Pyrimidine+derivatives+useful+in+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DButtar%26aufirst%3DD.%26atitle%3DPyrimidine%2520derivatives%2520useful%2520in%2520the%2520treatment%2520of%2520cancer%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span> <span> </span><span class="NLM_article-title">Lipophilicity in drug discovery</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">235</span>â <span class="NLM_lpage">248</span>, <span class="refDoi">Â DOI: 10.1517/17460441003605098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1517%2F17460441003605098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=22823020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=235-248&author=M.+J.+Waring&title=Lipophilicity+in+drug+discovery&doi=10.1517%2F17460441003605098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in drug discovery</span></div><div class="casAuthors">Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The role of lipophilicity in detg. the overall quality of candidate drug mols. is of paramount importance.  Recent developments suggest that, as well as detg. pre-clin. ADMET (absorption, distribution, metab., elimination and toxicol.) properties, compds. of optimal lipophilicity might have increased chances of success in development.  Areas covered in this review: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compd.  Quality' with lipophilicity.  What the reader will gain: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region.  Take home message: The review of the data shows that this optimal space is defined by a narrow range of logD between â¼ 1 and 3.  Some of the implications of this for medicinal chem. optimization are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJrmVgvPaZLVg90H21EOLACvtfcHk0liEYQkUIgrzKg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D&md5=94424042ea49fcf5fcc7f1e4b17c10d6</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1517%2F17460441003605098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441003605098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DLipophilicity%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26spage%3D235%26epage%3D248%26doi%3D10.1517%2F17460441003605098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dress, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M.</span></span> <span> </span><span class="NLM_article-title">Using the golden triangle to optimize clearance and oral absorption</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">5560</span>â <span class="NLM_lpage">5564</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2009.08.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1016%2Fj.bmcl.2009.08.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=19720530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFaktbfE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5560-5564&author=T.+W.+Johnsonauthor=K.+R.+Dressauthor=M.+Edwards&title=Using+the+golden+triangle+to+optimize+clearance+and+oral+absorption&doi=10.1016%2Fj.bmcl.2009.08.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Using the Golden Triangle to optimize clearance and oral absorption</span></div><div class="casAuthors">Johnson, Ted W.; Dress, Klaus R.; Edwards, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5560-5564</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Golden Triangle is a visualization tool developed from in vitro permeability, in vitro clearance and computational data designed to aid medicinal chemists in achieving metabolically stable, permeable and potent drug candidates.  Classifying compds. as permeable and stable and plotting mol. wt. (MW) vs. octanol:buffer (pH 7.4) distribution coeffs. (log D) or estd. octanol:buffer (pH 7.4) distribution coeffs. (elog D) reveals useful trends.  Anal. of at least 2 orthogonal trends, such as permeability and clearance, can be extremely effective in balancing and optimizing multiple properties.  In addn., mol. wt. and log D impact potency-efficiency calcns., allowing potency, clearance and permeability to be optimized simultaneously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjGjEaOp0237Vg90H21EOLACvtfcHk0liEYQkUIgrzKg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFaktbfE&md5=3cfed1288ec451eb4419f1db753ae4b4</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.045%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DUsing%2520the%2520golden%2520triangle%2520to%2520optimize%2520clearance%2520and%2520oral%2520absorption%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5560%26epage%3D5564%26doi%3D10.1016%2Fj.bmcl.2009.08.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahr, A.</span></span> <span> </span><span class="NLM_article-title">Lipophilicity and its relationship with passive drug permeation</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">962</span>â <span class="NLM_lpage">977</span>, <span class="refDoi">Â DOI: 10.1007/s11095-010-0303-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1007%2Fs11095-010-0303-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=21052797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlOqtrzK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2011&pages=962-977&author=X.+Liuauthor=B.+Testaauthor=A.+Fahr&title=Lipophilicity+and+its+relationship+with+passive+drug+permeation&doi=10.1007%2Fs11095-010-0303-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity and Its Relationship with Passive Drug Permeation</span></div><div class="casAuthors">Liu, Xiangli; Testa, Bernard; Fahr, Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">962-977</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In this review, we first summarize the structure and properties of biol. membranes and the routes of passive drug transfer through physiol. barriers.  Lipophilicity is then introduced in terms of the intermol. interactions it encodes.  Finally, lipophilicity indexes from isotropic solvent systems and from anisotropic membrane-like systems are discussed for their capacity to predict passive drug permeation across biol. membranes such as the intestinal epithelium, the blood-brain barrier (BBB) or the skin.  The broad evidence presented here shows that beyond the predictive power of lipophilicity parameters, the various intermol. forces they encode allow a mechanistic interpretation of passive drug permeation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxn2Ic1yX8SbVg90H21EOLACvtfcHk0liEYQkUIgrzKg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlOqtrzK&md5=6bd2bb54a14574f31b046204f260595a</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1007%2Fs11095-010-0303-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-010-0303-7%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DFahr%26aufirst%3DA.%26atitle%3DLipophilicity%2520and%2520its%2520relationship%2520with%2520passive%2520drug%2520permeation%26jtitle%3DPharm.%2520Res.%26date%3D2011%26volume%3D28%26spage%3D962%26epage%3D977%26doi%3D10.1007%2Fs11095-010-0303-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topliss, J. G.</span></span> <span> </span><span class="NLM_article-title">QSAR Model for Drug Human Oral Bioavailability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2575</span>â <span class="NLM_lpage">2585</span>, <span class="refDoi">Â DOI: 10.1021/jm0000564</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0000564" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjslGluro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2575-2585&author=F.+Yoshidaauthor=J.+G.+Topliss&title=QSAR+Model+for+Drug+Human+Oral+Bioavailability&doi=10.1021%2Fjm0000564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">QSAR Model for Drug Human Oral Bioavailability</span></div><div class="casAuthors">Yoshida, Fumitaka; Topliss, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2575-2585</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The quant. structure-bioavailability relationship of 232 structurally diverse drugs was studied to evaluate the feasibility of constructing a predictive model for the human oral bioavailability of prospective new medicinal agents.  The oral bioavailability detd. in human adults was assigned one of four ratings and analyzed in relation to physicochem. and structural factors by the ORMUCS (ordered multicategorical classification method using the simplex technique) method.  A systematic examn. of various physicochem. parameters relating primarily to absorption, and structural elements which could influence metab., was carried out to analyze their effects on the bioavailability classification of drugs in the data set.  Lipophilicity, expressed as the distribution coeff. at pH 6.5, was found to be a significant factor influencing bioavailability.  The observation that acids generally had better bioavailability characteristics than bases, with neutral compds. between, led to the formulation of a new parameter, Î log D (log D6.5 - log D7.4), which proved to be an important contributor in improving the classification results.  The addn. of 15 structural descriptors relating primarily to well-known metabolic processes yielded a satisfactory QSAR equation which had a correct classification rate of 71% (97% within one class) and a Spearman rank correlation coeff. (Rs) of 0.851, despite the diversity of structure and pharmacol. activity in the compd. set.  In leave-one-out tests, an av. of 67% of drugs were correctly classified (96% within one class) with an Rs of 0.812.  The relationship formulated identified significant factors influencing bioavailability and assigned them quant. values expressing their contribution.  The predictive power of the model was evaluated using a sep. test set of 40 compds., of which 60% (95% within one class) were correctly classified.  Since the necessary physicochem. parameters can be calcd. or estd. and the structural descriptors are obtained from an inspection of the structure, the model enables a rough est. to be made of the prospective human oral bioavailability of unsynthesized compds.  Also, the model has the advantage of transparency in that it indicates which factors may affect bioavailability and the extent of that effect.  This could be useful in designing compds. which are more bioavailable.  Refinement of the model is possible as more bioavailability data becomes available.  Potential uses are in drug design, prioritization of compds. for synthesis, and selection for detailed studies of early compd. leads in drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrCuiR5_SKw7Vg90H21EOLACvtfcHk0liEYQkUIgrzKg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjslGluro%253D&md5=79075f57b7f47c7290d7e8ee14a564bc</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm0000564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0000564%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DF.%26aulast%3DTopliss%26aufirst%3DJ.%2BG.%26atitle%3DQSAR%2520Model%2520for%2520Drug%2520Human%2520Oral%2520Bioavailability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2575%26epage%3D2585%26doi%3D10.1021%2Fjm0000564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moldavski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bading, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bengtson, C. P.</span></span> <span> </span><span class="NLM_article-title">A novel method using ambient glutamate for the electrophysiological quantification of extrasynaptic NMDA receptor function in acute brain slices</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>598</i></span>,  <span class="NLM_fpage">633</span>â <span class="NLM_lpage">650</span>, <span class="refDoi">Â DOI: 10.1113/JP278362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1113%2FJP278362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=31876958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFOku7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=598&publication_year=2020&pages=633-650&author=A.+Moldavskiauthor=J.+Behrauthor=H.+Badingauthor=C.+P.+Bengtson&title=A+novel+method+using+ambient+glutamate+for+the+electrophysiological+quantification+of+extrasynaptic+NMDA+receptor+function+in+acute+brain+slices&doi=10.1113%2FJP278362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">A novel method using ambient glutamate for the electrophysiological quantification of extrasynaptic NMDA receptor function in acute brain slices</span></div><div class="casAuthors">Moldavski, Alexander; Behr, Joachim; Bading, Hilmar; Bengtson, C. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">598</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">633-650</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">1469-7793</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Key points : We present a novel protocol to quantify extrasynaptic NMDA receptor function utilizing the semi-selective activation of extrasynaptic receptors by ambient extracellular glutamate in acute brain slices from adult rats.  We use whole cell patch clamp to measure the effect of the NMDA receptor antagonist MK-801 on both synaptic and brief, local agonist application-evoked responses.  The level of ambient glutamate was estd. from tonic NMDA receptor activity to be â¼77 nM and an equiv. concn. of NMDA was used to est. the degree of extrasynaptic blockade (>82%) by our MK-801 protocol.  The extrasynaptic component of the total NMDA receptor pool can be math. derived from these data and was estd. to be 29-39% in the stratum radiatum of the CA1 region of the rat hippocampus.  This technique could be used to quantify extrasynaptic NMDA receptor function in rodent models of diseases where extrasynaptic NMDA receptors are implicated in neuron death.  Synaptic NMDA receptors (NMDARs) play a central role in pro-survival signalling and synaptic plasticity in the majority of excitatory synapses in the central nervous system whereas extrasynaptic NMDARs (ES-NMDARs) activate pro-death pathways and have been implicated in many neurodegenerative diseases.  ES-NMDARs have been characterized in acute brain slice prepns. using the largely irreversible, activity-dependent NMDAR antagonist MK-801 to block synaptic NMDARs.  This approach is limited by the concomitant MK-801 blockade of ES-NMDARs activated by ambient extracellular glutamate, which is largely absent from the synaptic cleft due to the high d. of nearby glutamate transporters.  In acute hippocampal slices from rats aged 35-42 postnatal days, we estd. ambient glutamate to be 72-83 nM resulting in a block of more than 82% of ES-NMDARs during a 5 min MK-801 application.  This paper describes a novel electrophysiol. and math. method to quantify the proportion of NMDARs located at extrasynaptic locations in a confined region of an acute brain slice prepn. using MK-801 to preferentially block ES-NMDARs.  The protocol uses whole cell patch clamp measurement of NMDAR responses to synaptic stimulation and brief local pressure application of NMDA before and after MK-801 application.  After math. correcting for the relative block of both synaptic and extrasynaptic receptors, ES-NMDARs were estd. to comprise 29-39% of the total NMDAR pool in the apical dendrites of hippocampal CA1 pyramidal neurons.  This new method may prove useful for accurate quantification of NMDAR distributions in neurodegenerative diseases that are assocd. with increased toxic ES-NMDAR signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP4lNB5DzbfbVg90H21EOLACvtfcHk0lgHEQa26q0dHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFOku7o%253D&md5=b3769c179ccbc44a54f5daa7084c89c7</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1113%2FJP278362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252FJP278362%26sid%3Dliteratum%253Aachs%26aulast%3DMoldavski%26aufirst%3DA.%26aulast%3DBehr%26aufirst%3DJ.%26aulast%3DBading%26aufirst%3DH.%26aulast%3DBengtson%26aufirst%3DC.%2BP.%26atitle%3DA%2520novel%2520method%2520using%2520ambient%2520glutamate%2520for%2520the%2520electrophysiological%2520quantification%2520of%2520extrasynaptic%2520NMDA%2520receptor%2520function%2520in%2520acute%2520brain%2520slices%26jtitle%3DJ.%2520Physiol.%26date%3D2020%26volume%3D598%26spage%3D633%26epage%3D650%26doi%3D10.1113%2FJP278362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span>The
active enantiomers
of this series have been previously shown to be brain penetrant:<span class="NLM_contrib-group"><span class="NLM_string-name">Gawai, P.</span>; <span class="NLM_string-name">Upadhyay, R.</span>; <span class="NLM_string-name">Gakare, S. G.</span>; <span class="NLM_string-name">Sarode, L.</span>; <span class="NLM_string-name">Dravid, S.</span>; <span class="NLM_string-name">Ugale, R. R.</span></span> <span> </span><span class="NLM_article-title">Antipsychotic-like profile of CIQ isomers in animal models of schizophrenia</span> <i>Behav. Pharmacol.</i> [Online early access].<span class="refDoi">Â DOI: 10.1097/FBP.0000000000000532</span> . Published Online: Dec 18, <span class="NLM_year">2019</span>. <a href="https://journals.lww.com/behaviouralpharm/Abstract/9000/Antipsychotic_like_profile_of_CIQ_isomers_in.99204.aspx" class="extLink">https://journals.lww.com/behaviouralpharm/Abstract/9000/Antipsychotic_like_profile_of_CIQ_isomers_in.99204.aspx</a> (accessed May 7, 2020).</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1097%2FFBP.0000000000000532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=31860561" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=P.+Gawai&author=R.+Upadhyay&author=S.+G.+Gakare&author=L.+Sarode&author=S.+Dravid&author=R.+R.+Ugale&title=Antipsychotic-like+profile+of+CIQ+isomers+in+animal+models+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1097%2FFBP.0000000000000532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.1097%252FFBP.0000000000000532%26sid%3Dliteratum%253Aachs%26aulast%3DGawai%26aufirst%3DP.%26atitle%3DAntipsychotic-like%2520profile%2520of%2520CIQ%2520isomers%2520in%2520animal%2520models%2520of%2520schizophrenia%26jtitle%3DBehav.%2520Pharmacol.%26doi%3D10.1097%2FFBP.0000000000000532%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dravid, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erreger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyuboslavsky, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almonte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">Subunit-Specific Mechanisms and Proton Sensitivity of NMDA Receptor Channel Block</span>. <i>J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>581</i></span>,  <span class="NLM_fpage">107</span>â <span class="NLM_lpage">128</span>, <span class="refDoi">Â DOI: 10.1113/jphysiol.2006.124958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=10.1113%2Fjphysiol.2006.124958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=17303642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A280%3ADC%252BD2s3ovVyguw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2007&pages=107-128&author=S.+M.+Dravidauthor=K.+Erregerauthor=H.+Yuanauthor=K.+Nicholsonauthor=P.+Leauthor=P.+Lyuboslavskyauthor=A.+Almonteauthor=E.+Murrayauthor=C.+Mosleyauthor=J.+Barberauthor=A.+Frenchauthor=R.+Balsterauthor=T.+F.+Murrayauthor=S.+F.+Traynelis&title=Subunit-Specific+Mechanisms+and+Proton+Sensitivity+of+NMDA+Receptor+Channel+Block&doi=10.1113%2Fjphysiol.2006.124958"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block</span></div><div class="casAuthors">Dravid Shashank M; Erreger Kevin; Yuan Hongjie; Nicholson Katherine; Le Phuong; Lyuboslavsky Polina; Almonte Antoine; Murray Ernest; Mosely Cara; Barber Jeremy; French Adam; Balster Robert; Murray Thomas F; Traynelis Stephen F</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of physiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">581</span>
        (<span class="NLM_cas:issue">Pt 1</span>),
    <span class="NLM_cas:pages">107-28</span>
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    </div><div class="casAbstract">We have compared the potencies of structurally distinct channel blockers at recombinant NR1/NR2A, NR1/NR2B, NR1/NR2C and NR1/NR2D receptors.  The IC50 values varied with stereochemistry and subunit composition, suggesting that it may be possible to design subunit-selective channel blockers.  For dizocilpine (MK-801), the differential potency of MK-801 stereoisomers determined at recombinant NMDA receptors was confirmed at native receptors in vitro and in vivo.  Since the proton sensor is tightly linked both structurally and functionally to channel gating, we examined whether blocking molecules that interact in the channel pore with the gating machinery can differentially sense protonation of the receptor.  Blockers capable of remaining trapped in the pore during agonist unbinding showed the strongest dependence on extracellular pH, appearing more potent at acidic pH values that promote channel closure.  Determination of pK(a) values for channel blockers suggests that the ionization of ketamine but not of other blockers can influence its pH-dependent potency.  Kinetic modelling and single channel studies suggest that the pH-dependent block of NR1/NR2A by (-)MK-801 but not (+)MK-801 reflects an increase in the MK-801 association rate even though protons reduce channel open probability and thus MK-801 access to its binding site.  Allosteric modulators that alter pH sensitivity alter the potency of MK-801, supporting the interpretation that the pH sensitivity of MK-801 binding reflects the changes at the proton sensor rather than a secondary effect of pH.  These data suggest a tight coupling between the proton sensor and the ion channel gate as well as unique subunit-specific mechanisms of channel block.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcStu9_z3ViyDvIW7hznt0zpfW6udTcc2eb2PR1qbcR_-rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3ovVyguw%253D%253D&md5=925d12d73740bf616173011163f9945b</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2006.124958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2006.124958%26sid%3Dliteratum%253Aachs%26aulast%3DDravid%26aufirst%3DS.%2BM.%26aulast%3DErreger%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DNicholson%26aufirst%3DK.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DLyuboslavsky%26aufirst%3DP.%26aulast%3DAlmonte%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DE.%26aulast%3DMosley%26aufirst%3DC.%26aulast%3DBarber%26aufirst%3DJ.%26aulast%3DFrench%26aufirst%3DA.%26aulast%3DBalster%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DT.%2BF.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DSubunit-Specific%2520Mechanisms%2520and%2520Proton%2520Sensitivity%2520of%2520NMDA%2520Receptor%2520Channel%2520Block%26jtitle%3DJ.%2520Physiol.%26date%3D2007%26volume%3D581%26spage%3D107%26epage%3D128%26doi%3D10.1113%2Fjphysiol.2006.124958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallego, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. P.</span></span> <span> </span><span class="NLM_article-title">Lipophilic efficiency as an important metric in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6401</span>â <span class="NLM_lpage">6420</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b00077</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00077" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsVahsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6401-6420&author=T.+W.+Johnsonauthor=R.+A.+Gallegoauthor=M.+P.+Edwards&title=Lipophilic+efficiency+as+an+important+metric+in+drug+design&doi=10.1021%2Facs.jmedchem.8b00077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilic Efficiency as an Important Metric in Drug Design</span></div><div class="casAuthors">Johnson, Ted W.; Gallego, Rebecca A.; Edwards, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6401-6420</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Lipophilic efficiency (LipE) is an important metric that has been increasingly applied in drug discovery medicinal chem. lead optimization programs.  In this perspective, using literature drug discovery examples, we discuss the concept of rigorously applying LipE to guide medicinal chem. lead optimization toward drug candidates with potential for superior in vivo efficacy and safety, esp. when guided by physiochem. property-based optimization (PPBO).  Also highlighted are examples of small structural modifications such as addn. of single atoms, small functional groups, and cyclizations that produce large increases in LipE.  Understanding the factors that may contribute to LipE changes through anal. of ligand-protein crystal structures and using structure-based drug design (SBDD) to increase LipE by design is also discussed.  Herein we advocate for use of LipE anal. coupled with PPBO and SBDD as an efficient mechanism for drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXQ8DOcOj6GrVg90H21EOLACvtfcHk0li683mXIqJwfg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsVahsbg%253D&md5=29f38880914fa75c33be3a640ace4309</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00077%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DGallego%26aufirst%3DR.%2BA.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DLipophilic%2520efficiency%2520as%2520an%2520important%2520metric%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6401%26epage%3D6420%26doi%3D10.1021%2Facs.jmedchem.8b00077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawryluk, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieters, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rech, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sales, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velter, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaventure, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contreras, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morton, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickenden, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Pharmacological Characterization of Two Novel, Brain Penetrating P2X7 Antagonists</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">419</span>â <span class="NLM_lpage">422</span>, <span class="refDoi">Â DOI: 10.1021/ml400040v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400040v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVahtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=419-422&author=M.+A.+Letavicauthor=B.+Lordauthor=F.+Bischoffauthor=N.+A.+Hawrylukauthor=S.+Pietersauthor=J.+C.+Rechauthor=Z.+Salesauthor=A.+I.+Velterauthor=H.+Aoauthor=P.+Bonaventureauthor=V.+Contrerasauthor=X.+Jiangauthor=K.+L.+Mortonauthor=B.+Scottauthor=Q.+Wangauthor=A.+D.+Wickendenauthor=N.+I.+Carruthersauthor=A.+Bhattacharya&title=Synthesis+and+Pharmacological+Characterization+of+Two+Novel%2C+Brain+Penetrating+P2X7+Antagonists&doi=10.1021%2Fml400040v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Pharmacological Characterization of Two Novel, Brain Penetrating P2X7 Antagonists</span></div><div class="casAuthors">Letavic, Michael A.; Lord, Brian; Bischoff, Francois; Hawryluk, Natalie A.; Pieters, Serge; Rech, Jason C.; Sales, Zachary; Velter, Adriana I.; Ao, Hong; Bonaventure, Pascal; Contreras, Victor; Jiang, Xiaohui; Morton, Kirsten L.; Scott, Brian; Wang, Qi; Wickenden, Alan D.; Carruthers, Nicholas I.; Bhattacharya, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">419-422</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and preclin. characterization of two novel, brain penetrating P2X7 compds. will be described.  Both compds. are shown to be high potency P2X7 antagonists in human, rat, and mouse cell lines and both were shown to have high brain concns. and robust receptor occupancy in rat.  Compd. I is of particular interest as a probe compd. for the preclin. assessment of P2X7 blockade in animal models of neuro-inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFnpKdjd4_XLVg90H21EOLACvtfcHk0li683mXIqJwfg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVahtbw%253D&md5=7c1d0561aad7338b75840181756c9295</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fml400040v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400040v%26sid%3Dliteratum%253Aachs%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DBischoff%26aufirst%3DF.%26aulast%3DHawryluk%26aufirst%3DN.%2BA.%26aulast%3DPieters%26aufirst%3DS.%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DSales%26aufirst%3DZ.%26aulast%3DVelter%26aufirst%3DA.%2BI.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DContreras%26aufirst%3DV.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DMorton%26aufirst%3DK.%2BL.%26aulast%3DScott%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWickenden%26aufirst%3DA.%2BD.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DBhattacharya%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520Pharmacological%2520Characterization%2520of%2520Two%2520Novel%252C%2520Brain%2520Penetrating%2520P2X7%2520Antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D419%26epage%3D422%26doi%3D10.1021%2Fml400040v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i163"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01733">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_44627"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01733?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01733</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Chemistry experimental procedures along with crystal structure information (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_002.csv">CSV</a>)</p></li><li><p class="inline">LCMS and HPLC traces for key compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_003.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_001.pdf">jm9b01733_si_001.pdf (257.98 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_002.csv">jm9b01733_si_002.csv (4.86 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01733/suppl_file/jm9b01733_si_003.pdf">jm9b01733_si_003.pdf (199.77 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01733&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-14%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01733%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01733" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a1ce40fc03c46","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
